{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Create Network Diagram using NetworkX"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Gene Name</th>\n",
       "      <th>Mutation ID Number</th>\n",
       "      <th>Mutation Position</th>\n",
       "      <th>Mutation Value</th>\n",
       "      <th>Clinical Significance</th>\n",
       "      <th>Clinical Significance Grouped</th>\n",
       "      <th>Disease Implicated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>9636</td>\n",
       "      <td>183381</td>\n",
       "      <td>1:1014143</td>\n",
       "      <td>C-&gt;T</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Immunodeficiency 38 with basal ganglia calcifi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>9636</td>\n",
       "      <td>161455</td>\n",
       "      <td>1:1014316</td>\n",
       "      <td>C-&gt;CG</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Immunodeficiency 38 with basal ganglia calcifi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>9636</td>\n",
       "      <td>161454</td>\n",
       "      <td>1:1014359</td>\n",
       "      <td>G-&gt;T</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Immunodeficiency 38 with basal ganglia calcifi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>375790</td>\n",
       "      <td>243036</td>\n",
       "      <td>1:1022225</td>\n",
       "      <td>G-&gt;A</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Congenital myasthenic syndrome</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>375790</td>\n",
       "      <td>243037</td>\n",
       "      <td>1:1022313</td>\n",
       "      <td>A-&gt;T</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Pathogenic</td>\n",
       "      <td>Congenital myasthenic syndrome</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Gene Name  Mutation ID Number Mutation Position Mutation Value  \\\n",
       "0      9636              183381         1:1014143           C->T   \n",
       "1      9636              161455         1:1014316          C->CG   \n",
       "2      9636              161454         1:1014359           G->T   \n",
       "3    375790              243036         1:1022225           G->A   \n",
       "4    375790              243037         1:1022313           A->T   \n",
       "\n",
       "  Clinical Significance Clinical Significance Grouped  \\\n",
       "0            Pathogenic                    Pathogenic   \n",
       "1            Pathogenic                    Pathogenic   \n",
       "2            Pathogenic                    Pathogenic   \n",
       "3            Pathogenic                    Pathogenic   \n",
       "4            Pathogenic                    Pathogenic   \n",
       "\n",
       "                                  Disease Implicated  \n",
       "0  Immunodeficiency 38 with basal ganglia calcifi...  \n",
       "1  Immunodeficiency 38 with basal ganglia calcifi...  \n",
       "2  Immunodeficiency 38 with basal ganglia calcifi...  \n",
       "3                     Congenital myasthenic syndrome  \n",
       "4                     Congenital myasthenic syndrome  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "import altair as alt\n",
    "\n",
    "data =  pd.read_csv(\"Clinvar/harmful_mutations.csv\")\n",
    "data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "  #altair-viz-0dcd5423658d4f73bb00f8b13e449e02.vega-embed {\n",
       "    width: 100%;\n",
       "    display: flex;\n",
       "  }\n",
       "\n",
       "  #altair-viz-0dcd5423658d4f73bb00f8b13e449e02.vega-embed details,\n",
       "  #altair-viz-0dcd5423658d4f73bb00f8b13e449e02.vega-embed details summary {\n",
       "    position: relative;\n",
       "  }\n",
       "</style>\n",
       "<div id=\"altair-viz-0dcd5423658d4f73bb00f8b13e449e02\"></div>\n",
       "<script type=\"text/javascript\">\n",
       "  var VEGA_DEBUG = (typeof VEGA_DEBUG == \"undefined\") ? {} : VEGA_DEBUG;\n",
       "  (function(spec, embedOpt){\n",
       "    let outputDiv = document.currentScript.previousElementSibling;\n",
       "    if (outputDiv.id !== \"altair-viz-0dcd5423658d4f73bb00f8b13e449e02\") {\n",
       "      outputDiv = document.getElementById(\"altair-viz-0dcd5423658d4f73bb00f8b13e449e02\");\n",
       "    }\n",
       "    const paths = {\n",
       "      \"vega\": \"https://cdn.jsdelivr.net/npm/vega@5?noext\",\n",
       "      \"vega-lib\": \"https://cdn.jsdelivr.net/npm/vega-lib?noext\",\n",
       "      \"vega-lite\": \"https://cdn.jsdelivr.net/npm/vega-lite@5.17.0?noext\",\n",
       "      \"vega-embed\": \"https://cdn.jsdelivr.net/npm/vega-embed@6?noext\",\n",
       "    };\n",
       "\n",
       "    function maybeLoadScript(lib, version) {\n",
       "      var key = `${lib.replace(\"-\", \"\")}_version`;\n",
       "      return (VEGA_DEBUG[key] == version) ?\n",
       "        Promise.resolve(paths[lib]) :\n",
       "        new Promise(function(resolve, reject) {\n",
       "          var s = document.createElement('script');\n",
       "          document.getElementsByTagName(\"head\")[0].appendChild(s);\n",
       "          s.async = true;\n",
       "          s.onload = () => {\n",
       "            VEGA_DEBUG[key] = version;\n",
       "            return resolve(paths[lib]);\n",
       "          };\n",
       "          s.onerror = () => reject(`Error loading script: ${paths[lib]}`);\n",
       "          s.src = paths[lib];\n",
       "        });\n",
       "    }\n",
       "\n",
       "    function showError(err) {\n",
       "      outputDiv.innerHTML = `<div class=\"error\" style=\"color:red;\">${err}</div>`;\n",
       "      throw err;\n",
       "    }\n",
       "\n",
       "    function displayChart(vegaEmbed) {\n",
       "      vegaEmbed(outputDiv, spec, embedOpt)\n",
       "        .catch(err => showError(`Javascript Error: ${err.message}<br>This usually means there's a typo in your chart specification. See the javascript console for the full traceback.`));\n",
       "    }\n",
       "\n",
       "    if(typeof define === \"function\" && define.amd) {\n",
       "      requirejs.config({paths});\n",
       "      require([\"vega-embed\"], displayChart, err => showError(`Error loading script: ${err.message}`));\n",
       "    } else {\n",
       "      maybeLoadScript(\"vega\", \"5\")\n",
       "        .then(() => maybeLoadScript(\"vega-lite\", \"5.17.0\"))\n",
       "        .then(() => maybeLoadScript(\"vega-embed\", \"6\"))\n",
       "        .catch(showError)\n",
       "        .then(() => displayChart(vegaEmbed));\n",
       "    }\n",
       "  })({\"config\": {\"view\": {\"continuousWidth\": 300, \"continuousHeight\": 300}}, \"layer\": [{\"data\": {\"name\": \"data-beb62a7e7f55eb75a63138ed80a337e5\"}, \"mark\": {\"type\": \"circle\", \"size\": 400}, \"encoding\": {\"tooltip\": [{\"field\": \"id\", \"type\": \"nominal\"}], \"x\": {\"axis\": null, \"field\": \"id\", \"type\": \"nominal\"}, \"y\": {\"axis\": null, \"field\": \"id\", \"type\": \"nominal\"}}}, {\"data\": {\"name\": \"data-23bffc8ec4585e8ebc78b078397b583c\"}, \"mark\": {\"type\": \"line\"}, \"encoding\": {\"color\": {\"field\": \"Clinical Significance Grouped\", \"type\": \"nominal\"}, \"x\": {\"field\": \"source\", \"type\": \"nominal\"}, \"y\": {\"field\": \"target\", \"type\": \"nominal\"}}}], \"height\": 800, \"width\": 800, \"$schema\": \"https://vega.github.io/schema/vega-lite/v5.17.0.json\", \"datasets\": {\"data-beb62a7e7f55eb75a63138ed80a337e5\": [{\"id\": \"9636\"}, {\"id\": \"Immunodeficiency 38 with basal ganglia calcification\"}, {\"id\": \"375790\"}, {\"id\": \"Congenital myasthenic syndrome\"}, {\"id\": \"Congenital myasthenic syndrome, Myasthenic syndrome, congenital, 8\"}, {\"id\": \"Not Given\"}, {\"id\": \"7293\"}, {\"id\": \"Immunodeficiency 16\"}, {\"id\": \"126792\"}, {\"id\": \"Spondyloepimetaphyseal dysplasia with joint laxity\"}, {\"id\": \"Ehlers-Danlos syndrome, progeroid type, 2\"}, {\"id\": \"Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with fractures\"}, {\"id\": \"1855\"}, {\"id\": \"Robinow syndrome, autosomal dominant 2\"}, {\"id\": \"Inborn genetic diseases\"}, {\"id\": \"54587\"}, {\"id\": \"Abnormality of brain morphology\"}, {\"id\": \"55210\"}, {\"id\": \"Harel-Yoon syndrome\"}, {\"id\": \"Harel-Yoon syndrome, not provided\"}, {\"id\": \"339453\"}, {\"id\": \"Spinocerebellar ataxia 21\"}, {\"id\": \"Spinocerebellar ataxia 21, not provided\"}, {\"id\": \"2782\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Generalized tonic-clonic seizures\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Generalized tonic-clonic seizures, Developmental regression, Focal seizures with impairment of consciousness or awareness, Expressive language delay, Multifocal epileptiform discharges, EEG with generalized epileptiform discharges, Mental retardation, autosomal dominant 42, not provided\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Strabismus, Nystagmus, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Failure to thrive, Growth delay, Expressive language delay, Limb hypertonia, Inability to walk, Multifocal epileptiform discharges, Feeding difficulties, Cortical visual impairment\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Cleft palate, Strabismus, Nystagmus, Hypothyroidism, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Dystonia, Failure to thrive, Growth delay, Developmental regression, Expressive language delay, Limb hypertonia, Inability to walk, Infantile axial hypotonia, Multifocal epileptiform discharges, EEG with generalized epileptiform discharges, Upper limb hypertonia, Myelodysplastic syndrome, Inborn genetic diseases, Mental retardation, autosomal dominant 42, not provided\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Seizures, Muscular hypotonia, Global developmental delay, Failure to thrive, Growth delay, Focal seizures with impairment of consciousness or awareness, Limb hypertonia, Infantile muscular hypotonia, Multifocal epileptiform discharges, Feeding difficulties, Cortical visual impairment, Acute lymphoid leukemia, Mental retardation, autosomal dominant 42\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Strabismus, Seizures, Muscular hypotonia, Global developmental delay, Growth delay, Infantile muscular hypotonia, EEG with generalized epileptiform discharges, Feeding difficulties, Mental retardation, autosomal dominant 42, not provided\"}, {\"id\": \"Mental retardation, autosomal dominant 42\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Seizures, Muscular hypotonia, Global developmental delay, Inborn genetic diseases\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Strabismus, Seizures, Global developmental delay, Failure to thrive, Focal seizures with impairment of consciousness or awareness, Limb hypertonia\"}, {\"id\": \"Neurodevelopmental Disability, hypotonia, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Infantile muscular hypotonia, Acute lymphoid leukemia, Mental retardation, autosomal dominant 42\"}, {\"id\": \"6497\"}, {\"id\": \"Shprintzen-Goldberg syndrome\"}, {\"id\": \"Inborn genetic diseases, Shprintzen-Goldberg syndrome, not provided\"}, {\"id\": \"Inborn genetic diseases, Shprintzen-Goldberg syndrome\"}, {\"id\": \"Shprintzen-Goldberg syndrome, not provided\"}, {\"id\": \"Disproportionate tall stature\"}, {\"id\": \"5192\"}, {\"id\": \"Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B\"}, {\"id\": \"Peroxisome biogenesis disorder 6B\"}, {\"id\": \"Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B, not provided\"}, {\"id\": \"Peroxisome biogenesis disorder, complementation group 7, Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B, not provided\"}, {\"id\": \"5192|PLCH2\"}, {\"id\": \"63976\"}, {\"id\": \"Dilated cardiomyopathy 1LL\"}, {\"id\": \"Left ventricular noncompaction 8\"}, {\"id\": \"9731\"}, {\"id\": \"Joubert syndrome 25\"}, {\"id\": \"261734\"}, {\"id\": \"Nephronophthisis 4\"}, {\"id\": \"Nephronophthisis, Nephronophthisis 4\"}, {\"id\": \"Nephronophthisis, Senior-Loken syndrome 4\"}, {\"id\": \"Infertility, Nephronophthisis 4, Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities)\"}, {\"id\": \"Nephronophthisis, Senior-Loken syndrome 4, Nephronophthisis 4\"}, {\"id\": \"387509\"}, {\"id\": \"Childhood-Onset Schizophrenia\"}, {\"id\": \"83715\"}, {\"id\": \"Deafness, without vestibular involvement, autosomal dominant\"}, {\"id\": \"Deafness, autosomal recessive 36, with or without vestibular involvement\"}, {\"id\": \"57449\"}, {\"id\": \"Distal spinal muscular atrophy, autosomal recessive 4, Charcot-Marie-Tooth disease, recessive intermediate c\"}, {\"id\": \"Charcot-Marie-Tooth disease, recessive intermediate c\"}, {\"id\": \"Distal spinal muscular atrophy, autosomal recessive 4\"}, {\"id\": \"Distal spinal muscular atrophy, autosomal recessive 4, Charcot-Marie-Tooth disease, recessive intermediate c, not provided\"}, {\"id\": \"23261\"}, {\"id\": \"Cerebellar ataxia, nonprogressive, with mental retardation\"}, {\"id\": \"8863\"}, {\"id\": \"Advanced sleep phase syndrome, familial, 3\"}, {\"id\": \"11315\"}, {\"id\": \"Parkinson disease 7\"}, {\"id\": \"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1\"}, {\"id\": \"50651\"}, {\"id\": \"INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES\"}, {\"id\": \"473\"}, {\"id\": \"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart\"}, {\"id\": \"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, not provided\"}, {\"id\": \"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, Cerebral visual impairment and intellectual disability, not provided\"}, {\"id\": \"9563\"}, {\"id\": \"Cortisone reductase deficiency 1\"}, {\"id\": \"5293\"}, {\"id\": \"Immunodeficiency 14\"}, {\"id\": \"Immunodeficiency 14, not specified, not provided\"}, {\"id\": \"64802\"}, {\"id\": \"Leber congenital amaurosis 9\"}, {\"id\": \"Leber congenital amaurosis\"}, {\"id\": \"Cone/cone-rod dystrophy\"}, {\"id\": \"Leber congenital amaurosis 9, not provided\"}, {\"id\": \"Leber congenital amaurosis, Leber congenital amaurosis 9, not provided\"}, {\"id\": \"23095\"}, {\"id\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type 2A1\"}, {\"id\": \"Neuroblastoma, Neuroblastoma 1\"}, {\"id\": \"Pheochromocytoma, Neuroblastoma 1\"}, {\"id\": \"5195\"}, {\"id\": \"Peroxisome biogenesis disorder 13A\"}, {\"id\": \"23435\"}, {\"id\": \"FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED\"}, {\"id\": \"Amyotrophic lateral sclerosis type 10\"}, {\"id\": \"Amyotrophic lateral sclerosis type 10, not provided\"}, {\"id\": \"Amyotrophic lateral sclerosis type 10, TARDBP-related frontotemporal dementia\"}, {\"id\": \"Motor neuron disease\"}, {\"id\": \"Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED, not provided\"}, {\"id\": \"Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED\"}, {\"id\": \"2475\"}, {\"id\": \"Kidney Carcinoma\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the breast, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Focal cortical dysplasia type II\"}, {\"id\": \"Transitional cell carcinoma of the bladder, not provided\"}, {\"id\": \"Smith-Kingsmore syndrome\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the large intestine, Papillary renal cell carcinoma, sporadic, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Focal cortical dysplasia type II, not provided\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the large intestine, Papillary renal cell carcinoma, sporadic, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Kidney Carcinoma, Focal cortical dysplasia type II\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the large intestine, Papillary renal cell carcinoma, sporadic, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus\"}, {\"id\": \"Metastatic pancreatic neuroendocrine tumours\"}, {\"id\": \"Transitional cell carcinoma of the bladder\"}, {\"id\": \"MTOR-related megalencephaly and pigmentary mosaicism in skin\"}, {\"id\": \"Smith-Kingsmore syndrome, not provided\"}, {\"id\": \"2475|MTOR-AS1\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the breast, Glioblastoma\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the breast, Glioblastoma, Smith-Kingsmore syndrome, not provided\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Hemimegalencephaly, Neoplasm of the breast, Glioblastoma\"}, {\"id\": \"Kidney Carcinoma, Focal cortical dysplasia type II\"}, {\"id\": \"29914\"}, {\"id\": \"Schnyder crystalline corneal dystrophy\"}, {\"id\": \"10459\"}, {\"id\": \"Fanconi anemia, complementation group V\"}, {\"id\": \"4524\"}, {\"id\": \"Homocysteinemia due to MTHFR deficiency\"}, {\"id\": \"Homocystinuria due to MTHFR deficiency\"}, {\"id\": \"4878|NPPA-AS1\"}, {\"id\": \"Atrial standstill 2\"}, {\"id\": \"5351\"}, {\"id\": \"Cardiovascular phenotype\"}, {\"id\": \"Ehlers-Danlos syndrome, hydroxylysine-deficient\"}, {\"id\": \"Ehlers-Danlos syndrome, hydroxylysine-deficient, not provided\"}, {\"id\": \"Ehlers-Danlos syndrome, hydroxylysine-deficient, Cardiovascular phenotype, not provided\"}, {\"id\": \"Scrotal hypoplasia, High palate, Hydrocephalus, Dolichocephaly, Short chin, Narrow chest, Generalized hypotonia, Neonatal hypotonia, Joint hypermobility, Umbilical hernia, Congenital omphalocele, Porencephalic cyst, Thoracolumbar scoliosis, Macrocephaly at birth, Depressed nasal bridge, Bilateral cryptorchidism, Generalized neonatal hypotonia, Severe global developmental delay, Feeding difficulties\"}, {\"id\": \"9927\"}, {\"id\": \"Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2A2A\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A, not provided\"}, {\"id\": \"Abnormality of the dentition, Microcephaly, Abnormality of dental enamel, Hyperpigmentation of the skin, Failure to thrive, Alopecia of scalp, Distal muscle weakness, EMG abnormality, Short stature, Decreased body weight, Scarring alopecia of scalp, Abnormal blistering of the skin, Nail dystrophy, Scarring, Charcot-Marie-Tooth disease, type 2, Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease, type 2A2A, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type 2, Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease, type 2A2A, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2A2A, not provided\"}, {\"id\": \"not specified\"}, {\"id\": \"Hereditary motor and sensory neuropathy with optic atrophy\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B, not provided\"}, {\"id\": \"Distal muscle weakness, Peripheral axonal neuropathy, Distal lower limb amyotrophy, Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2A2A, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease, type 2A2A, not provided\"}, {\"id\": \"Inborn genetic diseases, Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B, not provided\"}, {\"id\": \"55187\"}, {\"id\": \"Spinocerebellar ataxia autosomal recessive 4\"}, {\"id\": \"11330\"}, {\"id\": \"Hereditary pancreatitis\"}, {\"id\": \"Hereditary pancreatitis, Pancreatitis, chronic, susceptibility to\"}, {\"id\": \"1187|LOC106501712\"}, {\"id\": \"Bartter syndrome, type 4b\"}, {\"id\": \"Deafness\"}, {\"id\": \"1188\"}, {\"id\": \"1188|LOC106501713\"}, {\"id\": \"Bartter syndrome, type 3, with hypocalciuria\"}, {\"id\": \"Bartter syndrome type 3\"}, {\"id\": \"Bartter syndrome type 3, not provided\"}, {\"id\": \"Bartter syndrome, type 3, with hypocalciuria, not provided\"}, {\"id\": \"BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS\"}, {\"id\": \"1969\"}, {\"id\": \"Cataract 6, multiple types\"}, {\"id\": \"Cataract 6, multiple types, not provided\"}, {\"id\": \"Squamous cell lung carcinoma\"}, {\"id\": \"23400\"}, {\"id\": \"Spastic paraplegia 78, autosomal recessive\"}, {\"id\": \"Parkinson disease 9, not provided\"}, {\"id\": \"Parkinson disease 9\"}, {\"id\": \"6390\"}, {\"id\": \"Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Hereditary Paraganglioma-Pheochromocytoma Syndromes\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not provided\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 4\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 4, not provided\"}, {\"id\": \"Paragangliomas 4\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Paragangliomas 4\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Cowden syndrome, Hereditary cancer-predisposing syndrome, Paragangliomas 4\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not provided\"}, {\"id\": \"Gastrointestinal stroma tumor\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, SDHB-Related Disorders, not provided\"}, {\"id\": \"Paraganglioma and gastric stromal sarcoma\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not specified, not provided\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Carney triad, Paragangliomas 4, not provided\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not provided\"}, {\"id\": \"Pheochromocytoma\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Paragangliomas 4\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4\"}, {\"id\": \"Variant of unknown significance, Pheochromocytoma, Gastrointestinal stroma tumor, Paragangliomas 4\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, SDHB-Related Disorders, not provided\"}, {\"id\": \"Pheochromocytoma, Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paraganglioma and gastric stromal sarcoma, Paragangliomas 4, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, SDHB-Related Disorders\"}, {\"id\": \"51702\"}, {\"id\": \"Uncombable hair syndrome\"}, {\"id\": \"Central centrifugal cicatricial alopecia\"}, {\"id\": \"353238\"}, {\"id\": \"Preimplantation embryonic lethality 2\"}, {\"id\": \"55160\"}, {\"id\": \"Cerebral visual impairment and intellectual disability\"}, {\"id\": \"8659\"}, {\"id\": \"Deficiency of pyrroline-5-carboxylate reductase\"}, {\"id\": \"23352\"}, {\"id\": \"Short stature\"}, {\"id\": \"23065|EMC1-AS1\"}, {\"id\": \"23065\"}, {\"id\": \"65018\"}, {\"id\": \"PINK1-Related Parkinsonism, not provided\"}, {\"id\": \"Parkinson disease 6, autosomal recessive early-onset\"}, {\"id\": \"65018|PINK1-AS\"}, {\"id\": \"Parkinson disease 6, autosomal recessive early-onset, not provided\"}, {\"id\": \"1650\"}, {\"id\": \"Congenital disorder of glycosylation type Ir\"}, {\"id\": \"Congenital disorder of glycosylation type Ir, not provided\"}, {\"id\": \"1889\"}, {\"id\": \"Hirschsprung disease, cardiac defects, and autonomic dysfunction\"}, {\"id\": \"Hirschsprung disease\"}, {\"id\": \"249\"}, {\"id\": \"Infantile hypophosphatasia\"}, {\"id\": \"Low alkaline phosphatase\"}, {\"id\": \"Odontohypophosphatasia\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, Childhood hypophosphatasia, Adult hypophosphatasia, Odontohypophosphatasia, not provided\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, Childhood hypophosphatasia\"}, {\"id\": \"Infantile hypophosphatasia, not provided\"}, {\"id\": \"Infantile hypophosphatasia, Childhood hypophosphatasia\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, Childhood hypophosphatasia, Adult hypophosphatasia, not provided\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, perinatal lethal\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, Adult hypophosphatasia, not provided\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, not provided\"}, {\"id\": \"Infantile hypophosphatasia, Hypophosphatasia, perinatal lethal, not provided\"}, {\"id\": \"3339\"}, {\"id\": \"Lethal Kniest-like syndrome, not provided\"}, {\"id\": \"Schwartz Jampel syndrome type 1\"}, {\"id\": \"998\"}, {\"id\": \"Takenouchi-Kosaki syndrome, not provided\"}, {\"id\": \"Inborn genetic diseases, Takenouchi-Kosaki syndrome\"}, {\"id\": \"Takenouchi-Kosaki syndrome, Noonan-Like Syndrome Disorder\"}, {\"id\": \"54361\"}, {\"id\": \"Mullerian aplasia and hyperandrogenism\"}, {\"id\": \"Serkal syndrome\"}, {\"id\": \"712\"}, {\"id\": \"C1q deficiency\"}, {\"id\": \"714\"}, {\"id\": \"713\"}, {\"id\": \"2048\"}, {\"id\": \"Prostate cancer/brain cancer susceptibility\"}, {\"id\": \"Neoplasm of the large intestine\"}, {\"id\": \"23028\"}, {\"id\": \"Cleft palate, psychomotor retardation, and distinctive facial features\"}, {\"id\": \"10236\"}, {\"id\": \"6135\"}, {\"id\": \"Diamond-Blackfan anemia\"}, {\"id\": \"Diamond-Blackfan anemia, Diamond-Blackfan anemia 7\"}, {\"id\": \"2582\"}, {\"id\": \"UDPglucose-4-epimerase deficiency\"}, {\"id\": \"UDPglucose-4-epimerase deficiency, not provided\"}, {\"id\": \"UDPglucose-4-epimerase deficiency, Galactose epimerase deficiency, severe, not provided\"}, {\"id\": \"3155\"}, {\"id\": \"Deficiency of hydroxymethylglutaryl-CoA lyase\"}, {\"id\": \"Deficiency of hydroxymethylglutaryl-CoA lyase, not provided\"}, {\"id\": \"Inborn genetic diseases, Deficiency of hydroxymethylglutaryl-CoA lyase\"}, {\"id\": \"2517\"}, {\"id\": \"Fucosidosis\"}, {\"id\": \"Fucosidosis, not provided\"}, {\"id\": \"57822\"}, {\"id\": \"nonsyndromic cleft palate\"}, {\"id\": \"Van der Woude syndrome 2\"}, {\"id\": \"Van der Woude syndrome\"}, {\"id\": \"25932\"}, {\"id\": \"6007|RSRP1\"}, {\"id\": \"RhD category D-VII\"}, {\"id\": \"Rhd, weak d, type I\"}, {\"id\": \"26119\"}, {\"id\": \"Hypercholesterolemia, autosomal recessive\"}, {\"id\": \"57190\"}, {\"id\": \"Eichsfeld type congenital muscular dystrophy, not provided\"}, {\"id\": \"Eichsfeld type congenital muscular dystrophy\"}, {\"id\": \"SEPN1-Related Disorders\"}, {\"id\": \"Eichsfeld type congenital muscular dystrophy, Congenital myopathy with fiber type disproportion, not provided\"}, {\"id\": \"7780\"}, {\"id\": \"Zinc deficiency, transient neonatal\"}, {\"id\": \"79947\"}, {\"id\": \"Retinitis pigmentosa 59\"}, {\"id\": \"Congenital disorder of glycosylation type 1bb\"}, {\"id\": \"DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES\"}, {\"id\": \"8289\"}, {\"id\": \"Mental retardation, autosomal dominant 14\"}, {\"id\": \"Microcephaly, Seizures, Congenital cerebellar hypoplasia, Absent speech, Periventricular leukomalacia, Severe global developmental delay\"}, {\"id\": \"Coffin-Siris syndrome, not provided\"}, {\"id\": \"55650\"}, {\"id\": \"Hyperphosphatasia with mental retardation syndrome 1\"}, {\"id\": \"Hyperphosphatasia with mental retardation syndrome 1, not provided\"}, {\"id\": \"Inborn genetic diseases, Hyperphosphatasia-intellectual disability syndrome, Hyperphosphatasia with mental retardation syndrome 1, not provided\"}, {\"id\": \"8431|NUDC\"}, {\"id\": \"Obesity, mild, early-onset\"}, {\"id\": \"126695\"}, {\"id\": \"Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type\"}, {\"id\": \"6548\"}, {\"id\": \"Lichtenstein-knorr syndrome\"}, {\"id\": \"8547\"}, {\"id\": \"Immunodeficiency due to ficolin 3 deficiency\"}, {\"id\": \"27245\"}, {\"id\": \"Xia-Gibbs syndrome\"}, {\"id\": \"Delayed speech and language development, Intellectual disability, Muscular hypotonia, Global developmental delay, Neonatal hypotonia, Sleep apnea, Xia-Gibbs syndrome\"}, {\"id\": \"Abdominal obesity-metabolic syndrome 3\"}, {\"id\": \"2035\"}, {\"id\": \"Elliptocytosis 1\"}, {\"id\": \"51102\"}, {\"id\": \"Optic atrophy, Childhood Onset Dystonias, Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities\"}, {\"id\": \"Optic atrophy, Childhood Onset Dystonias, Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, not provided\"}, {\"id\": \"10076\"}, {\"id\": \"9698\"}, {\"id\": \"SPINOCEREBELLAR ATAXIA 47\"}, {\"id\": \"576\"}, {\"id\": \"Progressive spastic paraparesis\"}, {\"id\": \"3932\"}, {\"id\": \"Immunodeficiency 22\"}, {\"id\": \"3065\"}, {\"id\": \"8565\"}, {\"id\": \"Charcot-Marie-Tooth disease, dominant intermediate C\"}, {\"id\": \"3208\"}, {\"id\": \"Dystonia 2, torsion, autosomal recessive\"}, {\"id\": \"204\"}, {\"id\": \"Reticular dysgenesis\"}, {\"id\": \"127534\"}, {\"id\": \"Erythrokeratodermia variabilis et progressiva 2\"}, {\"id\": \"Erythrokeratodermia variabilis et progressiva 2, not provided\"}, {\"id\": \"Erythrokeratodermia variabilis\"}, {\"id\": \"2707\"}, {\"id\": \"Deafness, autosomal recessive\"}, {\"id\": \"Deafness, digenic, GJB2/GJB3\"}, {\"id\": \"Nonsyndromic hearing loss\"}, {\"id\": \"54936\"}, {\"id\": \"NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES\"}, {\"id\": \"1296\"}, {\"id\": \"Corneal dystrophy, Fuchs endothelial 1, Corneal dystrophy, posterior polymorphous, 2\"}, {\"id\": \"27095\"}, {\"id\": \"Bardet-Biedl syndrome\"}, {\"id\": \"1441\"}, {\"id\": \"Hereditary neutrophilia\"}, {\"id\": \"Acute myeloid leukemia, Chronic myelogenous leukemia, Early T cell progenitor acute lymphoblastic leukemia\"}, {\"id\": \"Chronic myelogenous leukemia\"}, {\"id\": \"Neutropenia, severe congenital, 7, autosomal recessive\"}, {\"id\": \"Severe congenital neutropenia, Neutropenia, severe congenital, 7, autosomal recessive\"}, {\"id\": \"79753\"}, {\"id\": \"Psychomotor retardation, epilepsy, and craniofacial dysmorphism\"}, {\"id\": \"Rolandic epilepsy\"}, {\"id\": \"3633\"}, {\"id\": \"Dent disease 2\"}, {\"id\": \"23499\"}, {\"id\": \"Lissencephaly\"}, {\"id\": \"Lissencephaly with decussation defect\"}, {\"id\": \"54802\"}, {\"id\": \"Macrocephalus\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 35, TRIT1 Deficiency\"}, {\"id\": \"84879\"}, {\"id\": \"Primary autosomal recessive microcephaly 15\"}, {\"id\": \"5538\"}, {\"id\": \"Ceroid lipofuscinosis neuronal 1\"}, {\"id\": \"Ceroid lipofuscinosis neuronal 1, not provided\"}, {\"id\": \"Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis neuronal 1\"}, {\"id\": \"Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis neuronal 1, History of neurodevelopmental disorder, Neuronal Ceroid-Lipofuscinosis, Recessive, not provided\"}, {\"id\": \"Inborn genetic diseases, Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis neuronal 1, not provided\"}, {\"id\": \"Ceroid lipofuscinosis neuronal 1, History of neurodevelopmental disorder, not provided\"}, {\"id\": \"10269\"}, {\"id\": \"Mandibuloacral dysplasia with type B lipodystrophy, not provided\"}, {\"id\": \"Lethal tight skin contracture syndrome, not provided\"}, {\"id\": \"1298\"}, {\"id\": \"9132\"}, {\"id\": \"DFNA 2 Nonsyndromic Hearing Loss\"}, {\"id\": \"Nonsyndromic hearing loss and deafness\"}, {\"id\": \"Nonsyndromic hearing loss and deafness, not specified\"}, {\"id\": \"DFNA 2 Nonsyndromic Hearing Loss, Nonsyndromic hearing loss and deafness\"}, {\"id\": \"1503\"}, {\"id\": \"Immunodeficiency 24, not provided\"}, {\"id\": \"79717|CCDC30\"}, {\"id\": \"CARDIOMYOPATHY, DILATED, 2C\"}, {\"id\": \"149461\"}, {\"id\": \"Nephrocalcinosis, Nephrolithiasis\"}, {\"id\": \"Hypomagnesemia 5, renal, with ocular involvement\"}, {\"id\": \"64175\"}, {\"id\": \"Osteogenesis imperfecta type 8\"}, {\"id\": \"Osteogenesis imperfecta type 8, not provided\"}, {\"id\": \"114625\"}, {\"id\": \"SCIANNA BLOOD GROUP SYSTEM, SC:-1,2\"}, {\"id\": \"6513\"}, {\"id\": \"GLUT1 deficiency syndrome 1, autosomal recessive\"}, {\"id\": \"GLUT1 deficiency syndrome 1, autosomal recessive, Epilepsy, idiopathic generalized, susceptibility to, 12, not provided\"}, {\"id\": \"GLUT1 deficiency syndrome 1\"}, {\"id\": \"History of neurodevelopmental disorder\"}, {\"id\": \"GLUT1 deficiency syndrome 1, autosomal recessive, GLUT1 deficiency syndrome 1, not provided\"}, {\"id\": \"GLUT1 deficiency syndrome 1, autosomal recessive, not provided\"}, {\"id\": \"Glucose transporter type 1 deficiency syndrome, History of neurodevelopmental disorder, Epilepsy, idiopathic generalized, susceptibility to, 12, not provided\"}, {\"id\": \"Microcephaly, Epilepsy, Inborn genetic diseases, GLUT1 deficiency syndrome 1, autosomal recessive, GLUT1 deficiency syndrome 1, intellectual deficiency, not provided\"}, {\"id\": \"GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, autosomal recessive, Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1, not provided\"}, {\"id\": \"GLUT1 deficiency syndrome 2\"}, {\"id\": \"GLUT1 deficiency syndrome 1, not provided\"}, {\"id\": \"Stomatin-deficient cryohydrocytosis with neurologic defects\"}, {\"id\": \"GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, not provided\"}, {\"id\": \"Inborn genetic diseases, not provided\"}, {\"id\": \"Intellectual disability, GLUT1 deficiency syndrome 1\"}, {\"id\": \"Epilepsy, idiopathic generalized, susceptibility to, 12, not provided\"}, {\"id\": \"Dystonia 9, not provided\"}, {\"id\": \"Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1, not provided\"}, {\"id\": \"Dystonia 9, GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, autosomal recessive, Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1, not provided\"}, {\"id\": \"GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, autosomal recessive, not provided\"}, {\"id\": \"Dystonia 9, Stomatin-deficient cryohydrocytosis with neurologic defects, GLUT1 deficiency syndrome 2, Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1\"}, {\"id\": \"Glucose transporter type 1 deficiency syndrome\"}, {\"id\": \"4352\"}, {\"id\": \"Congenital amegakaryocytic thrombocytopenia, not specified, not provided\"}, {\"id\": \"Congenital amegakaryocytic thrombocytopenia\"}, {\"id\": \"Congenital amegakaryocytic thrombocytopenia, not specified\"}, {\"id\": \"not specified, not provided\"}, {\"id\": \"Myeloproliferative Neoplasm\"}, {\"id\": \"Myelofibrosis, Essential thrombocythemia, Myeloproliferative Neoplasm, Thrombocytosis, benign familial microcytic\"}, {\"id\": \"Hematologic neoplasm, Myelofibrosis with myeloid metaplasia, Congenital amegakaryocytic thrombocytopenia, Thrombocythemia 2, somatic\"}, {\"id\": \"23334\"}, {\"id\": \"Early infantile epileptic encephalopathy 18\"}, {\"id\": \"Cryptorchidism, Abnormality of the anterior fontanelle, Macrocephalus, Seizures, Global developmental delay, Deep plantar creases, Abnormality of the cerebral white matter, Central hypotonia\"}, {\"id\": \"Early infantile epileptic encephalopathy 18, not provided\"}, {\"id\": \"6487\"}, {\"id\": \"Mental retardation, autosomal recessive 12\"}, {\"id\": \"6536\"}, {\"id\": \"Glycine encephalopathy with normal serum glycine\"}, {\"id\": \"8643\"}, {\"id\": \"Basal cell carcinoma, somatic\"}, {\"id\": \"Gorlin syndrome\"}, {\"id\": \"8891\"}, {\"id\": \"Leukoencephalopathy with vanishing white matter\"}, {\"id\": \"7389\"}, {\"id\": \"Hepatoerythropoietic porphyria\"}, {\"id\": \"Porphyria cutanea tarda\"}, {\"id\": \"Familial porphyria cutanea tarda\"}, {\"id\": \"Porphyria cutanea tarda, Hepatoerythropoietic porphyria, Familial porphyria cutanea tarda\"}, {\"id\": \"Hepatoerythropoietic porphyria, Porphyria cutanea tarda, type I\"}, {\"id\": \"4595\"}, {\"id\": \"MYH-associated polyposis\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, MUTYH-associated polyposis, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, not provided\"}, {\"id\": \"MYH-associated polyposis, not provided\"}, {\"id\": \"Neoplasm of stomach\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, B lymphoblastic leukemia lymphoma, no ICD-O subtype, not provided\"}, {\"id\": \"Small intestine carcinoid, Neoplasm of stomach, Endometrial carcinoma, Pilomatrixoma, Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, MUTYH-associated polyposis, Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, not specified, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis\"}, {\"id\": \"MYH-associated polyposis, MUTYH-associated polyposis\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, Familial colorectal cancer, not specified, not provided\"}, {\"id\": \"Neoplasm of stomach, Pilomatrixoma, Hereditary cancer-predisposing syndrome, MYH-associated polyposis, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, MUTYH-associated polyposis, Familial colorectal cancer, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, MUTYH-associated polyposis, not specified, not provided\"}, {\"id\": \"Neoplasm of stomach, Endometrial carcinoma, Pilomatrixoma, Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, MUTYH-associated polyposis, not specified, not provided\"}, {\"id\": \"MUTYH-associated polyposis\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, Familial colorectal cancer, not provided\"}, {\"id\": \"4595|TOE1\"}, {\"id\": \"114034\"}, {\"id\": \"Pontocerebellar hypoplasia, type 7\"}, {\"id\": \"25974\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria, not provided\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria\"}, {\"id\": \"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria, not specified, not provided\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, not provided\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria, Disorders of Intracellular Cobalamin Metabolism, not provided\"}, {\"id\": \"Inborn genetic diseases, Methylmalonic acidemia with homocystinuria, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, not provided\"}, {\"id\": \"5052\"}, {\"id\": \"10103|POMGNT1\"}, {\"id\": \"Muscle eye brain disease\"}, {\"id\": \"Muscle eye brain disease, Retinitis pigmentosa 76\"}, {\"id\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3, Muscle eye brain disease\"}, {\"id\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3\"}, {\"id\": \"Muscle eye brain disease, Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3\"}, {\"id\": \"Muscle eye brain disease, Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, Limb-girdle muscular dystrophy-dystroglycanopathy, type C3, POMGNT1-Related Disorders, Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies, not provided\"}, {\"id\": \"Retinitis pigmentosa 76\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3\"}, {\"id\": \"Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, Limb-girdle muscular dystrophy-dystroglycanopathy, type C3\"}, {\"id\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3, not provided\"}, {\"id\": \"Muscle eye brain disease, not provided\"}, {\"id\": \"Muscle eye brain disease, Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, not provided\"}, {\"id\": \"Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, Limb-girdle muscular dystrophy-dystroglycanopathy, type C3, not provided\"}, {\"id\": \"55624\"}, {\"id\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3, Retinitis pigmentosa 76\"}, {\"id\": \"8438\"}, {\"id\": \"Adenocarcinoma of the colon\"}, {\"id\": \"Ductal breast carcinoma\"}, {\"id\": \"Non-Hodgkin lymphoma\"}, {\"id\": \"127343\"}, {\"id\": \"Hearing impairment, Strabismus, Hypermetropia, Seizures, Muscular hypotonia, Global developmental delay\"}, {\"id\": \"6491\"}, {\"id\": \"Primary autosomal recessive microcephaly 7\"}, {\"id\": \"2301|LINC01389\"}, {\"id\": \"Congenital primary aphakia\"}, {\"id\": \"Cataract 34, multiple types\"}, {\"id\": \"Acute aortic dissection, Aortic aneurysm, familial thoracic 11, susceptibility to, Familial thoracic aortic aneurysm\"}, {\"id\": \"Acute aortic dissection, Familial thoracic aortic aneurysm\"}, {\"id\": \"Congenital primary aphakia, not provided\"}, {\"id\": \"4998\"}, {\"id\": \"Meier-Gorlin syndrome 1\"}, {\"id\": \"Meier-Gorlin syndrome, Meier-Gorlin syndrome 1\"}, {\"id\": \"65260\"}, {\"id\": \"Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency\"}, {\"id\": \"6342\"}, {\"id\": \"Leukoencephalopathy with dystonia and motor neuropathy\"}, {\"id\": \"1376\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, infantile\"}, {\"id\": \"Arthritis, Pancytopenia, Dysautonomia, Gastrointestinal dysmotility, Polyarticular arthritis, Sinus tachycardia, Chronic pain, Inappropriate sinus tachycardia, Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, not provided\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, lethal neonatal\"}, {\"id\": \"Rhabdomyolysis, Inborn genetic diseases, Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal, Encephalopathy, acute, infection-induced, 4, susceptibility to, not provided\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal, not provided\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, not provided\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, infantile\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal, not provided\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, infantile, not provided\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced\"}, {\"id\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile\"}, {\"id\": \"25973\"}, {\"id\": \"1718\"}, {\"id\": \"Desmosterolosis\"}, {\"id\": \"7809\"}, {\"id\": \"Bartter syndrome type 4\"}, {\"id\": \"Sensorineural deafness with mild renal dysfunction\"}, {\"id\": \"255738\"}, {\"id\": \"Familial hypercholesterolemia\"}, {\"id\": \"Familial hypercholesterolemia, not provided\"}, {\"id\": \"Hypercholesterolemia, autosomal dominant, 3\"}, {\"id\": \"Hypocholesterolemia\"}, {\"id\": \"Familial hypercholesterolemias, Hypercholesterolemia, autosomal dominant, 3\"}, {\"id\": \"Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3\"}, {\"id\": \"Low density lipoprotein cholesterol level quantitative trait locus 1, not provided\"}, {\"id\": \"23358\"}, {\"id\": \"732\"}, {\"id\": \"Complement component 8 deficiency type 2, not provided\"}, {\"id\": \"Complement component 8 deficiency type 2\"}, {\"id\": \"4070\"}, {\"id\": \"Lattice corneal dystrophy Type III\"}, {\"id\": \"114803\"}, {\"id\": \"BONE MARROW FAILURE SYNDROME 4\"}, {\"id\": \"4774\"}, {\"id\": \"Brain malformations and urinary tract defects\"}, {\"id\": \"Cleft palate, Macrocephalus\"}, {\"id\": \"85440\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 23\"}, {\"id\": \"27329|DOCK7\"}, {\"id\": \"Hypobetalipoproteinemia, familial, 2\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 23, not provided\"}, {\"id\": \"29929\"}, {\"id\": \"Congenital disorder of glycosylation type 1C\"}, {\"id\": \"Congenital disorder of glycosylation type 1C, not provided\"}, {\"id\": \"5236\"}, {\"id\": \"Congenital disorder of glycosylation type 1t\"}, {\"id\": \"Congenital disorder of glycosylation type 1t, not provided\"}, {\"id\": \"4919\"}, {\"id\": \"DEAFNESS, AUTOSOMAL RECESSIVE 108\"}, {\"id\": \"3716\"}, {\"id\": \"Acute myeloid leukemia, Polycythemia vera, Lymphoblastic leukemia, acute, with lymphomatous features, Leukemia, acute, ?X-linked\"}, {\"id\": \"Lymphoblastic leukemia, acute, with lymphomatous features\"}, {\"id\": \"Inborn genetic diseases, Lymphoblastic leukemia, acute, with lymphomatous features\"}, {\"id\": \"9829\"}, {\"id\": \"Parkinson disease 19a, juvenile-onset\"}, {\"id\": \"Parkinson disease 19b, early-onset\"}, {\"id\": \"3953\"}, {\"id\": \"Obesity\"}, {\"id\": \"23169\"}, {\"id\": \"Schneckenbecken dysplasia\"}, {\"id\": \"6121\"}, {\"id\": \"Retinitis pigmentosa, Leber congenital amaurosis 2, Retinitis pigmentosa 20, not provided\"}, {\"id\": \"Retinitis pigmentosa 20, not provided\"}, {\"id\": \"Abnormality of vision, Abnormal electroretinogram, Retinal degeneration, Congenital blindness\"}, {\"id\": \"Leber congenital amaurosis 2, not provided\"}, {\"id\": \"Leber congenital amaurosis 2, Retinitis pigmentosa 20, RPE65-Related Disorders, not provided\"}, {\"id\": \"Retinitis pigmentosa 20\"}, {\"id\": \"Adrenocorticotropic hormone deficiency\"}, {\"id\": \"Leber congenital amaurosis 2\"}, {\"id\": \"Leber congenital amaurosis 2, Retinitis pigmentosa 20, not provided\"}, {\"id\": \"Retinitis pigmentosa, not provided\"}, {\"id\": \"Retinal dystrophy\"}, {\"id\": \"Retinal dystrophy, Leber congenital amaurosis 2, Retinitis pigmentosa 20, not provided\"}, {\"id\": \"Leber congenital amaurosis 2, Retinitis pigmentosa 20\"}, {\"id\": \"1491\"}, {\"id\": \"Cystathioninuria\"}, {\"id\": \"51086|FPGT-TNNI3K\"}, {\"id\": \"Cardiac conduction disease with or without dilated cardiomyopathy\"}, {\"id\": \"34\"}, {\"id\": \"Medium-chain acyl-coenzyme A dehydrogenase deficiency\"}, {\"id\": \"Medium-chain acyl-coenzyme A dehydrogenase deficiency, not provided\"}, {\"id\": \"Medium-chain acyl-coenzyme A dehydrogenase deficiency, not specified, not provided\"}, {\"id\": \"Hydrocephalus, congenital, 2, with or without brain or eye anomalies, not provided\"}, {\"id\": \"91624\"}, {\"id\": \"Familial hypertrophic cardiomyopathy 20\"}, {\"id\": \"Dilated cardiomyopathy 1CC\"}, {\"id\": \"8915\"}, {\"id\": \"Malignant tumor of testis\"}, {\"id\": \"Mucosa-associated lymphoma\"}, {\"id\": \"Follicular lymphoma\"}, {\"id\": \"Male germ cell tumor, somatic\"}, {\"id\": \"Immunodeficiency 37\"}, {\"id\": \"84146\"}, {\"id\": \"Myopia 21, autosomal dominant\"}, {\"id\": \"164045\"}, {\"id\": \"Premature ovarian failure 9\"}, {\"id\": \"676\"}, {\"id\": \"SPERMATOGENIC FAILURE 21\"}, {\"id\": \"11146\"}, {\"id\": \"Blue rubber bleb nevus\"}, {\"id\": \"Glomuvenous malformations\"}, {\"id\": \"Venous malformation\"}, {\"id\": \"2672\"}, {\"id\": \"Neutropenia, nonimmune chronic idiopathic, of adults\"}, {\"id\": \"Severe congenital neutropenia 2, autosomal dominant\"}, {\"id\": \"6125|DIPK1A\"}, {\"id\": \"Diamond-Blackfan anemia 6, not provided\"}, {\"id\": \"Wide anterior fontanel, Low-set, posteriorly rotated ears, Abnormality of the pinna, Downslanted palpebral fissures, Hypotelorism, Dry skin, Hemangioma, Atrial septal defect, Aplastic anemia, Pulmonary arterial hypertension, Hepatomegaly, Relative macrocephaly, Dilation of lateral ventricles, Intracerebral periventricular calcifications, Aplasia of the ovary, Erythroid hypoplasia, Vaginal hydrocele\"}, {\"id\": \"Diamond-Blackfan anemia 6\"}, {\"id\": \"24\"}, {\"id\": \"Stargardt disease 1\"}, {\"id\": \"Cone/cone-rod dystrophy, Stargardt disease 1, not provided\"}, {\"id\": \"Stargardt disease 1, not provided\"}, {\"id\": \"Stargardt disease 1, Cone-rod dystrophy 3, not provided\"}, {\"id\": \"Retinal dystrophy, Visual loss, Macular degeneration, Blindness, Stargardt disease 1, not provided\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Congenital stationary night blindness\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, Retinal dystrophy, early-onset severe, not provided\"}, {\"id\": \"Retinal dystrophy, not provided\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, Age-related macular degeneration 2, not provided\"}, {\"id\": \"Stargardt disease, not provided\"}, {\"id\": \"Cone-rod dystrophy 3\"}, {\"id\": \"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO, Retinal dystrophy, Macular dystrophy, Stargardt disease 1, Inborn genetic diseases, Cone-rod dystrophy 3, Age-related macular degeneration 2, ABCA4-Related Disorders, not provided\"}, {\"id\": \"Stargardt disease 1, Stargardt disease, Cone-rod dystrophy 3, not provided\"}, {\"id\": \"Stargardt disease 1, Stargardt disease, Cone-rod dystrophy 3, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Retinal dystrophy, Macular dystrophy, Stargardt disease 1, Bull's eye maculopathy, Cone-rod dystrophy 3, Age-related macular degeneration 2, not provided\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, not provided\"}, {\"id\": \"Stargardt disease 1, Cone-rod dystrophy 3\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1\"}, {\"id\": \"Retinitis pigmentosa\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, Leber congenital amaurosis, not provided\"}, {\"id\": \"Stargardt disease 1, Inborn genetic diseases, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Cone-rod dystrophy 3, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Macular dystrophy\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, Stargardt disease\"}, {\"id\": \"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO, Stargardt disease 1, Mandibulofacial dysostosis with mental deficiency, not provided\"}, {\"id\": \"Retinitis pigmentosa, Stargardt disease 1, not provided\"}, {\"id\": \"Retinal dystrophy, Stargardt disease 1, Cone-rod dystrophy 3, not provided\"}, {\"id\": \"Retinitis pigmentosa, Retinal dystrophy, not provided\"}, {\"id\": \"Cone-rod dystrophy 3, not provided\"}, {\"id\": \"Stargardt disease 1, Leber congenital amaurosis, Bull's eye maculopathy, not provided\"}, {\"id\": \"Macular dystrophy, Stargardt disease 1, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Macular dystrophy, Stargardt disease 1, not provided\"}, {\"id\": \"Retinitis pigmentosa, Retinal dystrophy\"}, {\"id\": \"Retinal dystrophy, Cone-rod dystrophy 3\"}, {\"id\": \"Retinal dystrophy, early-onset severe\"}, {\"id\": \"Macular dystrophy, not provided\"}, {\"id\": \"Stargardt disease 1, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Visual impairment, Central scotoma, Macular degeneration, Retinal atrophy\"}, {\"id\": \"Stargardt disease 1, Cone-rod dystrophy 3, Retinitis pigmentosa 19, not provided\"}, {\"id\": \"Visual impairment, Central scotoma, Macular degeneration, Retinal atrophy, Stargardt disease 1, not provided\"}, {\"id\": \"9411\"}, {\"id\": \"Nonsyndromic cleft lip with or without cleft palate\"}, {\"id\": \"199857\"}, {\"id\": \"Myasthenic syndrome, congenital, 15\"}, {\"id\": \"199857|LOC101928098\"}, {\"id\": \"1806\"}, {\"id\": \"Fluorouracil response\"}, {\"id\": \"1806|DPYD-AS1\"}, {\"id\": \"Dihydropyrimidine dehydrogenase deficiency\"}, {\"id\": \"Dihydropyrimidine dehydrogenase deficiency, not provided\"}, {\"id\": \"178\"}, {\"id\": \"Glycogen storage disease type III\"}, {\"id\": \"Glycogen storage disease type III, Glycogen storage disease IIIb, not provided\"}, {\"id\": \"Glycogen storage disease type III, not provided\"}, {\"id\": \"Glycogen storage disease type III, Glycogen storage disease IIIa, not provided\"}, {\"id\": \"Glycogen storage disease type III, Glycogen storage disease IIIa\"}, {\"id\": \"Glycogen storage disease IIIb\"}, {\"id\": \"Glycogen storage disease IIIc\"}, {\"id\": \"Glycogen storage disease type III, Glycogen storage disease IIIa, Glycogen storage disease IIIb, not provided\"}, {\"id\": \"Glycogen storage disease IIIa\"}, {\"id\": \"23443\"}, {\"id\": \"Arthrogryposis, mental retardation, and seizures\"}, {\"id\": \"163786\"}, {\"id\": \"Primary autosomal recessive microcephaly 14\"}, {\"id\": \"1629\"}, {\"id\": \"Intermediate maple syrup urine disease type 2\"}, {\"id\": \"Maple syrup urine disease\"}, {\"id\": \"Maple syrup urine disease, thiamine-responsive, type II\"}, {\"id\": \"Maple syrup urine disease type 2\"}, {\"id\": \"Maple syrup urine disease, not provided\"}, {\"id\": \"8556\"}, {\"id\": \"Deafness, autosomal recessive 32\"}, {\"id\": \"54112\"}, {\"id\": \"Chorea, childhood-onset, with psychomotor retardation\"}, {\"id\": \"1301\"}, {\"id\": \"Marshall syndrome, not provided\"}, {\"id\": \"Stickler syndrome, type 2\"}, {\"id\": \"Connective tissue disorder\"}, {\"id\": \"Inborn genetic diseases, Marshall syndrome, not provided\"}, {\"id\": \"Fibrochondrogenesis\"}, {\"id\": \"Stickler syndrome, type 2, not provided\"}, {\"id\": \"Marshall/Stickler syndrome\"}, {\"id\": \"sporadic abdominal aortic aneurysm\"}, {\"id\": \"55599\"}, {\"id\": \"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V\"}, {\"id\": \"29957\"}, {\"id\": \"Fontaine progeroid syndrome\"}, {\"id\": \"29899\"}, {\"id\": \"Chudley-McCullough syndrome, Autosomal recessive non-syndromic sensorineural deafness type DFNB\"}, {\"id\": \"Chudley-McCullough syndrome, not provided\"}, {\"id\": \"Autosomal recessive non-syndromic sensorineural deafness type DFNB\"}, {\"id\": \"Chudley-McCullough syndrome, not specified\"}, {\"id\": \"Chudley-McCullough syndrome\"}, {\"id\": \"Chudley-McCullough syndrome, GPSM2-Related Disorders, not provided\"}, {\"id\": \"6884\"}, {\"id\": \"Mental retardation, autosomal recessive 60, not provided\"}, {\"id\": \"6301\"}, {\"id\": \"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES\"}, {\"id\": \"Cerebral arteriovenous malformation\"}, {\"id\": \"1952\"}, {\"id\": \"Intellectual disability, Global developmental delay\"}, {\"id\": \"2773\"}, {\"id\": \"Auriculocondylar syndrome 1\"}, {\"id\": \"2780\"}, {\"id\": \"Abnormality of the eye\"}, {\"id\": \"Achromatopsia 4\"}, {\"id\": \"271\"}, {\"id\": \"Spastic paraplegia 63, autosomal recessive\"}, {\"id\": \"Pontocerebellar hypoplasia, type 9\"}, {\"id\": \"Seizures, Global developmental delay, Brain malformation\"}, {\"id\": \"257\"}, {\"id\": \"Frontonasal dysplasia 1\"}, {\"id\": \"388662\"}, {\"id\": \"Mental retardation, autosomal recessive 48\"}, {\"id\": \"3737\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 32, not provided\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 32\"}, {\"id\": \"Inborn genetic diseases, Epileptic encephalopathy, early infantile, 32, not provided\"}, {\"id\": \"128338\"}, {\"id\": \"Cone-rod dystrophy 21\"}, {\"id\": \"Retinal dystrophy, Cone-rod dystrophy 21\"}, {\"id\": \"3752\"}, {\"id\": \"Spinocerebellar ataxia 19\"}, {\"id\": \"Spinocerebellar ataxia 19, not provided\"}, {\"id\": \"7482\"}, {\"id\": \"Failure to thrive, Failure to thrive in infancy, Diarrhea, Chronic diarrhea, Impaired feeding ability, DIARRHEA 9\"}, {\"id\": \"6566\"}, {\"id\": \"Monocarboxylate transporter 1 deficiency, autosomal recessive\"}, {\"id\": \"Monocarboxylate transporter 1 deficiency, autosomal dominant\"}, {\"id\": \"Erythrocyte lactate transporter defect\"}, {\"id\": \"Exercise-induced hyperinsulinemic hypoglycemia\"}, {\"id\": \"9860\"}, {\"id\": \"Urofacial syndrome 2\"}, {\"id\": \"10717|AP4B1-AS1\"}, {\"id\": \"Spastic paraplegia 47, autosomal recessive, not provided\"}, {\"id\": \"Spastic paraplegia 47, autosomal recessive\"}, {\"id\": \"10717\"}, {\"id\": \"270\"}, {\"id\": \"4893\"}, {\"id\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the thyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma, not provided\"}, {\"id\": \"Acute myeloid leukemia, Cutaneous melanoma, Non-small cell lung cancer\"}, {\"id\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Cutaneous melanoma, Lung adenocarcinoma, Non-small cell lung cancer, Neoplasm of brain, Neoplasm of the thyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma\"}, {\"id\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Congenital giant melanocytic nevus, Follicular thyroid carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Epidermal nevus, Cutaneous melanoma, Lung adenocarcinoma, Non-small cell lung cancer, Neoplasm of brain, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Epidermal nevus syndrome, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma, Neurocutaneous melanosis, not provided\"}, {\"id\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Cutaneous melanoma, Lung adenocarcinoma, Non-small cell lung cancer, Neoplasm of brain, Neoplasm of the thyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma, not provided\"}, {\"id\": \"Cutaneous melanoma\"}, {\"id\": \"Noonan syndrome 6, Noonan syndrome 1, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 6, Noonan syndrome 1, Rasopathy\"}, {\"id\": \"Epidermal nevus, Noonan syndrome 1\"}, {\"id\": \"Noonan syndrome 1, not provided\"}, {\"id\": \"Neoplasm, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Cutaneous melanoma, Non-Hodgkin lymphoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Adenocarcinoma of stomach\"}, {\"id\": \"Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Cutaneous melanoma, Juvenile myelomonocytic leukemia, Non-Hodgkin lymphoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Adenocarcinoma of stomach, RAS-associated autoimmune leukoproliferative disorder, Noonan syndrome 6, not provided\"}, {\"id\": \"Medulloblastoma, Acute myeloid leukemia, Congenital giant melanocytic nevus, Transitional cell carcinoma of the bladder, Multiple myeloma, Cutaneous melanoma, Non-Hodgkin lymphoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Adenocarcinoma of stomach, Carcinoma of colon\"}, {\"id\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Noonan syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\"}, {\"id\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Myelodysplastic syndrome progressed to acute myeloid leukemia, not provided\"}, {\"id\": \"Acute myeloid leukemia, Multiple myeloma, Epidermal nevus, Cutaneous melanoma, Juvenile myelomonocytic leukemia, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\"}, {\"id\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\"}, {\"id\": \"Acute myeloid leukemia, Chronic myelogenous leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\"}, {\"id\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Rasopathy, not provided\"}, {\"id\": \"7252\"}, {\"id\": \"Secondary hypothyroidism\"}, {\"id\": \"Secondary hypothyroidism, not provided\"}, {\"id\": \"4803\"}, {\"id\": \"Congenital sensory neuropathy with selective loss of small myelinated fibers\"}, {\"id\": \"81839\"}, {\"id\": \"Caudal regression syndrome, not provided\"}, {\"id\": \"845\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype, not provided\"}, {\"id\": \"Ventricular tachycardia, catecholaminergic polymorphic, 2\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia type 1\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype\"}, {\"id\": \"Ventricular tachycardia, catecholaminergic polymorphic, 2, Cardiovascular phenotype\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia, Ventricular tachycardia, catecholaminergic polymorphic, 2, not provided\"}, {\"id\": \"Wolff-Parkinson-White syndrome, not provided\"}, {\"id\": \"476\"}, {\"id\": \"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD\"}, {\"id\": \"Aldosterone Producing Adrenal Cortex Adenoma\"}, {\"id\": \"476|ATP1A1-AS1\"}, {\"id\": \"200162\"}, {\"id\": \"Cranioectodermal dysplasia 2\"}, {\"id\": \"10352\"}, {\"id\": \"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES\"}, {\"id\": \"10352|WARS2-AS1\"}, {\"id\": \"3284\"}, {\"id\": \"3 beta-Hydroxysteroid dehydrogenase deficiency\"}, {\"id\": \"26227\"}, {\"id\": \"Seizures, Epileptic encephalopathy, not provided\"}, {\"id\": \"Seizures, Epileptic encephalopathy\"}, {\"id\": \"Neu-Laxova syndrome 1, not provided\"}, {\"id\": \"Phosphoglycerate dehydrogenase deficiency\"}, {\"id\": \"Phosphoglycerate dehydrogenase deficiency, Neu-Laxova syndrome 1\"}, {\"id\": \"Neu-Laxova syndrome 1\"}, {\"id\": \"3158\"}, {\"id\": \"mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency\"}, {\"id\": \"mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency, not provided\"}, {\"id\": \"4853\"}, {\"id\": \"Hajdu-Cheney syndrome\"}, {\"id\": \"Alagille syndrome 2, not provided\"}, {\"id\": \"Alagille syndrome 2\"}, {\"id\": \"Hajdu-Cheney syndrome, not provided\"}, {\"id\": \"8799\"}, {\"id\": \"Peroxisome biogenesis disorder 14B\"}, {\"id\": \"Peroxisome biogenesis disorder 14B, not provided\"}, {\"id\": \"9939\"}, {\"id\": \"Radial aplasia-thrombocytopenia syndrome\"}, {\"id\": \"9939|LIX1L-AS1\"}, {\"id\": \"Radial aplasia-thrombocytopenia syndrome, not provided\"}, {\"id\": \"148738\"}, {\"id\": \"Hemochromatosis type 2A\"}, {\"id\": \"Hemochromatosis type 2A, Hemochromatosis type 1\"}, {\"id\": \"51205\"}, {\"id\": \"2702\"}, {\"id\": \"Atrial fibrillation, familial, 11\"}, {\"id\": \"Atrial fibrillation, familial, 11, not provided\"}, {\"id\": \"Atrial fibrillation, somatic\"}, {\"id\": \"2703\"}, {\"id\": \"Cataract 1\"}, {\"id\": \"Congenital cataract\"}, {\"id\": \"Congenital cataract, Cataract 1\"}, {\"id\": \"2209|HIST2H2BF\"}, {\"id\": \"IGG receptor I, phagocytic, familial deficiency of\"}, {\"id\": \"10262\"}, {\"id\": \"Nager syndrome\"}, {\"id\": \"Nager syndrome, Inborn genetic diseases\"}, {\"id\": \"Hereditary hearing loss and deafness, not provided\"}, {\"id\": \"11311\"}, {\"id\": \"Severe congenital neutropenia 5, autosomal recessive\"}, {\"id\": \"9129\"}, {\"id\": \"Retinitis pigmentosa 18\"}, {\"id\": \"Retinitis pigmentosa 18, not provided\"}, {\"id\": \"80222\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 21\"}, {\"id\": \"1893\"}, {\"id\": \"Lipid proteinosis\"}, {\"id\": \"54507\"}, {\"id\": \"Ectopia lentis, isolated autosomal recessive\"}, {\"id\": \"1513\"}, {\"id\": \"Pyknodysostosis\"}, {\"id\": \"Inborn genetic diseases, Pyknodysostosis\"}, {\"id\": \"58497\"}, {\"id\": \"Abnormality of brain morphology, Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, not provided\"}, {\"id\": \"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies\"}, {\"id\": \"Abnormality of brain morphology, Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies\"}, {\"id\": \"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, not provided\"}, {\"id\": \"57592\"}, {\"id\": \"Paget disease of bone 6\"}, {\"id\": \"8991\"}, {\"id\": \"Extra oral halitosis, EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY\"}, {\"id\": \"EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY\"}, {\"id\": \"5692\"}, {\"id\": \"PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3\"}, {\"id\": \"Nakajo syndrome\"}, {\"id\": \"23126\"}, {\"id\": \"White-sutton syndrome\"}, {\"id\": \"White-sutton syndrome, not provided\"}, {\"id\": \"Inborn genetic diseases, White-sutton syndrome\"}, {\"id\": \"81609\"}, {\"id\": \"Severe myoclonic epilepsy in infancy\"}, {\"id\": \"11022\"}, {\"id\": \"Distal spinal muscular atrophy\"}, {\"id\": \"6097\"}, {\"id\": \"Immunodeficiency 42\"}, {\"id\": \"7062\"}, {\"id\": \"Uncombable hair syndrome 3\"}, {\"id\": \"2312\"}, {\"id\": \"Ichthyosis vulgaris, not provided\"}, {\"id\": \"Dermatitis, atopic, 2, susceptibility to, Ichthyosis vulgaris\"}, {\"id\": \"Ichthyosis vulgaris\"}, {\"id\": \"Dermatitis, atopic, 2\"}, {\"id\": \"Dermatitis, atopic, 2, susceptibility to, Ichthyosis vulgaris, not provided\"}, {\"id\": \"Dermatitis, atopic, 2, susceptibility to, Ichthyosis vulgaris, Dermatitis, atopic, 2, not provided\"}, {\"id\": \"2312|FLG-AS1\"}, {\"id\": \"Microcephaly, Abnormality of the skin, Dry skin, Congenital cerebellar hypoplasia, Paroxysmal dystonia, Ichthyosis, Feeding difficulties, Abnormality of salivation\"}, {\"id\": \"339400|FLG2\"}, {\"id\": \"PEELING SKIN SYNDROME 6\"}, {\"id\": \"23557\"}, {\"id\": \"57459\"}, {\"id\": \"Mental retardation, autosomal dominant 18\"}, {\"id\": \"Mental retardation, autosomal dominant 18, not provided\"}, {\"id\": \"GATAD2B-Related Disorder, not provided\"}, {\"id\": \"9909\"}, {\"id\": \"6232\"}, {\"id\": \"Diamond-Blackfan anemia 17\"}, {\"id\": \"7170\"}, {\"id\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 1\"}, {\"id\": \"Muscular Diseases\"}, {\"id\": \"Congenital myopathy with fiber type disproportion, not provided\"}, {\"id\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 1, Cap myopathy 1, not provided\"}, {\"id\": \"Inborn genetic diseases, Congenital myopathy with fiber type disproportion, Nemaline myopathy 1, Cap myopathy 1, not provided\"}, {\"id\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 1, not provided\"}, {\"id\": \"Nemaline myopathy 1, not provided\"}, {\"id\": \"10456\"}, {\"id\": \"Severe congenital neutropenia 3, autosomal recessive, not provided\"}, {\"id\": \"Severe congenital neutropenia 3, autosomal recessive\"}, {\"id\": \"1141\"}, {\"id\": \"Epilepsy, nocturnal frontal lobe, type 3\"}, {\"id\": \"Epilepsy, nocturnal frontal lobe, type 3, not provided\"}, {\"id\": \"103\"}, {\"id\": \"Symmetrical dyschromatosis of extremities\"}, {\"id\": \"Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6\"}, {\"id\": \"Aicardi-Goutieres syndrome 6\"}, {\"id\": \"10654\"}, {\"id\": \"Porokeratosis of Mibelli\"}, {\"id\": \"80308\"}, {\"id\": \"Glutaric aciduria, type 2\"}, {\"id\": \"Glutaric aciduria, type 2, Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, not provided\"}, {\"id\": \"54344\"}, {\"id\": \"Congenital disorder of glycosylation type 1O\"}, {\"id\": \"Cardiomyopathy, Muscular Diseases, EMG: myopathic abnormalities\"}, {\"id\": \"2629|LOC106627981\"}, {\"id\": \"Gaucher disease, Gaucher's disease, type 1\"}, {\"id\": \"Gaucher's disease, type 1\"}, {\"id\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1, Parkinson disease, late-onset, not provided\"}, {\"id\": \"Acute neuronopathic Gaucher's disease, not provided\"}, {\"id\": \"Acute neuronopathic Gaucher's disease\"}, {\"id\": \"Gaucher disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1\"}, {\"id\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Subacute neuronopathic Gaucher's disease, Gaucher disease, perinatal lethal, Gaucher disease type 3C, Gaucher's disease, type 1, not provided\"}, {\"id\": \"Gaucher disease\"}, {\"id\": \"Gaucher disease, perinatal lethal\"}, {\"id\": \"Parkinson disease, late-onset\"}, {\"id\": \"Gaucher disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1, not provided\"}, {\"id\": \"Gaucher disease, perinatal lethal, Gaucher's disease, type 1, not provided\"}, {\"id\": \"Subacute neuronopathic Gaucher's disease\"}, {\"id\": \"Acute neuronopathic Gaucher's disease, Gaucher's disease, type 1\"}, {\"id\": \"Gaucher disease, Gaucher disease, perinatal lethal, Gaucher's disease, type 1, not provided\"}, {\"id\": \"Gaucher's disease, type 1, not provided\"}, {\"id\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1\"}, {\"id\": \"Gaucher disease, Gaucher's disease, type 1, not provided\"}, {\"id\": \"Gaucher disease, Gaucher disease, perinatal lethal\"}, {\"id\": \"Gaucher disease, Gaucher disease, perinatal lethal, Gaucher's disease, type 1\"}, {\"id\": \"Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1\"}, {\"id\": \"2629\"}, {\"id\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Gaucher's disease, type 1\"}, {\"id\": \"5313\"}, {\"id\": \"Pyruvate kinase deficiency of red cells, not provided\"}, {\"id\": \"Pyruvate kinase deficiency of red cells\"}, {\"id\": \"Pyruvate kinase deficiency of red cells, not specified\"}, {\"id\": \"Adenosine triphosphate, elevated, of erythrocytes\"}, {\"id\": \"2224|RUSC1-AS1\"}, {\"id\": \"Porokeratosis 9, multiple types\"}, {\"id\": \"55870\"}, {\"id\": \"MENTAL RETARDATION, AUTOSOMAL DOMINANT 52\"}, {\"id\": \"55154\"}, {\"id\": \"MYOPATHY, MITOCHONDRIAL, AND ATAXIA\"}, {\"id\": \"55249\"}, {\"id\": \"Grange syndrome\"}, {\"id\": \"6016\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 8, not provided\"}, {\"id\": \"Noonan syndrome 8, not provided\"}, {\"id\": \"Noonan syndrome, not provided\"}, {\"id\": \"Noonan syndrome, Inborn genetic diseases, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 8, not specified, not provided\"}, {\"id\": \"Noonan syndrome\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 8\"}, {\"id\": \"Noonan syndrome 8\"}, {\"id\": \"9181\"}, {\"id\": \"Neurodevelopmental disorder with midbrain and hindbrain malformations\"}, {\"id\": \"4000\"}, {\"id\": \"Primary dilated cardiomyopathy, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, not provided\"}, {\"id\": \"Lipodystrophy, Inborn genetic diseases, Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, not provided\"}, {\"id\": \"Congenital muscular dystrophy, LMNA-related\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 1B, not provided\"}, {\"id\": \"Muscular dystrophy, not provided\"}, {\"id\": \"Emery-Dreifuss muscular dystrophy\"}, {\"id\": \"Congenital muscular dystrophy\"}, {\"id\": \"Primary dilated cardiomyopathy\"}, {\"id\": \"Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, not provided\"}, {\"id\": \"Familial partial lipodystrophy 2, not provided\"}, {\"id\": \"Arrhythmogenic right ventricular cardiomyopathy, type 9\"}, {\"id\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Familial dilated cardiomyopathy, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, Familial partial lipodystrophy 2, Hutchinson-Gilford progeria syndrome, childhood-onset, not provided\"}, {\"id\": \"Hutchinson-Gilford progeria syndrome, childhood-onset, not provided\"}, {\"id\": \"Congenital muscular dystrophy, LMNA-related, not provided\"}, {\"id\": \"Hutchinson-Gilford syndrome, Hutchinson-Gilford progeria syndrome, atypical, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Cardiovascular phenotype, not provided\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1S, Cardiovascular phenotype, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Cardiovascular phenotype, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1A\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Emery-Dreifuss muscular dystrophy 3, autosomal recessive, not provided\"}, {\"id\": \"Hutchinson-Gilford syndrome\"}, {\"id\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Limb-girdle muscular dystrophy, type 1B, not provided\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Emery-Dreifuss muscular dystrophy 3, autosomal recessive\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Cardiovascular phenotype, not provided\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Congenital muscular dystrophy, LMNA-related, not provided\"}, {\"id\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2B1, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Cardiovascular phenotype, not provided\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Limb-girdle muscular dystrophy, type 1B, Congenital muscular dystrophy, LMNA-related\"}, {\"id\": \"Muscular dystrophy\"}, {\"id\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease type 2B1, not provided\"}, {\"id\": \"Lipodystrophy, not provided\"}, {\"id\": \"Hutchinson-Gilford progeria syndrome, atypical\"}, {\"id\": \"Right ventricular cardiomyopathy, Hutchinson-Gilford progeria syndrome, childhood-onset\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Hutchinson-Gilford syndrome, Charcot-Marie-Tooth disease, type 2, Lethal tight skin contracture syndrome, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Mandibuloacral dysostosis, Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, Limb-girdle muscular dystrophy, type 1B, Charcot-Marie-Tooth disease type 2B1, Heart-hand syndrome, Slovenian type, Emery-Dreifuss muscular dystrophy 3, autosomal recessive, Congenital muscular dystrophy, LMNA-related, Cardiovascular phenotype, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Familial partial lipodystrophy 2, Monogenic diabetes, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Cardiovascular phenotype, not provided\"}, {\"id\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, Limb-girdle muscular dystrophy, type 1B, Congenital muscular dystrophy, LMNA-related, not provided\"}, {\"id\": \"Laminopathy\"}, {\"id\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Cardiovascular phenotype, not provided\"}, {\"id\": \"Cardiovascular phenotype, not provided\"}, {\"id\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Limb-girdle muscular dystrophy, type 1B, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Familial partial lipodystrophy 2, Emery-Dreifuss muscular dystrophy 3, autosomal recessive, Monogenic diabetes, Partial lipodystrophy, Dunnigan, Laminopathy, not provided\"}, {\"id\": \"Mandibuloacral dysostosis, Limb-girdle muscular dystrophy, type 1B, not provided\"}, {\"id\": \"Familial dilated cardiomyopathy\"}, {\"id\": \"Charcot-Marie-Tooth disease, Hutchinson-Gilford syndrome, Mandibuloacral dysostosis, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Mandibuloacral dysostosis, Mandibuloacral dysplasia with type A lipodystrophy, atypical, Mandibuloacral dysplasia, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Familial partial lipodystrophy 2, not provided\"}, {\"id\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Mandibuloacral dysostosis, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 2, Familial partial lipodystrophy 2, not provided\"}, {\"id\": \"Mandibuloacral dysostosis, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, Charcot-Marie-Tooth disease, type 2, not provided\"}, {\"id\": \"Heart-hand syndrome, Slovenian type, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1A, not provided\"}, {\"id\": \"Hutchinson-Gilford syndrome, not provided\"}, {\"id\": \"Mandibuloacral dysplasia with type A lipodystrophy\"}, {\"id\": \"Hutchinson-Gilford syndrome, Lethal tight skin contracture syndrome, Mandibuloacral dysostosis, Laminopathy, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, not provided\"}, {\"id\": \"Hutchinson-Gilford syndrome, Hutchinson-Gilford progeria syndrome, atypical\"}, {\"id\": \"Hutchinson-Gilford syndrome, Lethal tight skin contracture syndrome, not provided\"}, {\"id\": \"64218\"}, {\"id\": \"Cone-rod dystrophy 10, Retinitis pigmentosa 35\"}, {\"id\": \"128240\"}, {\"id\": \"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy\"}, {\"id\": \"Infantile encephalopathy\"}, {\"id\": \"4914\"}, {\"id\": \"Hereditary insensitivity to pain with anhidrosis\"}, {\"id\": \"Familial medullary thyroid carcinoma\"}, {\"id\": \"Inborn genetic diseases, Hereditary insensitivity to pain with anhidrosis\"}, {\"id\": \"Hereditary insensitivity to pain with anhidrosis, not provided\"}, {\"id\": \"6708\"}, {\"id\": \"Congenital hemolytic anemia\"}, {\"id\": \"Spherocytosis type 3\"}, {\"id\": \"Hereditary pyropoikilocytosis\"}, {\"id\": \"Elliptocytosis 2\"}, {\"id\": \"Elliptocytosis 2, not provided\"}, {\"id\": \"Hereditary pyropoikilocytosis, Elliptocytosis 2\"}, {\"id\": \"Hereditary pyropoikilocytosis, Elliptocytosis 2, not specified, not provided\"}, {\"id\": \"2532\"}, {\"id\": \"DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE, Plasmodium vivax, resistance to, White blood cell count quantitative trait locus 1\"}, {\"id\": \"DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE\"}, {\"id\": \"93183\"}, {\"id\": \"Glycosylphosphatidylinositol deficiency\"}, {\"id\": \"3766\"}, {\"id\": \"SeSAME syndrome, not provided\"}, {\"id\": \"SeSAME syndrome\"}, {\"id\": \"Enlarged vestibular aqueduct\"}, {\"id\": \"3765|KCNJ10\"}, {\"id\": \"477\"}, {\"id\": \"Familial hemiplegic migraine type 2\"}, {\"id\": \"Alternating hemiplegia of childhood 1\"}, {\"id\": \"Familial hemiplegic migraine, not provided\"}, {\"id\": \"Migraine, familial basilar, not provided\"}, {\"id\": \"Familial hemiplegic migraine\"}, {\"id\": \"Inborn genetic diseases, Familial hemiplegic migraine\"}, {\"id\": \"Polymicrogyria\"}, {\"id\": \"Familial hemiplegic migraine, Familial hemiplegic migraine type 2\"}, {\"id\": \"844\"}, {\"id\": \"Myopathy, vacuolar, with casq1 aggregates\"}, {\"id\": \"50717\"}, {\"id\": \"Giant axonal neuropathy 2, autosomal dominant\"}, {\"id\": \"5824\"}, {\"id\": \"1314\"}, {\"id\": \"Autoimmune interstitial lung, joint, and kidney disease\"}, {\"id\": \"1314|NCSTN\"}, {\"id\": \"23385\"}, {\"id\": \"Familial acne inversa 1\"}, {\"id\": \"81607\"}, {\"id\": \"Ectodermal dysplasia-syndactyly syndrome 1\"}, {\"id\": \"51506\"}, {\"id\": \"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH\"}, {\"id\": \"5498\"}, {\"id\": \"Variegate porphyria, Variegate porphyria, homozygous\"}, {\"id\": \"Variegate porphyria\"}, {\"id\": \"Variegate porphyria, not provided\"}, {\"id\": \"Variegate porphyria, homozygous\"}, {\"id\": \"Abnormal blistering of the skin, Porphyrinuria, Abdominal colic\"}, {\"id\": \"Constipation, Migraine, Abnormal blistering of the skin, Abnormal urinary color\"}, {\"id\": \"4720\"}, {\"id\": \"Leber's optic atrophy\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6, not provided\"}, {\"id\": \"4359\"}, {\"id\": \"Tremor, EMG: neuropathic changes, Limb muscle weakness, Sensorimotor neuropathy\"}, {\"id\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I\"}, {\"id\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b\"}, {\"id\": \"Neuropathy, congenital hypomyelinating, autosomal dominant\"}, {\"id\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, not provided\"}, {\"id\": \"Dejerine-Sottas disease\"}, {\"id\": \"Dejerine-Sottas disease, Roussy-L\\u00e9vy syndrome, Charcot-Marie-Tooth disease, demyelinating, type 1b, Congenital hypomyelinating neuropathy 1, autosomal recessive, Charcot-Marie-Tooth disease dominant intermediate 3, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I, Dejerine-Sottas syndrome, autosomal dominant\"}, {\"id\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, not provided\"}, {\"id\": \"Dejerine-Sottas disease, Roussy-L\\u00e9vy syndrome, Charcot-Marie-Tooth disease, demyelinating, type 1b, Congenital hypomyelinating neuropathy 1, autosomal recessive, Charcot-Marie-Tooth disease dominant intermediate 3, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I\"}, {\"id\": \"Charcot-Marie-Tooth disease, type I\"}, {\"id\": \"Charcot-Marie-Tooth disease, type I, not provided\"}, {\"id\": \"Roussy-L\\u00e9vy syndrome, Charcot-Marie-Tooth disease, demyelinating, type 1b, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2J, not provided\"}, {\"id\": \"Congenital hypomyelinating neuropathy 2\"}, {\"id\": \"Charcot-Marie-Tooth disease type 2J, not provided\"}, {\"id\": \"Decreased nerve conduction velocity, Sensory neuropathy, Pes cavus, Distal muscle weakness, Distal lower limb amyotrophy, Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease type 2J\"}, {\"id\": \"Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease dominant intermediate 3\"}, {\"id\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease type 2J\"}, {\"id\": \"Dejerine-Sottas syndrome, autosomal dominant, not provided\"}, {\"id\": \"Charcot-Marie-Tooth disease type 2I\"}, {\"id\": \"Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths\"}, {\"id\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I\"}, {\"id\": \"6391\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Paragangliomas 3\"}, {\"id\": \"Paragangliomas 3\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Carney triad\"}, {\"id\": \"Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 3, not provided\"}, {\"id\": \"Gastrointestinal stroma tumor, Paragangliomas 3\"}, {\"id\": \"Gastrointestinal stroma tumor, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paraganglioma and gastric stromal sarcoma, Carney triad\"}, {\"id\": \"Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 3\"}, {\"id\": \"Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 3, not provided\"}, {\"id\": \"22926\"}, {\"id\": \"Achromatopsia 7\"}, {\"id\": \"Achromatopsia\"}, {\"id\": \"25903\"}, {\"id\": \"127933\"}, {\"id\": \"4921\"}, {\"id\": \"Non-small cell lung cancer, Squamous cell lung carcinoma\"}, {\"id\": \"Spondylometaepiphyseal dysplasia short limb-hand type\"}, {\"id\": \"Warburg-Cinotti syndrome\"}, {\"id\": \"Squamous cell carcinoma, Non-small cell lung cancer\"}, {\"id\": \"5087\"}, {\"id\": \"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY\"}, {\"id\": \"4009\"}, {\"id\": \"Sensorineural hearing loss\"}, {\"id\": \"54499\"}, {\"id\": \"Cryptorchidism, Renal agenesis, Unilateral renal agenesis, Cleft palate, Sensorineural hearing loss, Strabismus, Autistic disorder of childhood onset, Delayed speech and language development, Abnormality of the sternum, Rib fusion, Severe visual impairment, Global developmental delay, Pulmonic stenosis, Scoliosis, Bilateral cleft lip and palate, Hemivertebrae, Relative macrocephaly, Bilateral cleft lip, Bilateral cleft palate\"}, {\"id\": \"Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome\"}, {\"id\": \"919\"}, {\"id\": \"Immunodeficiency due to defect in cd3-zeta\"}, {\"id\": \"55827\"}, {\"id\": \"23432\"}, {\"id\": \"Pituitary stalk interruption syndrome, not provided\"}, {\"id\": \"9095\"}, {\"id\": \"Adrenocorticotropic hormone deficiency, not provided\"}, {\"id\": \"1805\"}, {\"id\": \"Progressive sensorineural hearing impairment\"}, {\"id\": \"10560\"}, {\"id\": \"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness\"}, {\"id\": \"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness, not provided\"}, {\"id\": \"2153\"}, {\"id\": \"Factor V deficiency\"}, {\"id\": \"Thrombophilia due to activated protein C resistance\"}, {\"id\": \"Factor V Hong Kong\"}, {\"id\": \"6403\"}, {\"id\": \"Premature coronary artery disease\"}, {\"id\": \"92344\"}, {\"id\": \"Geroderma osteodysplastica\"}, {\"id\": \"5396\"}, {\"id\": \"Dysgnathia complex\"}, {\"id\": \"2328\"}, {\"id\": \"Trimethylaminuria\"}, {\"id\": \"FMO3 activity, decreased\"}, {\"id\": \"4653\"}, {\"id\": \"Primary open angle glaucoma juvenile onset 1\"}, {\"id\": \"Glaucoma 1, open angle, a, digenic\"}, {\"id\": \"Primary open angle glaucoma\"}, {\"id\": \"Primary open angle glaucoma juvenile onset 1, not provided\"}, {\"id\": \"Lymphopenia, Immunodeficiency, Severe combined immunodeficiency disease, Combined immunodeficiency, Abnormality of cellular immune system, Abnormality of T cell physiology, Primary open angle glaucoma, Primary open angle glaucoma juvenile onset 1\"}, {\"id\": \"Primary open angle glaucoma juvenile onset 1, Glaucoma 3, primary congenital, a, digenic, MYOC-Related Disorders\"}, {\"id\": \"Glaucoma 1, open angle, a, autosomal recessive\"}, {\"id\": \"5279|C1orf105\"}, {\"id\": \"Non-immune hydrops fetalis\"}, {\"id\": \"GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16\"}, {\"id\": \"55157\"}, {\"id\": \"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation\"}, {\"id\": \"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation\"}, {\"id\": \"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, not provided\"}, {\"id\": \"Hypertension, Dysmetria, Abnormality of the foot, Talipes equinovarus, Gout, Gait ataxia, Cerebral cortical atrophy, Gait imbalance, Impaired vibration sensation in the lower limbs, Difficulty walking, EMG: axonal abnormality, Sensorimotor neuropathy, CNS demyelination, Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, not provided\"}, {\"id\": \"462\"}, {\"id\": \"Reduced antithrombin III activity\"}, {\"id\": \"Reduced antithrombin III activity, Antithrombin deficiency\"}, {\"id\": \"Reduced antithrombin III activity, not provided\"}, {\"id\": \"460\"}, {\"id\": \"7827|AXDND1\"}, {\"id\": \"Nephrotic syndrome, idiopathic, steroid-resistant\"}, {\"id\": \"Nephrotic syndrome, idiopathic, steroid-resistant, not provided\"}, {\"id\": \"Nephrotic syndrome, type 2, susceptibility to, Idiopathic nephrotic syndrome, Nephrotic syndrome, idiopathic, steroid-resistant, not provided\"}, {\"id\": \"Idiopathic nephrotic syndrome, not provided\"}, {\"id\": \"7827\"}, {\"id\": \"Hereditary nephrotic syndrome, Nephrotic syndrome, idiopathic, steroid-resistant\"}, {\"id\": \"Proteinuria\"}, {\"id\": \"26092|TOR1AIP2\"}, {\"id\": \"Muscular dystrophy, limb-girdle, type 2y\"}, {\"id\": \"26092\"}, {\"id\": \"89884\"}, {\"id\": \"Pituitary hormone deficiency, combined 4\"}, {\"id\": \"89884|ACBD6\"}, {\"id\": \"9213\"}, {\"id\": \"Basal ganglia calcification, idiopathic, 6\"}, {\"id\": \"777\"}, {\"id\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69, not provided\"}, {\"id\": \"Inborn genetic diseases, EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69\"}, {\"id\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69\"}, {\"id\": \"Episodic coma\"}, {\"id\": \"2752\"}, {\"id\": \"Glutamine deficiency, congenital\"}, {\"id\": \"6041\"}, {\"id\": \"Prostate cancer, hereditary, 1\"}, {\"id\": \"3918\"}, {\"id\": \"Junctional epidermolysis bullosa gravis of Herlitz\"}, {\"id\": \"Adult junctional epidermolysis bullosa\"}, {\"id\": \"23057\"}, {\"id\": \"4688\"}, {\"id\": \"Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2\"}, {\"id\": \"Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2, not provided\"}, {\"id\": \"116461\"}, {\"id\": \"Seizures, Global developmental delay, Primary microcephaly, Pontocerebellar hypoplasia, type 2f\"}, {\"id\": \"Pontocerebellar hypoplasia, type 2f\"}, {\"id\": \"80267\"}, {\"id\": \"83872\"}, {\"id\": \"Age-related macular degeneration 1\"}, {\"id\": \"7175\"}, {\"id\": \"Intellectual disability\"}, {\"id\": \"5321\"}, {\"id\": \"Phospholipase a2, group IV a, deficiency of\"}, {\"id\": \"5997\"}, {\"id\": \"79577\"}, {\"id\": \"Parathyroid carcinoma\"}, {\"id\": \"Hyperparathyroidism 2\"}, {\"id\": \"Hyperparathyroidism 1, Parathyroid adenoma, somatic, not provided\"}, {\"id\": \"Hyperparathyroidism 1\"}, {\"id\": \"Hyperparathyroidism 2, not provided\"}, {\"id\": \"343450\"}, {\"id\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57, KCNT2-related condition\"}, {\"id\": \"3075\"}, {\"id\": \"Atypical hemolytic-uremic syndrome 1\"}, {\"id\": \"Basal laminar drusen\"}, {\"id\": \"Factor H deficiency\"}, {\"id\": \"Factor H deficiency, Age-related macular degeneration 4, Atypical hemolytic-uremic syndrome 1\"}, {\"id\": \"10878\"}, {\"id\": \"81494\"}, {\"id\": \"CFHR5 deficiency\"}, {\"id\": \"2165\"}, {\"id\": \"Factor XIII subunit B deficiency\"}, {\"id\": \"259266\"}, {\"id\": \"Inborn genetic diseases, Primary autosomal recessive microcephaly 5\"}, {\"id\": \"Primary autosomal recessive microcephaly 5\"}, {\"id\": \"Primary autosomal recessive microcephaly 5, not provided\"}, {\"id\": \"Microcephaly\"}, {\"id\": \"Primary autosomal recessive microcephaly\"}, {\"id\": \"23418\"}, {\"id\": \"Leber congenital amaurosis 8\"}, {\"id\": \"Leber congenital amaurosis 8, not provided\"}, {\"id\": \"Retinitis pigmentosa 12\"}, {\"id\": \"Retinitis pigmentosa 12, not provided\"}, {\"id\": \"Macular dystrophy, Retinitis pigmentosa 12, not provided\"}, {\"id\": \"Retinitis pigmentosa 12, Leber congenital amaurosis 8, not provided\"}, {\"id\": \"Retinitis pigmentosa 12, Leber congenital amaurosis 8\"}, {\"id\": \"Macular dystrophy, Retinitis pigmentosa 12, Leber congenital amaurosis 8, not provided\"}, {\"id\": \"Retinal dystrophy, Retinitis pigmentosa 12, Leber congenital amaurosis 8, not provided\"}, {\"id\": \"Inborn genetic diseases, Stargardt disease\"}, {\"id\": \"5788\"}, {\"id\": \"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive\"}, {\"id\": \"Not_Given\"}, {\"id\": \"Acute myeloid leukemia with maturation\"}, {\"id\": \"100131234\"}, {\"id\": \"9928\"}, {\"id\": \"MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE\"}, {\"id\": \"Meckel syndrome 12\"}, {\"id\": \"83479\"}, {\"id\": \"Orofaciodigital syndrome 5\"}, {\"id\": \"Orofaciodigital syndrome 5, not provided\"}, {\"id\": \"779\"}, {\"id\": \"Malignant hyperthermia susceptibility type 5, Hypokalemic periodic paralysis 1\"}, {\"id\": \"Malignant hyperthermia susceptibility type 5, Hypokalemic periodic paralysis 1, not provided\"}, {\"id\": \"Hypokalemic periodic paralysis 1\"}, {\"id\": \"Rhabdomyolysis\"}, {\"id\": \"5317\"}, {\"id\": \"Ectodermal dysplasia skin fragility syndrome\"}, {\"id\": \"7139\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, Cardiovascular phenotype, not provided\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, not provided\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy\"}, {\"id\": \"Familial hypertrophic cardiomyopathy 2\"}, {\"id\": \"Left ventricular noncompaction 6\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, Cardiovascular phenotype\"}, {\"id\": \"Primary dilated cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, not provided\"}, {\"id\": \"Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3\"}, {\"id\": \"Primary dilated cardiomyopathy, Cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, Familial isolated dilated cardiomyopathy, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Cardiovascular phenotype, not provided\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, not provided\"}, {\"id\": \"Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, not provided\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, not specified\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, Familial hypertrophic cardiomyopathy 2, Cardiovascular phenotype, not provided\"}, {\"id\": \"Familial restrictive cardiomyopathy, Familial hypertrophic cardiomyopathy 2, Cardiovascular phenotype, not provided\"}, {\"id\": \"Wolff-Parkinson-White pattern\"}, {\"id\": \"25802\"}, {\"id\": \"Visceral myopathy\"}, {\"id\": \"29089\"}, {\"id\": \"Fanconi anemia, complementation group T\"}, {\"id\": \"127833\"}, {\"id\": \"Myasthenic syndrome, congenital, 7, presynaptic\"}, {\"id\": \"10765\"}, {\"id\": \"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65\"}, {\"id\": \"6635\"}, {\"id\": \"Hypotrichosis 11\"}, {\"id\": \"5972\"}, {\"id\": \"Hyperproreninemia, familial\"}, {\"id\": \"Renal dysplasia\"}, {\"id\": \"5972|LOC107548112\"}, {\"id\": \"Hyperuricemic nephropathy, familial juvenile, 2\"}, {\"id\": \"3814\"}, {\"id\": \"Hypogonadotropic hypogonadism 13 with or without anosmia\"}, {\"id\": \"84919\"}, {\"id\": \"Microcephaly, short stature, and impaired glucose metabolism 2\"}, {\"id\": \"6900\"}, {\"id\": \"Epilepsy, familial adult myoclonic, 5\"}, {\"id\": \"25778\"}, {\"id\": \"Congenital anomalies of kidney and urinary tract 1, susceptibility to\"}, {\"id\": \"23380\"}, {\"id\": \"3586\"}, {\"id\": \"Rheumatoid arthritis, progression of\"}, {\"id\": \"1604\"}, {\"id\": \"Protein-losing enteropathy\"}, {\"id\": \"CROMER BLOOD GROUP SYSTEM, Dr(a-) PHENOTYPE\"}, {\"id\": \"1380\"}, {\"id\": \"Common variable immunodeficiency 7\"}, {\"id\": \"4179\"}, {\"id\": \"Atypical hemolytic uremic syndrome\"}, {\"id\": \"Atypical hemolytic-uremic syndrome 2\"}, {\"id\": \"5362\"}, {\"id\": \"atypical cerebral palsy\"}, {\"id\": \"3914\"}, {\"id\": \"Amelogenesis imperfecta, type IA\"}, {\"id\": \"3914|MIR4260\"}, {\"id\": \"Junctional epidermolysis bullosa gravis of Herlitz, not provided\"}, {\"id\": \"Junctional epidermolysis bullosa gravis of Herlitz, Adult junctional epidermolysis bullosa, not provided\"}, {\"id\": \"3290|HSD11B1-AS1\"}, {\"id\": \"Cortisone reductase deficiency 2\"}, {\"id\": \"3664\"}, {\"id\": \"Popliteal pterygium syndrome\"}, {\"id\": \"Popliteal pterygium syndrome, Orofacial cleft 6, susceptibility to, Van der Woude syndrome\"}, {\"id\": \"Popliteal pterygium syndrome, Van der Woude syndrome\"}, {\"id\": \"Popliteal pterygium syndrome, not provided\"}, {\"id\": \"Popliteal pterygium syndrome, Orofacial cleft 6, susceptibility to, Van der Woude syndrome, not provided\"}, {\"id\": \"Van der Woude syndrome, not provided\"}, {\"id\": \"Cleft palate, Van der Woude syndrome, not provided\"}, {\"id\": \"255928\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 11\"}, {\"id\": \"55733\"}, {\"id\": \"3756\"}, {\"id\": \"Temple-Baraitser syndrome\"}, {\"id\": \"Inborn genetic diseases, Zimmermann-Laband syndrome 1, not provided\"}, {\"id\": \"Temple-Baraitser syndrome, Zimmermann-Laband syndrome 1\"}, {\"id\": \"Zimmermann-Laband syndrome 1\"}, {\"id\": \"KCNH1-related phenotype\"}, {\"id\": \"343035\"}, {\"id\": \"Leber congenital amaurosis 12\"}, {\"id\": \"28982\"}, {\"id\": \"Jeune thoracic dystrophy\"}, {\"id\": \"Posterior column ataxia with retinitis pigmentosa\"}, {\"id\": \"Short Rib Polydactyly Syndrome\"}, {\"id\": \"26750\"}, {\"id\": \"Muscular hypotonia, Global developmental delay, Hypoplasia of the corpus callosum, Abnormality of the cerebral white matter, Periventricular leukomalacia, Delayed myelination\"}, {\"id\": \"1063\"}, {\"id\": \"Stromme syndrome\"}, {\"id\": \"7399\"}, {\"id\": \"Usher syndrome, type 2A, not provided\"}, {\"id\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39\"}, {\"id\": \"Usher syndrome, type 2A\"}, {\"id\": \"Retinitis pigmentosa, Retinitis pigmentosa 39\"}, {\"id\": \"Retinitis pigmentosa, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"Retinitis pigmentosa 39\"}, {\"id\": \"Usher syndrome\"}, {\"id\": \"Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39\"}, {\"id\": \"Hearing impairment, Retinitis pigmentosa, Congenital sensorineural hearing impairment, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"Retinal dystrophy, Usher syndrome, type 2A, Retinitis pigmentosa 39\"}, {\"id\": \"Usher syndrome, Usher syndrome, type 2A\"}, {\"id\": \"Retinitis pigmentosa, Usher syndrome, type 2A, Retinitis pigmentosa 39\"}, {\"id\": \"Inborn genetic diseases, Usher syndrome, type 2A\"}, {\"id\": \"Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"Retinitis pigmentosa, Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"Congenital sensorineural hearing impairment\"}, {\"id\": \"7399|LOC102723833\"}, {\"id\": \"Retinitis pigmentosa, Usher syndrome, Usher syndrome, type 2A, not provided\"}, {\"id\": \"High palate, Retinitis pigmentosa, Retinal dystrophy, Anxiety, Brisk reflexes, Dysautonomia, Abnormality of the upper limb, Multiple joint contractures, Dislocated radial head, Short stature, Distal arthrogryposis, Abnormality of upper limb joint, Chronic pain, Abnormality of upper limb bone, Cognitive impairment, Inborn genetic diseases, Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39, USH2A-Related Disorders\"}, {\"id\": \"Usher syndrome, Usher syndrome, type 2A, not provided\"}, {\"id\": \"Rod-cone dystrophy, Pigmentary retinopathy, Blindness, Abnormal macular morphology, Retinal pigment epithelial atrophy, Usher syndrome, type 2A, not provided\"}, {\"id\": \"Hearing impairment, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\"}, {\"id\": \"7042\"}, {\"id\": \"Loeys-Dietz syndrome 4\"}, {\"id\": \"Holt-Oram syndrome\"}, {\"id\": \"Holt-Oram syndrome, Loeys-Dietz syndrome\"}, {\"id\": \"Loeys-Dietz syndrome\"}, {\"id\": \"Holt-Oram syndrome, not provided\"}, {\"id\": \"Loeys-Dietz syndrome 4, not provided\"}, {\"id\": \"Holt-Oram syndrome, Loeys-Dietz syndrome 4, not provided\"}, {\"id\": \"55532\"}, {\"id\": \"Hypermanganesemia with dystonia 1\"}, {\"id\": \"Hypermanganesemia with dystonia 1, not provided\"}, {\"id\": \"2058\"}, {\"id\": \"LEUKODYSTROPHY, HYPOMYELINATING, 15\"}, {\"id\": \"55699\"}, {\"id\": \"Cataract, Peripheral neuropathy, Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, growth hormone deficiency with short stature, partial sensorineural deafness\"}, {\"id\": \"25782\"}, {\"id\": \"Warburg micro syndrome 2\"}, {\"id\": \"Martsolf syndrome\"}, {\"id\": \"84976\"}, {\"id\": \"microform holoprosencephaly\"}, {\"id\": \"80232\"}, {\"id\": \"SKRABAN-DEARDORFF SYNDROME\"}, {\"id\": \"Intellectual disability, seizures, abnormal gait and distinctive facial features\"}, {\"id\": \"3930\"}, {\"id\": \"PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES\"}, {\"id\": \"Greenberg dysplasia\"}, {\"id\": \"Retrognathia, Femoral bowing, Short long bone, Disproportionate short stature, Rhizomelic arm shortening, Rhizomelic leg shortening, Pelger-Hu\\u00ebt anomaly\"}, {\"id\": \"Pelger-Hu\\u00ebt anomaly\"}, {\"id\": \"Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia\"}, {\"id\": \"Reynolds syndrome\"}, {\"id\": \"29920\"}, {\"id\": \"Leukodystrophy, hypomyelinating, 10, not provided\"}, {\"id\": \"Leukodystrophy, hypomyelinating, 10\"}, {\"id\": \"29920|MIR6741\"}, {\"id\": \"7044\"}, {\"id\": \"3020\"}, {\"id\": \"Astrocytoma, Brainstem glioma\"}, {\"id\": \"Adrenocortical carcinoma, Brainstem glioma, Neoplasm of brain, Glioblastoma\"}, {\"id\": \"H3F3A-related condition, Inborn genetic diseases\"}, {\"id\": \"5664\"}, {\"id\": \"Alzheimer disease, type 4, not provided\"}, {\"id\": \"56997\"}, {\"id\": \"Coenzyme Q10 deficiency, primary, 4\"}, {\"id\": \"Coenzyme Q10 deficiency, primary, 4, not provided\"}, {\"id\": \"375\"}, {\"id\": \"PERIVENTRICULAR NODULAR HETEROTOPIA 8\"}, {\"id\": \"57165\"}, {\"id\": \"Leukodystrophy, hypomyelinating, 2\"}, {\"id\": \"Spastic paraplegia, Leukodystrophy, hypomyelinating, 2\"}, {\"id\": \"Spastic paraplegia 44, autosomal recessive\"}, {\"id\": \"Spastic paraplegia\"}, {\"id\": \"Lymphedema, hereditary, IC\"}, {\"id\": \"200205\"}, {\"id\": \"Multiple mitochondrial dysfunctions syndrome 3\"}, {\"id\": \"Multiple mitochondrial dysfunctions syndrome 3, not provided\"}, {\"id\": \"Spastic paraplegia 74, autosomal recessive\"}, {\"id\": \"84033\"}, {\"id\": \"58\"}, {\"id\": \"Nemaline myopathy 3\"}, {\"id\": \"Myopathy, actin, congenital, with cores\"}, {\"id\": \"Congenital myopathy with fiber type disproportion\"}, {\"id\": \"Nemaline myopathy 3, autosomal dominant or recessive, not provided\"}, {\"id\": \"Congenital myopathy, Nemaline myopathy 3\"}, {\"id\": \"ACTA1 gene related myopathy, Nemaline myopathy 3, not provided\"}, {\"id\": \"Myopathy, scapulohumeroperoneal, not provided\"}, {\"id\": \"Nemaline myopathy 3, autosomal dominant or recessive\"}, {\"id\": \"Myopathy, scapulohumeroperoneal\"}, {\"id\": \"Congenital muscular dystrophy with rigid spine\"}, {\"id\": \"Nemaline myopathy 3, not provided\"}, {\"id\": \"Myopathy, actin, congenital, with excess of thin myofilaments\"}, {\"id\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 3\"}, {\"id\": \"55746\"}, {\"id\": \"GALLOWAY-MOWAT SYNDROME 8\"}, {\"id\": \"NEPHROTIC SYNDROME, TYPE 18\"}, {\"id\": \"22796\"}, {\"id\": \"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq\"}, {\"id\": \"183\"}, {\"id\": \"64801\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 38, ARV1-related condition\"}, {\"id\": \"Blindness, Neurodegeneration, Epileptic encephalopathy, early infantile, 38\"}, {\"id\": \"8443\"}, {\"id\": \"Rhizomelic chondrodysplasia punctata type 2\"}, {\"id\": \"83932\"}, {\"id\": \"Ruijs-Aalfs syndrome\"}, {\"id\": \"54583\"}, {\"id\": \"Erythrocytosis, familial, 3\"}, {\"id\": \"388753\"}, {\"id\": \"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4\"}, {\"id\": \"359948\"}, {\"id\": \"IMMUNODEFICIENCY, COMMON VARIABLE, 14\"}, {\"id\": \"6905\"}, {\"id\": \"Encephalopathy, progressive, with amyotrophy and optic atrophy\"}, {\"id\": \"Hypoparathyroidism retardation dysmorphism syndrome\"}, {\"id\": \"148789\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11, not provided\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11\"}, {\"id\": \"Inborn genetic diseases, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11\"}, {\"id\": \"1130\"}, {\"id\": \"Ch\\u00e9diak-Higashi syndrome\"}, {\"id\": \"Ch\\u00e9diak-Higashi syndrome, Chediak-Higashi syndrome, adult type\"}, {\"id\": \"Ch\\u00e9diak-Higashi syndrome, Chediak-Higashi syndrome, adult type, not provided\"}, {\"id\": \"Ch\\u00e9diak-Higashi syndrome, Chediak-Higashi syndrome, childhood type\"}, {\"id\": \"Recurrent infections\"}, {\"id\": \"4811\"}, {\"id\": \"Hydrocephalus, Hemiparesis, Focal epilepsy\"}, {\"id\": \"128178\"}, {\"id\": \"Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive\"}, {\"id\": \"Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal dominant hypohidrotic ectodermal dysplasia\"}, {\"id\": \"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT\"}, {\"id\": \"Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive, Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant\"}, {\"id\": \"Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome\"}, {\"id\": \"88\"}, {\"id\": \"Familial hypertrophic cardiomyopathy 23\"}, {\"id\": \"Cardiomyopathy, Dilated cardiomyopathy 1AA, Familial hypertrophic cardiomyopathy 23\"}, {\"id\": \"Dilated cardiomyopathy 1AA, Cardiovascular phenotype\"}, {\"id\": \"Arrhythmogenic right ventricular cardiomyopathy\"}, {\"id\": \"4548\"}, {\"id\": \"METHYLCOBALAMIN DEFICIENCY, cblG TYPE\"}, {\"id\": \"Intellectual disability, profound, Inborn genetic diseases, METHYLCOBALAMIN DEFICIENCY, cblG TYPE, Seizure disorder, not provided\"}, {\"id\": \"6262\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia type 1, not provided\"}, {\"id\": \"Ventricular fibrillation, Catecholaminergic polymorphic ventricular tachycardia, Arrhythmogenic right ventricular dysplasia, familial, 2, Catecholaminergic polymorphic ventricular tachycardia type 1, not provided\"}, {\"id\": \"Long QT syndrome, Cardiovascular phenotype, not provided\"}, {\"id\": \"Long QT syndrome, Catecholaminergic polymorphic ventricular tachycardia, Arrhythmogenic right ventricular dysplasia, familial, 2\"}, {\"id\": \"Cardiac arrhythmia, not specified\"}, {\"id\": \"Arrhythmogenic right ventricular dysplasia, familial, 2\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia, not provided\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia type 1, Cardiovascular phenotype, not provided\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia type 1, Cardiovascular phenotype\"}, {\"id\": \"Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia type 1, Cardiovascular phenotype, not provided\"}, {\"id\": \"Inborn genetic diseases, Catecholaminergic polymorphic ventricular tachycardia, not provided\"}, {\"id\": \"Cardiac arrhythmia\"}, {\"id\": \"Left ventricular noncompaction cardiomyopathy\"}, {\"id\": \"56776\"}, {\"id\": \"Mental retardation, autosomal recessive 47, not provided\"}, {\"id\": \"Mental retardation, autosomal recessive 47\"}, {\"id\": \"64388\"}, {\"id\": \"Tooth agenesis, selective, 9\"}, {\"id\": \"2271\"}, {\"id\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"Multiple cutaneous leiomyomas\"}, {\"id\": \"Fumarase deficiency, not provided\"}, {\"id\": \"Multiple cutaneous leiomyomas, Fumarase deficiency, not provided\"}, {\"id\": \"Fumarase deficiency\"}, {\"id\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome, Fumarase deficiency, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Fumarase deficiency\"}, {\"id\": \"Multiple cutaneous leiomyomas, not provided\"}, {\"id\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome, Fumarase deficiency\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Fumarase deficiency, not provided\"}, {\"id\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Uterine leiomyoma, Multiple cutaneous leiomyomas, Cutaneous leiomyoma, Fumarase deficiency\"}, {\"id\": \"Multiple cutaneous leiomyomas, Fumarase deficiency\"}, {\"id\": \"9156\"}, {\"id\": \"10806\"}, {\"id\": \"Senior-Loken syndrome 7, Bardet-Biedl syndrome 16\"}, {\"id\": \"Senior-Loken syndrome 7\"}, {\"id\": \"Bardet-Biedl syndrome 16\"}, {\"id\": \"Bardet-Biedl syndrome, Senior-Loken syndrome 7, not provided\"}, {\"id\": \"Bardet-Biedl syndrome 16, not provided\"}, {\"id\": \"10000\"}, {\"id\": \"Macrocephalus, Global developmental delay, Polymicrogyria, Capillary hemangiomas, Inborn genetic diseases, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2\"}, {\"id\": \"Megalencephaly cutis marmorata telangiectatica congenita, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2\"}, {\"id\": \"Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2\"}, {\"id\": \"10472\"}, {\"id\": \"Mental retardation, autosomal dominant 22\"}, {\"id\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 22\"}, {\"id\": \"116228|HNRNPU-AS1\"}, {\"id\": \"3192\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 54\"}, {\"id\": \"Intellectual disability, Seizures, Epileptic encephalopathy\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 54, not provided\"}, {\"id\": \"heterogeneous nuclear ribonucleoprotein G, human\"}, {\"id\": \"Epileptic encephalopathy\"}, {\"id\": \"heterogeneous nuclear ribonucleoprotein G, human, Epileptic encephalopathy, early infantile, 54\"}, {\"id\": \"114548\"}, {\"id\": \"Keratitis fugax hereditaria\"}, {\"id\": \"Familial amyloid nephropathy with urticaria AND deafness, Familial cold urticaria, not provided\"}, {\"id\": \"Familial amyloid nephropathy with urticaria AND deafness, Chronic infantile neurological, cutaneous and articular syndrome, Cryopyrin associated periodic syndrome, Familial cold urticaria, not provided\"}, {\"id\": \"Familial cold urticaria, not provided\"}, {\"id\": \"Chronic infantile neurological, cutaneous and articular syndrome, Familial cold urticaria\"}, {\"id\": \"Familial amyloid nephropathy with urticaria AND deafness, Cryopyrin associated periodic syndrome, Familial cold urticaria, not provided\"}, {\"id\": \"Familial amyloid nephropathy with urticaria AND deafness, Familial cold urticaria\"}, {\"id\": \"Cryopyrin associated periodic syndrome, Familial cold urticaria, not provided\"}, {\"id\": \"Pericardial effusion, Fever, Pleural effusion\"}, {\"id\": \"Familial cold urticaria\"}, {\"id\": \"7173\"}, {\"id\": \"Deficiency of iodide peroxidase\"}, {\"id\": \"Deficiency of iodide peroxidase, not provided\"}, {\"id\": \"Delayed speech and language development, Congenital hypothyroidism, Global developmental delay, Delayed gross motor development, Short stature, Protruding tongue, Intellectual disability, severe\"}, {\"id\": \"Congenital hypothyroidism, Deficiency of iodide peroxidase\"}, {\"id\": \"7837\"}, {\"id\": \"Anterior segment dysgenesis 7\"}, {\"id\": \"23040\"}, {\"id\": \"Mental retardation, autosomal dominant 39, not provided\"}, {\"id\": \"Mental retardation, autosomal dominant 39\"}, {\"id\": \"51112\"}, {\"id\": \"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY, Progressive childhood encephalopathy\"}, {\"id\": \"246243\"}, {\"id\": \"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2\"}, {\"id\": \"6201\"}, {\"id\": \"Diamond-Blackfan anemia 8\"}, {\"id\": \"78989\"}, {\"id\": \"Carnevale syndrome\"}, {\"id\": \"6664\"}, {\"id\": \"Mental retardation, autosomal dominant 27\"}, {\"id\": \"57498\"}, {\"id\": \"Spastic paraplegia, intellectual disability, nystagmus, and obesity\"}, {\"id\": \"8462\"}, {\"id\": \"Maturity-onset diabetes of the young, type 7\"}, {\"id\": \"23175\"}, {\"id\": \"Myoglobinuria, acute recurrent, autosomal recessive\"}, {\"id\": \"Myoglobinuria, acute recurrent, autosomal recessive, not provided\"}, {\"id\": \"51594\"}, {\"id\": \"Infantile liver failure syndrome 2\"}, {\"id\": \"Short stature, optic nerve atrophy, and Pelger-Huet anomaly, not provided\"}, {\"id\": \"Short stature, optic nerve atrophy, and Pelger-Huet anomaly\"}, {\"id\": \"Fever-associated acute infantile liver failure syndrome\"}, {\"id\": \"4613|MYCNOS\"}, {\"id\": \"Medulloblastoma, Neuroblastoma, Pancreatic adenocarcinoma, Glioblastoma, Malignant neoplasm of body of uterus\"}, {\"id\": \"Feingold syndrome 1\"}, {\"id\": \"4613\"}, {\"id\": \"57539\"}, {\"id\": \"Cranioectodermal dysplasia 2, Short rib polydactyly syndrome 5\"}, {\"id\": \"Short rib polydactyly syndrome 5, not provided\"}, {\"id\": \"Cranioectodermal dysplasia 2, not provided\"}, {\"id\": \"Jeune thoracic dystrophy, Cranioectodermal dysplasia 2, Short rib polydactyly syndrome 5, WDR35-Related Disorders\"}, {\"id\": \"Short rib polydactyly syndrome 5\"}, {\"id\": \"SHORT-RIB THORACIC DYSPLASIA 7 WITHOUT POLYDACTYLY, not provided\"}, {\"id\": \"SHORT-RIB THORACIC DYSPLASIA 7 WITHOUT POLYDACTYLY, Short-rib thoracic dysplasia 7/20 with polydactyly, digenic, Jeune thoracic dystrophy, Short rib polydactyly syndrome 5\"}, {\"id\": \"4148|LOC101928222\"}, {\"id\": \"Spondyloepimetaphyseal dysplasia Matrilin-3 related\"}, {\"id\": \"4148\"}, {\"id\": \"Multiple epiphyseal dysplasia 5\"}, {\"id\": \"Multiple epiphyseal dysplasia 5, Multiple Epiphyseal Dysplasia, Dominant\"}, {\"id\": \"338\"}, {\"id\": \"Hypobetalipoproteinemia\"}, {\"id\": \"Familial hypobetalipoproteinemia\"}, {\"id\": \"Hypercholesterolemia, autosomal dominant, type B, Hypobetalipoproteinemia, familial, 1\"}, {\"id\": \"Hypercholesterolemia, autosomal dominant, type B\"}, {\"id\": \"Hypobetalipoproteinemia, familial, 1\"}, {\"id\": \"Hypobetalipoproteinemia, normotriglyceridemic\"}, {\"id\": \"338|LOC106560211\"}, {\"id\": \"50618\"}, {\"id\": \"Epilepsy, focal, with speech disorder and with or without mental retardation\"}, {\"id\": \"5443\"}, {\"id\": \"Proopiomelanocortin deficiency\"}, {\"id\": \"1788\"}, {\"id\": \"Tatton-Brown-rahman syndrome\"}, {\"id\": \"Acute myeloid leukemia\"}, {\"id\": \"Acute myeloid leukemia, Lung adenocarcinoma, Myelodysplastic syndrome\"}, {\"id\": \"Acute myeloid leukemia, Lung adenocarcinoma, Myelodysplastic syndrome, Tatton-Brown-rahman syndrome\"}, {\"id\": \"Acute myeloid leukemia, Tatton-Brown-rahman syndrome\"}, {\"id\": \"Inborn genetic diseases, Tatton-Brown-rahman syndrome\"}, {\"id\": \"Early T cell progenitor acute lymphoblastic leukemia\"}, {\"id\": \"55252\"}, {\"id\": \"Shashi-Pena syndrome\"}, {\"id\": \"3030|GAREM2\"}, {\"id\": \"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency\"}, {\"id\": \"Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, not provided\"}, {\"id\": \"Mitochondrial trifunctional protein deficiency\"}, {\"id\": \"Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency\"}, {\"id\": \"Mitochondrial trifunctional protein deficiency, not provided\"}, {\"id\": \"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, not provided\"}, {\"id\": \"Inborn genetic diseases, Lchad deficiency with maternal acute fatty liver of pregnancy, Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, LCHAD Deficiency, not provided\"}, {\"id\": \"3030\"}, {\"id\": \"3032\"}, {\"id\": \"92749\"}, {\"id\": \"Ciliary dyskinesia, Ciliary dyskinesia, primary, 21, Kartagener syndrome, not provided\"}, {\"id\": \"Ciliary dyskinesia\"}, {\"id\": \"Ciliary dyskinesia, primary, 21, Kartagener syndrome\"}, {\"id\": \"9381\"}, {\"id\": \"Auditory neuropathy, autosomal recessive, 1\"}, {\"id\": \"Deafness, autosomal recessive 9\"}, {\"id\": \"Deafness, autosomal recessive 9, Nonsyndromic hearing loss and deafness, not provided\"}, {\"id\": \"Deafness, autosomal recessive 9, Auditory neuropathy, autosomal recessive, 1\"}, {\"id\": \"Deafness, autosomal recessive 9, Nonsyndromic hearing loss and deafness\"}, {\"id\": \"Hearing impairment, Deafness, autosomal recessive 9\"}, {\"id\": \"Deafness, autosomal recessive 9, not provided\"}, {\"id\": \"Hearing impairment\"}, {\"id\": \"Deafness, autosomal recessive 9, Auditory neuropathy, autosomal recessive, 1, Nonsyndromic hearing loss and deafness\"}, {\"id\": \"3777\"}, {\"id\": \"Primary pulmonary hypertension 4\"}, {\"id\": \"Primary pulmonary hypertension 4, Primary pulmonary hypertension\"}, {\"id\": \"60509\"}, {\"id\": \"Retinitis pigmentosa 75\"}, {\"id\": \"790\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 50, not provided\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 50\"}, {\"id\": \"57159\"}, {\"id\": \"4358\"}, {\"id\": \"Navajo neurohepatopathy\"}, {\"id\": \"Navajo neurohepatopathy, not provided\"}, {\"id\": \"Navajo neurohepatopathy, MPV17-Related Disorders, not provided\"}, {\"id\": \"MPV17-related mitochondrial DNA maintenance defect, Navajo neurohepatopathy\"}, {\"id\": \"8890\"}, {\"id\": \"Ovarioleukodystrophy\"}, {\"id\": \"130557\"}, {\"id\": \"Retinitis pigmentosa 58\"}, {\"id\": \"26160|KRTCAP3\"}, {\"id\": \"Short-rib thoracic dysplasia 10 with or without polydactyly\"}, {\"id\": \"Retinitis pigmentosa 71\"}, {\"id\": \"26160\"}, {\"id\": \"Joubert syndrome, Short-rib thoracic dysplasia 10 with or without polydactyly\"}, {\"id\": \"Short-rib thoracic dysplasia 10 without polydactyly\"}, {\"id\": \"Short-rib thoracic dysplasia 10 with polydactyly\"}, {\"id\": \"Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71\"}, {\"id\": \"2646\"}, {\"id\": \"Fasting plasma glucose level quantitative trait locus 5\"}, {\"id\": \"5500\"}, {\"id\": \"Noonan syndrome-like disorder with loose anagen hair 2, not provided\"}, {\"id\": \"Noonan syndrome-like disorder with loose anagen hair 2\"}, {\"id\": \"388939\"}, {\"id\": \"Retinitis pigmentosa 54\"}, {\"id\": \"238\"}, {\"id\": \"Neuroblastoma, Neuroblastoma 3\"}, {\"id\": \"Neuroblastoma, Neoplasm of the breast\"}, {\"id\": \"Neuroblastoma, Neoplasm of brain, Neoplasm of the breast, Neuroblastoma 3\"}, {\"id\": \"Lung adenocarcinoma, Non-small cell lung cancer\"}, {\"id\": \"Neuroblastoma\"}, {\"id\": \"Neuroblastoma 3\"}, {\"id\": \"Rhabdomyosarcoma\"}, {\"id\": \"Neuroblastoma, Neoplasm of brain, Neuroblastoma 3\"}, {\"id\": \"Neuroblastoma, Lung adenocarcinoma, Neuroblastoma 3\"}, {\"id\": \"Neuroblastoma, Lung adenocarcinoma, Non-small cell lung cancer, Benign Soft Tissue Neoplasm of Uncertain Differentiation, Neuroblastoma 3\"}, {\"id\": \"79623\"}, {\"id\": \"7498\"}, {\"id\": \"Xanthinuria type 2\"}, {\"id\": \"Deficiency of xanthine oxidase\"}, {\"id\": \"Deficiency of xanthine oxidase, Xanthinuria type 2\"}, {\"id\": \"6716\"}, {\"id\": \"3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency\"}, {\"id\": \"Micropenis, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, not provided\"}, {\"id\": \"3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, not provided\"}, {\"id\": \"Micropenis\"}, {\"id\": \"6683\"}, {\"id\": \"Spastic paraplegia 4, autosomal dominant\"}, {\"id\": \"Spastic paraplegia 4, autosomal dominant, not provided\"}, {\"id\": \"Spastic paraplegia, Spastic paraplegia 4, autosomal dominant\"}, {\"id\": \"Seizures, Fatigue, Abnormal myelination\"}, {\"id\": \"Hereditary spastic paraplegia\"}, {\"id\": \"Inborn genetic diseases, Spastic paraplegia 4, autosomal dominant, not provided\"}, {\"id\": \"Spastic paraparesis, Spastic paraplegia 4, autosomal dominant, not provided\"}, {\"id\": \"Spastic paraparesis\"}, {\"id\": \"58484\"}, {\"id\": \"Familial cold autoinflammatory syndrome 4\"}, {\"id\": \"Autoinflammation with infantile enterocolitis, Syndrome of entercolitis and autoinflmmation caused by mutation of NLRC4 (SCAN4), not provided\"}, {\"id\": \"Autoinflammation with infantile enterocolitis\"}, {\"id\": \"55471\"}, {\"id\": \"1545\"}, {\"id\": \"Glaucoma 3, primary congenital, A, not provided\"}, {\"id\": \"Glaucoma 3, primary congenital, A\"}, {\"id\": \"Glaucoma 3, primary congenital, A, Glaucoma, primary open angle, juvenile-onset\"}, {\"id\": \"Congenital glaucoma, not provided\"}, {\"id\": \"Irido-corneo-trabecular dysgenesis, Congenital glaucoma, Glaucoma 3, primary congenital, A, Anterior segment dysgenesis 6, CYP1B1-Related Disorders, not provided\"}, {\"id\": \"Anterior segment dysgenesis 6\"}, {\"id\": \"6654\"}, {\"id\": \"Noonan syndrome, Rasopathy, not provided\"}, {\"id\": \"Noonan syndrome 3, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 4, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 4, Gingival fibromatosis 1, Rasopathy, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 4, Rasopathy, not provided\"}, {\"id\": \"Abnormality of the aortic valve, Noonan syndrome, Rasopathy, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 3, not provided\"}, {\"id\": \"Noonan syndrome, Inborn genetic diseases, Rasopathy, not provided\"}, {\"id\": \"Ptosis, Abnormality of the sternum, Pulmonic stenosis, Short stature, Noonan syndrome\"}, {\"id\": \"Noonan syndrome, Inborn genetic diseases, Noonan syndrome 4, Rasopathy, not provided\"}, {\"id\": \"Lung adenocarcinoma, Malignant neoplasm of body of uterus\"}, {\"id\": \"Rasopathy\"}, {\"id\": \"91461\"}, {\"id\": \"57504\"}, {\"id\": \"23498|MTA3\"}, {\"id\": \"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1, Congenital NAD deficiency disorder\"}, {\"id\": \"51626\"}, {\"id\": \"Short-rib thoracic dysplasia 15 with polydactyly\"}, {\"id\": \"Short-rib thoracic dysplasia 1 with or without polydactyly, Short-rib thoracic dysplasia 15 with polydactyly\"}, {\"id\": \"51626|ABCG5\"}, {\"id\": \"Sitosterolemia\"}, {\"id\": \"64240\"}, {\"id\": \"64240|ABCG8\"}, {\"id\": \"64241\"}, {\"id\": \"Sitosterolemia, not provided\"}, {\"id\": \"10128\"}, {\"id\": \"Leigh syndrome, French Canadian type\"}, {\"id\": \"6519\"}, {\"id\": \"Cystinuria\"}, {\"id\": \"Cystinuria, not provided\"}, {\"id\": \"6519|PREPL\"}, {\"id\": \"9581\"}, {\"id\": \"Myasthenic syndrome, congenital, 22\"}, {\"id\": \"6496\"}, {\"id\": \"Holoprosencephaly 2, not specified\"}, {\"id\": \"SCHIZENCEPHALY, Holoprosencephaly 2\"}, {\"id\": \"SCHIZENCEPHALY\"}, {\"id\": \"Holoprosencephaly 2\"}, {\"id\": \"10736\"}, {\"id\": \"2034\"}, {\"id\": \"Erythrocytosis, familial, 4\"}, {\"id\": \"9419\"}, {\"id\": \"Short stature with microcephaly and distinctive facies\"}, {\"id\": \"90411\"}, {\"id\": \"Factor v and factor viii, combined deficiency of, 2\"}, {\"id\": \"57217\"}, {\"id\": \"Multiple gastrointestinal atresias, not provided\"}, {\"id\": \"Multiple gastrointestinal atresias\"}, {\"id\": \"805\"}, {\"id\": \"Long QT syndrome 1\"}, {\"id\": \"Long QT syndrome 15\"}, {\"id\": \"Long QT syndrome 15, Long QT syndrome 1\"}, {\"id\": \"4072\"}, {\"id\": \"Lynch syndrome\"}, {\"id\": \"Diarrhea 5, with tufting enteropathy, congenital\"}, {\"id\": \"Diarrhea 5, with tufting enteropathy, congenital, not provided\"}, {\"id\": \"Lynch syndrome, Diarrhea 5, with tufting enteropathy, congenital\"}, {\"id\": \"Hereditary nonpolyposis colon cancer\"}, {\"id\": \"4436\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome I, not specified, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, not provided\"}, {\"id\": \"Lynch syndrome I\"}, {\"id\": \"Lynch syndrome, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Malignant tumor of sigmoid colon, Lynch syndrome, not provided\"}, {\"id\": \"Lynch syndrome, Lynch syndrome I\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, Colorectal cancer, hereditary, nonpolyposis, type 1, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome I\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Carcinoma of colon, Lynch syndrome, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Muir-Torr\\u00e9 syndrome, Lynch syndrome, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Malignant tumor of ascending colon, Lynch syndrome, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified\"}, {\"id\": \"Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\"}, {\"id\": \"2956\"}, {\"id\": \"Endometrial carcinoma, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\"}, {\"id\": \"Hereditary nonpolyposis colorectal cancer type 5\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, not specified, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not specified, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal cancer type 5, Lynch syndrome I, not specified\"}, {\"id\": \"Endometrial carcinoma, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal cancer type 5, Lynch syndrome I, not provided\"}, {\"id\": \"Turcot syndrome, not provided\"}, {\"id\": \"Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5\"}, {\"id\": \"80204\"}, {\"id\": \"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES\"}, {\"id\": \"3973|STON1-GTF2A1L\"}, {\"id\": \"Leydig cell hypoplasia, partial\"}, {\"id\": \"Leydig cell agenesis\"}, {\"id\": \"Leydig hypoplasia, type I\"}, {\"id\": \"Leydig cell agenesis, Luteinizing hormone resistance, female\"}, {\"id\": \"Precocious puberty in males, Gonadotropin-independent familial sexual precocity, not provided\"}, {\"id\": \"Gonadotropin-independent familial sexual precocity\"}, {\"id\": \"Leydig cell adenoma, somatic, with male-limited precocious puberty\"}, {\"id\": \"Gonadotropin-independent familial sexual precocity, not provided\"}, {\"id\": \"Precocious puberty in males, Gonadotropin-independent familial sexual precocity\"}, {\"id\": \"Pseudohermaphroditism\"}, {\"id\": \"2492\"}, {\"id\": \"Ovarian dysgenesis 1\"}, {\"id\": \"Ovarian hyperstimulation syndrome\"}, {\"id\": \"Ovarian dysgenesis 1, not provided\"}, {\"id\": \"Amenorrhea\"}, {\"id\": \"9378\"}, {\"id\": \"Pitt-Hopkins-like syndrome 2\"}, {\"id\": \"130162\"}, {\"id\": \"Waddling gait, Marked Hypotonia\"}, {\"id\": \"87178\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 13\"}, {\"id\": \"Deafness, autosomal recessive 70\"}, {\"id\": \"2202\"}, {\"id\": \"Blindness, Nyctalopia, Retinal pigment epithelial atrophy, Macular dystrophy, Optic disc drusen\"}, {\"id\": \"Doyne honeycomb retinal dystrophy, Malattia leventinese, not provided\"}, {\"id\": \"7444|FANCL\"}, {\"id\": \"Fanconi anemia\"}, {\"id\": \"55120\"}, {\"id\": \"Fanconi anemia, complementation group L\"}, {\"id\": \"53335\"}, {\"id\": \"Fetal hemoglobin quantitative trait locus 5\"}, {\"id\": \"Intellectual developmental disorder with persistence of fetal hemoglobin\"}, {\"id\": \"Microcephaly, Intellectual disability, Global developmental delay, Profound global developmental delay\"}, {\"id\": \"5194\"}, {\"id\": \"Peroxisome biogenesis disorder 11A\"}, {\"id\": \"Peroxisome biogenesis disorder 11B\"}, {\"id\": \"7514\"}, {\"id\": \"Chronic lymphocytic leukemia, Neoplasm of the breast, Neoplasm of the large intestine, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\"}, {\"id\": \"84140\"}, {\"id\": \"Retinitis pigmentosa 28\"}, {\"id\": \"Retinitis pigmentosa 28, not provided\"}, {\"id\": \"Retinitis pigmentosa 28, Cone-rod dystrophy, not provided\"}, {\"id\": \"23301\"}, {\"id\": \"Prostate cancer, hereditary, 12\"}, {\"id\": \"51057\"}, {\"id\": \"Bardet-Biedl syndrome 15\"}, {\"id\": \"6509\"}, {\"id\": \"Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, not provided\"}, {\"id\": \"Spastic tetraplegia, thin corpus callosum, and progressive microcephaly\"}, {\"id\": \"Inborn genetic diseases, Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, not provided\"}, {\"id\": \"10887\"}, {\"id\": \"84168\"}, {\"id\": \"Odontotrichomelic syndrome\"}, {\"id\": \"2673\"}, {\"id\": \"Congenital myasthenic syndrome 12\"}, {\"id\": \"27247\"}, {\"id\": \"Multiple mitochondrial dysfunctions syndrome 1, not provided\"}, {\"id\": \"Multiple mitochondrial dysfunctions syndrome 1\"}, {\"id\": \"7072\"}, {\"id\": \"Welander distal myopathy, not provided\"}, {\"id\": \"84908\"}, {\"id\": \"M\\u00e9ni\\u00e8re's disease\"}, {\"id\": \"50489\"}, {\"id\": \"Birbeck granule deficiency\"}, {\"id\": \"525\"}, {\"id\": \"Renal tubular acidosis, distal, with progressive deafness\"}, {\"id\": \"Inborn genetic diseases, Renal tubular acidosis, distal, with progressive deafness\"}, {\"id\": \"Nephrocalcinosis, Nephrolithiasis, Renal tubular acidosis, distal, with progressive deafness\"}, {\"id\": \"Renal tubular acidosis with progressive nerve deafness\"}, {\"id\": \"Renal tubular acidosis with progressive nerve deafness, not provided\"}, {\"id\": \"84693\"}, {\"id\": \"Methylmalonyl-CoA epimerase deficiency, not provided\"}, {\"id\": \"8291\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2B\"}, {\"id\": \"Dysferlinopathy\"}, {\"id\": \"Dysferlinopathy, not provided\"}, {\"id\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, not provided\"}, {\"id\": \"Myopathy, distal, with anterior tibial onset, Miyoshi muscular dystrophy 1, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy\"}, {\"id\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy, not provided\"}, {\"id\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B\"}, {\"id\": \"Miyoshi muscular dystrophy 1, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2B, not provided\"}, {\"id\": \"DYSF- Related Disorder, Miyoshi muscular dystrophy 1, not provided\"}, {\"id\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, DYSF-Related Disorders, not provided\"}, {\"id\": \"not provided, Miyoshi muscular dystrophy 1, not provided\"}, {\"id\": \"not provided, Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy, not provided\"}, {\"id\": \"Foot dorsiflexor weakness, Peroneal muscle atrophy, Distal lower limb muscle weakness, Absent muscle fiber dysferlin\"}, {\"id\": \"not provided, not provided\"}, {\"id\": \"DYSF-Related Disorders, not provided\"}, {\"id\": \"not provided, Miyoshi muscular dystrophy 1, Dysferlinopathy, not provided\"}, {\"id\": \"Proximal muscle weakness, Limb-girdle muscular dystrophy, type 2B\"}, {\"id\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy\"}, {\"id\": \"Myopathy, distal, with anterior tibial onset, Dysferlinopathy\"}, {\"id\": \"8291|LOC110121121\"}, {\"id\": \"not provided, Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, not provided\"}, {\"id\": \"Myopathy, distal, with anterior tibial onset, Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, not provided\"}, {\"id\": \"56603\"}, {\"id\": \"Radiohumeral fusions with other skeletal and craniofacial anomalies, not provided\"}, {\"id\": \"23233\"}, {\"id\": \"6697\"}, {\"id\": \"Sepiapterin reductase deficiency\"}, {\"id\": \"Sepiapterin reductase deficiency, not provided\"}, {\"id\": \"Dystonia, Sepiapterin reductase deficiency, not provided\"}, {\"id\": \"10574\"}, {\"id\": \"Myocardial infarction 1\"}, {\"id\": \"7840\"}, {\"id\": \"Alstrom syndrome\"}, {\"id\": \"Alstrom syndrome, not provided\"}, {\"id\": \"51002\"}, {\"id\": \"GALLOWAY-MOWAT SYNDROME 5\"}, {\"id\": \"10617\"}, {\"id\": \"Microcephaly-capillary malformation syndrome, not provided\"}, {\"id\": \"Microcephaly-capillary malformation syndrome\"}, {\"id\": \"72\"}, {\"id\": \"Chronic intestinal pseudoobstruction\"}, {\"id\": \"Visceral myopathy, not provided\"}, {\"id\": \"Visceral myopathy, Chronic intestinal pseudoobstruction\"}, {\"id\": \"Inborn genetic diseases, Visceral myopathy\"}, {\"id\": \"Megacystis, Inborn genetic diseases, Visceral myopathy, Chronic intestinal pseudoobstruction, Visceral neuropathy, familial, autosomal dominant, not provided\"}, {\"id\": \"Megacystis, Inborn genetic diseases, Chronic intestinal pseudoobstruction\"}, {\"id\": \"1716\"}, {\"id\": \"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4\"}, {\"id\": \"MITOCHONDRIAL DNA DEPLETION SYNDROME 3, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, Portal hypertension, noncirrhotic\"}, {\"id\": \"Mitochondrial DNA-depletion syndrome 3, hepatocerebral\"}, {\"id\": \"Mitochondrial DNA-depletion syndrome 3, hepatocerebral, not provided\"}, {\"id\": \"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, not provided\"}, {\"id\": \"1716|DGUOK-AS1\"}, {\"id\": \"MITOCHONDRIAL DNA DEPLETION SYNDROME 3\"}, {\"id\": \"388962\"}, {\"id\": \"Multiple mitochondrial dysfunctions syndrome 2\"}, {\"id\": \"1639\"}, {\"id\": \"Perry syndrome\"}, {\"id\": \"Distal hereditary motor neuronopathy type 7B, Amyotrophic lateral sclerosis type 1, Perry syndrome\"}, {\"id\": \"7841\"}, {\"id\": \"Congenital disorder of glycosylation type 2B\"}, {\"id\": \"27429\"}, {\"id\": \"3-methylglutaconic aciduria, type VIII\"}, {\"id\": \"27429|LOXL3\"}, {\"id\": \"1496\"}, {\"id\": \"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9\"}, {\"id\": \"8802\"}, {\"id\": \"Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)\"}, {\"id\": \"84173\"}, {\"id\": \"Deafness, autosomal recessive 88\"}, {\"id\": \"2677\"}, {\"id\": \"Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency\"}, {\"id\": \"Vitamin k-dependent clotting factors, combined deficiency of, 1\"}, {\"id\": \"6439\"}, {\"id\": \"Surfactant metabolism dysfunction, pulmonary, 1\"}, {\"id\": \"8869\"}, {\"id\": \"Salt and pepper developmental regression syndrome\"}, {\"id\": \"25885\"}, {\"id\": \"Acrofacial dysostosis, Cincinnati type\"}, {\"id\": \"65055\"}, {\"id\": \"Spastic paraplegia 31, autosomal dominant\"}, {\"id\": \"Distal hereditary motor neuronopathy type 5B\"}, {\"id\": \"Spastic paraplegia 31, autosomal dominant, not provided\"}, {\"id\": \"925\"}, {\"id\": \"Cd8 deficiency, familial\"}, {\"id\": \"9451|LOC101928371\"}, {\"id\": \"Wolcott-Rallison dysplasia\"}, {\"id\": \"9451\"}, {\"id\": \"22934\"}, {\"id\": \"Deficiency of ribose-5-phosphate isomerase\"}, {\"id\": \"151\"}, {\"id\": \"55654\"}, {\"id\": \"Pheochromocytoma, Hereditary cancer-predisposing syndrome, Pheochromocytoma, susceptibility to\"}, {\"id\": \"Hereditary Paraganglioma-Pheochromocytoma Syndromes, not provided\"}, {\"id\": \"Pheochromocytoma, Pheochromocytoma, susceptibility to\"}, {\"id\": \"23020\"}, {\"id\": \"Retinitis pigmentosa 33\"}, {\"id\": \"Retinitis pigmentosa, Retinitis pigmentosa 33\"}, {\"id\": \"23397\"}, {\"id\": \"MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE\"}, {\"id\": \"81562\"}, {\"id\": \"Mental retardation, autosomal recessive 52\"}, {\"id\": \"26504\"}, {\"id\": \"Cone-rod dystrophy amelogenesis imperfecta\"}, {\"id\": \"7535\"}, {\"id\": \"Combined immunodeficiency, Autoimmune disease, multisystem, infantile-onset, 2\"}, {\"id\": \"Severe combined immunodeficiency, atypical\"}, {\"id\": \"Severe combined immunodeficiency, atypical, not provided\"}, {\"id\": \"200403\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 22\"}, {\"id\": \"1261\"}, {\"id\": \"Achromatopsia 2, not provided\"}, {\"id\": \"Achromatopsia 2\"}, {\"id\": \"Achromatopsia, not provided\"}, {\"id\": \"Abnormality of color vision, Macular degeneration, Photophobia, Achromatopsia, Achromatopsia 2\"}, {\"id\": \"Monochromacy, Achromatopsia 2\"}, {\"id\": \"Macular dystrophy, Achromatopsia, not provided\"}, {\"id\": \"Achromatopsia, Achromatopsia 2\"}, {\"id\": \"Abnormality of the eye, not provided\"}, {\"id\": \"493753\"}, {\"id\": \"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3\"}, {\"id\": \"80705\"}, {\"id\": \"SPERMATOGENIC FAILURE 26\"}, {\"id\": \"51601|MITD1\"}, {\"id\": \"Lipoyltransferase 1 deficiency\"}, {\"id\": \"Lipoyltransferase 1 deficiency, not provided\"}, {\"id\": \"3899\"}, {\"id\": \"4862|LOC101927142\"}, {\"id\": \"Non-obstructive azoospermia\"}, {\"id\": \"9448\"}, {\"id\": \"5455\"}, {\"id\": \"60482\"}, {\"id\": \"Myasthenic syndrome, congenital, 20, presynaptic\"}, {\"id\": \"5903\"}, {\"id\": \"Encephalopathy, acute, infection-induced, 3, suceptibility to\"}, {\"id\": \"5903|EDAR\"}, {\"id\": \"Autosomal dominant hypohidrotic ectodermal dysplasia\"}, {\"id\": \"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal dominant hypohidrotic ectodermal dysplasia, not provided\"}, {\"id\": \"Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Autosomal dominant hypohidrotic ectodermal dysplasia\"}, {\"id\": \"Autosomal recessive hypohidrotic ectodermal dysplasia syndrome\"}, {\"id\": \"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Autosomal dominant hypohidrotic ectodermal dysplasia, not provided\"}, {\"id\": \"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant\"}, {\"id\": \"Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Autosomal dominant hypohidrotic ectodermal dysplasia, not provided\"}, {\"id\": \"Ectodermal dysplasia\"}, {\"id\": \"Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4B, MNGIE type, Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome\"}, {\"id\": \"Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4B, MNGIE type\"}, {\"id\": \"4867\"}, {\"id\": \"Nephronophthisis 1\"}, {\"id\": \"Nephronophthisis, Nephronophthisis 1\"}, {\"id\": \"Nephronophthisis\"}, {\"id\": \"Nephronophthisis, Nephronophthisis 1, not provided\"}, {\"id\": \"699\"}, {\"id\": \"Colorectal cancer with chromosomal instability\"}, {\"id\": \"10461\"}, {\"id\": \"Retinitis pigmentosa 38\"}, {\"id\": \"Inborn genetic diseases, Retinitis pigmentosa 38\"}, {\"id\": \"84910\"}, {\"id\": \"150468\"}, {\"id\": \"Filippi syndrome\"}, {\"id\": \"26525\"}, {\"id\": \"Pustular psoriasis, generalized\"}, {\"id\": \"3557\"}, {\"id\": \"Osteomyelitis, sterile multifocal, with periostitis and pustulosis, not provided\"}, {\"id\": \"7849|PAX8-AS1\"}, {\"id\": \"Thyroid dysgenesis\"}, {\"id\": \"55240|STEAP3-AS1\"}, {\"id\": \"Hypochromic microcytic anemia with iron overload 2\"}, {\"id\": \"2736\"}, {\"id\": \"Holoprosencephaly 9\"}, {\"id\": \"Culler-Jones syndrome\"}, {\"id\": \"Holoprosencephaly 9, Culler-Jones syndrome\"}, {\"id\": \"23332|RNU4ATAC\"}, {\"id\": \"Roifman syndrome\"}, {\"id\": \"Osteodysplastic primordial dwarfism, type 1\"}, {\"id\": \"Roifman syndrome, Osteodysplastic primordial dwarfism, type 1\"}, {\"id\": \"274\"}, {\"id\": \"Autosomal recessive centronuclear myopathy\"}, {\"id\": \"2071\"}, {\"id\": \"Xeroderma pigmentosum, complementation group b\"}, {\"id\": \"Trichothiodystrophy 2, photosensitive\"}, {\"id\": \"5624\"}, {\"id\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant\"}, {\"id\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant, not provided\"}, {\"id\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive\"}, {\"id\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant, Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive\"}, {\"id\": \"55679\"}, {\"id\": \"MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE\"}, {\"id\": \"112714\"}, {\"id\": \"Seizures, Global developmental delay, Lissencephaly, Primary microcephaly\"}, {\"id\": \"84317\"}, {\"id\": \"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo, Congenital disorders of glycosylation type II\"}, {\"id\": \"55997\"}, {\"id\": \"Heterotaxy, visceral, 2, autosomal\"}, {\"id\": \"113457|MZT2A\"}, {\"id\": \"KERATOCONUS 9\"}, {\"id\": \"22930\"}, {\"id\": \"Warburg micro syndrome 1\"}, {\"id\": \"Warburg micro syndrome 1, not provided\"}, {\"id\": \"22930|ZRANB3\"}, {\"id\": \"3938\"}, {\"id\": \"Congenital lactase deficiency\"}, {\"id\": \"1615\"}, {\"id\": \"Hypomyelination with brainstem and spinal cord involvement and leg spasticity\"}, {\"id\": \"Hypomyelination with brainstem and spinal cord involvement and leg spasticity, not provided\"}, {\"id\": \"7852\"}, {\"id\": \"Warts, hypogammaglobulinemia, infections, and myelokathexis\"}, {\"id\": \"Warts, hypogammaglobulinemia, infections, and myelokathexis, Myelokathexis, isolated\"}, {\"id\": \"3176\"}, {\"id\": \"Mental retardation, autosomal recessive 51\"}, {\"id\": \"8942\"}, {\"id\": \"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2, Congenital NAD deficiency disorder\"}, {\"id\": \"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2, Congenital NAD deficiency disorder, not provided\"}, {\"id\": \"Hydroxykynureninuria\"}, {\"id\": \"9839\"}, {\"id\": \"Mowat-Wilson syndrome\"}, {\"id\": \"Smith-Magenis Syndrome-like\"}, {\"id\": \"Mowat-Wilson syndrome, not provided\"}, {\"id\": \"Mowat-Wilson syndrome, History of neurodevelopmental disorder\"}, {\"id\": \"Inborn genetic diseases, Mowat-Wilson syndrome\"}, {\"id\": \"9839|LOC111721705\"}, {\"id\": \"5000\"}, {\"id\": \"Meier-Gorlin syndrome 2\"}, {\"id\": \"Meier-Gorlin syndrome 2, not provided\"}, {\"id\": \"55777\"}, {\"id\": \"Mental retardation, autosomal dominant 1\"}, {\"id\": \"Mental retardation, autosomal dominant 1, not provided\"}, {\"id\": \"Inborn genetic diseases, Autism spectrum disorder\"}, {\"id\": \"3800\"}, {\"id\": \"Cortical dysplasia, complex, with other brain malformations 2, not provided\"}, {\"id\": \"Cortical dysplasia, complex, with other brain malformations 2\"}, {\"id\": \"27249\"}, {\"id\": \"Homocystinuria, cblD type, variant 1\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria cblD\"}, {\"id\": \"Methylmalonic acidemia with homocystinuria cblD, Methylmalonic aciduria, cblD type, variant 2\"}, {\"id\": \"4703|RIF1\"}, {\"id\": \"Nemaline myopathy 2\"}, {\"id\": \"Nemaline myopathy 2, not provided\"}, {\"id\": \"Nemaline myopathy\"}, {\"id\": \"Nemaline myopathy, Nemaline myopathy 2\"}, {\"id\": \"Muscular dystrophy, Progressive proximal muscle weakness, Limb pain, Nemaline myopathy 2, not provided\"}, {\"id\": \"4703\"}, {\"id\": \"Non-immune hydrops fetalis, Nemaline myopathy 2\"}, {\"id\": \"Inborn genetic diseases, Nemaline myopathy 2\"}, {\"id\": \"Nemaline myopathy 2, autosomal recessive\"}, {\"id\": \"785\"}, {\"id\": \"Epilepsy, idiopathic generalized 9\"}, {\"id\": \"2820\"}, {\"id\": \"Diabetes mellitus type 2\"}, {\"id\": \"90\"}, {\"id\": \"Progressive myositis ossificans\"}, {\"id\": \"Brainstem glioma\"}, {\"id\": \"Brainstem glioma, Inborn genetic diseases, Progressive myositis ossificans\"}, {\"id\": \"Brainstem glioma, Adenocarcinoma of stomach\"}, {\"id\": \"Brainstem glioma, Progressive myositis ossificans, Adenocarcinoma of stomach\"}, {\"id\": \"Progressive myositis ossificans, not provided\"}, {\"id\": \"3694\"}, {\"id\": \"Amelogenesis imperfecta, type IH\"}, {\"id\": \"Adolescent alopeciam dentogingival abnormalitites and intellectual disability\"}, {\"id\": \"10716\"}, {\"id\": \"Autistic behavior, Moderate global developmental delay\"}, {\"id\": \"Autistic behavior, Severe global developmental delay\"}, {\"id\": \"Moderate global developmental delay\"}, {\"id\": \"Autism 5\"}, {\"id\": \"64135\"}, {\"id\": \"Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1\"}, {\"id\": \"Singleton-Merten syndrome 1, not provided\"}, {\"id\": \"Neonatal hypotonia, Hyperreflexia, Abnormal upper motor neuron morphology, Abnormality of the basal ganglia, Clonus, Developmental regression, Abnormality of the cerebral white matter, Aicardi-Goutieres syndrome 7, not provided\"}, {\"id\": \"Aicardi-Goutieres syndrome 7, not provided\"}, {\"id\": \"Aicardi-Goutieres syndrome 7\"}, {\"id\": \"6328\"}, {\"id\": \"Inborn genetic diseases, Early infantile epileptic encephalopathy 62\"}, {\"id\": \"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4\"}, {\"id\": \"Early infantile epileptic encephalopathy 62, not provided\"}, {\"id\": \"Polymicrogyria, Developmental delay, Early infantile epileptic encephalopathy 62, not provided\"}, {\"id\": \"6326\"}, {\"id\": \"Early infantile epileptic encephalopathy 11\"}, {\"id\": \"Early infantile epileptic encephalopathy 11, not provided\"}, {\"id\": \"Benign familial neonatal-infantile seizures\"}, {\"id\": \"Focal epilepsy\"}, {\"id\": \"Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11\"}, {\"id\": \"SCN2A-related condition, Epileptic encephalopathy, Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11, not provided\"}, {\"id\": \"Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11, not provided\"}, {\"id\": \"Seizures, not provided\"}, {\"id\": \"Epileptic encephalopathy, Early infantile epileptic encephalopathy 11\"}, {\"id\": \"Seizures, Episodic ataxia, Vertigo, Early infantile epileptic encephalopathy 11, not provided\"}, {\"id\": \"Mental retardation, autosomal dominant\"}, {\"id\": \"Epileptic encephalopathy, not provided\"}, {\"id\": \"Benign familial neonatal-infantile seizures, not provided\"}, {\"id\": \"Malignant migrating partial seizures of infancy\"}, {\"id\": \"Inborn genetic diseases, Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11, not provided\"}, {\"id\": \"2591\"}, {\"id\": \"Tumoral calcinosis, familial, hyperphosphatemic\"}, {\"id\": \"Tumoral calcinosis, familial, hyperphosphatemic, not provided\"}, {\"id\": \"79809\"}, {\"id\": \"Type IV short rib polydactyly syndrome, Asphyxiating thoracic dystrophy 4\"}, {\"id\": \"Nephronophthisis, Jeune thoracic dystrophy\"}, {\"id\": \"Nephronophthisis 12\"}, {\"id\": \"Short rib-polydactyly syndrome, Majewski type\"}, {\"id\": \"Asphyxiating thoracic dystrophy 4\"}, {\"id\": \"Type IV short rib polydactyly syndrome\"}, {\"id\": \"Asphyxiating thoracic dystrophy 4, not provided\"}, {\"id\": \"79809|TTC21B-AS1\"}, {\"id\": \"Nephronophthisis, Jeune thoracic dystrophy, Nephronophthisis 12, not provided\"}, {\"id\": \"6323|LOC102724058\"}, {\"id\": \"Early infantile epileptic encephalopathy\"}, {\"id\": \"Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"Autosomal dominant epilepsy\"}, {\"id\": \"Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 1, Severe myoclonic epilepsy in infancy\"}, {\"id\": \"Seizures, Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy\"}, {\"id\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 1, Generalized epilepsy with febrile seizures plus, type 2\"}, {\"id\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"Inborn genetic diseases, Epileptic encephalopathy Lennox-Gastaut type, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\"}, {\"id\": \"Delayed speech and language development, Seizures, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2, not provided\"}, {\"id\": \"Focal epilepsy, not provided\"}, {\"id\": \"Familial hemiplegic migraine type 3\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2\"}, {\"id\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\"}, {\"id\": \"Inborn genetic diseases, Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"History of neurodevelopmental disorder, not provided\"}, {\"id\": \"Primary generalized epilepsy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2, History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"Inborn genetic diseases, History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy\"}, {\"id\": \"6323\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\"}, {\"id\": \"Seizures\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 1, Generalized epilepsy with febrile seizures plus, type 2, History of neurodevelopmental disorder, Early infantile epileptic encephalopathy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 1, not provided\"}, {\"id\": \"Generalized epilepsy, Severe myoclonic epilepsy in infancy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 2, Familial hemiplegic migraine type 3, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\"}, {\"id\": \"Early infantile epileptic encephalopathy, not provided\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 1, Severe myoclonic epilepsy in infancy, not provided\"}, {\"id\": \"Seizures, Severe myoclonic epilepsy in infancy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 1, Generalized epilepsy with febrile seizures plus, type 2, Early infantile epileptic encephalopathy\"}, {\"id\": \"Febrile seizures\"}, {\"id\": \"6335|SCN1A-AS1\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA\"}, {\"id\": \"Paroxysmal extreme pain disorder, not provided\"}, {\"id\": \"Hereditary sensory and autonomic neuropathy\"}, {\"id\": \"Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA, not provided\"}, {\"id\": \"Paroxysmal extreme pain disorder\"}, {\"id\": \"Primary erythromelalgia\"}, {\"id\": \"Paroxysmal extreme pain disorder, Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA\"}, {\"id\": \"Indifference to pain, congenital, autosomal recessive\"}, {\"id\": \"Small fiber neuropathy\"}, {\"id\": \"Pain insensitivity\"}, {\"id\": \"6335\"}, {\"id\": \"Febrile seizures, familial, 3b\"}, {\"id\": \"8647\"}, {\"id\": \"Benign recurrent intrahepatic cholestasis 2, not provided\"}, {\"id\": \"Benign recurrent intrahepatic cholestasis 2\"}, {\"id\": \"Progressive familial intrahepatic cholestasis 2, not provided\"}, {\"id\": \"Pruritus, Intrahepatic cholestasis, Abnormal liver function tests during pregnancy\"}, {\"id\": \"Benign recurrent intrahepatic cholestasis 2, Progressive familial intrahepatic cholestasis 2, not provided\"}, {\"id\": \"Progressive familial intrahepatic cholestasis 2\"}, {\"id\": \"Familial Intrahepatic Cholestasis, Benign recurrent intrahepatic cholestasis 2, Progressive familial intrahepatic cholestasis 2, not provided\"}, {\"id\": \"4036\"}, {\"id\": \"Pituitary prolactin cell adenoma, Severe Myopia\"}, {\"id\": \"Donnai Barrow syndrome, not provided\"}, {\"id\": \"Donnai Barrow syndrome\"}, {\"id\": \"129880\"}, {\"id\": \"Bardet-Biedl syndrome 5\"}, {\"id\": \"Bardet-Biedl syndrome, not provided\"}, {\"id\": \"10324\"}, {\"id\": \"Nemaline myopathy 9\"}, {\"id\": \"79675\"}, {\"id\": \"Glaucoma 1, open angle, B\"}, {\"id\": \"2571\"}, {\"id\": \"Cerebral palsy, spastic quadriplegic, 1\"}, {\"id\": \"79828|DCAF17\"}, {\"id\": \"Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities\"}, {\"id\": \"80067\"}, {\"id\": \"Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities, not provided\"}, {\"id\": \"8604\"}, {\"id\": \"Hypomyelination, global cerebral\"}, {\"id\": \"51776\"}, {\"id\": \"MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION\"}, {\"id\": \"51776|MAP3K20-AS1\"}, {\"id\": \"Split-hand/foot malformation 1, Split-foot malformation with mesoaxial polydactyly\"}, {\"id\": \"83879\"}, {\"id\": \"Immunodeficiency-centromeric instability-facial anomalies syndrome 3\"}, {\"id\": \"1134\"}, {\"id\": \"Autism, Seizures, Lethal multiple pterygium syndrome, not provided\"}, {\"id\": \"Myasthenic syndrome, slow-channel congenital\"}, {\"id\": \"Congenital myasthenic syndrome 1B, fast-channel\"}, {\"id\": \"Inborn genetic diseases, Myasthenic syndrome, slow-channel congenital\"}, {\"id\": \"Lethal multiple pterygium syndrome\"}, {\"id\": \"Lethal multiple pterygium syndrome, Myasthenic syndrome, slow-channel congenital\"}, {\"id\": \"1123\"}, {\"id\": \"Duane syndrome type 2\"}, {\"id\": \"Dandy-Walker syndrome, Hydroureter, Hydronephrosis, Microglossia, Cleft palate, Micrognathia, Sensorineural hearing loss, Nyctalopia, Abnormality of the diaphragm, Abnormality of the vertebral column, Arachnodactyly, Global developmental delay, Cerebellar vermis hypoplasia, Laryngomalacia, Abnormality of the cervical spine, Diaphragmatic eventration, Duane anomaly, Feeding difficulties, Small hand\"}, {\"id\": \"80856\"}, {\"id\": \"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM\"}, {\"id\": \"3239\"}, {\"id\": \"Synpolydactyly 1\"}, {\"id\": \"Type D brachydactyly, Brachydactyly type E1\"}, {\"id\": \"Brachydactyly-syndactyly-oligodactyly syndrome\"}, {\"id\": \"Syndactyly, type V\"}, {\"id\": \"3236\"}, {\"id\": \"Vertical talus, congenital\"}, {\"id\": \"4780\"}, {\"id\": \"IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA\"}, {\"id\": \"Colorectal cancer, IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Malignant neoplasm of body of uterus\"}, {\"id\": \"8540\"}, {\"id\": \"Rhizomelic chondrodysplasia punctata type 3\"}, {\"id\": \"50940\"}, {\"id\": \"Pigmented nodular adrenocortical disease, primary, 2\"}, {\"id\": \"8575|PRKRA-AS1\"}, {\"id\": \"Dystonia 16\"}, {\"id\": \"494513\"}, {\"id\": \"Deafness, autosomal recessive 59\"}, {\"id\": \"Deafness, autosomal recessive 59, Nonsyndromic hearing loss and deafness\"}, {\"id\": \"7273|TTN-AS1\"}, {\"id\": \"Distal myopathy Markesbery-Griggs type\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, not provided\"}, {\"id\": \"Waddling gait, Muscular dystrophy, Limb-girdle muscular dystrophy, Proximal lower limb amyotrophy, Decreased patellar reflex, Limb-girdle muscular dystrophy, type 2J\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1G, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1G\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Cardiovascular phenotype\"}, {\"id\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\"}, {\"id\": \"Hereditary myopathy with early respiratory failure\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Hereditary myopathy with early respiratory failure, not provided\"}, {\"id\": \"Hereditary myopathy with early respiratory failure, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype, not provided\"}, {\"id\": \"Congenital titinopathy, Myopathy, early-onset, with fatal cardiomyopathy\"}, {\"id\": \"Primary dilated cardiomyopathy, Wolff-Parkinson-White pattern\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype\"}, {\"id\": \"Dilated cardiomyopathy 1S, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype\"}, {\"id\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G\"}, {\"id\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G\"}, {\"id\": \"Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Left ventricular noncompaction 2\"}, {\"id\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Familial dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\"}, {\"id\": \"Familial hypertrophic cardiomyopathy 9\"}, {\"id\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1G, not specified, Cardiovascular phenotype\"}, {\"id\": \"Inborn genetic diseases, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G\"}, {\"id\": \"Dilated cardiomyopathy 1S\"}, {\"id\": \"not specified, Cardiovascular phenotype, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\"}, {\"id\": \"Dilated cardiomyopathy 1S, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Cardiomyopathy, Low-output congestive heart failure, Noncompaction cardiomyopathy\"}, {\"id\": \"7273\"}, {\"id\": \"Myopathy, early-onset, with fatal cardiomyopathy\"}, {\"id\": \"Noncompaction cardiomyopathy\"}, {\"id\": \"7273|LOC101927055\"}, {\"id\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J\"}, {\"id\": \"375298\"}, {\"id\": \"Retinitis pigmentosa 26\"}, {\"id\": \"Retinitis pigmentosa, Cone/cone-rod dystrophy, Retinal dystrophy, Retinal pigment epithelial atrophy, Retinitis pigmentosa 26, Cone-rod dystrophy, Retinitis Pigmentosa, Recessive, not provided\"}, {\"id\": \"Severe photosensitivity, Macular dystrophy, Adult-onset night blindness\"}, {\"id\": \"Cone/cone-rod dystrophy, Retinal pigment epithelial atrophy\"}, {\"id\": \"4760\"}, {\"id\": \"Maturity-onset diabetes of the young, type 6\"}, {\"id\": \"401024\"}, {\"id\": \"SPERMATOGENIC FAILURE 34\"}, {\"id\": \"1281\"}, {\"id\": \"Ehlers-Danlos syndrome, type 4\"}, {\"id\": \"POLYMICROGYRIA WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME\"}, {\"id\": \"Thoracic aortic aneurysm and aortic dissection\"}, {\"id\": \"Ehlers-Danlos syndrome, type 4, not provided\"}, {\"id\": \"Ehlers-Danlos syndrome, type 4, Cardiovascular phenotype\"}, {\"id\": \"Ehlers-Danlos syndrome\"}, {\"id\": \"Ehlers-Danlos syndrome, type 4, Cardiovascular phenotype, not provided\"}, {\"id\": \"Familial aortopathy\"}, {\"id\": \"Ehlers-Danlos syndrome, type 4, Thoracic aortic aneurysm and aortic dissection, not provided\"}, {\"id\": \"EHLERS-DANLOS SYNDROME, NONVASCULAR VARIANT\"}, {\"id\": \"Seizures, Connective tissue nevi, Ehlers-Danlos syndrome, type 4\"}, {\"id\": \"Ehlers-Danlos syndrome, type 4, Loeys-Dietz syndrome\"}, {\"id\": \"Ehlers-Danlos syndrome, type 3, Ehlers-Danlos syndrome, type 4\"}, {\"id\": \"1290\"}, {\"id\": \"Ehlers-Danlos syndrome, classic type\"}, {\"id\": \"Telecanthus, Hyperextensible skin, Joint hypermobility, Spinal deformities\"}, {\"id\": \"30061\"}, {\"id\": \"Hemochromatosis type 4\"}, {\"id\": \"Hemochromatosis type 4, not provided\"}, {\"id\": \"2660|C2orf88\"}, {\"id\": \"Muscle hypertrophy\"}, {\"id\": \"26275\"}, {\"id\": \"Beta-hydroxyisobutyryl-CoA deacylase deficiency\"}, {\"id\": \"Beta-hydroxyisobutyryl-CoA deacylase deficiency, not provided\"}, {\"id\": \"Neurodegeneration due to 3-hydroxyisobutyryl coenzyme A hydrolase deficiency\"}, {\"id\": \"Inborn genetic diseases, Beta-hydroxyisobutyryl-CoA deacylase deficiency, not provided\"}, {\"id\": \"2744\"}, {\"id\": \"INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT\"}, {\"id\": \"6772\"}, {\"id\": \"Immunodeficiency 31a\"}, {\"id\": \"Mycobacterial and viral infections, susceptibility to, autosomal recessive\"}, {\"id\": \"Mycobacterial and viral infections, susceptibility to, autosomal recessive, Immunodeficiency 31C, Immunodeficiency 31a\"}, {\"id\": \"Delayed speech and language development, Hypothyroidism, Primary hypothyroidism, Failure to thrive, Chronic diarrhea, Bronchiectasis, Short stature, Severe T-cell immunodeficiency, Combined immunodeficiency, Chronic oral candidiasis, Liver abscess, Cognitive impairment, Mycobacterial and viral infections, susceptibility to, autosomal recessive, Immunodeficiency 31C, Immunodeficiency 31a\"}, {\"id\": \"Immunodeficiency 31C\"}, {\"id\": \"Blepharitis, Eczema, Recurrent skin infections, Recurrent infections, Recurrent Staphylococcus aureus infections, Chronic mucocutaneous candidiasis, Recurrent fungal infections, Recurrent candida infections, Recurrent bacterial skin infections, Chronic oral candidiasis, Onychomycosis, Immunodeficiency 31C\"}, {\"id\": \"56171\"}, {\"id\": \"Situs inversus, Ciliary dyskinesia\"}, {\"id\": \"Seizures, Hypoplasia of the corpus callosum, Dyspnea, Abnormality of the basal ganglia, Abnormal muscle tone\"}, {\"id\": \"57520\"}, {\"id\": \"Neurodevelopmental disorder with hypotonia, seizures, and absent language\"}, {\"id\": \"Neurodevelopmental disorder with hypotonia, seizures, and absent language, not provided\"}, {\"id\": \"80055\"}, {\"id\": \"Mental retardation, autosomal recessive 42\"}, {\"id\": \"23451\"}, {\"id\": \"Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1\"}, {\"id\": \"Acute myeloid leukemia, Myelodysplastic syndrome, Myelodysplastic syndrome progressed to acute myeloid leukemia\"}, {\"id\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Neoplasm of the breast, Malignant melanoma of skin\"}, {\"id\": \"Hepatocellular carcinoma, Chronic lymphocytic leukemia, Neoplasm of the breast, Malignant melanoma of skin\"}, {\"id\": \"Chronic lymphocytic leukemia, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Adenoid cystic carcinoma\"}, {\"id\": \"3329\"}, {\"id\": \"Spastic paraplegia 13\"}, {\"id\": \"Leukodystrophy, hypomyelinating, 4\"}, {\"id\": \"92935\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 25\"}, {\"id\": \"23314\"}, {\"id\": \"Chromosome 2q32-q33 deletion syndrome\"}, {\"id\": \"Microcephaly, Micrognathia, Global developmental delay, Abnormal facial shape, Downturned corners of mouth, Speech articulation difficulties, Hyperplasia of midface\"}, {\"id\": \"Chromosome 2q32-q33 deletion syndrome, not provided\"}, {\"id\": \"Cleft palate, isolated, Chromosome 2q32-q33 deletion syndrome, History of neurodevelopmental disorder\"}, {\"id\": \"Inborn genetic diseases, Chromosome 2q32-q33 deletion syndrome, not provided\"}, {\"id\": \"SATB2-Related Disorder, not provided\"}, {\"id\": \"4709\"}, {\"id\": \"Inborn genetic diseases, Mitochondrial complex I deficiency, MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25, not provided\"}, {\"id\": \"Inborn genetic diseases, MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25, not provided\"}, {\"id\": \"843\"}, {\"id\": \"Neoplasm of stomach, Non-Hodgkin lymphoma\"}, {\"id\": \"Autoimmune lymphoproliferative syndrome, type 2A\"}, {\"id\": \"841\"}, {\"id\": \"Caspase-8 deficiency\"}, {\"id\": \"65062\"}, {\"id\": \"Joubert syndrome 14\"}, {\"id\": \"Meckel-Gruber syndrome\"}, {\"id\": \"Joubert syndrome, Joubert syndrome 14\"}, {\"id\": \"58538\"}, {\"id\": \"High palate, Wide nasal bridge, Strabismus, Intellectual disability, Seizures, Global developmental delay, Generalized hypotonia\"}, {\"id\": \"57679\"}, {\"id\": \"Peripheral axonal neuropathy\"}, {\"id\": \"Inborn genetic diseases, Amyotrophic lateral sclerosis type 2, not provided\"}, {\"id\": \"Infantile-onset ascending hereditary spastic paralysis\"}, {\"id\": \"Juvenile primary lateral sclerosis\"}, {\"id\": \"Infantile-onset ascending hereditary spastic paralysis, not provided\"}, {\"id\": \"Amyotrophic lateral sclerosis type 2\"}, {\"id\": \"659\"}, {\"id\": \"Primary pulmonary hypertension\"}, {\"id\": \"Pulmonary venoocclusive disease 1, Primary pulmonary hypertension\"}, {\"id\": \"Pulmonary venoocclusive disease 1\"}, {\"id\": \"Pulmonary arterial hypertension associated with congenital heart disease\"}, {\"id\": \"Pulmonary hypertension, primary, dexfenfluramine-associated\"}, {\"id\": \"Primary pulmonary hypertension, not provided\"}, {\"id\": \"Primary pulmonary hypertension, not specified\"}, {\"id\": \"Pulmonary hypertension, primary, dexfenfluramine-associated, Primary pulmonary hypertension, not provided\"}, {\"id\": \"Pulmonary veno-occlusive disease\"}, {\"id\": \"Pulmonary arterial hypertension associated with congenital heart disease, Primary pulmonary hypertension\"}, {\"id\": \"Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia, Primary pulmonary hypertension\"}, {\"id\": \"1493\"}, {\"id\": \"Autoimmune lymphoproliferatiVe syndrome, type V\"}, {\"id\": \"29851\"}, {\"id\": \"Common variable immunodeficiency 1\"}, {\"id\": \"8828\"}, {\"id\": \"4719\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5, not provided\"}, {\"id\": \"Juvenile myopathy, encephalopathy, lactic acidosis AND stroke\"}, {\"id\": \"22868\"}, {\"id\": \"1421|LOC100507443\"}, {\"id\": \"Cataract 4\"}, {\"id\": \"Congenital cataract, Cataract 4\"}, {\"id\": \"1420|LOC100507443\"}, {\"id\": \"Congenital cataract, Cataract, coppock-like\"}, {\"id\": \"Cataract, coppock-like\"}, {\"id\": \"Cataract, coppock-like, not provided\"}, {\"id\": \"Cataract 2, Coppock-like\"}, {\"id\": \"1419|LOC100507443\"}, {\"id\": \"Cataract 39, multiple types\"}, {\"id\": \"1418\"}, {\"id\": \"3417\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Brainstem glioma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Malignant melanoma of skin, Adenoid cystic carcinoma, Glioblastoma, Myelodysplastic syndrome, Adenocarcinoma of prostate\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Astrocytoma, Brainstem glioma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Malignant melanoma of skin, Adenoid cystic carcinoma, Glioblastoma, Myelodysplastic syndrome, Oligodendroglioma, Adenocarcinoma of prostate, Glioblastoma multiforme, somatic\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Astrocytoma, Brainstem glioma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Malignant melanoma of skin, Adenoid cystic carcinoma, Glioblastoma, Myelodysplastic syndrome, Adenocarcinoma of prostate\"}, {\"id\": \"200576\"}, {\"id\": \"Fleck corneal dystrophy\"}, {\"id\": \"5746\"}, {\"id\": \"Syndromic intellectual disability\"}, {\"id\": \"285175\"}, {\"id\": \"Hypotonia, infantile, with psychomotor retardation and characteristic facies 2\"}, {\"id\": \"Encephalopathy, Hypotonia, infantile, with psychomotor retardation and characteristic facies 2\"}, {\"id\": \"UNC80-Related Disorder, not provided\"}, {\"id\": \"1373\"}, {\"id\": \"Congenital hyperammonemia, type I\"}, {\"id\": \"Congenital hyperammonemia, type I, not provided\"}, {\"id\": \"2066\"}, {\"id\": \"Amyotrophic lateral sclerosis 19, not provided\"}, {\"id\": \"580\"}, {\"id\": \"Familial cancer of breast\"}, {\"id\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome, Triple-Negative Breast Cancer Finding, not provided\"}, {\"id\": \"Hereditary breast and ovarian cancer syndrome, Familial cancer of breast, Hereditary cancer-predisposing syndrome, Triple-Negative Breast Cancer Finding, not provided\"}, {\"id\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome, Breast cancer, susceptibility to, not provided\"}, {\"id\": \"Familial cancer of breast, not provided\"}, {\"id\": \"Neoplasm of the breast\"}, {\"id\": \"Hereditary breast and ovarian cancer syndrome, Familial cancer of breast, Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"26154|SNHG31\"}, {\"id\": \"Autosomal recessive congenital ichthyosis 4B, not provided\"}, {\"id\": \"Autosomal recessive congenital ichthyosis 4B\"}, {\"id\": \"26154\"}, {\"id\": \"Autosomal recessive congenital ichthyosis 4A\"}, {\"id\": \"Autosomal recessive congenital ichthyosis 4A, not provided\"}, {\"id\": \"Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4A, not provided\"}, {\"id\": \"471\"}, {\"id\": \"AICAR transformylase/IMP cyclohydrolase deficiency\"}, {\"id\": \"2335\"}, {\"id\": \"Glomerulopathy with fibronectin deposits 2\"}, {\"id\": \"Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia - Sutcliffe type\"}, {\"id\": \"Spondylometaphyseal dysplasia, not provided\"}, {\"id\": \"Spondylometaphyseal dysplasia\"}, {\"id\": \"50485\"}, {\"id\": \"Schimke immunoosseous dysplasia\"}, {\"id\": \"Focal segmental glomerulosclerosis, Microcephaly, Small for gestational age, Disproportionate short-trunk short stature, Short stature, Decreased body weight, Atrioventricular canal defect, Congenital microcephaly, Steroid-resistant nephrotic syndrome\"}, {\"id\": \"Focal segmental glomerulosclerosis, Microcephaly, Small for gestational age, Disproportionate short-trunk short stature, Short stature, Decreased body weight, Atrioventricular canal defect, Congenital microcephaly, Steroid-resistant nephrotic syndrome, Schimke immunoosseous dysplasia\"}, {\"id\": \"25953\"}, {\"id\": \"Paroxysmal nonkinesigenic dyskinesia 1\"}, {\"id\": \"Paroxysmal dystonia, Paroxysmal dyskinesia, Episodic hemiplegia, Paroxysmal nonkinesigenic dyskinesia 1\"}, {\"id\": \"25953|CATIP-AS2\"}, {\"id\": \"9125\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Adenocarcinoma of prostate, Adenocarcinoma of stomach\"}, {\"id\": \"Malignant melanoma of skin\"}, {\"id\": \"617\"}, {\"id\": \"GRACILE syndrome\"}, {\"id\": \"Bjornstad syndrome with mild mitochondrial complex III deficiency\"}, {\"id\": \"Mitochondrial complex III deficiency\"}, {\"id\": \"GRACILE syndrome, Mitochondrial complex III deficiency, BCS1L-Related Disorders, not provided\"}, {\"id\": \"GRACILE syndrome, not provided\"}, {\"id\": \"Leigh syndrome due to mitochondrial complex III deficiency, GRACILE syndrome\"}, {\"id\": \"Pili torti-deafness syndrome\"}, {\"id\": \"Mitochondrial complex III deficiency, Bjornstad syndrome with mild mitochondrial complex III deficiency, not provided\"}, {\"id\": \"GRACILE syndrome, Mitochondrial complex III deficiency, not provided\"}, {\"id\": \"1593\"}, {\"id\": \"Cholestanol storage disease\"}, {\"id\": \"Cholestanol storage disease, not provided\"}, {\"id\": \"Regression of motor development with severe dystonia and corresponding basal ganglia lesions, not provided\"}, {\"id\": \"53632\"}, {\"id\": \"Glycogen content in skeletal muscle, increased\"}, {\"id\": \"80326\"}, {\"id\": \"Odontoonychodermal dysplasia\"}, {\"id\": \"Inborn genetic diseases, Odontoonychodermal dysplasia, Tooth agenesis, selective, 4, Schopf-Schulz-Passarge syndrome, not provided\"}, {\"id\": \"Odontoonychodermal dysplasia, Tooth agenesis, selective, 4, not provided\"}, {\"id\": \"Odontoonychodermal dysplasia, Tooth agenesis, selective, 4, Schopf-Schulz-Passarge syndrome\"}, {\"id\": \"Odontoonychodermal dysplasia, not provided\"}, {\"id\": \"3549\"}, {\"id\": \"Acrocapitofemoral dysplasia\"}, {\"id\": \"Type A1 brachydactyly\"}, {\"id\": \"Hirschsprung disease 1\"}, {\"id\": \"79840\"}, {\"id\": \"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation\"}, {\"id\": \"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, not provided\"}, {\"id\": \"10058\"}, {\"id\": \"Microphthalmia, isolated, with coloboma 7\"}, {\"id\": \"Pseudohyperkalemia, familial, 2, due to red cell leak\"}, {\"id\": \"Dyschromatosis universalis hereditaria 3\"}, {\"id\": \"7277\"}, {\"id\": \"Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia\"}, {\"id\": \"Amyotrophic lateral sclerosis 22 with frontotemporal dementia\"}, {\"id\": \"3300\"}, {\"id\": \"Charcot-Marie-Tooth disease, Spinal muscular atrophy, distal, autosomal recessive, 5\"}, {\"id\": \"Spinal muscular atrophy, distal, autosomal recessive, 5, not provided\"}, {\"id\": \"Spinal muscular atrophy, distal, autosomal recessive, 5\"}, {\"id\": \"Charcot-Marie-Tooth disease, axonal, type 2T\"}, {\"id\": \"1674\"}, {\"id\": \"Myofibrillar myopathy 1, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Myofibrillar myopathy 1, not provided\"}, {\"id\": \"Myofibrillar myopathy, not provided\"}, {\"id\": \"Myofibrillar myopathy 1, Muscular dystrophy, limb-girdle, type 2R, not provided\"}, {\"id\": \"Myofibrillar myopathy 1\"}, {\"id\": \"Myofibrillar myopathy 1, Muscular dystrophy, limb-girdle, type 2R\"}, {\"id\": \"Myofibrillar myopathy 1, Scapuloperoneal syndrome, neurogenic, Kaeser type, Muscular dystrophy, limb-girdle, type 2R, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Primary familial hypertrophic cardiomyopathy, Myofibrillar myopathy 1, Dilated cardiomyopathy 1I, Muscular dystrophy, limb-girdle, type 2R, not provided\"}, {\"id\": \"10290\"}, {\"id\": \"Myopathy, centronuclear, 5\"}, {\"id\": \"29926\"}, {\"id\": \"Alacrima, achalasia, and mental retardation syndrome\"}, {\"id\": \"23363\"}, {\"id\": \"Three M syndrome 2\"}, {\"id\": \"2043\"}, {\"id\": \"5077\"}, {\"id\": \"Waardenburg syndrome type 1\"}, {\"id\": \"Waardenburg syndrome type 1, not provided\"}, {\"id\": \"Waardenburg syndrome\"}, {\"id\": \"Klein-Waardenberg's syndrome\"}, {\"id\": \"Klein-Waardenberg's syndrome, Waardenburg syndrome type 1\"}, {\"id\": \"Craniofacial deafness hand syndrome\"}, {\"id\": \"5077|CCDC140\"}, {\"id\": \"10056\"}, {\"id\": \"Liver cirrhosis, Cerebral calcification, Dilatation, Interstitial pneumonitis\"}, {\"id\": \"Liver cirrhosis, Cerebral calcification, Dilatation, Interstitial pneumonitis, Rajab syndrome\"}, {\"id\": \"Rajab syndrome, not provided\"}, {\"id\": \"Rajab syndrome, Neurodevelopmental disorder with brain, liver, and lung abnormalities\"}, {\"id\": \"Rajab syndrome, Interstitial lung and liver disease\"}, {\"id\": \"65080\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 16, not provided\"}, {\"id\": \"8452\"}, {\"id\": \"Pseudohypoaldosteronism, type 2\"}, {\"id\": \"Pseudohypoaldosteronism, type 2, Pseudohypoaldosteronism type 2E\"}, {\"id\": \"3667\"}, {\"id\": \"1286\"}, {\"id\": \"Alport syndrome, autosomal recessive\"}, {\"id\": \"Alport syndrome 3, autosomal dominant\"}, {\"id\": \"Alport syndrome, autosomal recessive, not provided\"}, {\"id\": \"Benign familial hematuria\"}, {\"id\": \"Benign familial hematuria, Alport syndrome, autosomal recessive, not provided\"}, {\"id\": \"Proteinuria, Hearing impairment, Myopia, Hematuria, Hypertension, Alport syndrome, autosomal recessive\"}, {\"id\": \"1285\"}, {\"id\": \"1285|LOC654841\"}, {\"id\": \"Benign familial hematuria, Alport syndrome 3, autosomal dominant, Alport syndrome, autosomal recessive\"}, {\"id\": \"Alport syndrome\"}, {\"id\": \"Alport syndrome 3, autosomal dominant, not provided\"}, {\"id\": \"Alport syndrome 3, autosomal dominant, Alport syndrome, autosomal recessive\"}, {\"id\": \"Alport syndrome 3, autosomal dominant, Alport syndrome, autosomal recessive, not provided\"}, {\"id\": \"56947\"}, {\"id\": \"Global developmental delay, Mitochondrial encephalomyopathy, Encephalopathy due to defective mitochondrial and peroxisomal fission 2\"}, {\"id\": \"Encephalopathy due to defective mitochondrial and peroxisomal fission 2\"}, {\"id\": \"80704\"}, {\"id\": \"Biotin-thiamine-responsive basal ganglia disease, not provided\"}, {\"id\": \"Thiamine Metabolism Dysfunction Syndrome\"}, {\"id\": \"Biotin-thiamine-responsive basal ganglia disease\"}, {\"id\": \"9320\"}, {\"id\": \"MENTAL RETARDATION, AUTOSOMAL DOMINANT 49\"}, {\"id\": \"3431|SP140\"}, {\"id\": \"Hepatic venoocclusive disease with immunodeficiency\"}, {\"id\": \"80210\"}, {\"id\": \"ARMC9-related Joubert syndrome\"}, {\"id\": \"JOUBERT SYNDROME 30, ARMC9-related Joubert syndrome\"}, {\"id\": \"JOUBERT SYNDROME 30\"}, {\"id\": \"5147\"}, {\"id\": \"Joubert syndrome 22\"}, {\"id\": \"129563\"}, {\"id\": \"Renal hamartomas nephroblastomatosis and fetal gigantism\"}, {\"id\": \"9427\"}, {\"id\": \"Distal arthrogryposis type 5D\"}, {\"id\": \"Distal arthrogryposis type 5D, not provided\"}, {\"id\": \"646960\"}, {\"id\": \"Microphthalmia, isolated 6\"}, {\"id\": \"1144\"}, {\"id\": \"Myasthenic syndrome, congenital, 3b, fast-channel\"}, {\"id\": \"Myasthenic syndrome, congenital, 3a, slow-channel\"}, {\"id\": \"Myasthenic syndrome, congenital, 3c, associated with acetylcholine receptor deficiency\"}, {\"id\": \"Ptosis, Muscle weakness, Dyspnea, Breathing dysregulation\"}, {\"id\": \"1146\"}, {\"id\": \"Multiple pterygium syndrome Escobar type\"}, {\"id\": \"Multiple pterygium syndrome Escobar type, Lethal multiple pterygium syndrome\"}, {\"id\": \"Peripheral neuropathy\"}, {\"id\": \"26058|KCNJ13\"}, {\"id\": \"Leber congenital amaurosis 16\"}, {\"id\": \"Snowflake vitreoretinal degeneration\"}, {\"id\": \"Leber congenital amaurosis, Leber congenital amaurosis 16\"}, {\"id\": \"Leber congenital amaurosis 16, not provided\"}, {\"id\": \"26058\"}, {\"id\": \"Parkinson disease 11\"}, {\"id\": \"6295\"}, {\"id\": \"Oguchi's disease\"}, {\"id\": \"Retinitis pigmentosa 47, Oguchi's disease\"}, {\"id\": \"7361|UGT1A10\"}, {\"id\": \"Crigler-Najjar syndrome, type II\"}, {\"id\": \"Crigler Najjar syndrome, type 1\"}, {\"id\": \"Crigler-Najjar syndrome, Crigler-Najjar syndrome, type II, not provided\"}, {\"id\": \"Inborn genetic diseases, Crigler-Najjar syndrome\"}, {\"id\": \"Crigler Najjar syndrome, type 1, not provided\"}, {\"id\": \"Crigler-Najjar syndrome, not provided\"}, {\"id\": \"Gilbert's syndrome, Crigler Najjar syndrome, type 1\"}, {\"id\": \"Crigler-Najjar syndrome, type II, not provided\"}, {\"id\": \"Hyperbilirubinemia, not provided\"}, {\"id\": \"Gilbert's syndrome, Crigler-Najjar syndrome, type II\"}, {\"id\": \"Hyperbilirubinemia, Lucey-Driscoll syndrome, Crigler-Najjar syndrome, type II\"}, {\"id\": \"1293\"}, {\"id\": \"Dystonia 27, Bethlem myopathy 1, not provided\"}, {\"id\": \"Dystonia 27, Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1\"}, {\"id\": \"Bethlem myopathy 1\"}, {\"id\": \"Bethlem myopathy 1, not provided\"}, {\"id\": \"Inborn genetic diseases, Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1, not provided\"}, {\"id\": \"Ullrich congenital muscular dystrophy 1, not provided\"}, {\"id\": \"Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1\"}, {\"id\": \"Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1, not provided\"}, {\"id\": \"Ullrich congenital muscular dystrophy 1\"}, {\"id\": \"Dystonia 27, Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1, not provided\"}, {\"id\": \"79083\"}, {\"id\": \"Griscelli syndrome type 3\"}, {\"id\": \"8864\"}, {\"id\": \"Familial advanced sleep phase syndrome 1\"}, {\"id\": \"26146\"}, {\"id\": \"Senior-Loken syndrome 9\"}, {\"id\": \"117581\"}, {\"id\": \"Congenital ectodermal dysplasia of face\"}, {\"id\": \"Inborn genetic diseases, Ablepharon macrostomia syndrome\"}, {\"id\": \"Barber-Say syndrome\"}, {\"id\": \"9759\"}, {\"id\": \"4705\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\"}, {\"id\": \"547\"}, {\"id\": \"Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9\"}, {\"id\": \"Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIA, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9\"}, {\"id\": \"Mental retardation, autosomal dominant 9\"}, {\"id\": \"Spastic paraplegia 30, autosomal recessive\"}, {\"id\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 9, not provided\"}, {\"id\": \"Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9, not provided\"}, {\"id\": \"Mental retardation, autosomal dominant 9, not provided\"}, {\"id\": \"PEHO syndrome, Mental retardation, autosomal dominant 9\"}, {\"id\": \"Spastic paraplegia 30, autosomal recessive, PEHO syndrome, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9, not provided\"}, {\"id\": \"Spastic paraplegia, Hyperreflexia, Clonus, Lower limb hyperreflexia\"}, {\"id\": \"Hereditary spastic paraplegia, Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9\"}, {\"id\": \"Spastic paraplegia, Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9, not provided\"}, {\"id\": \"189\"}, {\"id\": \"Primary hyperoxaluria, type I\"}, {\"id\": \"Nephrocalcinosis, Nephrolithiasis, Primary hyperoxaluria, type I\"}, {\"id\": \"Primary hyperoxaluria, type I, not provided\"}, {\"id\": \"Primary hyperoxaluria, Primary hyperoxaluria, type I, not provided\"}, {\"id\": \"Nephrocalcinosis, Nephrolithiasis, Primary hyperoxaluria, Primary hyperoxaluria, type I\"}, {\"id\": \"728294\"}, {\"id\": \"D-2-hydroxyglutaric aciduria 1\"}, {\"id\": \"D-2-hydroxyglutaric aciduria\"}, {\"id\": \"64090\"}, {\"id\": \"27255\"}, {\"id\": \"Autistic behavior\"}, {\"id\": \"51095\"}, {\"id\": \"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay\"}, {\"id\": \"Retinitis pigmentosa and erythrocytic microcytosis\"}, {\"id\": \"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, not provided\"}, {\"id\": \"51095|CRBN\"}, {\"id\": \"Mental retardation, autosomal recessive 2\"}, {\"id\": \"Mental retardation, autosomal recessive 2, not provided\"}, {\"id\": \"285362\"}, {\"id\": \"Multiple sulfatase deficiency\"}, {\"id\": \"Multiple sulfatase deficiency, not provided\"}, {\"id\": \"3708\"}, {\"id\": \"Inborn genetic diseases, Spinocerebellar ataxia 29, not provided\"}, {\"id\": \"Spinocerebellar ataxia 29\"}, {\"id\": \"Gillespie syndrome\"}, {\"id\": \"Spinocerebellar ataxia 15\"}, {\"id\": \"Inborn genetic diseases, Spinocerebellar ataxia 29\"}, {\"id\": \"Inborn genetic diseases, Gillespie syndrome\"}, {\"id\": \"ITPR1-associated cerebellar ataxia spectrum disorder\"}, {\"id\": \"2917\"}, {\"id\": \"Seizures, Muscular hypotonia, Global developmental delay, Hypoplasia of the corpus callosum, Brain atrophy\"}, {\"id\": \"Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, CNS hypomyelination, Brain atrophy\"}, {\"id\": \"859|SSUH2\"}, {\"id\": \"Long QT syndrome\"}, {\"id\": \"Long QT syndrome 9, not provided\"}, {\"id\": \"Elevated serum creatine phosphokinase, Long QT syndrome, Rippling muscle disease 2, Limb-girdle muscular dystrophy, type 1C, Distal myopathy, Tateyama type, not provided\"}, {\"id\": \"Rippling muscle disease 2, not provided\"}, {\"id\": \"Elevated serum creatine phosphokinase, not provided\"}, {\"id\": \"Distal myopathy, Tateyama type\"}, {\"id\": \"859\"}, {\"id\": \"Elevated serum creatine phosphokinase, Limb-girdle muscular dystrophy, type 1C, not provided\"}, {\"id\": \"Rippling muscle disease 2, Distal myopathy, Tateyama type, not provided\"}, {\"id\": \"Long QT syndrome, not provided\"}, {\"id\": \"Limb-girdle muscular dystrophy, type 1C, not provided\"}, {\"id\": \"55209\"}, {\"id\": \"Mental retardation, autosomal dominant 23\"}, {\"id\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 23\"}, {\"id\": \"7862\"}, {\"id\": \"Intellectual developmental disorder with dysmorphic facies and ptosis\"}, {\"id\": \"Intellectual developmental disorder with dysmorphic facies and ptosis, not provided\"}, {\"id\": \"4968\"}, {\"id\": \"Clear cell carcinoma of kidney\"}, {\"id\": \"285367\"}, {\"id\": \"63924\"}, {\"id\": \"Familial partial lipodystrophy 5\"}, {\"id\": \"84522\"}, {\"id\": \"Severe congenital neutropenia, Severe congenital neutropenia 6, autosomal recessive\"}, {\"id\": \"Severe congenital neutropenia\"}, {\"id\": \"84818\"}, {\"id\": \"Candidiasis, familial, 9\"}, {\"id\": \"78987\"}, {\"id\": \"2177|LOC107303338\"}, {\"id\": \"Fanconi anemia, complementation group D2\"}, {\"id\": \"Fanconi anemia, not provided\"}, {\"id\": \"2177|FANCD2OS\"}, {\"id\": \"7428\"}, {\"id\": \"Pheochromocytoma, Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\"}, {\"id\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Von Hippel-Lindau syndrome\"}, {\"id\": \"Von Hippel-Lindau syndrome, not provided\"}, {\"id\": \"Pancreatic cysts, Cerebellar hemangioblastoma, Retinal capillary hemangioma, Spinal hemangioblastoma, Von Hippel-Lindau syndrome\"}, {\"id\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\"}, {\"id\": \"Neoplasm\"}, {\"id\": \"Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2, not provided\"}, {\"id\": \"Cerebellar hemangioblastoma, Von Hippel-Lindau syndrome\"}, {\"id\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2\"}, {\"id\": \"Renal cell carcinoma, papillary, 1\"}, {\"id\": \"Pheochromocytoma, Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\"}, {\"id\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\"}, {\"id\": \"7428|LOC107303340\"}, {\"id\": \"Erythrocytosis, familial, 2\"}, {\"id\": \"Cerebellar hemangioblastoma\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, not provided\"}, {\"id\": \"Renal cell carcinoma with paraneoplastic erythrocytosis\"}, {\"id\": \"Pheochromocytoma, Renal cell carcinoma, papillary, 1, Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\"}, {\"id\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not specified, not provided\"}, {\"id\": \"Renal cell carcinoma, papillary, 1, Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\"}, {\"id\": \"51738|GHRLOS\"}, {\"id\": \"Metabolic syndrome, susceptibility to, Obesity, age at onset of\"}, {\"id\": \"491\"}, {\"id\": \"6529|SLC6A1-AS1\"}, {\"id\": \"Myoclonic-atonic epilepsy\"}, {\"id\": \"Myoclonic-atonic epilepsy, not provided\"}, {\"id\": \"6529\"}, {\"id\": \"Inborn genetic diseases, Myoclonic-atonic epilepsy, not provided\"}, {\"id\": \"5468\"}, {\"id\": \"Morbid obesity\"}, {\"id\": \"Familial partial lipodystrophy 3\"}, {\"id\": \"Carcinoma of colon\"}, {\"id\": \"80746\"}, {\"id\": \"Pontocerebellar hypoplasia type 2B\"}, {\"id\": \"5894\"}, {\"id\": \"Cardiomyopathy, dilated, 1NN\"}, {\"id\": \"Noonan syndrome, Noonan syndrome with multiple lentigines, LEOPARD syndrome 2, Noonan syndrome 5, Rasopathy, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome with multiple lentigines, Rasopathy, Cardiovascular phenotype, not provided\"}, {\"id\": \"Noonan syndrome 5, not provided\"}, {\"id\": \"Noonan syndrome with multiple lentigines\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 5, not provided\"}, {\"id\": \"Noonan syndrome, Noonan syndrome 5, Rasopathy, not provided\"}, {\"id\": \"Noonan syndrome, Inborn genetic diseases, Primary familial hypertrophic cardiomyopathy, Noonan syndrome 5, Rasopathy, Cardiovascular phenotype, not provided\"}, {\"id\": \"Noonan syndrome, Primary familial hypertrophic cardiomyopathy, not provided\"}, {\"id\": \"Noonan syndrome, Rasopathy\"}, {\"id\": \"Rasopathy, not provided\"}, {\"id\": \"Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Noonan syndrome, Inborn genetic diseases, Noonan syndrome with multiple lentigines, Adenocarcinoma of stomach, LEOPARD syndrome 2, Noonan syndrome 5, Cardiomyopathy, dilated, 1NN, Rasopathy, not provided\"}, {\"id\": \"Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of stomach\"}, {\"id\": \"Cutaneous melanoma, Noonan syndrome, Primary familial hypertrophic cardiomyopathy, Rasopathy, not provided\"}, {\"id\": \"LEOPARD syndrome 2, Noonan syndrome 5, not provided\"}, {\"id\": \"7476\"}, {\"id\": \"Ulna and fibula absence of with severe limb deficiency\"}, {\"id\": \"Ulna and fibula absence of with severe limb deficiency, not provided\"}, {\"id\": \"Fuhrmann syndrome\"}, {\"id\": \"79188\"}, {\"id\": \"Emery-Dreifuss muscular dystrophy 7, autosomal dominant\"}, {\"id\": \"Cardiomyopathy\"}, {\"id\": \"Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, type 5, Arrhythmogenic right ventricular dysplasia/cardiomyopathy, Cardiovascular phenotype, not provided\"}, {\"id\": \"7508\"}, {\"id\": \"Xeroderma pigmentosum, group C\"}, {\"id\": \"Xeroderma pigmentosum, Xeroderma pigmentosum, group C\"}, {\"id\": \"Xeroderma pigmentosum, type 1\"}, {\"id\": \"Xeroderma pigmentosum, group C, not specified\"}, {\"id\": \"Xeroderma pigmentosum\"}, {\"id\": \"51244\"}, {\"id\": \"Hypotonia, infantile, with psychomotor retardation\"}, {\"id\": \"8292\"}, {\"id\": \"Endplate acetylcholinesterase deficiency, not provided\"}, {\"id\": \"Endplate acetylcholinesterase deficiency\"}, {\"id\": \"686\"}, {\"id\": \"Biotinidase deficiency\"}, {\"id\": \"Biotinidase deficiency, not specified\"}, {\"id\": \"Biotinidase deficiency, not provided\"}, {\"id\": \"Inborn genetic diseases, Biotinidase deficiency, not provided\"}, {\"id\": \"Biotinidase deficiency, not specified, not provided\"}, {\"id\": \"151648|SGO1-AS1\"}, {\"id\": \"Chronic atrial and intestinal dysrhythmia\"}, {\"id\": \"6138\"}, {\"id\": \"7068\"}, {\"id\": \"Thyroid hormone resistance, generalized, autosomal dominant\"}, {\"id\": \"Thyroid hormone resistance, generalized\"}, {\"id\": \"Thyroid hormone resistance, generalized, autosomal recessive\"}, {\"id\": \"Thyroid hormone resistance, generalized, autosomal dominant, not provided\"}, {\"id\": \"Thyroid hormone resistance, generalized, autosomal dominant, Thyroid Hormone Resistance\"}, {\"id\": \"Thyroid hormone resistance, selective pituitary, Thyroid hormone resistance, generalized, autosomal dominant\"}, {\"id\": \"Thyroid hormone resistance, selective pituitary\"}, {\"id\": \"5915\"}, {\"id\": \"Microphthalmia, syndromic 12\"}, {\"id\": \"Inborn genetic diseases, Microphthalmia, syndromic 12, not provided\"}, {\"id\": \"7155\"}, {\"id\": \"Autism spectrum disorder\"}, {\"id\": \"55768\"}, {\"id\": \"Congenital disorder of deglycosylation, not provided\"}, {\"id\": \"Congenital disorder of deglycosylation\"}, {\"id\": \"Inborn genetic diseases, Congenital disorder of deglycosylation, not provided\"}, {\"id\": \"7048\"}, {\"id\": \"Loeys-Dietz syndrome 2\"}, {\"id\": \"Loeys-Dietz syndrome 2, Loeys-Dietz syndrome\"}, {\"id\": \"Loeys-Dietz syndrome 1, Thoracic aortic aneurysm and aortic dissection, not provided\"}, {\"id\": \"Loeys-Dietz syndrome 2, Thoracic aortic aneurysm and aortic dissection, Cardiovascular phenotype, not provided\"}, {\"id\": \"Loeys-Dietz syndrome 2, Thoracic aortic aneurysm and aortic dissection, not provided\"}, {\"id\": \"Loeys-Dietz syndrome 2, Cardiovascular phenotype\"}, {\"id\": \"Loeys-Dietz syndrome 2, Loeys-Dietz syndrome, Thoracic aortic aneurysm and aortic dissection, not provided\"}, {\"id\": \"Loeys-Dietz syndrome, not provided\"}, {\"id\": \"Hereditary nonpolyposis colorectal cancer type 6, Loeys-Dietz syndrome 2, Loeys-Dietz syndrome, Thoracic aortic aneurysm and aortic dissection, not provided\"}, {\"id\": \"201595\"}, {\"id\": \"Congenital disorder of glycosylation type 1x\"}, {\"id\": \"2720\"}, {\"id\": \"GM1-gangliosidosis, type I, with cardiac involvement\"}, {\"id\": \"GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, Gangliosidosis GM1 type 3, not provided\"}, {\"id\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3\"}, {\"id\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, not provided\"}, {\"id\": \"Mucopolysaccharidosis, MPS-IV-B\"}, {\"id\": \"GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3\"}, {\"id\": \"Gangliosidosis GM1 type 3\"}, {\"id\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, GM1-gangliosidosis, type I, with cardiac involvement\"}, {\"id\": \"Infantile GM1 gangliosidosis\"}, {\"id\": \"Inborn genetic diseases, GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, not provided\"}, {\"id\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, GLB1-Related Disorders, not provided\"}, {\"id\": \"GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, GM1 gangliosidosis type 2\"}, {\"id\": \"Infantile GM1 gangliosidosis, not provided\"}, {\"id\": \"Inborn genetic diseases, GM1 gangliosidosis type 2\"}, {\"id\": \"Inborn genetic diseases, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3\"}, {\"id\": \"Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2\"}, {\"id\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, GM1-gangliosidosis, type I, with cardiac involvement, not provided\"}, {\"id\": \"GM1 gangliosidosis type 2, not provided\"}, {\"id\": \"10491\"}, {\"id\": \"Osteogenesis imperfecta type 7\"}, {\"id\": \"Osteogenesis imperfecta type 7, not provided\"}, {\"id\": \"4292\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not specified\"}, {\"id\": \"Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Turcot syndrome, Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not specified\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Lynch syndrome I, not specified, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I, not specified, not provided\"}, {\"id\": \"Lynch syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Lynch syndrome II\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Colon cancer\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome II\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Carcinoma of colon, Lynch syndrome, Lynch syndrome II, not provided\"}, {\"id\": \"Colon cancer, Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Colon cancer, Lynch syndrome, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I, not specified, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome II, not provided\"}, {\"id\": \"Colon cancer, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, Lynch syndrome II\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Muir-Torr\\u00e9 syndrome, Lynch syndrome II, Lynch syndrome I\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome I, not provided\"}, {\"id\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, not specified, not provided\"}, {\"id\": \"5333\"}, {\"id\": \"Leukonychia totalis\"}, {\"id\": \"4615\"}, {\"id\": \"Myd88 deficiency\"}, {\"id\": \"93\"}, {\"id\": \"Heterotaxy, visceral, 4, autosomal\"}, {\"id\": \"6331\"}, {\"id\": \"Arrhythmogenic right ventricular dysplasia/cardiomyopathy\"}, {\"id\": \"Brugada syndrome\"}, {\"id\": \"Atrial fibrillation, not provided\"}, {\"id\": \"Congenital long QT syndrome, not provided\"}, {\"id\": \"Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3\"}, {\"id\": \"Brugada syndrome, Brugada syndrome 1\"}, {\"id\": \"Sinus node disease, Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3, Long QT syndrome 1, Brugada syndrome 1, Cardiovascular phenotype, not provided\"}, {\"id\": \"Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3, Cardiovascular phenotype, not provided\"}, {\"id\": \"Long QT syndrome 3\"}, {\"id\": \"Brugada syndrome, not provided\"}, {\"id\": \"Heart block, nonprogressive\"}, {\"id\": \"Ventricular fibrillation, Brugada syndrome, Paroxysmal familial ventricular fibrillation 1, Brugada syndrome 1, Cardiovascular phenotype, not provided\"}, {\"id\": \"Brugada syndrome, Long QT syndrome 3, not provided\"}, {\"id\": \"Brugada syndrome, Cardiovascular phenotype, not provided\"}, {\"id\": \"Congenital long QT syndrome, Cardiovascular phenotype, not provided\"}, {\"id\": \"Congenital long QT syndrome, Long QT syndrome 3, Long qt syndrome 3/6, digenic\"}, {\"id\": \"Sick sinus syndrome 1, autosomal recessive, Long QT syndrome 3, Arrhythmogenic right ventricular dysplasia/cardiomyopathy, Cardiovascular phenotype, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1E\"}, {\"id\": \"Atrioventricular block, Brugada syndrome, Progressive familial heart block type 1A, not provided\"}, {\"id\": \"Brugada syndrome 1\"}, {\"id\": \"Brugada syndrome, Cardiovascular phenotype\"}, {\"id\": \"Cardiac conduction defect, nonspecific, Brugada syndrome, Sick sinus syndrome 1, autosomal recessive, Brugada syndrome 1, not provided\"}, {\"id\": \"SCN5A-related disorder, Congenital long QT syndrome, Cardiovascular phenotype, not provided\"}, {\"id\": \"Congenital long QT syndrome, Long QT syndrome 3\"}, {\"id\": \"Progressive familial heart block type 1A\"}, {\"id\": \"Brugada syndrome, Long QT syndrome 3, Cardiovascular phenotype, not provided\"}, {\"id\": \"Brugada syndrome (shorter-than-normal QT interval), not provided\"}, {\"id\": \"Sick sinus syndrome, Sick sinus syndrome 1, autosomal recessive\"}, {\"id\": \"Brugada syndrome, Dilated cardiomyopathy 1E, Long QT syndrome 3, Atrial fibrillation, familial, 10, Atrial standstill 1, digenic, Cardiovascular phenotype, not provided\"}, {\"id\": \"6331|LOC110121269\"}, {\"id\": \"Congenital long QT syndrome, Long QT syndrome 3, not provided\"}, {\"id\": \"Inborn genetic diseases, Brugada syndrome, Cardiovascular phenotype\"}, {\"id\": \"Brugada syndrome, Long QT syndrome 1, not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Brugada syndrome, Cardiovascular phenotype, not provided\"}, {\"id\": \"Atrial fibrillation, Atrial fibrillation, familial, 10, not provided\"}, {\"id\": \"Long QT syndrome, Brugada syndrome, not provided\"}, {\"id\": \"Arrhythmia\"}, {\"id\": \"Cardiac conduction defect, nonspecific, Cardiac conduction defect, nonprogressive\"}, {\"id\": \"Atrial fibrillation, Atrial fibrillation, familial, 10\"}, {\"id\": \"Syncope\"}, {\"id\": \"Sick sinus syndrome\"}, {\"id\": \"Long QT syndrome, Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3, Cardiovascular phenotype, not provided\"}, {\"id\": \"Congenital long QT syndrome, Brugada syndrome, not provided\"}, {\"id\": \"Brugada syndrome, Brugada syndrome 1, Brugada syndrome (shorter-than-normal QT interval), not provided\"}, {\"id\": \"Primary dilated cardiomyopathy, Congenital long QT syndrome, Brugada syndrome, Dilated cardiomyopathy 1E, Long QT syndrome 3, not provided\"}, {\"id\": \"Congenital long QT syndrome, Atrial standstill 1, digenic\"}, {\"id\": \"Dilated cardiomyopathy 1E, Long QT syndrome 3, Atrial fibrillation, familial, 10, Brugada syndrome 1, SCN5A-Related Disorders\"}, {\"id\": \"Brugada syndrome, Brugada syndrome 1, Cardiovascular phenotype, not provided\"}, {\"id\": \"6336\"}, {\"id\": \"Episodic pain syndrome, familial, 2\"}, {\"id\": \"11280\"}, {\"id\": \"Neuropathy, hereditary sensory and autonomic, type VII\"}, {\"id\": \"Episodic pain syndrome, familial, 3\"}, {\"id\": \"Neuropathy, hereditary sensory and autonomic, type VII, not provided\"}, {\"id\": \"165904\"}, {\"id\": \"Classical primary microcephaly\"}, {\"id\": \"54977\"}, {\"id\": \"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive\"}, {\"id\": \"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, not provided\"}, {\"id\": \"3921\"}, {\"id\": \"Asplenia, isolated congenital\"}, {\"id\": \"1499\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Esophageal Squamous Cell Carcinoma, Uterine cervical neoplasms, Endometrial neoplasm, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Cutaneous melanoma, Malignant melanoma of skin, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Hepatoblastoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Craniopharyngioma, Pilomatrixoma, Malignant melanoma of skin, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Cutaneous melanoma, Pilomatrixoma, Malignant melanoma of skin, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Uterine cervical neoplasms, Endometrial neoplasm, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Pilomatrixoma, Neoplasm of the large intestine, Malignant melanoma of skin, Endometrial neoplasm, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Carcinoma of colon\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the parathyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Ovarian Neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"ADRENAL CORTICAL NEOPLASM, Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Pilomatrixoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Craniopharyngioma, Pilomatrixoma\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Adrenocortical carcinoma, Craniopharyngioma, Lung adenocarcinoma, Pilomatrixoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Adrenocortical carcinoma, Lung adenocarcinoma, Pilomatrixoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Ovarian Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Adrenocortical carcinoma, Lung adenocarcinoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Neoplasm of stomach, Carcinoma of esophagus, Lung adenocarcinoma, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Neoplasm of the parathyroid gland, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Neoplasm of stomach, Carcinoma of esophagus, Cutaneous melanoma, Lung adenocarcinoma, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Neoplasm of ovary, Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Pilomatrixoma, Uterine cervical neoplasms, Ovarian Neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\"}, {\"id\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Cutaneous melanoma, Lung adenocarcinoma, Pilomatrixoma, Uterine cervical neoplasms, Ovarian Neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Pancreatic adenocarcinoma, Adrenocortical carcinoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\"}, {\"id\": \"Hepatocellular carcinoma, Pancreatic adenocarcinoma, Adrenocortical carcinoma, Lung adenocarcinoma, Pilomatrixoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Disease, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, not provided\"}, {\"id\": \"Neoplasm of brain, Disease\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Disease, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Disease, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Wilms Tumor\"}, {\"id\": \"Mental retardation, autosomal dominant 19, not provided\"}, {\"id\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 19, not provided\"}, {\"id\": \"Mental retardation, autosomal dominant 19\"}, {\"id\": \"Microcephaly, Global developmental delay, Absent speech, Imperforate anus, Teratoma\"}, {\"id\": \"Exudative vitreoretinopathy 1, EXUDATIVE VITREORETINOPATHY 7\"}, {\"id\": \"22906\"}, {\"id\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68\"}, {\"id\": \"131377\"}, {\"id\": \"Nemaline myopathy 8, not provided\"}, {\"id\": \"Nemaline myopathy 8\"}, {\"id\": \"84892\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8, MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8\"}, {\"id\": \"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8\"}, {\"id\": \"Neonatal death, Severe hydrocephalus, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8\"}, {\"id\": \"55129\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 10\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 10, not provided\"}, {\"id\": \"51099|ANO10\"}, {\"id\": \"Triglyceride storage disease with ichthyosis\"}, {\"id\": \"51099\"}, {\"id\": \"23395\"}, {\"id\": \"Perrault syndrome 4\"}, {\"id\": \"23395|LARS2-AS1\"}, {\"id\": \"Hydrops, lactic acidosis, and sideroblastic anemia\"}, {\"id\": \"Perrault syndrome\"}, {\"id\": \"Perrault syndrome, Perrault syndrome 4, Hydrops, lactic acidosis, and sideroblastic anemia, not provided\"}, {\"id\": \"54585\"}, {\"id\": \"Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 17\"}, {\"id\": \"79443\"}, {\"id\": \"Cataract, autosomal recessive congenital 2\"}, {\"id\": \"1234|LOC102724297\"}, {\"id\": \"Human immunodeficiency virus type 1, increased perinatal transmission of\"}, {\"id\": \"6997|LRRC2\"}, {\"id\": \"Forebrain defects\"}, {\"id\": \"259236\"}, {\"id\": \"Deafness, autosomal recessive 6\"}, {\"id\": \"4634\"}, {\"id\": \"Hypertrophic cardiomyopathy, Familial hypertrophic cardiomyopathy 8, not provided\"}, {\"id\": \"Primary familial hypertrophic cardiomyopathy, Familial hypertrophic cardiomyopathy 8, not provided\"}, {\"id\": \"5745\"}, {\"id\": \"Chondrodysplasia Blomstrand type\"}, {\"id\": \"Failure of tooth eruption, primary\"}, {\"id\": \"Metaphyseal chondrodysplasia, Jansen type\"}, {\"id\": \"Eiken skeletal dysplasia\"}, {\"id\": \"23218\"}, {\"id\": \"Gray platelet syndrome\"}, {\"id\": \"29072\"}, {\"id\": \"Luscan-lumish syndrome\"}, {\"id\": \"25930\"}, {\"id\": \"Seizures, Global developmental delay, Brain atrophy\"}, {\"id\": \"22907\"}, {\"id\": \"Microcephaly, Strabismus, Oculomotor apraxia, Seizures, Unsteady gait, Short stature, NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\"}, {\"id\": \"Microcephaly, Hearing impairment, Strabismus, Delayed speech and language development, Global developmental delay, Sleep disturbance, Muscular hypotonia of the trunk, NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\"}, {\"id\": \"NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\"}, {\"id\": \"Microcephaly, Hirsutism, Intellectual disability, Global developmental delay, Generalized hypotonia, Failure to thrive, EEG abnormality, Short stature, NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\"}, {\"id\": \"NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE, not provided\"}, {\"id\": \"11277|ATRIP-TREX1\"}, {\"id\": \"Aicardi Goutieres syndrome 1, Aicardi Goutieres syndrome 1, autosomal dominant, Chilblain lupus 1, not provided\"}, {\"id\": \"Aicardi Goutieres syndrome 1\"}, {\"id\": \"Aicardi Goutieres syndrome 1, not provided\"}, {\"id\": \"Aicardi Goutieres syndrome 1, Aicardi Goutieres syndrome 1, autosomal dominant\"}, {\"id\": \"Aicardi Goutieres syndrome 1, Vasculopathy, retinal, with cerebral leukodystrophy, Chilblain lupus erythematosus\"}, {\"id\": \"1294\"}, {\"id\": \"Epidermolysis bullosa dystrophica inversa, autosomal recessive\"}, {\"id\": \"Recessive dystrophic epidermolysis bullosa\"}, {\"id\": \"Toe syndactyly, Short stature, Finger syndactyly, Palmoplantar blistering\"}, {\"id\": \"Pretibial epidermolysis bullosa\"}, {\"id\": \"Epidermolysis bullosa dystrophica, AD, Epidermolysis bullosa dystrophica, AR\"}, {\"id\": \"Recessive dystrophic epidermolysis bullosa, not provided\"}, {\"id\": \"Generalized dominant dystrophic epidermolysis bullosa\"}, {\"id\": \"Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa, Nail disorder, nonsyndromic congenital, 8, not provided\"}, {\"id\": \"Nail disorder, nonsyndromic congenital, 8, Transient bullous dermolysis of the newborn, Epidermolysis bullosa pruriginosa, autosomal dominant\"}, {\"id\": \"Epidermolysis bullosa pruriginosa, autosomal dominant\"}, {\"id\": \"Abnormality of the dentition, Microcephaly, Abnormality of dental enamel, Hyperpigmentation of the skin, Failure to thrive, Alopecia of scalp, Distal muscle weakness, EMG abnormality, Short stature, Decreased body weight, Scarring alopecia of scalp, Abnormal blistering of the skin, Nail dystrophy, Scarring, Epidermolysis bullosa dystrophica inversa, autosomal recessive, not provided\"}, {\"id\": \"Generalized dominant dystrophic epidermolysis bullosa, not provided\"}, {\"id\": \"Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa\"}, {\"id\": \"Dystrophic epidermolysis bullosa\"}, {\"id\": \"Inborn genetic diseases, Dominant dystrophic epidermolysis bullosa with absence of skin, not provided\"}, {\"id\": \"Recessive dystrophic epidermolysis bullosa, Dominant dystrophic epidermolysis bullosa with absence of skin, Nail disorder, nonsyndromic congenital, 8\"}, {\"id\": \"Epidermolysis bullosa, pretibial, autosomal recessive\"}, {\"id\": \"Epidermolysis bullosa pruriginosa, autosomal recessive, not provided\"}, {\"id\": \"Recessive dystrophic epidermolysis bullosa, Nail disorder, nonsyndromic congenital, 8\"}, {\"id\": \"Transient bullous dermolysis of the newborn\"}, {\"id\": \"Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant, not provided\"}, {\"id\": \"Abnormality of the skin, Toe syndactyly, Anonychia, Short stature, Finger syndactyly, Palmoplantar blistering, Abnormal blistering of the skin, Nail dystrophy, Skin erosion, not provided\"}, {\"id\": \"Dystrophic epidermolysis bullosa, not provided\"}, {\"id\": \"Abnormality of the thyroid gland, Bullous ichthyosiform erythroderma, Ichthyosis, Epidermal nevus\"}, {\"id\": \"Abnormality of the dentition, Microcephaly, Abnormality of dental enamel, Hyperpigmentation of the skin, Failure to thrive, Alopecia of scalp, Distal muscle weakness, EMG abnormality, Short stature, Decreased body weight, Scarring alopecia of scalp, Abnormal blistering of the skin, Nail dystrophy, Scarring, Recessive dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica inversa, autosomal recessive\"}, {\"id\": \"Abnormality of the skin, Anonychia, Nail dystrophy, Skin erosion, Recessive dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica inversa, autosomal recessive, not provided\"}, {\"id\": \"788\"}, {\"id\": \"Carnitine acylcarnitine translocase deficiency, not provided\"}, {\"id\": \"Carnitine acylcarnitine translocase deficiency\"}, {\"id\": \"11180\"}, {\"id\": \"25915\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18\"}, {\"id\": \"54870\"}, {\"id\": \"VERVERI-BRADY SYNDROME\"}, {\"id\": \"5859\"}, {\"id\": \"Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy\"}, {\"id\": \"Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy, not provided\"}, {\"id\": \"Microcephaly, Strabismus, Impaired use of nonverbal behaviors, Seizures, Short foot, Hypoplasia of the corpus callosum, Heterotopia, Profound global developmental delay, Cortical visual impairment, Insomnia, Small hand\"}, {\"id\": \"10869\"}, {\"id\": \"3913\"}, {\"id\": \"Nephrotic syndrome, type 5, with or without ocular abnormalities\"}, {\"id\": \"Pierson syndrome\"}, {\"id\": \"Pierson syndrome, Nephrotic syndrome, type 5, with or without ocular abnormalities\"}, {\"id\": \"200942\"}, {\"id\": \"Hodgkin lymphoma\"}, {\"id\": \"387\"}, {\"id\": \"Non-Hodgkin lymphoma, Squamous cell carcinoma of the head and neck, Adenocarcinoma of stomach\"}, {\"id\": \"Lung adenocarcinoma, Neoplasm of the breast, Squamous cell carcinoma of the head and neck, Adenocarcinoma of stomach\"}, {\"id\": \"Carcinoma of esophagus, Non-Hodgkin lymphoma, Neoplasm of the breast, Neoplasm of the large intestine, Adenocarcinoma of stomach\"}, {\"id\": \"275\"}, {\"id\": \"Non-ketotic hyperglycinemia\"}, {\"id\": \"275|NICN1\"}, {\"id\": \"1605\"}, {\"id\": \"Limb-girdle muscular dystrophy-dystroglycanopathy, type C9\"}, {\"id\": \"Limb-girdle muscular dystrophy-dystroglycanopathy, type C9, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9\"}, {\"id\": \"Limb-girdle muscular dystrophy-dystroglycanopathy, type C9, not provided\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9\"}, {\"id\": \"29925\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14, not provided\"}, {\"id\": \"Muscular dystrophy, Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, not provided\"}, {\"id\": \"Inborn genetic diseases, Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14, Muscular dystrophy-dystroglycanopathy\"}, {\"id\": \"Elevated serum creatine phosphokinase\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14\"}, {\"id\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14\"}, {\"id\": \"Muscular dystrophy, Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14, not provided\"}, {\"id\": \"10293\"}, {\"id\": \"Seckel syndrome 9\"}, {\"id\": \"2779\"}, {\"id\": \"Congenital stationary night blindness, autosomal dominant 3\"}, {\"id\": \"Night blindness, congenital stationary, type 1g\"}, {\"id\": \"2771\"}, {\"id\": \"Pituitary dependent hypercortisolism\"}, {\"id\": \"Granulosa cell tumor of the ovary, Thecoma, somatic, Adrenocortical tumor, somatic\"}, {\"id\": \"Ventricular tachycardia, somatic\"}, {\"id\": \"3373\"}, {\"id\": \"Deficiency of hyaluronoglucosaminidase\"}, {\"id\": \"51364\"}, {\"id\": \"Ciliary dyskinesia, primary, 22\"}, {\"id\": \"Ciliary dyskinesia, Ciliary dyskinesia, primary, 22, Kartagener syndrome\"}, {\"id\": \"10641\"}, {\"id\": \"Epilepsy, familial focal, with variable foci 2\"}, {\"id\": \"9254\"}, {\"id\": \"7867\"}, {\"id\": \"Macular dystrophy, patterned, 3\"}, {\"id\": \"1795\"}, {\"id\": \"Inborn genetic diseases, NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA\"}, {\"id\": \"Muscular hypotonia, Global developmental delay\"}, {\"id\": \"95|ABHD14A-ACY1\"}, {\"id\": \"Aminoacylase 1 deficiency\"}, {\"id\": \"25886\"}, {\"id\": \"Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis\"}, {\"id\": \"Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, Primordial dwarfism\"}, {\"id\": \"132158\"}, {\"id\": \"Deficiency of glycerate kinase\"}, {\"id\": \"25981\"}, {\"id\": \"Ciliary dyskinesia, primary, 37, Kartagener syndrome\"}, {\"id\": \"SPERMATOGENIC FAILURE 18\"}, {\"id\": \"SPERMATOGENIC FAILURE 18, Ciliary dyskinesia, primary, 37\"}, {\"id\": \"8314\"}, {\"id\": \"Tumor susceptibility linked to germline BAP1 mutations\"}, {\"id\": \"Tumor susceptibility linked to germline BAP1 mutations, not provided\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Tumor susceptibility linked to germline BAP1 mutations, BAP1 Cancer Syndrome\"}, {\"id\": \"Hereditary cancer-predisposing syndrome, Tumor susceptibility linked to germline BAP1 mutations\"}, {\"id\": \"7134\"}, {\"id\": \"Dilated cardiomyopathy 1Z, not provided\"}, {\"id\": \"Familial hypertrophic cardiomyopathy 13\"}, {\"id\": \"91869\"}, {\"id\": \"Congenital disorder of glycosylation type 1N\"}, {\"id\": \"5580\"}, {\"id\": \"Autoimmune lymphoproliferative syndrome, type III\"}, {\"id\": \"7086\"}, {\"id\": \"Short stature, developmental delay, and congenital heart defects\"}, {\"id\": \"776\"}, {\"id\": \"Sinoatrial node dysfunction and deafness\"}, {\"id\": \"Primary aldosteronism, seizures, and neurologic abnormalities, not provided\"}, {\"id\": \"7474\"}, {\"id\": \"Robinow syndrome\"}, {\"id\": \"54756\"}, {\"id\": \"Hypogonadotropic hypogonadism 18 with anosmia\"}, {\"id\": \"Delayed puberty\"}, {\"id\": \"8820\"}, {\"id\": \"Septo-optic dysplasia sequence\"}, {\"id\": \"Growth hormone deficiency with pituitary anomalies\"}, {\"id\": \"Pituitary hormone deficiency, combined 5\"}, {\"id\": \"Septo-optic dysplasia sequence, Pituitary hormone deficiency, combined 1\"}, {\"id\": \"Septo-optic dysplasia sequence, Pituitary hormone deficiency, combined 1, not provided\"}, {\"id\": \"Septo-optic dysplasia sequence, Growth hormone deficiency with pituitary anomalies\"}, {\"id\": \"26060\"}, {\"id\": \"Maturity-onset diabetes of the young, type 14\"}, {\"id\": \"2317\"}, {\"id\": \"Atelosteogenesis type 1\"}, {\"id\": \"Larsen syndrome, Larsen syndrome, dominant type\"}, {\"id\": \"FLNB-Related Disorders\"}, {\"id\": \"Boomerang dysplasia\"}, {\"id\": \"Atelosteogenesis type 3\"}, {\"id\": \"Atelosteogenesis type 1, Atelosteogenesis type 3\"}, {\"id\": \"Larsen syndrome, dominant type\"}, {\"id\": \"Spondylocarpotarsal synostosis syndrome\"}, {\"id\": \"Atelosteogenesis type 3, not specified\"}, {\"id\": \"2317|FLNB-AS1\"}, {\"id\": \"5162\"}, {\"id\": \"Pyruvate dehydrogenase E1-beta deficiency\"}, {\"id\": \"8309\"}, {\"id\": \"Bile acid synthesis defect, congenital, 6\"}, {\"id\": \"166336|PRICKLE2-AS1\"}, {\"id\": \"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, Epilepsy, progressive myoclonic 5\"}, {\"id\": \"166336\"}, {\"id\": \"Epilepsy, progressive myoclonic 5\"}, {\"id\": \"115286\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 28\"}, {\"id\": \"285203\"}, {\"id\": \"Adams-Oliver syndrome 4\"}, {\"id\": \"Adams-Oliver syndrome, Adams-Oliver syndrome 4\"}, {\"id\": \"56203\"}, {\"id\": \"Nemaline myopathy 10\"}, {\"id\": \"4286\"}, {\"id\": \"Waardenburg syndrome type 2A\"}, {\"id\": \"Waardenburg syndrome type 2\"}, {\"id\": \"Tietz syndrome, Waardenburg syndrome type 2A\"}, {\"id\": \"Waardenburg syndrome type 2A, Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness\"}, {\"id\": \"Tietz syndrome\"}, {\"id\": \"Hearing impairment, Prelingual sensorineural hearing impairment, Heterochromia iridis, Poliosis, Waardenburg syndrome type 2A\"}, {\"id\": \"Congenital sensorineural hearing impairment, Waardenburg syndrome type 2A, not provided\"}, {\"id\": \"27086\"}, {\"id\": \"Mental retardation with language impairment and with or without autistic features\"}, {\"id\": \"Mental retardation with language impairment and with or without autistic features, not provided\"}, {\"id\": \"Inborn genetic diseases, Mental retardation with language impairment and with or without autistic features, not provided\"}, {\"id\": \"Strabismus, Delayed speech and language development, Glabellar hemangioma, Intellectual disability, Anterior creases of earlobe\"}, {\"id\": \"Autistic disorder of childhood onset\"}, {\"id\": \"Autistic disorder of childhood onset, Intellectual disability\"}, {\"id\": \"60675\"}, {\"id\": \"Hypogonadotropic hypogonadism 4 with or without anosmia\"}, {\"id\": \"23024\"}, {\"id\": \"6092\"}, {\"id\": \"Vesicoureteral reflux 2\"}, {\"id\": \"2632\"}, {\"id\": \"GBE1-Related Disorders\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, childhood neuromuscular\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, congenital neuromuscular\"}, {\"id\": \"Glycogen storage disease, type IV\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, fatal perinatal neuromuscular\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, combined hepatic and myopathic, Adult polyglucosan body neuropathy\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, Glycogen storage disease IV, childhood neuromuscular, not provided\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, Adult polyglucosan body neuropathy, not provided\"}, {\"id\": \"Inborn genetic diseases, Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, Glycogen storage disease IV, nonprogressive hepatic, Adult polyglucosan body neuropathy, GBE1-Related Disorders, not provided\"}, {\"id\": \"Polyglucosan body disease, adult, Glycogen storage disease IV, congenital neuromuscular\"}, {\"id\": \"Glycogen storage disease IV, congenital neuromuscular\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, not provided\"}, {\"id\": \"Glycogen storage disease, type IV, Polyglucosan body disease, adult, Glycogen storage disease IV, classic hepatic, GBE1-Related Disorders, not provided\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, nonprogressive hepatic, Adult polyglucosan body neuropathy\"}, {\"id\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic\"}, {\"id\": \"25978\"}, {\"id\": \"Frontotemporal Dementia, Chromosome 3-Linked, not provided\"}, {\"id\": \"Frontotemporal Dementia, Chromosome 3-Linked\"}, {\"id\": \"Frontotemporal Dementia, Chromosome 3-Linked, Amyotrophic lateral sclerosis 17, not provided\"}, {\"id\": \"5449\"}, {\"id\": \"Pituitary hormone deficiency, combined 1\"}, {\"id\": \"Pituitary hormone deficiency, combined 1, not provided\"}, {\"id\": \"5627\"}, {\"id\": \"Protein S deficiency\"}, {\"id\": \"Thrombophilia due to protein S deficiency, autosomal recessive\"}, {\"id\": \"200894\"}, {\"id\": \"Joubert syndrome 8\"}, {\"id\": \"Joubert Syndrome and Related Disorders\"}, {\"id\": \"84100\"}, {\"id\": \"Bardet-Biedl syndrome 3\"}, {\"id\": \"Bardet-Biedl syndrome 3, Retinitis pigmentosa 55\"}, {\"id\": \"Retinitis pigmentosa 55\"}, {\"id\": \"Bardet-Biedl syndrome 1, modifier of, Bardet-Biedl syndrome 3\"}, {\"id\": \"1371\"}, {\"id\": \"Hereditary coproporphyria, Coproporphyria\"}, {\"id\": \"Harderoporphyria, not provided\"}, {\"id\": \"Coproporphyria\"}, {\"id\": \"Harderoporphyria\"}, {\"id\": \"Coproporphyria, digenic\"}, {\"id\": \"55773\"}, {\"id\": \"PONTOCEREBELLAR HYPOPLASIA, TYPE 11\"}, {\"id\": \"Pontoneocerebellar hypoplasia, PONTOCEREBELLAR HYPOPLASIA, TYPE 11\"}, {\"id\": \"10342\"}, {\"id\": \"Spastic paraplegia 57, autosomal recessive\"}, {\"id\": \"Neuropathy, hereditary motor and sensory, Okinawa type\"}, {\"id\": \"Neuropathy, hereditary motor and sensory, Okinawa type, Spastic paraplegia 57, autosomal recessive, not provided\"}, {\"id\": \"50939\"}, {\"id\": \"Macular dystrophy, vitelliform, 5\"}, {\"id\": \"Retinitis pigmentosa 56\"}, {\"id\": \"Abnormality of the eye, Retinal dystrophy\"}, {\"id\": \"Macular dystrophy, vitelliform, 5, not provided\"}, {\"id\": \"54931\"}, {\"id\": \"Mitochondrial diseases, Combined oxidative phosphorylation deficiency 30\"}, {\"id\": \"79598\"}, {\"id\": \"55081\"}, {\"id\": \"OROFACIODIGITAL SYNDROME XVIII\"}, {\"id\": \"25945\"}, {\"id\": \"10225\"}, {\"id\": \"C syndrome\"}, {\"id\": \"55779\"}, {\"id\": \"SPERMATOGENIC FAILURE 20\"}, {\"id\": \"523\"}, {\"id\": \"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3\"}, {\"id\": \"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID\"}, {\"id\": \"26137\"}, {\"id\": \"Autistic behavior, Abnormal facial shape, Clinodactyly of the 5th finger, Moderate global developmental delay, Clinodactyly of the 4th toe\"}, {\"id\": \"Primrose syndrome\"}, {\"id\": \"Inborn genetic diseases, Primrose syndrome\"}, {\"id\": \"57514\"}, {\"id\": \"Adams-Oliver syndrome 1\"}, {\"id\": \"56983\"}, {\"id\": \"Dowling-degos disease 4\"}, {\"id\": \"Muscular dystrophy, limb-girdle, type 2z\"}, {\"id\": \"51300\"}, {\"id\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31\"}, {\"id\": \"3081\"}, {\"id\": \"Alkaptonuria\"}, {\"id\": \"9657\"}, {\"id\": \"Senior-Loken syndrome 5\"}, {\"id\": \"Nephronophthisis, Retinal dystrophy, Senior-Loken syndrome 5, not provided\"}, {\"id\": \"Nephronophthisis, Senior-Loken syndrome 5\"}, {\"id\": \"Nephronophthisis, Leber congenital amaurosis, Senior-Loken syndrome 5\"}, {\"id\": \"Leber congenital amaurosis, not provided\"}, {\"id\": \"286676\"}, {\"id\": \"Deafness, autosomal recessive 42\"}, {\"id\": \"846\"}, {\"id\": \"Hypocalciuric hypercalcemia, familial, type 1\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1, not provided\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, with bartter syndrome\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1\"}, {\"id\": \"Hypocalciuric hypercalcemia, familial, type 1, not provided\"}, {\"id\": \"Familial hypocalciuric hypercalcemia\"}, {\"id\": \"Neonatal severe hyperparathyroidism\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, Hypocalcemia, autosomal dominant 1, with bartter syndrome\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, not provided\"}, {\"id\": \"Familial hypocalciuric hypercalcemia, not provided\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1, Neonatal severe hyperparathyroidism, not provided\"}, {\"id\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1, Neonatal severe hyperparathyroidism\"}, {\"id\": \"Hypoparathyroidism familial isolated\"}, {\"id\": \"Hypocalciuric hypercalcemia, familial, type 1, Neonatal severe hyperparathyroidism\"}, {\"id\": \"Hypertrophic cardiomyopathy, Parathyroid adenoma, Hypercalcemia, Hypocalciuria\"}, {\"id\": \"1475\"}, {\"id\": \"Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like\"}, {\"id\": \"111\"}, {\"id\": \"Dyskinesia, familial, with facial myokymia\"}, {\"id\": \"Dyskinesia, familial, with facial myokymia, not provided\"}, {\"id\": \"4638|MYLK-AS1\"}, {\"id\": \"Aortic aneurysm, familial thoracic 7, Thoracic aortic aneurysm and aortic dissection\"}, {\"id\": \"4638\"}, {\"id\": \"Aortic aneurysm, familial thoracic 7\"}, {\"id\": \"7372\"}, {\"id\": \"Orotic aciduria\"}, {\"id\": \"7707\"}, {\"id\": \"Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies\"}, {\"id\": \"131669\"}, {\"id\": \"Urocanate hydratase deficiency\"}, {\"id\": \"4171\"}, {\"id\": \"Deafness, autosomal dominant 70\"}, {\"id\": \"29927\"}, {\"id\": \"Hyperuricemic nephropathy, familial juvenile, 4\"}, {\"id\": \"Decreased antibody level in blood\"}, {\"id\": \"8607|SEC61A1\"}, {\"id\": \"2624\"}, {\"id\": \"Acute myeloid leukemia, Leukemia, acute myeloid, susceptibility to, Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\"}, {\"id\": \"Lymphedema, primary, with myelodysplasia, Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\"}, {\"id\": \"Lymphedema, primary, with myelodysplasia\"}, {\"id\": \"Leukemia, acute myeloid, susceptibility to\"}, {\"id\": \"Acute myeloid leukemia, Myelodysplastic syndrome, Leukemia, acute myeloid, susceptibility to, Lymphedema, primary, with myelodysplasia, Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\"}, {\"id\": \"Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\"}, {\"id\": \"7879\"}, {\"id\": \"Charcot-Marie-Tooth disease, axonal, type 2b, not provided\"}, {\"id\": \"28976\"}, {\"id\": \"Acyl-CoA dehydrogenase family, member 9, deficiency of\"}, {\"id\": \"Mitochondrial complex I deficiency\"}, {\"id\": \"Acyl-CoA dehydrogenase family, member 9, deficiency of, not provided\"}, {\"id\": \"28976|KIAA1257\"}, {\"id\": \"2815\"}, {\"id\": \"Bernard-Soulier syndrome type C\"}, {\"id\": \"Bernard-Soulier syndrome type C, not provided\"}, {\"id\": \"Bernard Soulier syndrome, Bernard-Soulier syndrome type C\"}, {\"id\": \"55764\"}, {\"id\": \"Cranioectodermal dysplasia 1\"}, {\"id\": \"Cranioectodermal dysplasia, not provided\"}, {\"id\": \"6010\"}, {\"id\": \"Retinitis pigmentosa, Retinitis pigmentosa 4\"}, {\"id\": \"Retinitis pigmentosa 4\"}, {\"id\": \"Retinitis pigmentosa 4, not provided\"}, {\"id\": \"Congenital stationary night blindness, autosomal dominant 1\"}, {\"id\": \"Retinitis pigmentosa, Retinitis punctata albescens, Retinitis pigmentosa 4, not provided\"}, {\"id\": \"Retinitis pigmentosa 4, autosomal recessive\"}, {\"id\": \"Retinitis pigmentosa, Retinitis pigmentosa 4, not provided\"}, {\"id\": \"Exudative retinopathy, Rod-cone dystrophy, Cataract, Progressive visual loss, Retinal detachment, Blindness, Nystagmus, Retinal exudate, Abnormality of retinal pigmentation, Unilateral strabismus, Optic disc drusen\"}, {\"id\": \"Autosomal dominant retinitis pigmentosa, not provided\"}, {\"id\": \"Retinitis pigmentosa, Blurred vision, Nyctalopia, Peripheral visual field loss, Retinitis pigmentosa 4, not provided\"}, {\"id\": \"131873\"}, {\"id\": \"27032\"}, {\"id\": \"Familial benign pemphigus\"}, {\"id\": \"11222\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 9\"}, {\"id\": \"79876|NPHP3-ACAD11\"}, {\"id\": \"Epileptic encephalopathy, early infantile, 44\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 24, Epileptic encephalopathy, early infantile, 44\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 24\"}, {\"id\": \"Spinocerebellar ataxia, autosomal recessive 24, Epileptic encephalopathy, early infantile, 44, not provided\"}, {\"id\": \"27031|NPHP3-ACAD11\"}, {\"id\": \"Adolescent nephronophthisis\"}, {\"id\": \"Adolescent nephronophthisis, not provided\"}, {\"id\": \"Adolescent nephronophthisis, Renal-hepatic-pancreatic dysplasia\"}, {\"id\": \"Renal-hepatic-pancreatic dysplasia\"}, {\"id\": \"Nephronophthisis, Adolescent nephronophthisis\"}, {\"id\": \"Adolescent nephronophthisis, Meckel syndrome type 7, Renal-hepatic-pancreatic dysplasia\"}, {\"id\": \"27031|NPHP3-AS1\"}, {\"id\": \"8419|BFSP2-AS1\"}, {\"id\": \"Cataract 12, multiple types, not provided\"}, {\"id\": \"7018\"}, {\"id\": \"Atransferrinemia\"}, {\"id\": \"Transferrin variant d1\"}, {\"id\": \"Transferrin variant bv\"}, {\"id\": \"Transferrin variant b2\"}, {\"id\": \"6578\"}, {\"id\": \"Primary hypertrophic osteoarthropathy, autosomal recessive 2\"}, {\"id\": \"80254\"}, {\"id\": \"Seckel syndrome 6\"}, {\"id\": \"2047|CEP63\"}, {\"id\": \"Myopathy, myofibrillar, 7\"}, {\"id\": \"5096\"}, {\"id\": \"Propionyl-CoA carboxylase deficiency\"}, {\"id\": \"Propionyl-CoA carboxylase deficiency, not provided\"}, {\"id\": \"Propionyl-CoA carboxylase deficiency, not specified, not provided\"}, {\"id\": \"10274\"}, {\"id\": \"STAG1-related disorder\"}, {\"id\": \"STAG1-related disorder, MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}, {\"id\": \"STAG1-Related Disorders, not provided\"}, {\"id\": \"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}, {\"id\": \"STAG1-related disorder, Inborn genetic diseases, MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\"}, {\"id\": \"199221\"}, {\"id\": \"POLYCYSTIC KIDNEY DISEASE 5\"}, {\"id\": \"22808\"}, {\"id\": \"668\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1, Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2\"}, {\"id\": \"Premature ovarian failure 3\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus, Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus, not provided\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus, Premature ovarian failure 3\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2\"}, {\"id\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1, not provided\"}, {\"id\": \"56945\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 5\"}, {\"id\": \"46,XX gonadal dysgenesis, OVARIAN DYSGENESIS 7\"}, {\"id\": \"9276\"}, {\"id\": \"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE\"}, {\"id\": \"545\"}, {\"id\": \"Seckel syndrome 1\"}, {\"id\": \"Cutaneous telangiectasia and cancer syndrome, familial\"}, {\"id\": \"5352\"}, {\"id\": \"Cleft of soft palate, Talipes equinovarus, Femoral bowing, Radial bowing, Ulnar bowing, Short femur, Aplasia/hypoplasia of the femur, Bowing of the long bones, Camptodactyly, not provided\"}, {\"id\": \"Bruck syndrome 2\"}, {\"id\": \"Cleft of soft palate, Talipes equinovarus, Femoral bowing, Radial bowing, Ulnar bowing, Short femur, Aplasia/hypoplasia of the femur, Bowing of the long bones, Camptodactyly\"}, {\"id\": \"7545\"}, {\"id\": \"Craniosynostosis 6\"}, {\"id\": \"Craniosynostosis 6, not provided\"}, {\"id\": \"185\"}, {\"id\": \"2992\"}, {\"id\": \"Polyglucosan body myopathy 2, not provided\"}, {\"id\": \"Glycogen storage disease XV, Polyglucosan body myopathy 2\"}, {\"id\": \"Glycogen storage disease XV\"}, {\"id\": \"Glycogen storage disease XV, Polyglucosan body myopathy 2, not provided\"}, {\"id\": \"Polyglucosan body myopathy 2\"}, {\"id\": \"84343\"}, {\"id\": \"Hermansky-Pudlak syndrome 3, not provided\"}, {\"id\": \"Hermansky-Pudlak syndrome 3\"}, {\"id\": \"1356|HPS3\"}, {\"id\": \"1356\"}, {\"id\": \"Deficiency of ferroxidase, Hemosiderosis, systemic, due to aceruloplasminemia\"}, {\"id\": \"Deficiency of ferroxidase\"}, {\"id\": \"Deficiency of ferroxidase, Hypoceruloplasminemia, not provided\"}, {\"id\": \"Ceruloplasmin belfast, Deficiency of ferroxidase\"}, {\"id\": \"Deficiency of ferroxidase, not provided\"}, {\"id\": \"7401\"}, {\"id\": \"Usher syndrome, type 3A\"}, {\"id\": \"Usher syndrome, type 3A, not provided\"}, {\"id\": \"Retinitis pigmentosa 61\"}, {\"id\": \"Retinitis pigmentosa, Usher syndrome, type 3A\"}, {\"id\": \"7401|CLRN1-AS1\"}, {\"id\": \"64805|MED12L\"}, {\"id\": \"Platelet-type bleeding disorder 8\"}, {\"id\": \"4311\"}, {\"id\": \"Spinocerebellar ataxia 43\"}, {\"id\": \"Charcot-Marie-Tooth disease, axonal, type 2T, not provided\"}, {\"id\": \"Idiopathic membranous glomerulonephritis\"}, {\"id\": \"9197\"}, {\"id\": \"Spastic paraplegia 42, autosomal dominant\"}, {\"id\": \"Congenital cataracts, hearing loss, and neurodegeneration, not provided\"}, {\"id\": \"85476\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 1\"}, {\"id\": \"Combined oxidative phosphorylation deficiency 1, not provided\"}, {\"id\": \"57560|TRIM59-IFT80\"}, {\"id\": \"Asphyxiating thoracic dystrophy 2\"}, {\"id\": \"6476\"}, {\"id\": \"Sucrase-isomaltase deficiency\"}, {\"id\": \"Inborn genetic diseases, Sucrase-isomaltase deficiency\"}, {\"id\": \"Sucrase-isomaltase deficiency, not provided\"}, {\"id\": \"590\"}, {\"id\": \"Deficiency of butyrylcholine esterase\"}, {\"id\": \"Bche, j variant\"}, {\"id\": \"Butyrylcholinesterase deficiency, fluoride 1\"}, {\"id\": \"Bche, h variant\"}, {\"id\": \"Deficiency of butyrylcholine esterase, Postanesthetic apnea\"}, {\"id\": \"11235\"}, {\"id\": \"Cerebral cavernous malformations 3, not provided\"}, {\"id\": \"Cavernous hemangioma, Seizures, Hemiparesis, Cerebral arteriovenous malformation, Cerebral cavernous malformations 3, not provided\"}, {\"id\": \"Cerebral cavernous malformations 3\"}, {\"id\": \"5274\"}, {\"id\": \"Encephalopathy, familial, with neuroserpin inclusion bodies\"}, {\"id\": \"2122\"}, {\"id\": \"Radioulnar synostosis with amegakaryocytic thrombocytopenia 2\"}, {\"id\": \"7012\"}, {\"id\": \"Dyskeratosis congenita autosomal dominant\"}, {\"id\": \"Aplastic anemia\"}, {\"id\": \"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2, Dyskeratosis congenita autosomal dominant\"}, {\"id\": \"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2\"}, {\"id\": \"Idiopathic fibrosing alveolitis, chronic form, Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2\"}, {\"id\": \"Aplastic anemia, Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2\"}, {\"id\": \"7012|LOC110806306\"}, {\"id\": \"110806306\"}, {\"id\": \"Paroxysmal nocturnal hemoglobinuria 1\"}, {\"id\": \"57709\"}, {\"id\": \"Retinitis pigmentosa 68\"}, {\"id\": \"57709|SLC7A14-AS1\"}, {\"id\": \"6514\"}, {\"id\": \"Fanconi-Bickel syndrome\"}, {\"id\": \"23043\"}, {\"id\": \"Mental retardation, autosomal recessive 54\"}, {\"id\": \"5337\"}, {\"id\": \"Cardiac valvular defect, developmental\"}, {\"id\": \"2693\"}, {\"id\": \"Inborn genetic diseases, Short stature, idiopathic, autosomal\"}, {\"id\": \"Short stature, idiopathic, autosomal\"}, {\"id\": \"83893\"}, {\"id\": \"Globozoospermia\"}, {\"id\": \"79718\"}, {\"id\": \"Pierpont syndrome\"}, {\"id\": \"Fitzsimmons-Guilbert syndrome\"}, {\"id\": \"5290\"}, {\"id\": \"Squamous cell lung carcinoma, Neoplasm of the large intestine, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Squamous cell lung carcinoma, Neoplasm of the large intestine, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Malignant Colorectal Neoplasm\"}, {\"id\": \"Medulloblastoma, Renal cell carcinoma, papillary, 1, Lung adenocarcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus\"}, {\"id\": \"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC\"}, {\"id\": \"Transitional cell carcinoma of the bladder, Brainstem glioma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Glioblastoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Uterine Carcinosarcoma\"}, {\"id\": \"PIK3CA related overgrowth spectrum\"}, {\"id\": \"Transitional cell carcinoma of the bladder, Squamous cell lung carcinoma, Neoplasm of the large intestine, Uterine cervical neoplasms, Malignant neoplasm of body of uterus, Uterine Carcinosarcoma\"}, {\"id\": \"Neuroblastoma, Multiple myeloma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Megalencephaly cutis marmorata telangiectatica congenita\"}, {\"id\": \"Pancreatic adenocarcinoma, Squamous cell lung carcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the thyroid gland, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Glioblastoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Cowden syndrome 5\"}, {\"id\": \"Cowden syndrome 5\"}, {\"id\": \"Non-Hodgkin lymphoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Cowden syndrome, Malignant neoplasm of body of uterus, not provided\"}, {\"id\": \"Non-Hodgkin lymphoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus\"}, {\"id\": \"Lung adenocarcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Adenoid cystic carcinoma, Glioblastoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Uterine Carcinosarcoma\"}, {\"id\": \"Neoplasm of the breast, Neoplasm of the large intestine\"}, {\"id\": \"Megalencephaly cutis marmorata telangiectatica congenita, PIK3CA related overgrowth spectrum\"}, {\"id\": \"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC, Neoplasm of ovary, Squamous cell lung carcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Adenoid cystic carcinoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, PIK3CA related overgrowth spectrum\"}, {\"id\": \"Squamous cell lung carcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Adenoid cystic carcinoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}, {\"id\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Neoplasm of brain, Neoplasm of the breast, Squamous cell carcinoma of the head and neck, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\"}], \"data-23bffc8ec4585e8ebc78b078397b583c\": [{\"source\": \"9636\", \"target\": \"Immunodeficiency 38 with basal ganglia calcification\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"375790\", \"target\": \"Congenital myasthenic syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"375790\", \"target\": \"Congenital myasthenic syndrome, Myasthenic syndrome, congenital, 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"375790\", \"target\": \"Not Given\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"126792\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1855\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"339453\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2782\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5192\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"63976\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"261734\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"83715\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57449\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23261\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"473\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5293\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64802\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23095\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2475\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4524\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5351\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9927\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11330\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1188\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1188|LOC106501713\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1969\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23400\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6390\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23065|EMC1-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23065\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"65018|PINK1-AS\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"249\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3339\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"998\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"713\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23028\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2582\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2517\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26119\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57190\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8289\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55650\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27245\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2035\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8565\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"204\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2707\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5538\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10269\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1298\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9132\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64175\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6513\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4352\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23334\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6536\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8891\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4595\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4595|TOE1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"114034\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25974\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10103|POMGNT1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55624\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6491\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2301|LINC01389\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1376\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25973\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7809\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4774\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"85440\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5236\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3953\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6121\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"34\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11146\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6125|DIPK1A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"24\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1806\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1806|DPYD-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"178\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1629\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1301\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"29899\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2780\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"271\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3737\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3752\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6566\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9860\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10717\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"270\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4893\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"845\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10352\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3284\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26227\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3158\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4853\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8799\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2703\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10262\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11311\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80222\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"54507\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"58497\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23126\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2312\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2312|FLG-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57459\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7170\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"103\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80308\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2629|LOC106627981\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5313\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55870\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55154\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6016\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4000\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64218\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4914\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6708\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3765|KCNJ10\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"477\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5824\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1314|NCSTN\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4720\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4359\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"22926\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25903\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5087\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"54499\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"919\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10560\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2153\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"92344\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2328\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55157\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"462\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7827|AXDND1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7827\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"89884\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"89884|ACBD6\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"777\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2752\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3918\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4688\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5997\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79577\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"259266\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23418\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"779\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5317\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7139\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5972\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6900\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4179\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3914\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3664\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"255928\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3756\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"28982\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1063\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7399\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7399|LOC102723833\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7042\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55699\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80232\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3930\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"29920\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"29920|MIR6741\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7044\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"56997\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57165\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"58\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"183\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8443\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6905\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"148789\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1130\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4811\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"128178\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"88\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"56776\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2271\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9156\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10806\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10000\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10472\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"116228|HNRNPU-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3192\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"114548\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7173\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23040\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6664\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"51594\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4613|MYCNOS\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4613\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57539\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"338\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5443\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1788\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55252\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3030|GAREM2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3030\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3032\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9381\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"790\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57159\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4358\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8890\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26160\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2646\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5500\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"388939\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6716\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6683\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"58484\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55471\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1545\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6654\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"51626|ABCG5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64240\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64241\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10128\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6519\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6519|PREPL\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9581\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6496\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10736\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57217\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4436\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80204\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3973|STON1-GTF2A1L\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9378\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"87178\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55120\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"53335\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"84140\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2673\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27247\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"525\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8291\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8291|LOC110121121\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"56603\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23233\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6697\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7840\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10617\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"72\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1716\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7841\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8802\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25885\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"65055\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9451\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"151\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23020\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26504\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7535\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1261\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"51601|MITD1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3899\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5903\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5903|EDAR\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4867\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10461\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"84910\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3557\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2736\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"274\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2071\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5624\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"22930\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1615\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3176\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9839\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55777\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27249\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4703|RIF1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4703\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64135\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6328\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6326\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79809\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79809|TTC21B-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6323|LOC102724058\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6335|SCN1A-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8647\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4036\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10324\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80067\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1134\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"50940\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"375298\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1281\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1290\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"30061\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26275\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6772\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57520\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80055\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3329\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"92935\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23314\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"65062\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57679\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"659\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1493\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4719\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"22868\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1421|LOC100507443\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1420|LOC100507443\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"200576\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"285175\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1373\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"580\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26154|SNHG31\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26154\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"50485\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25953|CATIP-AS2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"617\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1593\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80326\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79840\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1674\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23363\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5077\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5077|CCDC140\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10056\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"65080\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8452\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1286\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1285|LOC654841\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"80704\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9320\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9427\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"646960\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1144\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1146\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6295\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1293\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79083\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26146\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9759\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4705\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"547\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"64090\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"51095\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3708\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"859\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55209\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7862\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"84818\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"78987\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2177|LOC107303338\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7428\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"491\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6529|SLC6A1-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6529\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79188\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"686\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6138\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7068\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5915\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55768\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7048\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2720\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6331\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6331|LOC110121269\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11280\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"54977\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1499\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"131377\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"84892\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55129\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"51099|ANO10\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"51099\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23395\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"54585\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79443\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"259236\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4634\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"23218\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"29072\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11277|ATRIP-TREX1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1294\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"788\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25915\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5859\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"3913\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"275|NICN1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1605\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"29925\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2779\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9254\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"25886\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8314\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7134\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"91869\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"776\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2317\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5162\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4286\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27086\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6092\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2632\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5449\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5627\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"200894\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"84100\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10342\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"50939\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"26137\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"56983\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"9657\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"846\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"111\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4638\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7372\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4171\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"8607|SEC61A1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"28976\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"28976|KIAA1257\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"55764\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6010\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"131873\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27032\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11222\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79876|NPHP3-ACAD11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27031|NPHP3-ACAD11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"27031|NPHP3-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6578\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"10274\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"56945\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"545\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5352\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7545\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2992\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"1356\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"4311\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"85476\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"57560|TRIM59-IFT80\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6476\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"11235\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"2122\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"7012\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"6514\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"79718\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not Given\", \"target\": \"5290\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7293\", \"target\": \"Immunodeficiency 16\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"126792\", \"target\": \"Spondyloepimetaphyseal dysplasia with joint laxity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"126792\", \"target\": \"Ehlers-Danlos syndrome, progeroid type, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"126792\", \"target\": \"Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with fractures\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1855\", \"target\": \"Robinow syndrome, autosomal dominant 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1855\", \"target\": \"Inborn genetic diseases\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"2782\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"5192\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23261\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"473\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23400\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23065|EMC1-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"998\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"10236\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"57822\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"8289\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6548\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"3065\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"5538\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6513\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"8438\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6491\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"4998\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"25973\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"4774\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"85440\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6125|DIPK1A\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1301\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"271\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"10717|AP4B1-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"2703\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"10262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"58497\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23126\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"57459\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1141\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"4000\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"4914\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"93183\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"477\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"5824\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"4359\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"54499\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"55157\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23057\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"79577\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"259266\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"55733\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"3756\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"28982\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"7399\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"25782\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"56997\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"57165\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"58\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6905\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"10472\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"3192\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6664\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1788\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6683\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6654\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"91461\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"53335\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"525\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23233\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"5455\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"2736\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"22930\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"9839\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"55777\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"4703\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"10716\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6328\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6326\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6323|LOC102724058\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6335|SCN1A-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"8647\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"26275\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"57520\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"23314\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"57679\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"8828\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"2335\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"8452\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1293\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"547\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"55209\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"285367\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"6529\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"55768\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"7048\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1499\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1294\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"776\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"27086\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"2632\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"846\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"111\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"27031|NPHP3-ACAD11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"80254\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"56945\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"1356\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"5337\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases\", \"target\": \"79718\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"54587\", \"target\": \"Abnormality of brain morphology\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Abnormality of brain morphology\", \"target\": \"6491\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Abnormality of brain morphology\", \"target\": \"10717|AP4B1-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Abnormality of brain morphology\", \"target\": \"23557\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Abnormality of brain morphology\", \"target\": \"460\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Abnormality of brain morphology\", \"target\": \"1615\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Abnormality of brain morphology\", \"target\": \"55768\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55210\", \"target\": \"Harel-Yoon syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55210\", \"target\": \"Harel-Yoon syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"339453\", \"target\": \"Spinocerebellar ataxia 21\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"339453\", \"target\": \"Spinocerebellar ataxia 21, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Generalized tonic-clonic seizures\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Generalized tonic-clonic seizures, Developmental regression, Focal seizures with impairment of consciousness or awareness, Expressive language delay, Multifocal epileptiform discharges, EEG with generalized epileptiform discharges, Mental retardation, autosomal dominant 42, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Strabismus, Nystagmus, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Failure to thrive, Growth delay, Expressive language delay, Limb hypertonia, Inability to walk, Multifocal epileptiform discharges, Feeding difficulties, Cortical visual impairment\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Cleft palate, Strabismus, Nystagmus, Hypothyroidism, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Dystonia, Failure to thrive, Growth delay, Developmental regression, Expressive language delay, Limb hypertonia, Inability to walk, Infantile axial hypotonia, Multifocal epileptiform discharges, EEG with generalized epileptiform discharges, Upper limb hypertonia, Myelodysplastic syndrome, Inborn genetic diseases, Mental retardation, autosomal dominant 42, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Seizures, Muscular hypotonia, Global developmental delay, Failure to thrive, Growth delay, Focal seizures with impairment of consciousness or awareness, Limb hypertonia, Infantile muscular hypotonia, Multifocal epileptiform discharges, Feeding difficulties, Cortical visual impairment, Acute lymphoid leukemia, Mental retardation, autosomal dominant 42\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Strabismus, Seizures, Muscular hypotonia, Global developmental delay, Growth delay, Infantile muscular hypotonia, EEG with generalized epileptiform discharges, Feeding difficulties, Mental retardation, autosomal dominant 42, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2782\", \"target\": \"Mental retardation, autosomal dominant 42\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Seizures, Muscular hypotonia, Global developmental delay, Inborn genetic diseases\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Strabismus, Seizures, Global developmental delay, Failure to thrive, Focal seizures with impairment of consciousness or awareness, Limb hypertonia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2782\", \"target\": \"Neurodevelopmental Disability, hypotonia, Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, Infantile muscular hypotonia, Acute lymphoid leukemia, Mental retardation, autosomal dominant 42\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6497\", \"target\": \"Shprintzen-Goldberg syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6497\", \"target\": \"Inborn genetic diseases, Shprintzen-Goldberg syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6497\", \"target\": \"Inborn genetic diseases, Shprintzen-Goldberg syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6497\", \"target\": \"Shprintzen-Goldberg syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6497\", \"target\": \"Disproportionate tall stature\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5192\", \"target\": \"Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5192\", \"target\": \"Peroxisome biogenesis disorder 6B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5192\", \"target\": \"Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5192\", \"target\": \"Peroxisome biogenesis disorder, complementation group 7, Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B\", \"target\": \"5192|PLCH2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Peroxisome biogenesis disorder 6A, Peroxisome biogenesis disorder 6B, not provided\", \"target\": \"5192|PLCH2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"63976\", \"target\": \"Dilated cardiomyopathy 1LL\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"63976\", \"target\": \"Left ventricular noncompaction 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9731\", \"target\": \"Joubert syndrome 25\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"261734\", \"target\": \"Nephronophthisis 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"261734\", \"target\": \"Nephronophthisis, Nephronophthisis 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"261734\", \"target\": \"Nephronophthisis, Senior-Loken syndrome 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"261734\", \"target\": \"Infertility, Nephronophthisis 4, Cerebello-oculo-renal syndrome (nephronophthisis, oculomotor apraxia and cerebellar abnormalities)\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"261734\", \"target\": \"Nephronophthisis, Senior-Loken syndrome 4, Nephronophthisis 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"387509\", \"target\": \"Childhood-Onset Schizophrenia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Childhood-Onset Schizophrenia\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Childhood-Onset Schizophrenia\", \"target\": \"23024\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"83715\", \"target\": \"Deafness, without vestibular involvement, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83715\", \"target\": \"Deafness, autosomal recessive 36, with or without vestibular involvement\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57449\", \"target\": \"Distal spinal muscular atrophy, autosomal recessive 4, Charcot-Marie-Tooth disease, recessive intermediate c\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57449\", \"target\": \"Charcot-Marie-Tooth disease, recessive intermediate c\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57449\", \"target\": \"Distal spinal muscular atrophy, autosomal recessive 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57449\", \"target\": \"Distal spinal muscular atrophy, autosomal recessive 4, Charcot-Marie-Tooth disease, recessive intermediate c, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23261\", \"target\": \"Cerebellar ataxia, nonprogressive, with mental retardation\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8863\", \"target\": \"Advanced sleep phase syndrome, familial, 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11315\", \"target\": \"Parkinson disease 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11315\", \"target\": \"Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50651\", \"target\": \"INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"473\", \"target\": \"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"473\", \"target\": \"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"473\", \"target\": \"Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, Cerebral visual impairment and intellectual disability, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9563\", \"target\": \"Cortisone reductase deficiency 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5293\", \"target\": \"Immunodeficiency 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5293\", \"target\": \"Immunodeficiency 14, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64802\", \"target\": \"Leber congenital amaurosis 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64802\", \"target\": \"Leber congenital amaurosis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"64802\", \"target\": \"Cone/cone-rod dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"64802\", \"target\": \"Leber congenital amaurosis 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64802\", \"target\": \"Leber congenital amaurosis, Leber congenital amaurosis 9, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Leber congenital amaurosis\", \"target\": \"6121\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Leber congenital amaurosis\", \"target\": \"23418\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Leber congenital amaurosis\", \"target\": \"9657\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cone/cone-rod dystrophy\", \"target\": \"1261\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cone/cone-rod dystrophy\", \"target\": \"129880\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23095\", \"target\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type 2A1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23095\", \"target\": \"Neuroblastoma, Neuroblastoma 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23095\", \"target\": \"Pheochromocytoma, Neuroblastoma 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5195\", \"target\": \"Peroxisome biogenesis disorder 13A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23435\", \"target\": \"FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23435\", \"target\": \"Amyotrophic lateral sclerosis type 10\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23435\", \"target\": \"Amyotrophic lateral sclerosis type 10, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23435\", \"target\": \"Amyotrophic lateral sclerosis type 10, TARDBP-related frontotemporal dementia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23435\", \"target\": \"Motor neuron disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23435\", \"target\": \"Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23435\", \"target\": \"Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2475\", \"target\": \"Kidney Carcinoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the breast, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Focal cortical dysplasia type II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2475\", \"target\": \"Transitional cell carcinoma of the bladder, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Smith-Kingsmore syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the large intestine, Papillary renal cell carcinoma, sporadic, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Focal cortical dysplasia type II, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the large intestine, Papillary renal cell carcinoma, sporadic, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Kidney Carcinoma, Focal cortical dysplasia type II\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the large intestine, Papillary renal cell carcinoma, sporadic, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Metastatic pancreatic neuroendocrine tumours\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Transitional cell carcinoma of the bladder\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"MTOR-related megalencephaly and pigmentary mosaicism in skin\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2475\", \"target\": \"Smith-Kingsmore syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the breast, Glioblastoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Neoplasm of the breast, Glioblastoma, Smith-Kingsmore syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2475\", \"target\": \"Renal cell carcinoma, papillary, 1, Hemimegalencephaly, Neoplasm of the breast, Glioblastoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2475\", \"target\": \"Kidney Carcinoma, Focal cortical dysplasia type II\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Smith-Kingsmore syndrome\", \"target\": \"2475|MTOR-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29914\", \"target\": \"Schnyder crystalline corneal dystrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10459\", \"target\": \"Fanconi anemia, complementation group V\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4524\", \"target\": \"Homocysteinemia due to MTHFR deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4524\", \"target\": \"Homocystinuria due to MTHFR deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4878|NPPA-AS1\", \"target\": \"Atrial standstill 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5351\", \"target\": \"Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5351\", \"target\": \"Ehlers-Danlos syndrome, hydroxylysine-deficient\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5351\", \"target\": \"Ehlers-Danlos syndrome, hydroxylysine-deficient, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5351\", \"target\": \"Ehlers-Danlos syndrome, hydroxylysine-deficient, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5351\", \"target\": \"Scrotal hypoplasia, High palate, Hydrocephalus, Dolichocephaly, Short chin, Narrow chest, Generalized hypotonia, Neonatal hypotonia, Joint hypermobility, Umbilical hernia, Congenital omphalocele, Porencephalic cyst, Thoracolumbar scoliosis, Macrocephaly at birth, Depressed nasal bridge, Bilateral cryptorchidism, Generalized neonatal hypotonia, Severe global developmental delay, Feeding difficulties\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"845\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"4000\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"7042\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"1281\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"7048\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"6331\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype\", \"target\": \"6331|LOC110121269\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2A2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Abnormality of the dentition, Microcephaly, Abnormality of dental enamel, Hyperpigmentation of the skin, Failure to thrive, Alopecia of scalp, Distal muscle weakness, EMG abnormality, Short stature, Decreased body weight, Scarring alopecia of scalp, Abnormal blistering of the skin, Nail dystrophy, Scarring, Charcot-Marie-Tooth disease, type 2, Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease, type 2A2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type 2, Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease, type 2A2A, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2A2A, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9927\", \"target\": \"not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Hereditary motor and sensory neuropathy with optic atrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9927\", \"target\": \"Distal muscle weakness, Peripheral axonal neuropathy, Distal lower limb amyotrophy, Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2A2A, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9927\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease, type 2A2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9927\", \"target\": \"Inborn genetic diseases, Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease, type 2A2A, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Charcot-Marie-Tooth disease, type 2\", \"target\": \"4000\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Charcot-Marie-Tooth disease, type 2, not provided\", \"target\": \"4000\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified\", \"target\": \"11330\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified\", \"target\": \"6335|SCN1A-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified\", \"target\": \"659\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified\", \"target\": \"686\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified\", \"target\": \"5449\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified\", \"target\": \"57560|TRIM59-IFT80\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55187\", \"target\": \"Spinocerebellar ataxia autosomal recessive 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11330\", \"target\": \"Hereditary pancreatitis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11330\", \"target\": \"Hereditary pancreatitis, Pancreatitis, chronic, susceptibility to\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1187|LOC106501712\", \"target\": \"Bartter syndrome, type 4b\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1187|LOC106501712\", \"target\": \"Deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Deafness\", \"target\": \"29899\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Deafness\", \"target\": \"7399\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Deafness\", \"target\": \"9381\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Deafness\", \"target\": \"494513\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1188|LOC106501713\", \"target\": \"Bartter syndrome, type 3, with hypocalciuria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1188|LOC106501713\", \"target\": \"Bartter syndrome type 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1188|LOC106501713\", \"target\": \"Bartter syndrome type 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1188|LOC106501713\", \"target\": \"Bartter syndrome, type 3, with hypocalciuria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1188|LOC106501713\", \"target\": \"BARTTER SYNDROME, TYPE 4B, WITH SENSORINEURAL DEAFNESS\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1969\", \"target\": \"Cataract 6, multiple types\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1969\", \"target\": \"Cataract 6, multiple types, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1969\", \"target\": \"Squamous cell lung carcinoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Squamous cell lung carcinoma\", \"target\": \"4921\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23400\", \"target\": \"Spastic paraplegia 78, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23400\", \"target\": \"Parkinson disease 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23400\", \"target\": \"Parkinson disease 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary Paraganglioma-Pheochromocytoma Syndromes\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Paragangliomas 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Cowden syndrome, Hereditary cancer-predisposing syndrome, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Gastrointestinal stroma tumor\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, SDHB-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Paraganglioma and gastric stromal sarcoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Carney triad, Paragangliomas 4, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Variant of unknown significance, Pheochromocytoma, Gastrointestinal stroma tumor, Paragangliomas 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 4, SDHB-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Pheochromocytoma, Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paraganglioma and gastric stromal sarcoma, Paragangliomas 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6390\", \"target\": \"Hereditary cancer-predisposing syndrome, SDHB-Related Disorders\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"4595\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"4595|TOE1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"6391\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"2271\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"4436\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"55654\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"580\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"7428\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome\", \"target\": \"8314\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary Paraganglioma-Pheochromocytoma Syndromes\", \"target\": \"55654\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"4595\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"6391\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"2271\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"4436\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"580\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"7428\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"8314\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, not provided\", \"target\": \"55654\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Pheochromocytoma\", \"target\": \"55654\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Pheochromocytoma\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Pheochromocytoma, Hereditary cancer-predisposing syndrome\", \"target\": \"55654\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51702\", \"target\": \"Uncombable hair syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51702\", \"target\": \"Central centrifugal cicatricial alopecia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"353238\", \"target\": \"Preimplantation embryonic lethality 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55160\", \"target\": \"Cerebral visual impairment and intellectual disability\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cerebral visual impairment and intellectual disability\", \"target\": \"51205\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cerebral visual impairment and intellectual disability\", \"target\": \"127933\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cerebral visual impairment and intellectual disability\", \"target\": \"55827\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cerebral visual impairment and intellectual disability\", \"target\": \"523\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8659\", \"target\": \"Deficiency of pyrroline-5-carboxylate reductase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23352\", \"target\": \"Short stature\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"25932\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"10076\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"23499\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"23358\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"9909\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"80267\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"84033\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"57504\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"11180\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Short stature\", \"target\": \"23024\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"65018\", \"target\": \"PINK1-Related Parkinsonism, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"65018\", \"target\": \"Parkinson disease 6, autosomal recessive early-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Parkinson disease 6, autosomal recessive early-onset\", \"target\": \"65018|PINK1-AS\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"65018|PINK1-AS\", \"target\": \"Parkinson disease 6, autosomal recessive early-onset, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1650\", \"target\": \"Congenital disorder of glycosylation type Ir\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1650\", \"target\": \"Congenital disorder of glycosylation type Ir, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1889\", \"target\": \"Hirschsprung disease, cardiac defects, and autonomic dysfunction\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1889\", \"target\": \"Hirschsprung disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hirschsprung disease\", \"target\": \"10887\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"249\", \"target\": \"Low alkaline phosphatase\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"249\", \"target\": \"Odontohypophosphatasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, Childhood hypophosphatasia, Adult hypophosphatasia, Odontohypophosphatasia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, Childhood hypophosphatasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Childhood hypophosphatasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, Childhood hypophosphatasia, Adult hypophosphatasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, perinatal lethal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, Adult hypophosphatasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"249\", \"target\": \"Infantile hypophosphatasia, Hypophosphatasia, perinatal lethal, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3339\", \"target\": \"Lethal Kniest-like syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3339\", \"target\": \"Schwartz Jampel syndrome type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"998\", \"target\": \"Takenouchi-Kosaki syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"998\", \"target\": \"Inborn genetic diseases, Takenouchi-Kosaki syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"998\", \"target\": \"Takenouchi-Kosaki syndrome, Noonan-Like Syndrome Disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54361\", \"target\": \"Mullerian aplasia and hyperandrogenism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54361\", \"target\": \"Serkal syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"712\", \"target\": \"C1q deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"C1q deficiency\", \"target\": \"714\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"C1q deficiency\", \"target\": \"713\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2048\", \"target\": \"Prostate cancer/brain cancer susceptibility\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2048\", \"target\": \"Neoplasm of the large intestine\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23028\", \"target\": \"Cleft palate, psychomotor retardation, and distinctive facial features\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6135\", \"target\": \"Diamond-Blackfan anemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6135\", \"target\": \"Diamond-Blackfan anemia, Diamond-Blackfan anemia 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Diamond-Blackfan anemia\", \"target\": \"6125|DIPK1A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2582\", \"target\": \"UDPglucose-4-epimerase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2582\", \"target\": \"UDPglucose-4-epimerase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2582\", \"target\": \"UDPglucose-4-epimerase deficiency, Galactose epimerase deficiency, severe, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3155\", \"target\": \"Deficiency of hydroxymethylglutaryl-CoA lyase\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3155\", \"target\": \"Deficiency of hydroxymethylglutaryl-CoA lyase, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3155\", \"target\": \"Inborn genetic diseases, Deficiency of hydroxymethylglutaryl-CoA lyase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2517\", \"target\": \"Fucosidosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2517\", \"target\": \"Fucosidosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57822\", \"target\": \"nonsyndromic cleft palate\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57822\", \"target\": \"Van der Woude syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57822\", \"target\": \"Van der Woude syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Van der Woude syndrome\", \"target\": \"3664\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6007|RSRP1\", \"target\": \"RhD category D-VII\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6007|RSRP1\", \"target\": \"Rhd, weak d, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26119\", \"target\": \"Hypercholesterolemia, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57190\", \"target\": \"Eichsfeld type congenital muscular dystrophy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57190\", \"target\": \"Eichsfeld type congenital muscular dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57190\", \"target\": \"SEPN1-Related Disorders\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57190\", \"target\": \"Eichsfeld type congenital muscular dystrophy, Congenital myopathy with fiber type disproportion, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7780\", \"target\": \"Zinc deficiency, transient neonatal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79947\", \"target\": \"Retinitis pigmentosa 59\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79947\", \"target\": \"Congenital disorder of glycosylation type 1bb\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79947\", \"target\": \"DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8289\", \"target\": \"Mental retardation, autosomal dominant 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8289\", \"target\": \"Microcephaly, Seizures, Congenital cerebellar hypoplasia, Absent speech, Periventricular leukomalacia, Severe global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8289\", \"target\": \"Coffin-Siris syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55650\", \"target\": \"Hyperphosphatasia with mental retardation syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55650\", \"target\": \"Hyperphosphatasia with mental retardation syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55650\", \"target\": \"Inborn genetic diseases, Hyperphosphatasia-intellectual disability syndrome, Hyperphosphatasia with mental retardation syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8431|NUDC\", \"target\": \"Obesity, mild, early-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"126695\", \"target\": \"Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6548\", \"target\": \"Lichtenstein-knorr syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8547\", \"target\": \"Immunodeficiency due to ficolin 3 deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27245\", \"target\": \"Xia-Gibbs syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27245\", \"target\": \"Delayed speech and language development, Intellectual disability, Muscular hypotonia, Global developmental delay, Neonatal hypotonia, Sleep apnea, Xia-Gibbs syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27245\", \"target\": \"Abdominal obesity-metabolic syndrome 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2035\", \"target\": \"Elliptocytosis 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51102\", \"target\": \"Optic atrophy, Childhood Onset Dystonias, Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"51102\", \"target\": \"Optic atrophy, Childhood Onset Dystonias, Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9698\", \"target\": \"SPINOCEREBELLAR ATAXIA 47\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"576\", \"target\": \"Progressive spastic paraparesis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3932\", \"target\": \"Immunodeficiency 22\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8565\", \"target\": \"Charcot-Marie-Tooth disease, dominant intermediate C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3208\", \"target\": \"Dystonia 2, torsion, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"204\", \"target\": \"Reticular dysgenesis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"127534\", \"target\": \"Erythrokeratodermia variabilis et progressiva 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"127534\", \"target\": \"Erythrokeratodermia variabilis et progressiva 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"127534\", \"target\": \"Erythrokeratodermia variabilis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Erythrokeratodermia variabilis\", \"target\": \"2707\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2707\", \"target\": \"Deafness, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2707\", \"target\": \"Deafness, digenic, GJB2/GJB3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2707\", \"target\": \"Nonsyndromic hearing loss\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Deafness, autosomal recessive\", \"target\": \"9381\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54936\", \"target\": \"NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1296\", \"target\": \"Corneal dystrophy, Fuchs endothelial 1, Corneal dystrophy, posterior polymorphous, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27095\", \"target\": \"Bardet-Biedl syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Bardet-Biedl syndrome\", \"target\": \"129880\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Bardet-Biedl syndrome\", \"target\": \"84100\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1441\", \"target\": \"Hereditary neutrophilia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1441\", \"target\": \"Acute myeloid leukemia, Chronic myelogenous leukemia, Early T cell progenitor acute lymphoblastic leukemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1441\", \"target\": \"Chronic myelogenous leukemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1441\", \"target\": \"Neutropenia, severe congenital, 7, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1441\", \"target\": \"Severe congenital neutropenia, Neutropenia, severe congenital, 7, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79753\", \"target\": \"Psychomotor retardation, epilepsy, and craniofacial dysmorphism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79753\", \"target\": \"Rolandic epilepsy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Rolandic epilepsy\", \"target\": \"6513\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Rolandic epilepsy\", \"target\": \"23334\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Rolandic epilepsy\", \"target\": \"6326\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Rolandic epilepsy\", \"target\": \"6529\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3633\", \"target\": \"Dent disease 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23499\", \"target\": \"Lissencephaly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23499\", \"target\": \"Lissencephaly with decussation defect\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54802\", \"target\": \"Macrocephalus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"54802\", \"target\": \"Combined oxidative phosphorylation deficiency 35, TRIT1 Deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"84879\", \"target\": \"Primary autosomal recessive microcephaly 15\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5538\", \"target\": \"Ceroid lipofuscinosis neuronal 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5538\", \"target\": \"Ceroid lipofuscinosis neuronal 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5538\", \"target\": \"Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis neuronal 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5538\", \"target\": \"Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis neuronal 1, History of neurodevelopmental disorder, Neuronal Ceroid-Lipofuscinosis, Recessive, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5538\", \"target\": \"Inborn genetic diseases, Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis neuronal 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5538\", \"target\": \"Ceroid lipofuscinosis neuronal 1, History of neurodevelopmental disorder, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10269\", \"target\": \"Mandibuloacral dysplasia with type B lipodystrophy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10269\", \"target\": \"Lethal tight skin contracture syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9132\", \"target\": \"DFNA 2 Nonsyndromic Hearing Loss\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9132\", \"target\": \"Nonsyndromic hearing loss and deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9132\", \"target\": \"Nonsyndromic hearing loss and deafness, not specified\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9132\", \"target\": \"DFNA 2 Nonsyndromic Hearing Loss, Nonsyndromic hearing loss and deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Nonsyndromic hearing loss and deafness\", \"target\": \"7399\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Nonsyndromic hearing loss and deafness\", \"target\": \"9381\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nonsyndromic hearing loss and deafness\", \"target\": \"259236\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1503\", \"target\": \"Immunodeficiency 24, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79717|CCDC30\", \"target\": \"CARDIOMYOPATHY, DILATED, 2C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"149461\", \"target\": \"Nephrocalcinosis, Nephrolithiasis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"149461\", \"target\": \"Hypomagnesemia 5, renal, with ocular involvement\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Nephrocalcinosis, Nephrolithiasis\", \"target\": \"6519\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nephrocalcinosis, Nephrolithiasis\", \"target\": \"189\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"64175\", \"target\": \"Osteogenesis imperfecta type 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64175\", \"target\": \"Osteogenesis imperfecta type 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114625\", \"target\": \"SCIANNA BLOOD GROUP SYSTEM, SC:-1,2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 1, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 1, autosomal recessive, Epilepsy, idiopathic generalized, susceptibility to, 12, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6513\", \"target\": \"History of neurodevelopmental disorder\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 1, autosomal recessive, GLUT1 deficiency syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 1, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Glucose transporter type 1 deficiency syndrome, History of neurodevelopmental disorder, Epilepsy, idiopathic generalized, susceptibility to, 12, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6513\", \"target\": \"Microcephaly, Epilepsy, Inborn genetic diseases, GLUT1 deficiency syndrome 1, autosomal recessive, GLUT1 deficiency syndrome 1, intellectual deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, autosomal recessive, Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Stomatin-deficient cryohydrocytosis with neurologic defects\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Inborn genetic diseases, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6513\", \"target\": \"Intellectual disability, GLUT1 deficiency syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Epilepsy, idiopathic generalized, susceptibility to, 12, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Dystonia 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Dystonia 9, GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, autosomal recessive, Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Dystonia 9, Stomatin-deficient cryohydrocytosis with neurologic defects, GLUT1 deficiency syndrome 2, Epilepsy, idiopathic generalized, susceptibility to, 12, GLUT1 deficiency syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6513\", \"target\": \"Glucose transporter type 1 deficiency syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder\", \"target\": \"6326\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder\", \"target\": \"6323|LOC102724058\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder\", \"target\": \"6529\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"24\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"2312\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"3756\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"56997\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"4613\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"23314\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"547\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"55209\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"1499\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"846\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Inborn genetic diseases, not provided\", \"target\": \"6476\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4352\", \"target\": \"Congenital amegakaryocytic thrombocytopenia, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4352\", \"target\": \"Congenital amegakaryocytic thrombocytopenia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4352\", \"target\": \"Congenital amegakaryocytic thrombocytopenia, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4352\", \"target\": \"not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4352\", \"target\": \"Myeloproliferative Neoplasm\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4352\", \"target\": \"Myelofibrosis, Essential thrombocythemia, Myeloproliferative Neoplasm, Thrombocytosis, benign familial microcytic\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4352\", \"target\": \"Hematologic neoplasm, Myelofibrosis with myeloid metaplasia, Congenital amegakaryocytic thrombocytopenia, Thrombocythemia 2, somatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"91624\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"4000\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"7139\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"88\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"859\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"not specified, not provided\", \"target\": \"7134\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23334\", \"target\": \"Early infantile epileptic encephalopathy 18\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23334\", \"target\": \"Cryptorchidism, Abnormality of the anterior fontanelle, Macrocephalus, Seizures, Global developmental delay, Deep plantar creases, Abnormality of the cerebral white matter, Central hypotonia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23334\", \"target\": \"Early infantile epileptic encephalopathy 18, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6487\", \"target\": \"Mental retardation, autosomal recessive 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6536\", \"target\": \"Glycine encephalopathy with normal serum glycine\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8643\", \"target\": \"Basal cell carcinoma, somatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8643\", \"target\": \"Gorlin syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8891\", \"target\": \"Leukoencephalopathy with vanishing white matter\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Leukoencephalopathy with vanishing white matter\", \"target\": \"8890\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7389\", \"target\": \"Hepatoerythropoietic porphyria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7389\", \"target\": \"Porphyria cutanea tarda\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7389\", \"target\": \"Familial porphyria cutanea tarda\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7389\", \"target\": \"Porphyria cutanea tarda, Hepatoerythropoietic porphyria, Familial porphyria cutanea tarda\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7389\", \"target\": \"Hepatoerythropoietic porphyria, Porphyria cutanea tarda, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"MYH-associated polyposis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, MUTYH-associated polyposis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"MYH-associated polyposis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Neoplasm of stomach\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, B lymphoblastic leukemia lymphoma, no ICD-O subtype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"Small intestine carcinoid, Neoplasm of stomach, Endometrial carcinoma, Pilomatrixoma, Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, MUTYH-associated polyposis, Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"MYH-associated polyposis, MUTYH-associated polyposis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, Familial colorectal cancer, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Neoplasm of stomach, Pilomatrixoma, Hereditary cancer-predisposing syndrome, MYH-associated polyposis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, MUTYH-associated polyposis, Familial colorectal cancer, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, MUTYH-associated polyposis, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"Neoplasm of stomach, Endometrial carcinoma, Pilomatrixoma, Hereditary cancer-predisposing syndrome, Carcinoma of colon, MYH-associated polyposis, MUTYH-associated polyposis, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4595\", \"target\": \"MUTYH-associated polyposis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4595\", \"target\": \"Hereditary cancer-predisposing syndrome, MYH-associated polyposis, Familial colorectal cancer, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Neoplasm of stomach\", \"target\": \"4893\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Neoplasm of stomach\", \"target\": \"843\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Neoplasm of stomach\", \"target\": \"1499\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"114034\", \"target\": \"Pontocerebellar hypoplasia, type 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25974\", \"target\": \"Methylmalonic acidemia with homocystinuria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25974\", \"target\": \"Methylmalonic acidemia with homocystinuria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25974\", \"target\": \"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25974\", \"target\": \"Methylmalonic acidemia with homocystinuria, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25974\", \"target\": \"Methylmalonic acidemia with homocystinuria, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25974\", \"target\": \"Methylmalonic acidemia with homocystinuria, Disorders of Intracellular Cobalamin Metabolism, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"25974\", \"target\": \"Inborn genetic diseases, Methylmalonic acidemia with homocystinuria, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC\", \"target\": \"5052\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscle eye brain disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscle eye brain disease, Retinitis pigmentosa 76\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3, Muscle eye brain disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscle eye brain disease, Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscle eye brain disease, Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, Limb-girdle muscular dystrophy-dystroglycanopathy, type C3, POMGNT1-Related Disorders, Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Retinitis pigmentosa 76\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, Limb-girdle muscular dystrophy-dystroglycanopathy, type C3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscle eye brain disease, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Muscle eye brain disease, Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10103|POMGNT1\", \"target\": \"Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3, Limb-girdle muscular dystrophy-dystroglycanopathy, type C3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Muscle eye brain disease\", \"target\": \"55624\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55624\", \"target\": \"Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3, Retinitis pigmentosa 76\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8438\", \"target\": \"Adenocarcinoma of the colon\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8438\", \"target\": \"Ductal breast carcinoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8438\", \"target\": \"Non-Hodgkin lymphoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Non-Hodgkin lymphoma\", \"target\": \"843\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"127343\", \"target\": \"Hearing impairment, Strabismus, Hypermetropia, Seizures, Muscular hypotonia, Global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6491\", \"target\": \"Primary autosomal recessive microcephaly 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2301|LINC01389\", \"target\": \"Congenital primary aphakia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2301|LINC01389\", \"target\": \"Cataract 34, multiple types\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2301|LINC01389\", \"target\": \"Acute aortic dissection, Aortic aneurysm, familial thoracic 11, susceptibility to, Familial thoracic aortic aneurysm\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2301|LINC01389\", \"target\": \"Acute aortic dissection, Familial thoracic aortic aneurysm\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2301|LINC01389\", \"target\": \"Congenital primary aphakia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4998\", \"target\": \"Meier-Gorlin syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4998\", \"target\": \"Meier-Gorlin syndrome, Meier-Gorlin syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"65260\", \"target\": \"Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency\", \"target\": \"116228|HNRNPU-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency\", \"target\": \"22868\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6342\", \"target\": \"Leukoencephalopathy with dystonia and motor neuropathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, infantile\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Arthritis, Pancytopenia, Dysautonomia, Gastrointestinal dysmotility, Polyarticular arthritis, Sinus tachycardia, Chronic pain, Inappropriate sinus tachycardia, Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, lethal neonatal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1376\", \"target\": \"Rhabdomyolysis, Inborn genetic diseases, Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal, Encephalopathy, acute, infection-induced, 4, susceptibility to, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, infantile\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, infantile, Carnitine palmitoyltransferase II deficiency, lethal neonatal, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, infantile, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1376\", \"target\": \"Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase II deficiency, infantile\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1718\", \"target\": \"Desmosterolosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7809\", \"target\": \"Bartter syndrome type 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7809\", \"target\": \"Sensorineural deafness with mild renal dysfunction\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"255738\", \"target\": \"Familial hypercholesterolemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"255738\", \"target\": \"Familial hypercholesterolemia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"255738\", \"target\": \"Hypercholesterolemia, autosomal dominant, 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"255738\", \"target\": \"Hypocholesterolemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"255738\", \"target\": \"Familial hypercholesterolemias, Hypercholesterolemia, autosomal dominant, 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"255738\", \"target\": \"Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"255738\", \"target\": \"Low density lipoprotein cholesterol level quantitative trait locus 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Familial hypercholesterolemia\", \"target\": \"338\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Familial hypercholesterolemia\", \"target\": \"338|LOC106560211\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"732\", \"target\": \"Complement component 8 deficiency type 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"732\", \"target\": \"Complement component 8 deficiency type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4070\", \"target\": \"Lattice corneal dystrophy Type III\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114803\", \"target\": \"BONE MARROW FAILURE SYNDROME 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4774\", \"target\": \"Brain malformations and urinary tract defects\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4774\", \"target\": \"Cleft palate, Macrocephalus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"85440\", \"target\": \"Epileptic encephalopathy, early infantile, 23\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"85440\", \"target\": \"Epileptic encephalopathy, early infantile, 23, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27329|DOCK7\", \"target\": \"Hypobetalipoproteinemia, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29929\", \"target\": \"Congenital disorder of glycosylation type 1C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29929\", \"target\": \"Congenital disorder of glycosylation type 1C, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5236\", \"target\": \"Congenital disorder of glycosylation type 1t\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5236\", \"target\": \"Congenital disorder of glycosylation type 1t, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4919\", \"target\": \"DEAFNESS, AUTOSOMAL RECESSIVE 108\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3716\", \"target\": \"Acute myeloid leukemia, Polycythemia vera, Lymphoblastic leukemia, acute, with lymphomatous features, Leukemia, acute, ?X-linked\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3716\", \"target\": \"Lymphoblastic leukemia, acute, with lymphomatous features\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3716\", \"target\": \"Inborn genetic diseases, Lymphoblastic leukemia, acute, with lymphomatous features\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9829\", \"target\": \"Parkinson disease 19a, juvenile-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9829\", \"target\": \"Parkinson disease 19b, early-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3953\", \"target\": \"Obesity\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23169\", \"target\": \"Schneckenbecken dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Retinitis pigmentosa, Leber congenital amaurosis 2, Retinitis pigmentosa 20, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Retinitis pigmentosa 20, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6121\", \"target\": \"Abnormality of vision, Abnormal electroretinogram, Retinal degeneration, Congenital blindness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Leber congenital amaurosis 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Leber congenital amaurosis 2, Retinitis pigmentosa 20, RPE65-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Retinitis pigmentosa 20\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Adrenocorticotropic hormone deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Leber congenital amaurosis 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6121\", \"target\": \"Leber congenital amaurosis 2, Retinitis pigmentosa 20, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Retinitis pigmentosa, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Retinal dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6121\", \"target\": \"Retinal dystrophy, Leber congenital amaurosis 2, Retinitis pigmentosa 20, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6121\", \"target\": \"Leber congenital amaurosis 2, Retinitis pigmentosa 20\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Adrenocorticotropic hormone deficiency\", \"target\": \"9095\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa, not provided\", \"target\": \"24\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinitis pigmentosa, not provided\", \"target\": \"388939\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa, not provided\", \"target\": \"50939\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"24\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"128338\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"23418\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"7399\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"388939\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"84140\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"1261\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"4036\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"375298\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"50939\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"9657\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinal dystrophy\", \"target\": \"7401\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1491\", \"target\": \"Cystathioninuria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"51086|FPGT-TNNI3K\", \"target\": \"Cardiac conduction disease with or without dilated cardiomyopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"34\", \"target\": \"Medium-chain acyl-coenzyme A dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"34\", \"target\": \"Medium-chain acyl-coenzyme A dehydrogenase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"34\", \"target\": \"Medium-chain acyl-coenzyme A dehydrogenase deficiency, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"34\", \"target\": \"Hydrocephalus, congenital, 2, with or without brain or eye anomalies, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"91624\", \"target\": \"Familial hypertrophic cardiomyopathy 20\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"91624\", \"target\": \"Dilated cardiomyopathy 1CC\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8915\", \"target\": \"Malignant tumor of testis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8915\", \"target\": \"Mucosa-associated lymphoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8915\", \"target\": \"Follicular lymphoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8915\", \"target\": \"Male germ cell tumor, somatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8915\", \"target\": \"Immunodeficiency 37\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84146\", \"target\": \"Myopia 21, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"164045\", \"target\": \"Premature ovarian failure 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"676\", \"target\": \"SPERMATOGENIC FAILURE 21\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11146\", \"target\": \"Blue rubber bleb nevus\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11146\", \"target\": \"Glomuvenous malformations\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"11146\", \"target\": \"Venous malformation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2672\", \"target\": \"Neutropenia, nonimmune chronic idiopathic, of adults\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2672\", \"target\": \"Severe congenital neutropenia 2, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6125|DIPK1A\", \"target\": \"Diamond-Blackfan anemia 6, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6125|DIPK1A\", \"target\": \"Wide anterior fontanel, Low-set, posteriorly rotated ears, Abnormality of the pinna, Downslanted palpebral fissures, Hypotelorism, Dry skin, Hemangioma, Atrial septal defect, Aplastic anemia, Pulmonary arterial hypertension, Hepatomegaly, Relative macrocephaly, Dilation of lateral ventricles, Intracerebral periventricular calcifications, Aplasia of the ovary, Erythroid hypoplasia, Vaginal hydrocele\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6125|DIPK1A\", \"target\": \"Diamond-Blackfan anemia 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Cone/cone-rod dystrophy, Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Cone-rod dystrophy 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Visual loss, Macular degeneration, Blindness, Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Congenital stationary night blindness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, Retinal dystrophy, early-onset severe, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, Age-related macular degeneration 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Cone-rod dystrophy 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO, Retinal dystrophy, Macular dystrophy, Stargardt disease 1, Inborn genetic diseases, Cone-rod dystrophy 3, Age-related macular degeneration 2, ABCA4-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Stargardt disease, Cone-rod dystrophy 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Stargardt disease, Cone-rod dystrophy 3, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Macular dystrophy, Stargardt disease 1, Bull's eye maculopathy, Cone-rod dystrophy 3, Age-related macular degeneration 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Cone-rod dystrophy 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinitis pigmentosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, Leber congenital amaurosis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Inborn genetic diseases, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Cone-rod dystrophy 3, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Macular dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, Stargardt disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO, Stargardt disease 1, Mandibulofacial dysostosis with mental deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinitis pigmentosa, Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Stargardt disease 1, Cone-rod dystrophy 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinitis pigmentosa, Retinal dystrophy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Cone-rod dystrophy 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Leber congenital amaurosis, Bull's eye maculopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Macular dystrophy, Stargardt disease 1, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Macular dystrophy, Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinitis pigmentosa, Retinal dystrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, Cone-rod dystrophy 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Retinal dystrophy, early-onset severe\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Macular dystrophy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"24\", \"target\": \"Visual impairment, Central scotoma, Macular degeneration, Retinal atrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Stargardt disease 1, Cone-rod dystrophy 3, Retinitis pigmentosa 19, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"24\", \"target\": \"Visual impairment, Central scotoma, Macular degeneration, Retinal atrophy, Stargardt disease 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"23418\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"7399\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"388939\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"23020\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"10461\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"84100\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"50939\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinitis pigmentosa\", \"target\": \"6010\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Macular dystrophy\", \"target\": \"22926\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Macular dystrophy\", \"target\": \"23418\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Macular dystrophy, not provided\", \"target\": \"23418\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9411\", \"target\": \"Nonsyndromic cleft lip with or without cleft palate\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"199857\", \"target\": \"Myasthenic syndrome, congenital, 15\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Myasthenic syndrome, congenital, 15\", \"target\": \"199857|LOC101928098\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1806\", \"target\": \"Fluorouracil response\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1806\", \"target\": \"Dihydropyrimidine dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1806\", \"target\": \"Dihydropyrimidine dehydrogenase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1806|DPYD-AS1\", \"target\": \"Dihydropyrimidine dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease type III\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease type III, Glycogen storage disease IIIb, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease type III, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease type III, Glycogen storage disease IIIa, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease type III, Glycogen storage disease IIIa\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease IIIb\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease IIIc\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease type III, Glycogen storage disease IIIa, Glycogen storage disease IIIb, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"178\", \"target\": \"Glycogen storage disease IIIa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23443\", \"target\": \"Arthrogryposis, mental retardation, and seizures\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"163786\", \"target\": \"Primary autosomal recessive microcephaly 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1629\", \"target\": \"Intermediate maple syrup urine disease type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1629\", \"target\": \"Maple syrup urine disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1629\", \"target\": \"Maple syrup urine disease, thiamine-responsive, type II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1629\", \"target\": \"Maple syrup urine disease type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1629\", \"target\": \"Maple syrup urine disease, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8556\", \"target\": \"Deafness, autosomal recessive 32\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54112\", \"target\": \"Chorea, childhood-onset, with psychomotor retardation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1301\", \"target\": \"Marshall syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1301\", \"target\": \"Stickler syndrome, type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1301\", \"target\": \"Connective tissue disorder\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1301\", \"target\": \"Inborn genetic diseases, Marshall syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1301\", \"target\": \"Fibrochondrogenesis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1301\", \"target\": \"Stickler syndrome, type 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1301\", \"target\": \"Marshall/Stickler syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1301\", \"target\": \"sporadic abdominal aortic aneurysm\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55599\", \"target\": \"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29957\", \"target\": \"Fontaine progeroid syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29899\", \"target\": \"Chudley-McCullough syndrome, Autosomal recessive non-syndromic sensorineural deafness type DFNB\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29899\", \"target\": \"Chudley-McCullough syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29899\", \"target\": \"Autosomal recessive non-syndromic sensorineural deafness type DFNB\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29899\", \"target\": \"Chudley-McCullough syndrome, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29899\", \"target\": \"Chudley-McCullough syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29899\", \"target\": \"Chudley-McCullough syndrome, GPSM2-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6884\", \"target\": \"Mental retardation, autosomal recessive 60, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6301\", \"target\": \"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6301\", \"target\": \"Cerebral arteriovenous malformation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cerebral arteriovenous malformation\", \"target\": \"9448\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cerebral arteriovenous malformation\", \"target\": \"54756\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1952\", \"target\": \"Intellectual disability, Global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Intellectual disability, Global developmental delay\", \"target\": \"79598\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2773\", \"target\": \"Auriculocondylar syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2780\", \"target\": \"Abnormality of the eye\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2780\", \"target\": \"Achromatopsia 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"271\", \"target\": \"Spastic paraplegia 63, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"271\", \"target\": \"Pontocerebellar hypoplasia, type 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"271\", \"target\": \"Seizures, Global developmental delay, Brain malformation\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"257\", \"target\": \"Frontonasal dysplasia 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"388662\", \"target\": \"Mental retardation, autosomal recessive 48\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3737\", \"target\": \"Epileptic encephalopathy, early infantile, 32, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3737\", \"target\": \"Epileptic encephalopathy, early infantile, 32\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3737\", \"target\": \"Inborn genetic diseases, Epileptic encephalopathy, early infantile, 32, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"128338\", \"target\": \"Cone-rod dystrophy 21\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"128338\", \"target\": \"Retinal dystrophy, Cone-rod dystrophy 21\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3752\", \"target\": \"Spinocerebellar ataxia 19\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3752\", \"target\": \"Spinocerebellar ataxia 19, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7482\", \"target\": \"Failure to thrive, Failure to thrive in infancy, Diarrhea, Chronic diarrhea, Impaired feeding ability, DIARRHEA 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6566\", \"target\": \"Monocarboxylate transporter 1 deficiency, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6566\", \"target\": \"Monocarboxylate transporter 1 deficiency, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6566\", \"target\": \"Erythrocyte lactate transporter defect\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6566\", \"target\": \"Exercise-induced hyperinsulinemic hypoglycemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9860\", \"target\": \"Urofacial syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10717|AP4B1-AS1\", \"target\": \"Spastic paraplegia 47, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10717|AP4B1-AS1\", \"target\": \"Spastic paraplegia 47, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Spastic paraplegia 47, autosomal recessive\", \"target\": \"10717\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the thyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Cutaneous melanoma, Non-small cell lung cancer\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4893\", \"target\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Cutaneous melanoma, Lung adenocarcinoma, Non-small cell lung cancer, Neoplasm of brain, Neoplasm of the thyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4893\", \"target\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Congenital giant melanocytic nevus, Follicular thyroid carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Epidermal nevus, Cutaneous melanoma, Lung adenocarcinoma, Non-small cell lung cancer, Neoplasm of brain, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Epidermal nevus syndrome, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma, Neurocutaneous melanosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Multiple myeloma, Cutaneous melanoma, Lung adenocarcinoma, Non-small cell lung cancer, Neoplasm of brain, Neoplasm of the thyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Glioblastoma, Nasopharyngeal Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Ovarian Serous Cystadenocarcinoma, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Cutaneous melanoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Noonan syndrome 6, Noonan syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Noonan syndrome, Noonan syndrome 6, Noonan syndrome 1, Rasopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Epidermal nevus, Noonan syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Noonan syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Neoplasm, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Cutaneous melanoma, Non-Hodgkin lymphoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4893\", \"target\": \"Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Cutaneous melanoma, Juvenile myelomonocytic leukemia, Non-Hodgkin lymphoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Adenocarcinoma of stomach, RAS-associated autoimmune leukoproliferative disorder, Noonan syndrome 6, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Medulloblastoma, Acute myeloid leukemia, Congenital giant melanocytic nevus, Transitional cell carcinoma of the bladder, Multiple myeloma, Cutaneous melanoma, Non-Hodgkin lymphoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Adenocarcinoma of stomach, Carcinoma of colon\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Noonan syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Myelodysplastic syndrome progressed to acute myeloid leukemia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Multiple myeloma, Epidermal nevus, Cutaneous melanoma, Juvenile myelomonocytic leukemia, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Chronic myelogenous leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4893\", \"target\": \"Acute myeloid leukemia, Multiple myeloma, Cutaneous melanoma, Non-small cell lung cancer, Neoplasm of the large intestine, Malignant melanoma of skin, Myelodysplastic syndrome, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cutaneous melanoma\", \"target\": \"2066\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cutaneous melanoma\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cutaneous melanoma\", \"target\": \"1499\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7252\", \"target\": \"Secondary hypothyroidism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7252\", \"target\": \"Secondary hypothyroidism, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4803\", \"target\": \"Congenital sensory neuropathy with selective loss of small myelinated fibers\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"81839\", \"target\": \"Caudal regression syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"845\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"845\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"845\", \"target\": \"Ventricular tachycardia, catecholaminergic polymorphic, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"845\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia type 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"845\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"845\", \"target\": \"Ventricular tachycardia, catecholaminergic polymorphic, 2, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"845\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia, Ventricular tachycardia, catecholaminergic polymorphic, 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"845\", \"target\": \"Wolff-Parkinson-White syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Catecholaminergic polymorphic ventricular tachycardia\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype, not provided\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Ventricular tachycardia, catecholaminergic polymorphic, 2\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Catecholaminergic polymorphic ventricular tachycardia type 1\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Catecholaminergic polymorphic ventricular tachycardia, Cardiovascular phenotype\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"476\", \"target\": \"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"476\", \"target\": \"Aldosterone Producing Adrenal Cortex Adenoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD\", \"target\": \"476|ATP1A1-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200162\", \"target\": \"Cranioectodermal dysplasia 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cranioectodermal dysplasia 2\", \"target\": \"57539\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10352\", \"target\": \"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES\", \"target\": \"10352|WARS2-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3284\", \"target\": \"3 beta-Hydroxysteroid dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26227\", \"target\": \"Seizures, Epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26227\", \"target\": \"Seizures, Epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26227\", \"target\": \"Neu-Laxova syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26227\", \"target\": \"Phosphoglycerate dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26227\", \"target\": \"Phosphoglycerate dehydrogenase deficiency, Neu-Laxova syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26227\", \"target\": \"Neu-Laxova syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3158\", \"target\": \"mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3158\", \"target\": \"mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4853\", \"target\": \"Hajdu-Cheney syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4853\", \"target\": \"Alagille syndrome 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4853\", \"target\": \"Alagille syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4853\", \"target\": \"Hajdu-Cheney syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8799\", \"target\": \"Peroxisome biogenesis disorder 14B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8799\", \"target\": \"Peroxisome biogenesis disorder 14B, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9939\", \"target\": \"Radial aplasia-thrombocytopenia syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9939|LIX1L-AS1\", \"target\": \"Radial aplasia-thrombocytopenia syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"148738\", \"target\": \"Hemochromatosis type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"148738\", \"target\": \"Hemochromatosis type 2A, Hemochromatosis type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2702\", \"target\": \"Atrial fibrillation, familial, 11\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2702\", \"target\": \"Atrial fibrillation, familial, 11, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2702\", \"target\": \"Atrial fibrillation, somatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2703\", \"target\": \"Cataract 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2703\", \"target\": \"Congenital cataract\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2703\", \"target\": \"Congenital cataract, Cataract 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Congenital cataract\", \"target\": \"1418\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Congenital cataract\", \"target\": \"25945\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2209|HIST2H2BF\", \"target\": \"IGG receptor I, phagocytic, familial deficiency of\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10262\", \"target\": \"Nager syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10262\", \"target\": \"Nager syndrome, Inborn genetic diseases\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10262\", \"target\": \"Hereditary hearing loss and deafness, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11311\", \"target\": \"Severe congenital neutropenia 5, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9129\", \"target\": \"Retinitis pigmentosa 18\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9129\", \"target\": \"Retinitis pigmentosa 18, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80222\", \"target\": \"Combined oxidative phosphorylation deficiency 21\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1893\", \"target\": \"Lipid proteinosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54507\", \"target\": \"Ectopia lentis, isolated autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1513\", \"target\": \"Pyknodysostosis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1513\", \"target\": \"Inborn genetic diseases, Pyknodysostosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58497\", \"target\": \"Abnormality of brain morphology, Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58497\", \"target\": \"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58497\", \"target\": \"Abnormality of brain morphology, Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58497\", \"target\": \"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57592\", \"target\": \"Paget disease of bone 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8991\", \"target\": \"Extra oral halitosis, EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8991\", \"target\": \"EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5692\", \"target\": \"PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5692\", \"target\": \"Nakajo syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23126\", \"target\": \"White-sutton syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23126\", \"target\": \"White-sutton syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23126\", \"target\": \"Inborn genetic diseases, White-sutton syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"81609\", \"target\": \"Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Severe myoclonic epilepsy in infancy\", \"target\": \"6323|LOC102724058\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Severe myoclonic epilepsy in infancy\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11022\", \"target\": \"Distal spinal muscular atrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6097\", \"target\": \"Immunodeficiency 42\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7062\", \"target\": \"Uncombable hair syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312\", \"target\": \"Ichthyosis vulgaris, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312\", \"target\": \"Dermatitis, atopic, 2, susceptibility to, Ichthyosis vulgaris\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312\", \"target\": \"Ichthyosis vulgaris\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312\", \"target\": \"Dermatitis, atopic, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312\", \"target\": \"Dermatitis, atopic, 2, susceptibility to, Ichthyosis vulgaris, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312\", \"target\": \"Dermatitis, atopic, 2, susceptibility to, Ichthyosis vulgaris, Dermatitis, atopic, 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Ichthyosis vulgaris, not provided\", \"target\": \"2312|FLG-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2312|FLG-AS1\", \"target\": \"Microcephaly, Abnormality of the skin, Dry skin, Congenital cerebellar hypoplasia, Paroxysmal dystonia, Ichthyosis, Feeding difficulties, Abnormality of salivation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"339400|FLG2\", \"target\": \"PEELING SKIN SYNDROME 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57459\", \"target\": \"Mental retardation, autosomal dominant 18\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57459\", \"target\": \"Mental retardation, autosomal dominant 18, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57459\", \"target\": \"GATAD2B-Related Disorder, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6232\", \"target\": \"Diamond-Blackfan anemia 17\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7170\", \"target\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7170\", \"target\": \"Muscular Diseases\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7170\", \"target\": \"Congenital myopathy with fiber type disproportion, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7170\", \"target\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 1, Cap myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7170\", \"target\": \"Inborn genetic diseases, Congenital myopathy with fiber type disproportion, Nemaline myopathy 1, Cap myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7170\", \"target\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7170\", \"target\": \"Nemaline myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Muscular Diseases\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Muscular Diseases\", \"target\": \"1293\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10456\", \"target\": \"Severe congenital neutropenia 3, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10456\", \"target\": \"Severe congenital neutropenia 3, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1141\", \"target\": \"Epilepsy, nocturnal frontal lobe, type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1141\", \"target\": \"Epilepsy, nocturnal frontal lobe, type 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"103\", \"target\": \"Symmetrical dyschromatosis of extremities\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"103\", \"target\": \"Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"103\", \"target\": \"Aicardi-Goutieres syndrome 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10654\", \"target\": \"Porokeratosis of Mibelli\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80308\", \"target\": \"Glutaric aciduria, type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80308\", \"target\": \"Glutaric aciduria, type 2, Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54344\", \"target\": \"Congenital disorder of glycosylation type 1O\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54344\", \"target\": \"Cardiomyopathy, Muscular Diseases, EMG: myopathic abnormalities\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1, Parkinson disease, late-onset, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Acute neuronopathic Gaucher's disease, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Acute neuronopathic Gaucher's disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Subacute neuronopathic Gaucher's disease, Gaucher disease, perinatal lethal, Gaucher disease type 3C, Gaucher's disease, type 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, perinatal lethal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Parkinson disease, late-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, perinatal lethal, Gaucher's disease, type 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Subacute neuronopathic Gaucher's disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Acute neuronopathic Gaucher's disease, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Gaucher disease, perinatal lethal, Gaucher's disease, type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher's disease, type 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Gaucher's disease, type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Gaucher disease, perinatal lethal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Gaucher disease, Gaucher disease, perinatal lethal, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629|LOC106627981\", \"target\": \"Subacute neuronopathic Gaucher's disease, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Gaucher's disease, type 1\", \"target\": \"2629\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2629\", \"target\": \"Gaucher disease, Acute neuronopathic Gaucher's disease, Gaucher's disease, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5313\", \"target\": \"Pyruvate kinase deficiency of red cells, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5313\", \"target\": \"Pyruvate kinase deficiency of red cells\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5313\", \"target\": \"Pyruvate kinase deficiency of red cells, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5313\", \"target\": \"Adenosine triphosphate, elevated, of erythrocytes\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2224|RUSC1-AS1\", \"target\": \"Porokeratosis 9, multiple types\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55870\", \"target\": \"MENTAL RETARDATION, AUTOSOMAL DOMINANT 52\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55154\", \"target\": \"MYOPATHY, MITOCHONDRIAL, AND ATAXIA\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55249\", \"target\": \"Grange syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome, Noonan syndrome 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome, Inborn genetic diseases, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome, Noonan syndrome 8, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome, Noonan syndrome 8\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6016\", \"target\": \"Noonan syndrome 8\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Noonan syndrome, not provided\", \"target\": \"6654\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Noonan syndrome, not provided\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Noonan syndrome\", \"target\": \"6654\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Noonan syndrome\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9181\", \"target\": \"Neurodevelopmental disorder with midbrain and hindbrain malformations\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Lipodystrophy, Inborn genetic diseases, Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Congenital muscular dystrophy, LMNA-related\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Limb-girdle muscular dystrophy, type 1B, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Muscular dystrophy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Emery-Dreifuss muscular dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Congenital muscular dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Familial partial lipodystrophy 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Arrhythmogenic right ventricular cardiomyopathy, type 9\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Familial dilated cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, Familial partial lipodystrophy 2, Hutchinson-Gilford progeria syndrome, childhood-onset, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford progeria syndrome, childhood-onset, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Congenital muscular dystrophy, LMNA-related, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford syndrome, Hutchinson-Gilford progeria syndrome, atypical, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1S, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Dilated cardiomyopathy 1A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Emery-Dreifuss muscular dystrophy 3, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Limb-girdle muscular dystrophy, type 1B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Emery-Dreifuss muscular dystrophy 3, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Congenital muscular dystrophy, LMNA-related, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2B1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Limb-girdle muscular dystrophy, type 1B, Congenital muscular dystrophy, LMNA-related\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Muscular dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type 2, Charcot-Marie-Tooth disease type 2B1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Lipodystrophy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford progeria syndrome, atypical\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Right ventricular cardiomyopathy, Hutchinson-Gilford progeria syndrome, childhood-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Hutchinson-Gilford syndrome, Charcot-Marie-Tooth disease, type 2, Lethal tight skin contracture syndrome, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Mandibuloacral dysostosis, Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, Limb-girdle muscular dystrophy, type 1B, Charcot-Marie-Tooth disease type 2B1, Heart-hand syndrome, Slovenian type, Emery-Dreifuss muscular dystrophy 3, autosomal recessive, Congenital muscular dystrophy, LMNA-related, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Familial partial lipodystrophy 2, Monogenic diabetes, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, Familial partial lipodystrophy 2, Limb-girdle muscular dystrophy, type 1B, Congenital muscular dystrophy, LMNA-related, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Laminopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Limb-girdle muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Dilated cardiomyopathy 1A, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Muscular dystrophy, Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Limb-girdle muscular dystrophy, type 1B, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Familial partial lipodystrophy 2, Emery-Dreifuss muscular dystrophy 3, autosomal recessive, Monogenic diabetes, Partial lipodystrophy, Dunnigan, Laminopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Mandibuloacral dysostosis, Limb-girdle muscular dystrophy, type 1B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Familial dilated cardiomyopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, Hutchinson-Gilford syndrome, Mandibuloacral dysostosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Mandibuloacral dysostosis, Mandibuloacral dysplasia with type A lipodystrophy, atypical, Mandibuloacral dysplasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Familial partial lipodystrophy 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Benign scapuloperoneal muscular dystrophy with cardiomyopathy, Mandibuloacral dysostosis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, type 2, Familial partial lipodystrophy 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Mandibuloacral dysostosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Limb-girdle muscular dystrophy, Charcot-Marie-Tooth disease, type 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Heart-hand syndrome, Slovenian type, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Limb-girdle muscular dystrophy, Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1A, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Mandibuloacral dysplasia with type A lipodystrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford syndrome, Lethal tight skin contracture syndrome, Mandibuloacral dysostosis, Laminopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Charcot-Marie-Tooth disease, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford syndrome, Hutchinson-Gilford progeria syndrome, atypical\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4000\", \"target\": \"Hutchinson-Gilford syndrome, Lethal tight skin contracture syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy\", \"target\": \"7139\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy\", \"target\": \"7273|LOC101927055\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Familial dilated cardiomyopathy, not provided\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy, not provided\", \"target\": \"7139\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy, not provided\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype, not provided\", \"target\": \"6262\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype, not provided\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Cardiovascular phenotype, not provided\", \"target\": \"1281\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Familial dilated cardiomyopathy\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64218\", \"target\": \"Cone-rod dystrophy 10, Retinitis pigmentosa 35\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"128240\", \"target\": \"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"128240\", \"target\": \"Infantile encephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4914\", \"target\": \"Hereditary insensitivity to pain with anhidrosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4914\", \"target\": \"Familial medullary thyroid carcinoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4914\", \"target\": \"Inborn genetic diseases, Hereditary insensitivity to pain with anhidrosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4914\", \"target\": \"Hereditary insensitivity to pain with anhidrosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Congenital hemolytic anemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Spherocytosis type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Hereditary pyropoikilocytosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Elliptocytosis 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Elliptocytosis 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Hereditary pyropoikilocytosis, Elliptocytosis 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6708\", \"target\": \"Hereditary pyropoikilocytosis, Elliptocytosis 2, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2532\", \"target\": \"DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE, Plasmodium vivax, resistance to, White blood cell count quantitative trait locus 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2532\", \"target\": \"DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"93183\", \"target\": \"Glycosylphosphatidylinositol deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3766\", \"target\": \"SeSAME syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3766\", \"target\": \"SeSAME syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3766\", \"target\": \"Enlarged vestibular aqueduct\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"477\", \"target\": \"Familial hemiplegic migraine type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"477\", \"target\": \"Alternating hemiplegia of childhood 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"477\", \"target\": \"Familial hemiplegic migraine, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"477\", \"target\": \"Migraine, familial basilar, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"477\", \"target\": \"Familial hemiplegic migraine\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"477\", \"target\": \"Inborn genetic diseases, Familial hemiplegic migraine\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"477\", \"target\": \"Polymicrogyria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"477\", \"target\": \"Familial hemiplegic migraine, Familial hemiplegic migraine type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"844\", \"target\": \"Myopathy, vacuolar, with casq1 aggregates\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"50717\", \"target\": \"Giant axonal neuropathy 2, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1314\", \"target\": \"Autoimmune interstitial lung, joint, and kidney disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23385\", \"target\": \"Familial acne inversa 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"81607\", \"target\": \"Ectodermal dysplasia-syndactyly syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51506\", \"target\": \"NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5498\", \"target\": \"Variegate porphyria, Variegate porphyria, homozygous\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5498\", \"target\": \"Variegate porphyria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5498\", \"target\": \"Variegate porphyria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5498\", \"target\": \"Variegate porphyria, homozygous\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5498\", \"target\": \"Abnormal blistering of the skin, Porphyrinuria, Abdominal colic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5498\", \"target\": \"Constipation, Migraine, Abnormal blistering of the skin, Abnormal urinary color\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4720\", \"target\": \"Leber's optic atrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4720\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4720\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Tremor, EMG: neuropathic changes, Limb muscle weakness, Sensorimotor neuropathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Neuropathy, congenital hypomyelinating, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Dejerine-Sottas disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Dejerine-Sottas disease, Roussy-L\\u00e9vy syndrome, Charcot-Marie-Tooth disease, demyelinating, type 1b, Congenital hypomyelinating neuropathy 1, autosomal recessive, Charcot-Marie-Tooth disease dominant intermediate 3, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I, Dejerine-Sottas syndrome, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Dejerine-Sottas disease, Roussy-L\\u00e9vy syndrome, Charcot-Marie-Tooth disease, demyelinating, type 1b, Congenital hypomyelinating neuropathy 1, autosomal recessive, Charcot-Marie-Tooth disease dominant intermediate 3, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, type I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Roussy-L\\u00e9vy syndrome, Charcot-Marie-Tooth disease, demyelinating, type 1b, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2J, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Congenital hypomyelinating neuropathy 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease type 2J, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4359\", \"target\": \"Decreased nerve conduction velocity, Sensory neuropathy, Pes cavus, Distal muscle weakness, Distal lower limb amyotrophy, Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease type 2J\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease dominant intermediate 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease type 2J\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Dejerine-Sottas syndrome, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease type 2I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4359\", \"target\": \"Charcot-Marie-Tooth disease, demyelinating, type 1b, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6391\", \"target\": \"Hereditary cancer-predisposing syndrome, Paragangliomas 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6391\", \"target\": \"Paragangliomas 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6391\", \"target\": \"Hereditary cancer-predisposing syndrome, Carney triad\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6391\", \"target\": \"Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paragangliomas 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6391\", \"target\": \"Gastrointestinal stroma tumor, Paragangliomas 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6391\", \"target\": \"Gastrointestinal stroma tumor, Hereditary Paraganglioma-Pheochromocytoma Syndromes, Paraganglioma and gastric stromal sarcoma, Carney triad\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6391\", \"target\": \"Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6391\", \"target\": \"Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome, Paragangliomas 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"22926\", \"target\": \"Achromatopsia 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22926\", \"target\": \"Achromatopsia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Achromatopsia\", \"target\": \"1261\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4921\", \"target\": \"Non-small cell lung cancer, Squamous cell lung carcinoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4921\", \"target\": \"Spondylometaepiphyseal dysplasia short limb-hand type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4921\", \"target\": \"Warburg-Cinotti syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4921\", \"target\": \"Squamous cell carcinoma, Non-small cell lung cancer\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5087\", \"target\": \"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4009\", \"target\": \"Sensorineural hearing loss\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54499\", \"target\": \"Cryptorchidism, Renal agenesis, Unilateral renal agenesis, Cleft palate, Sensorineural hearing loss, Strabismus, Autistic disorder of childhood onset, Delayed speech and language development, Abnormality of the sternum, Rib fusion, Severe visual impairment, Global developmental delay, Pulmonic stenosis, Scoliosis, Bilateral cleft lip and palate, Hemivertebrae, Relative macrocephaly, Bilateral cleft lip, Bilateral cleft palate\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54499\", \"target\": \"Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"919\", \"target\": \"Immunodeficiency due to defect in cd3-zeta\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23432\", \"target\": \"Pituitary stalk interruption syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9095\", \"target\": \"Adrenocorticotropic hormone deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1805\", \"target\": \"Progressive sensorineural hearing impairment\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10560\", \"target\": \"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10560\", \"target\": \"Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2153\", \"target\": \"Factor V deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2153\", \"target\": \"Thrombophilia due to activated protein C resistance\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2153\", \"target\": \"Factor V Hong Kong\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6403\", \"target\": \"Premature coronary artery disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"92344\", \"target\": \"Geroderma osteodysplastica\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5396\", \"target\": \"Dysgnathia complex\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2328\", \"target\": \"Trimethylaminuria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2328\", \"target\": \"FMO3 activity, decreased\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4653\", \"target\": \"Primary open angle glaucoma juvenile onset 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4653\", \"target\": \"Glaucoma 1, open angle, a, digenic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4653\", \"target\": \"Primary open angle glaucoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4653\", \"target\": \"Primary open angle glaucoma juvenile onset 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4653\", \"target\": \"Lymphopenia, Immunodeficiency, Severe combined immunodeficiency disease, Combined immunodeficiency, Abnormality of cellular immune system, Abnormality of T cell physiology, Primary open angle glaucoma, Primary open angle glaucoma juvenile onset 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4653\", \"target\": \"Primary open angle glaucoma juvenile onset 1, Glaucoma 3, primary congenital, a, digenic, MYOC-Related Disorders\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4653\", \"target\": \"Glaucoma 1, open angle, a, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5279|C1orf105\", \"target\": \"Non-immune hydrops fetalis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5279|C1orf105\", \"target\": \"GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Non-immune hydrops fetalis\", \"target\": \"79623\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Non-immune hydrops fetalis\", \"target\": \"1134\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55157\", \"target\": \"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55157\", \"target\": \"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55157\", \"target\": \"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55157\", \"target\": \"Hypertension, Dysmetria, Abnormality of the foot, Talipes equinovarus, Gout, Gait ataxia, Cerebral cortical atrophy, Gait imbalance, Impaired vibration sensation in the lower limbs, Difficulty walking, EMG: axonal abnormality, Sensorimotor neuropathy, CNS demyelination, Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation, Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"462\", \"target\": \"Reduced antithrombin III activity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"462\", \"target\": \"Reduced antithrombin III activity, Antithrombin deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"462\", \"target\": \"Reduced antithrombin III activity, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7827|AXDND1\", \"target\": \"Nephrotic syndrome, idiopathic, steroid-resistant\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7827|AXDND1\", \"target\": \"Nephrotic syndrome, idiopathic, steroid-resistant, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7827|AXDND1\", \"target\": \"Nephrotic syndrome, type 2, susceptibility to, Idiopathic nephrotic syndrome, Nephrotic syndrome, idiopathic, steroid-resistant, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7827|AXDND1\", \"target\": \"Idiopathic nephrotic syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Nephrotic syndrome, idiopathic, steroid-resistant\", \"target\": \"7827\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nephrotic syndrome, idiopathic, steroid-resistant, not provided\", \"target\": \"7827\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7827\", \"target\": \"Hereditary nephrotic syndrome, Nephrotic syndrome, idiopathic, steroid-resistant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7827\", \"target\": \"Proteinuria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26092|TOR1AIP2\", \"target\": \"Muscular dystrophy, limb-girdle, type 2y\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Muscular dystrophy, limb-girdle, type 2y\", \"target\": \"26092\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"89884\", \"target\": \"Pituitary hormone deficiency, combined 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Pituitary hormone deficiency, combined 4\", \"target\": \"89884|ACBD6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9213\", \"target\": \"Basal ganglia calcification, idiopathic, 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"777\", \"target\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"777\", \"target\": \"Inborn genetic diseases, EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"777\", \"target\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"777\", \"target\": \"Episodic coma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2752\", \"target\": \"Glutamine deficiency, congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6041\", \"target\": \"Prostate cancer, hereditary, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3918\", \"target\": \"Junctional epidermolysis bullosa gravis of Herlitz\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3918\", \"target\": \"Adult junctional epidermolysis bullosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Junctional epidermolysis bullosa gravis of Herlitz\", \"target\": \"3914\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Junctional epidermolysis bullosa gravis of Herlitz\", \"target\": \"3914|MIR4260\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Adult junctional epidermolysis bullosa\", \"target\": \"3914\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4688\", \"target\": \"Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4688\", \"target\": \"Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"116461\", \"target\": \"Seizures, Global developmental delay, Primary microcephaly, Pontocerebellar hypoplasia, type 2f\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"116461\", \"target\": \"Pontocerebellar hypoplasia, type 2f\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83872\", \"target\": \"Age-related macular degeneration 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Age-related macular degeneration 1\", \"target\": \"10878\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7175\", \"target\": \"Intellectual disability\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Intellectual disability\", \"target\": \"23380\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5321\", \"target\": \"Phospholipase a2, group IV a, deficiency of\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79577\", \"target\": \"Parathyroid carcinoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79577\", \"target\": \"Hyperparathyroidism 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79577\", \"target\": \"Hyperparathyroidism 1, Parathyroid adenoma, somatic, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79577\", \"target\": \"Hyperparathyroidism 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79577\", \"target\": \"Hyperparathyroidism 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"343450\", \"target\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57, KCNT2-related condition\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3075\", \"target\": \"Atypical hemolytic-uremic syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3075\", \"target\": \"Basal laminar drusen\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3075\", \"target\": \"Factor H deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3075\", \"target\": \"Factor H deficiency, Age-related macular degeneration 4, Atypical hemolytic-uremic syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"81494\", \"target\": \"CFHR5 deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2165\", \"target\": \"Factor XIII subunit B deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"259266\", \"target\": \"Inborn genetic diseases, Primary autosomal recessive microcephaly 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"259266\", \"target\": \"Primary autosomal recessive microcephaly 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"259266\", \"target\": \"Primary autosomal recessive microcephaly 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"259266\", \"target\": \"Microcephaly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"259266\", \"target\": \"Primary autosomal recessive microcephaly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23418\", \"target\": \"Leber congenital amaurosis 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Leber congenital amaurosis 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Retinitis pigmentosa 12\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23418\", \"target\": \"Retinitis pigmentosa 12, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Macular dystrophy, Retinitis pigmentosa 12, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Retinitis pigmentosa 12, Leber congenital amaurosis 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Retinitis pigmentosa 12, Leber congenital amaurosis 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Macular dystrophy, Retinitis pigmentosa 12, Leber congenital amaurosis 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Retinal dystrophy, Retinitis pigmentosa 12, Leber congenital amaurosis 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23418\", \"target\": \"Inborn genetic diseases, Stargardt disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5788\", \"target\": \"Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Not_Given\", \"target\": \"Acute myeloid leukemia with maturation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Acute myeloid leukemia with maturation\", \"target\": \"100131234\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9928\", \"target\": \"MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9928\", \"target\": \"Meckel syndrome 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83479\", \"target\": \"Orofaciodigital syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83479\", \"target\": \"Orofaciodigital syndrome 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"779\", \"target\": \"Malignant hyperthermia susceptibility type 5, Hypokalemic periodic paralysis 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"779\", \"target\": \"Malignant hyperthermia susceptibility type 5, Hypokalemic periodic paralysis 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"779\", \"target\": \"Hypokalemic periodic paralysis 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"779\", \"target\": \"Rhabdomyolysis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5317\", \"target\": \"Ectodermal dysplasia skin fragility syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Familial hypertrophic cardiomyopathy 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Left ventricular noncompaction 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary dilated cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7139\", \"target\": \"Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary dilated cardiomyopathy, Cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Familial restrictive cardiomyopathy 3, Familial isolated dilated cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary dilated cardiomyopathy, Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Left ventricular noncompaction 6, Familial hypertrophic cardiomyopathy 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy, not specified\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Primary familial hypertrophic cardiomyopathy, Familial hypertrophic cardiomyopathy 2, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Familial restrictive cardiomyopathy, Familial hypertrophic cardiomyopathy 2, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7139\", \"target\": \"Wolff-Parkinson-White pattern\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Primary familial hypertrophic cardiomyopathy\", \"target\": \"4634\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Primary familial hypertrophic cardiomyopathy, not provided\", \"target\": \"859\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Wolff-Parkinson-White pattern\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"25802\", \"target\": \"Visceral myopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Visceral myopathy\", \"target\": \"72\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Visceral myopathy\", \"target\": \"4638\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29089\", \"target\": \"Fanconi anemia, complementation group T\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"127833\", \"target\": \"Myasthenic syndrome, congenital, 7, presynaptic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10765\", \"target\": \"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6635\", \"target\": \"Hypotrichosis 11\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5972\", \"target\": \"Hyperproreninemia, familial\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5972\", \"target\": \"Renal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Renal dysplasia\", \"target\": \"183\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Renal dysplasia\", \"target\": \"185\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5972|LOC107548112\", \"target\": \"Hyperuricemic nephropathy, familial juvenile, 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3814\", \"target\": \"Hypogonadotropic hypogonadism 13 with or without anosmia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84919\", \"target\": \"Microcephaly, short stature, and impaired glucose metabolism 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6900\", \"target\": \"Epilepsy, familial adult myoclonic, 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"25778\", \"target\": \"Congenital anomalies of kidney and urinary tract 1, susceptibility to\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3586\", \"target\": \"Rheumatoid arthritis, progression of\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1604\", \"target\": \"Protein-losing enteropathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1604\", \"target\": \"CROMER BLOOD GROUP SYSTEM, Dr(a-) PHENOTYPE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1380\", \"target\": \"Common variable immunodeficiency 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4179\", \"target\": \"Atypical hemolytic uremic syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4179\", \"target\": \"Atypical hemolytic-uremic syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5362\", \"target\": \"atypical cerebral palsy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"atypical cerebral palsy\", \"target\": \"6328\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"atypical cerebral palsy\", \"target\": \"2043\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3914\", \"target\": \"Amelogenesis imperfecta, type IA\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3914\", \"target\": \"Junctional epidermolysis bullosa gravis of Herlitz, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3914\", \"target\": \"Junctional epidermolysis bullosa gravis of Herlitz, Adult junctional epidermolysis bullosa, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3290|HSD11B1-AS1\", \"target\": \"Cortisone reductase deficiency 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3664\", \"target\": \"Popliteal pterygium syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3664\", \"target\": \"Popliteal pterygium syndrome, Orofacial cleft 6, susceptibility to, Van der Woude syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3664\", \"target\": \"Popliteal pterygium syndrome, Van der Woude syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3664\", \"target\": \"Popliteal pterygium syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3664\", \"target\": \"Popliteal pterygium syndrome, Orofacial cleft 6, susceptibility to, Van der Woude syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3664\", \"target\": \"Van der Woude syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3664\", \"target\": \"Cleft palate, Van der Woude syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"255928\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 11\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3756\", \"target\": \"Temple-Baraitser syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3756\", \"target\": \"Inborn genetic diseases, Zimmermann-Laband syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3756\", \"target\": \"Temple-Baraitser syndrome, Zimmermann-Laband syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3756\", \"target\": \"Zimmermann-Laband syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3756\", \"target\": \"KCNH1-related phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"343035\", \"target\": \"Leber congenital amaurosis 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"28982\", \"target\": \"Jeune thoracic dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"28982\", \"target\": \"Posterior column ataxia with retinitis pigmentosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"28982\", \"target\": \"Short Rib Polydactyly Syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Jeune thoracic dystrophy\", \"target\": \"3930\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Jeune thoracic dystrophy\", \"target\": \"57539\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Jeune thoracic dystrophy\", \"target\": \"79809\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Jeune thoracic dystrophy\", \"target\": \"79809|TTC21B-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Jeune thoracic dystrophy\", \"target\": \"26146\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Jeune thoracic dystrophy\", \"target\": \"57560|TRIM59-IFT80\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26750\", \"target\": \"Muscular hypotonia, Global developmental delay, Hypoplasia of the corpus callosum, Abnormality of the cerebral white matter, Periventricular leukomalacia, Delayed myelination\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1063\", \"target\": \"Stromme syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, type 2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinitis pigmentosa, Retinitis pigmentosa 39\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinitis pigmentosa, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinitis pigmentosa 39\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Hearing impairment, Retinitis pigmentosa, Congenital sensorineural hearing impairment, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinal dystrophy, Usher syndrome, type 2A, Retinitis pigmentosa 39\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, Usher syndrome, type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinitis pigmentosa, Usher syndrome, type 2A, Retinitis pigmentosa 39\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Inborn genetic diseases, Usher syndrome, type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinitis pigmentosa, Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Congenital sensorineural hearing impairment\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Retinitis pigmentosa, Usher syndrome, Usher syndrome, type 2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"High palate, Retinitis pigmentosa, Retinal dystrophy, Anxiety, Brisk reflexes, Dysautonomia, Abnormality of the upper limb, Multiple joint contractures, Dislocated radial head, Short stature, Distal arthrogryposis, Abnormality of upper limb joint, Chronic pain, Abnormality of upper limb bone, Cognitive impairment, Inborn genetic diseases, Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39, USH2A-Related Disorders\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Usher syndrome, Usher syndrome, type 2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Rod-cone dystrophy, Pigmentary retinopathy, Blindness, Abnormal macular morphology, Retinal pigment epithelial atrophy, Usher syndrome, type 2A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7399\", \"target\": \"Hearing impairment, Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Usher syndrome, type 2A, not provided\", \"target\": \"7399|LOC102723833\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39\", \"target\": \"7399|LOC102723833\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Usher syndrome, type 2A\", \"target\": \"7399|LOC102723833\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Usher syndrome, type 2A, Retinitis pigmentosa 39, not provided\", \"target\": \"7399|LOC102723833\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Usher syndrome, Usher syndrome, type 2A, Retinitis pigmentosa 39\", \"target\": \"7399|LOC102723833\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7042\", \"target\": \"Loeys-Dietz syndrome 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7042\", \"target\": \"Holt-Oram syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7042\", \"target\": \"Holt-Oram syndrome, Loeys-Dietz syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7042\", \"target\": \"Loeys-Dietz syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7042\", \"target\": \"Holt-Oram syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7042\", \"target\": \"Loeys-Dietz syndrome 4, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7042\", \"target\": \"Holt-Oram syndrome, Loeys-Dietz syndrome 4, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Loeys-Dietz syndrome\", \"target\": \"7048\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55532\", \"target\": \"Hypermanganesemia with dystonia 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55532\", \"target\": \"Hypermanganesemia with dystonia 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2058\", \"target\": \"LEUKODYSTROPHY, HYPOMYELINATING, 15\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55699\", \"target\": \"Cataract, Peripheral neuropathy, Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, growth hormone deficiency with short stature, partial sensorineural deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25782\", \"target\": \"Warburg micro syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25782\", \"target\": \"Martsolf syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Martsolf syndrome\", \"target\": \"22930\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84976\", \"target\": \"microform holoprosencephaly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"microform holoprosencephaly\", \"target\": \"2736\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"80232\", \"target\": \"SKRABAN-DEARDORFF SYNDROME\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80232\", \"target\": \"Intellectual disability, seizures, abnormal gait and distinctive facial features\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3930\", \"target\": \"PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3930\", \"target\": \"Greenberg dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3930\", \"target\": \"Retrognathia, Femoral bowing, Short long bone, Disproportionate short stature, Rhizomelic arm shortening, Rhizomelic leg shortening, Pelger-Hu\\u00ebt anomaly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3930\", \"target\": \"Pelger-Hu\\u00ebt anomaly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3930\", \"target\": \"Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3930\", \"target\": \"Reynolds syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"29920\", \"target\": \"Leukodystrophy, hypomyelinating, 10, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29920\", \"target\": \"Leukodystrophy, hypomyelinating, 10\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3020\", \"target\": \"Astrocytoma, Brainstem glioma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3020\", \"target\": \"Adrenocortical carcinoma, Brainstem glioma, Neoplasm of brain, Glioblastoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3020\", \"target\": \"H3F3A-related condition, Inborn genetic diseases\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5664\", \"target\": \"Alzheimer disease, type 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56997\", \"target\": \"Coenzyme Q10 deficiency, primary, 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56997\", \"target\": \"Coenzyme Q10 deficiency, primary, 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"375\", \"target\": \"PERIVENTRICULAR NODULAR HETEROTOPIA 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57165\", \"target\": \"Leukodystrophy, hypomyelinating, 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57165\", \"target\": \"Spastic paraplegia, Leukodystrophy, hypomyelinating, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57165\", \"target\": \"Spastic paraplegia 44, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57165\", \"target\": \"Spastic paraplegia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57165\", \"target\": \"Lymphedema, hereditary, IC\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Spastic paraplegia\", \"target\": \"6683\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200205\", \"target\": \"Multiple mitochondrial dysfunctions syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200205\", \"target\": \"Multiple mitochondrial dysfunctions syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"200205\", \"target\": \"Spastic paraplegia 74, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Nemaline myopathy 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Myopathy, actin, congenital, with cores\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Congenital myopathy with fiber type disproportion\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Nemaline myopathy 3, autosomal dominant or recessive, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58\", \"target\": \"Congenital myopathy, Nemaline myopathy 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58\", \"target\": \"ACTA1 gene related myopathy, Nemaline myopathy 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Myopathy, scapulohumeroperoneal, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Nemaline myopathy 3, autosomal dominant or recessive\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58\", \"target\": \"Myopathy, scapulohumeroperoneal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Congenital muscular dystrophy with rigid spine\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58\", \"target\": \"Nemaline myopathy 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58\", \"target\": \"Myopathy, actin, congenital, with excess of thin myofilaments\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58\", \"target\": \"Congenital myopathy with fiber type disproportion, Nemaline myopathy 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55746\", \"target\": \"GALLOWAY-MOWAT SYNDROME 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55746\", \"target\": \"NEPHROTIC SYNDROME, TYPE 18\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22796\", \"target\": \"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64801\", \"target\": \"Epileptic encephalopathy, early infantile, 38, ARV1-related condition\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64801\", \"target\": \"Blindness, Neurodegeneration, Epileptic encephalopathy, early infantile, 38\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8443\", \"target\": \"Rhizomelic chondrodysplasia punctata type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83932\", \"target\": \"Ruijs-Aalfs syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54583\", \"target\": \"Erythrocytosis, familial, 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"388753\", \"target\": \"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"359948\", \"target\": \"IMMUNODEFICIENCY, COMMON VARIABLE, 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6905\", \"target\": \"Encephalopathy, progressive, with amyotrophy and optic atrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6905\", \"target\": \"Hypoparathyroidism retardation dysmorphism syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"148789\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"148789\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"148789\", \"target\": \"Inborn genetic diseases, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1130\", \"target\": \"Ch\\u00e9diak-Higashi syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1130\", \"target\": \"Ch\\u00e9diak-Higashi syndrome, Chediak-Higashi syndrome, adult type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1130\", \"target\": \"Ch\\u00e9diak-Higashi syndrome, Chediak-Higashi syndrome, adult type, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1130\", \"target\": \"Ch\\u00e9diak-Higashi syndrome, Chediak-Higashi syndrome, childhood type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1130\", \"target\": \"Recurrent infections\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4811\", \"target\": \"Hydrocephalus, Hemiparesis, Focal epilepsy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"128178\", \"target\": \"Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"128178\", \"target\": \"Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal dominant hypohidrotic ectodermal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"128178\", \"target\": \"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"128178\", \"target\": \"Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive, Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"128178\", \"target\": \"Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"88\", \"target\": \"Familial hypertrophic cardiomyopathy 23\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"88\", \"target\": \"Cardiomyopathy, Dilated cardiomyopathy 1AA, Familial hypertrophic cardiomyopathy 23\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"88\", \"target\": \"Dilated cardiomyopathy 1AA, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"88\", \"target\": \"Arrhythmogenic right ventricular cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Arrhythmogenic right ventricular cardiomyopathy\", \"target\": \"1674\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4548\", \"target\": \"METHYLCOBALAMIN DEFICIENCY, cblG TYPE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4548\", \"target\": \"Intellectual disability, profound, Inborn genetic diseases, METHYLCOBALAMIN DEFICIENCY, cblG TYPE, Seizure disorder, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia type 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Ventricular fibrillation, Catecholaminergic polymorphic ventricular tachycardia, Arrhythmogenic right ventricular dysplasia, familial, 2, Catecholaminergic polymorphic ventricular tachycardia type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6262\", \"target\": \"Long QT syndrome, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6262\", \"target\": \"Long QT syndrome, Catecholaminergic polymorphic ventricular tachycardia, Arrhythmogenic right ventricular dysplasia, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6262\", \"target\": \"Cardiac arrhythmia, not specified\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Arrhythmogenic right ventricular dysplasia, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6262\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia type 1, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia type 1, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Catecholaminergic polymorphic ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia type 1, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Inborn genetic diseases, Catecholaminergic polymorphic ventricular tachycardia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Cardiac arrhythmia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6262\", \"target\": \"Left ventricular noncompaction cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Left ventricular noncompaction cardiomyopathy\", \"target\": \"7273|TTN-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"56776\", \"target\": \"Mental retardation, autosomal recessive 47, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"56776\", \"target\": \"Mental retardation, autosomal recessive 47\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64388\", \"target\": \"Tooth agenesis, selective, 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Fumarase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, Fumarase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Fumarase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome, Fumarase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Hereditary cancer-predisposing syndrome, Fumarase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome, Fumarase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Hereditary cancer-predisposing syndrome, Fumarase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2271\", \"target\": \"Uterine leiomyoma, Multiple cutaneous leiomyomas, Cutaneous leiomyoma, Fumarase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2271\", \"target\": \"Multiple cutaneous leiomyomas, Fumarase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10806\", \"target\": \"Senior-Loken syndrome 7, Bardet-Biedl syndrome 16\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10806\", \"target\": \"Senior-Loken syndrome 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10806\", \"target\": \"Bardet-Biedl syndrome 16\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10806\", \"target\": \"Bardet-Biedl syndrome, Senior-Loken syndrome 7, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10806\", \"target\": \"Bardet-Biedl syndrome 16, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10000\", \"target\": \"Macrocephalus, Global developmental delay, Polymicrogyria, Capillary hemangiomas, Inborn genetic diseases, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10000\", \"target\": \"Megalencephaly cutis marmorata telangiectatica congenita, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10000\", \"target\": \"Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10472\", \"target\": \"Mental retardation, autosomal dominant 22\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10472\", \"target\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 22\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3192\", \"target\": \"Epileptic encephalopathy, early infantile, 54\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3192\", \"target\": \"Intellectual disability, Seizures, Epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3192\", \"target\": \"Epileptic encephalopathy, early infantile, 54, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3192\", \"target\": \"heterogeneous nuclear ribonucleoprotein G, human\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3192\", \"target\": \"Epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3192\", \"target\": \"heterogeneous nuclear ribonucleoprotein G, human, Epileptic encephalopathy, early infantile, 54\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Epileptic encephalopathy\", \"target\": \"6326\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Epileptic encephalopathy\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Epileptic encephalopathy\", \"target\": \"10869\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Keratitis fugax hereditaria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"114548\", \"target\": \"Familial amyloid nephropathy with urticaria AND deafness, Familial cold urticaria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Familial amyloid nephropathy with urticaria AND deafness, Chronic infantile neurological, cutaneous and articular syndrome, Cryopyrin associated periodic syndrome, Familial cold urticaria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Familial cold urticaria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Chronic infantile neurological, cutaneous and articular syndrome, Familial cold urticaria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Familial amyloid nephropathy with urticaria AND deafness, Cryopyrin associated periodic syndrome, Familial cold urticaria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Familial amyloid nephropathy with urticaria AND deafness, Familial cold urticaria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Cryopyrin associated periodic syndrome, Familial cold urticaria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"114548\", \"target\": \"Pericardial effusion, Fever, Pleural effusion\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"114548\", \"target\": \"Familial cold urticaria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7173\", \"target\": \"Deficiency of iodide peroxidase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7173\", \"target\": \"Deficiency of iodide peroxidase, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7173\", \"target\": \"Delayed speech and language development, Congenital hypothyroidism, Global developmental delay, Delayed gross motor development, Short stature, Protruding tongue, Intellectual disability, severe\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7173\", \"target\": \"Congenital hypothyroidism, Deficiency of iodide peroxidase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7837\", \"target\": \"Anterior segment dysgenesis 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23040\", \"target\": \"Mental retardation, autosomal dominant 39, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23040\", \"target\": \"Mental retardation, autosomal dominant 39\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"51112\", \"target\": \"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY, Progressive childhood encephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"246243\", \"target\": \"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6201\", \"target\": \"Diamond-Blackfan anemia 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"78989\", \"target\": \"Carnevale syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6664\", \"target\": \"Mental retardation, autosomal dominant 27\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57498\", \"target\": \"Spastic paraplegia, intellectual disability, nystagmus, and obesity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8462\", \"target\": \"Maturity-onset diabetes of the young, type 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23175\", \"target\": \"Myoglobinuria, acute recurrent, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23175\", \"target\": \"Myoglobinuria, acute recurrent, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51594\", \"target\": \"Infantile liver failure syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51594\", \"target\": \"Short stature, optic nerve atrophy, and Pelger-Huet anomaly, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51594\", \"target\": \"Short stature, optic nerve atrophy, and Pelger-Huet anomaly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51594\", \"target\": \"Fever-associated acute infantile liver failure syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4613|MYCNOS\", \"target\": \"Medulloblastoma, Neuroblastoma, Pancreatic adenocarcinoma, Glioblastoma, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4613|MYCNOS\", \"target\": \"Feingold syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Feingold syndrome 1\", \"target\": \"4613\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57539\", \"target\": \"Cranioectodermal dysplasia 2, Short rib polydactyly syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57539\", \"target\": \"Short rib polydactyly syndrome 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57539\", \"target\": \"Cranioectodermal dysplasia 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57539\", \"target\": \"Jeune thoracic dystrophy, Cranioectodermal dysplasia 2, Short rib polydactyly syndrome 5, WDR35-Related Disorders\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57539\", \"target\": \"Short rib polydactyly syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57539\", \"target\": \"SHORT-RIB THORACIC DYSPLASIA 7 WITHOUT POLYDACTYLY, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57539\", \"target\": \"SHORT-RIB THORACIC DYSPLASIA 7 WITHOUT POLYDACTYLY, Short-rib thoracic dysplasia 7/20 with polydactyly, digenic, Jeune thoracic dystrophy, Short rib polydactyly syndrome 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4148|LOC101928222\", \"target\": \"Spondyloepimetaphyseal dysplasia Matrilin-3 related\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4148\", \"target\": \"Multiple epiphyseal dysplasia 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4148\", \"target\": \"Multiple epiphyseal dysplasia 5, Multiple Epiphyseal Dysplasia, Dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"338\", \"target\": \"Hypobetalipoproteinemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"338\", \"target\": \"Familial hypobetalipoproteinemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"338\", \"target\": \"Hypercholesterolemia, autosomal dominant, type B, Hypobetalipoproteinemia, familial, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"338\", \"target\": \"Hypercholesterolemia, autosomal dominant, type B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"338\", \"target\": \"Hypobetalipoproteinemia, familial, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"338\", \"target\": \"Hypobetalipoproteinemia, normotriglyceridemic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50618\", \"target\": \"Epilepsy, focal, with speech disorder and with or without mental retardation\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5443\", \"target\": \"Proopiomelanocortin deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1788\", \"target\": \"Tatton-Brown-rahman syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1788\", \"target\": \"Acute myeloid leukemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1788\", \"target\": \"Acute myeloid leukemia, Lung adenocarcinoma, Myelodysplastic syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1788\", \"target\": \"Acute myeloid leukemia, Lung adenocarcinoma, Myelodysplastic syndrome, Tatton-Brown-rahman syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1788\", \"target\": \"Acute myeloid leukemia, Tatton-Brown-rahman syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1788\", \"target\": \"Inborn genetic diseases, Tatton-Brown-rahman syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1788\", \"target\": \"Early T cell progenitor acute lymphoblastic leukemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Acute myeloid leukemia\", \"target\": \"23451\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Acute myeloid leukemia\", \"target\": \"3417\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55252\", \"target\": \"Shashi-Pena syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Mitochondrial trifunctional protein deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Mitochondrial trifunctional protein deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3030|GAREM2\", \"target\": \"Inborn genetic diseases, Lchad deficiency with maternal acute fatty liver of pregnancy, Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, LCHAD Deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency\", \"target\": \"3030\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Mitochondrial trifunctional protein deficiency\", \"target\": \"3030\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Mitochondrial trifunctional protein deficiency\", \"target\": \"3032\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Mitochondrial trifunctional protein deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency\", \"target\": \"3030\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Mitochondrial trifunctional protein deficiency, not provided\", \"target\": \"3030\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Mitochondrial trifunctional protein deficiency, not provided\", \"target\": \"3032\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, not provided\", \"target\": \"3030\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"92749\", \"target\": \"Ciliary dyskinesia, Ciliary dyskinesia, primary, 21, Kartagener syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"92749\", \"target\": \"Ciliary dyskinesia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"92749\", \"target\": \"Ciliary dyskinesia, primary, 21, Kartagener syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Ciliary dyskinesia\", \"target\": \"51364\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Auditory neuropathy, autosomal recessive, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Deafness, autosomal recessive 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Deafness, autosomal recessive 9, Nonsyndromic hearing loss and deafness, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Deafness, autosomal recessive 9, Auditory neuropathy, autosomal recessive, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Deafness, autosomal recessive 9, Nonsyndromic hearing loss and deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Hearing impairment, Deafness, autosomal recessive 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Deafness, autosomal recessive 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9381\", \"target\": \"Hearing impairment\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9381\", \"target\": \"Deafness, autosomal recessive 9, Auditory neuropathy, autosomal recessive, 1, Nonsyndromic hearing loss and deafness\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3777\", \"target\": \"Primary pulmonary hypertension 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3777\", \"target\": \"Primary pulmonary hypertension 4, Primary pulmonary hypertension\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"60509\", \"target\": \"Retinitis pigmentosa 75\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"790\", \"target\": \"Epileptic encephalopathy, early infantile, 50, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"790\", \"target\": \"Epileptic encephalopathy, early infantile, 50\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4358\", \"target\": \"Navajo neurohepatopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4358\", \"target\": \"Navajo neurohepatopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4358\", \"target\": \"Navajo neurohepatopathy, MPV17-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4358\", \"target\": \"MPV17-related mitochondrial DNA maintenance defect, Navajo neurohepatopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8890\", \"target\": \"Ovarioleukodystrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"130557\", \"target\": \"Retinitis pigmentosa 58\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26160|KRTCAP3\", \"target\": \"Short-rib thoracic dysplasia 10 with or without polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26160|KRTCAP3\", \"target\": \"Retinitis pigmentosa 71\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Short-rib thoracic dysplasia 10 with or without polydactyly\", \"target\": \"26160\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Retinitis pigmentosa 71\", \"target\": \"26160\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26160\", \"target\": \"Joubert syndrome, Short-rib thoracic dysplasia 10 with or without polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26160\", \"target\": \"Short-rib thoracic dysplasia 10 without polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26160\", \"target\": \"Short-rib thoracic dysplasia 10 with polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26160\", \"target\": \"Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2646\", \"target\": \"Fasting plasma glucose level quantitative trait locus 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5500\", \"target\": \"Noonan syndrome-like disorder with loose anagen hair 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5500\", \"target\": \"Noonan syndrome-like disorder with loose anagen hair 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"388939\", \"target\": \"Retinitis pigmentosa 54\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma, Neuroblastoma 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma, Neoplasm of the breast\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma, Neoplasm of brain, Neoplasm of the breast, Neuroblastoma 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Lung adenocarcinoma, Non-small cell lung cancer\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Rhabdomyosarcoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma, Neoplasm of brain, Neuroblastoma 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma, Lung adenocarcinoma, Neuroblastoma 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"238\", \"target\": \"Neuroblastoma, Lung adenocarcinoma, Non-small cell lung cancer, Benign Soft Tissue Neoplasm of Uncertain Differentiation, Neuroblastoma 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7498\", \"target\": \"Xanthinuria type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7498\", \"target\": \"Deficiency of xanthine oxidase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7498\", \"target\": \"Deficiency of xanthine oxidase, Xanthinuria type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6716\", \"target\": \"3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6716\", \"target\": \"Micropenis, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6716\", \"target\": \"3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6716\", \"target\": \"Micropenis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6683\", \"target\": \"Spastic paraplegia 4, autosomal dominant\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6683\", \"target\": \"Spastic paraplegia 4, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6683\", \"target\": \"Spastic paraplegia, Spastic paraplegia 4, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6683\", \"target\": \"Seizures, Fatigue, Abnormal myelination\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6683\", \"target\": \"Hereditary spastic paraplegia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6683\", \"target\": \"Inborn genetic diseases, Spastic paraplegia 4, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6683\", \"target\": \"Spastic paraparesis, Spastic paraplegia 4, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6683\", \"target\": \"Spastic paraparesis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary spastic paraplegia\", \"target\": \"65055\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"58484\", \"target\": \"Familial cold autoinflammatory syndrome 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58484\", \"target\": \"Autoinflammation with infantile enterocolitis, Syndrome of entercolitis and autoinflmmation caused by mutation of NLRC4 (SCAN4), not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58484\", \"target\": \"Autoinflammation with infantile enterocolitis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1545\", \"target\": \"Glaucoma 3, primary congenital, A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1545\", \"target\": \"Glaucoma 3, primary congenital, A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1545\", \"target\": \"Glaucoma 3, primary congenital, A, Glaucoma, primary open angle, juvenile-onset\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1545\", \"target\": \"Congenital glaucoma, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1545\", \"target\": \"Irido-corneo-trabecular dysgenesis, Congenital glaucoma, Glaucoma 3, primary congenital, A, Anterior segment dysgenesis 6, CYP1B1-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1545\", \"target\": \"Anterior segment dysgenesis 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Noonan syndrome 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Noonan syndrome 4, Gingival fibromatosis 1, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Noonan syndrome 4, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Abnormality of the aortic valve, Noonan syndrome, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Noonan syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Inborn genetic diseases, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Ptosis, Abnormality of the sternum, Pulmonic stenosis, Short stature, Noonan syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Noonan syndrome, Inborn genetic diseases, Noonan syndrome 4, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6654\", \"target\": \"Lung adenocarcinoma, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6654\", \"target\": \"Rasopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Noonan syndrome, Rasopathy, not provided\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Noonan syndrome 3, not provided\", \"target\": \"5894\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Rasopathy\", \"target\": \"22808\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23498|MTA3\", \"target\": \"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1, Congenital NAD deficiency disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51626\", \"target\": \"Short-rib thoracic dysplasia 15 with polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51626\", \"target\": \"Short-rib thoracic dysplasia 1 with or without polydactyly, Short-rib thoracic dysplasia 15 with polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Short-rib thoracic dysplasia 1 with or without polydactyly, Short-rib thoracic dysplasia 15 with polydactyly\", \"target\": \"51626|ABCG5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51626|ABCG5\", \"target\": \"Sitosterolemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Sitosterolemia\", \"target\": \"64240|ABCG8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Sitosterolemia\", \"target\": \"64241\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64241\", \"target\": \"Sitosterolemia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10128\", \"target\": \"Leigh syndrome, French Canadian type\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6519\", \"target\": \"Cystinuria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6519\", \"target\": \"Cystinuria, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cystinuria\", \"target\": \"6519|PREPL\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9581\", \"target\": \"Myasthenic syndrome, congenital, 22\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6496\", \"target\": \"Holoprosencephaly 2, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6496\", \"target\": \"SCHIZENCEPHALY, Holoprosencephaly 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6496\", \"target\": \"SCHIZENCEPHALY\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6496\", \"target\": \"Holoprosencephaly 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2034\", \"target\": \"Erythrocytosis, familial, 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9419\", \"target\": \"Short stature with microcephaly and distinctive facies\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"90411\", \"target\": \"Factor v and factor viii, combined deficiency of, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57217\", \"target\": \"Multiple gastrointestinal atresias, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57217\", \"target\": \"Multiple gastrointestinal atresias\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"805\", \"target\": \"Long QT syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"805\", \"target\": \"Long QT syndrome 15\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"805\", \"target\": \"Long QT syndrome 15, Long QT syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Long QT syndrome 1\", \"target\": \"6331\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4072\", \"target\": \"Lynch syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4072\", \"target\": \"Diarrhea 5, with tufting enteropathy, congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4072\", \"target\": \"Diarrhea 5, with tufting enteropathy, congenital, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4072\", \"target\": \"Lynch syndrome, Diarrhea 5, with tufting enteropathy, congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4072\", \"target\": \"Hereditary nonpolyposis colon cancer\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome\", \"target\": \"4436\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Lynch syndrome\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer\", \"target\": \"4436\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome I, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Lynch syndrome I\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Malignant tumor of sigmoid colon, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Lynch syndrome, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, Colorectal cancer, hereditary, nonpolyposis, type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Carcinoma of colon, Lynch syndrome, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Muir-Torr\\u00e9 syndrome, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Malignant tumor of ascending colon, Lynch syndrome, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4436\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome I\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Lynch syndrome I\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome, Lynch syndrome I\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome I\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lynch syndrome I, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\", \"target\": \"2956\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I, not provided\", \"target\": \"4292\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2956\", \"target\": \"Endometrial carcinoma, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colorectal cancer type 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal cancer type 5, Lynch syndrome I, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Endometrial carcinoma, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2956\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal cancer type 5, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2956\", \"target\": \"Turcot syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2956\", \"target\": \"Lynch syndrome, Hereditary nonpolyposis colorectal cancer type 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80204\", \"target\": \"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Leydig cell hypoplasia, partial\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Leydig cell agenesis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Leydig hypoplasia, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Leydig cell agenesis, Luteinizing hormone resistance, female\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Precocious puberty in males, Gonadotropin-independent familial sexual precocity, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Gonadotropin-independent familial sexual precocity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Leydig cell adenoma, somatic, with male-limited precocious puberty\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Gonadotropin-independent familial sexual precocity, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Precocious puberty in males, Gonadotropin-independent familial sexual precocity\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3973|STON1-GTF2A1L\", \"target\": \"Pseudohermaphroditism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2492\", \"target\": \"Ovarian dysgenesis 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2492\", \"target\": \"Ovarian hyperstimulation syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2492\", \"target\": \"Ovarian dysgenesis 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2492\", \"target\": \"Amenorrhea\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9378\", \"target\": \"Pitt-Hopkins-like syndrome 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"130162\", \"target\": \"Waddling gait, Marked Hypotonia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"87178\", \"target\": \"Combined oxidative phosphorylation deficiency 13\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"87178\", \"target\": \"Deafness, autosomal recessive 70\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2202\", \"target\": \"Blindness, Nyctalopia, Retinal pigment epithelial atrophy, Macular dystrophy, Optic disc drusen\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2202\", \"target\": \"Doyne honeycomb retinal dystrophy, Malattia leventinese, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7444|FANCL\", \"target\": \"Fanconi anemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Fanconi anemia\", \"target\": \"55120\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Fanconi anemia\", \"target\": \"2177|LOC107303338\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55120\", \"target\": \"Fanconi anemia, complementation group L\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"53335\", \"target\": \"Fetal hemoglobin quantitative trait locus 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"53335\", \"target\": \"Intellectual developmental disorder with persistence of fetal hemoglobin\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"53335\", \"target\": \"Microcephaly, Intellectual disability, Global developmental delay, Profound global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5194\", \"target\": \"Peroxisome biogenesis disorder 11A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5194\", \"target\": \"Peroxisome biogenesis disorder 11B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7514\", \"target\": \"Chronic lymphocytic leukemia, Neoplasm of the breast, Neoplasm of the large intestine, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"84140\", \"target\": \"Retinitis pigmentosa 28\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84140\", \"target\": \"Retinitis pigmentosa 28, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84140\", \"target\": \"Retinitis pigmentosa 28, Cone-rod dystrophy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23301\", \"target\": \"Prostate cancer, hereditary, 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51057\", \"target\": \"Bardet-Biedl syndrome 15\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6509\", \"target\": \"Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6509\", \"target\": \"Spastic tetraplegia, thin corpus callosum, and progressive microcephaly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6509\", \"target\": \"Inborn genetic diseases, Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84168\", \"target\": \"Odontotrichomelic syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2673\", \"target\": \"Congenital myasthenic syndrome 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27247\", \"target\": \"Multiple mitochondrial dysfunctions syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27247\", \"target\": \"Multiple mitochondrial dysfunctions syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7072\", \"target\": \"Welander distal myopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84908\", \"target\": \"M\\u00e9ni\\u00e8re's disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50489\", \"target\": \"Birbeck granule deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"525\", \"target\": \"Renal tubular acidosis, distal, with progressive deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"525\", \"target\": \"Inborn genetic diseases, Renal tubular acidosis, distal, with progressive deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"525\", \"target\": \"Nephrocalcinosis, Nephrolithiasis, Renal tubular acidosis, distal, with progressive deafness\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"525\", \"target\": \"Renal tubular acidosis with progressive nerve deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"525\", \"target\": \"Renal tubular acidosis with progressive nerve deafness, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"84693\", \"target\": \"Methylmalonyl-CoA epimerase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Limb-girdle muscular dystrophy, type 2B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Dysferlinopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Dysferlinopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Myopathy, distal, with anterior tibial onset, Miyoshi muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8291\", \"target\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8291\", \"target\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Miyoshi muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Limb-girdle muscular dystrophy, type 2B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"DYSF- Related Disorder, Miyoshi muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, DYSF-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"not provided, Miyoshi muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"not provided, Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Foot dorsiflexor weakness, Peroneal muscle atrophy, Distal lower limb muscle weakness, Absent muscle fiber dysferlin\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"not provided, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"DYSF-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8291\", \"target\": \"not provided, Miyoshi muscular dystrophy 1, Dysferlinopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Proximal muscle weakness, Limb-girdle muscular dystrophy, type 2B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, Dysferlinopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"Myopathy, distal, with anterior tibial onset, Dysferlinopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8291\", \"target\": \"not provided, Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8291\", \"target\": \"Myopathy, distal, with anterior tibial onset, Miyoshi muscular dystrophy 1, Limb-girdle muscular dystrophy, type 2B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56603\", \"target\": \"Radiohumeral fusions with other skeletal and craniofacial anomalies, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6697\", \"target\": \"Sepiapterin reductase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6697\", \"target\": \"Sepiapterin reductase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6697\", \"target\": \"Dystonia, Sepiapterin reductase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10574\", \"target\": \"Myocardial infarction 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7840\", \"target\": \"Alstrom syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7840\", \"target\": \"Alstrom syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51002\", \"target\": \"GALLOWAY-MOWAT SYNDROME 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10617\", \"target\": \"Microcephaly-capillary malformation syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10617\", \"target\": \"Microcephaly-capillary malformation syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"72\", \"target\": \"Chronic intestinal pseudoobstruction\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"72\", \"target\": \"Visceral myopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"72\", \"target\": \"Visceral myopathy, Chronic intestinal pseudoobstruction\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"72\", \"target\": \"Inborn genetic diseases, Visceral myopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"72\", \"target\": \"Megacystis, Inborn genetic diseases, Visceral myopathy, Chronic intestinal pseudoobstruction, Visceral neuropathy, familial, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"72\", \"target\": \"Megacystis, Inborn genetic diseases, Chronic intestinal pseudoobstruction\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1716\", \"target\": \"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1716\", \"target\": \"MITOCHONDRIAL DNA DEPLETION SYNDROME 3, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, Portal hypertension, noncirrhotic\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1716\", \"target\": \"Mitochondrial DNA-depletion syndrome 3, hepatocerebral\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1716\", \"target\": \"Mitochondrial DNA-depletion syndrome 3, hepatocerebral, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1716\", \"target\": \"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Mitochondrial DNA-depletion syndrome 3, hepatocerebral\", \"target\": \"1716|DGUOK-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1716|DGUOK-AS1\", \"target\": \"MITOCHONDRIAL DNA DEPLETION SYNDROME 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"388962\", \"target\": \"Multiple mitochondrial dysfunctions syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1639\", \"target\": \"Perry syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1639\", \"target\": \"Distal hereditary motor neuronopathy type 7B, Amyotrophic lateral sclerosis type 1, Perry syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7841\", \"target\": \"Congenital disorder of glycosylation type 2B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27429\", \"target\": \"3-methylglutaconic aciduria, type VIII\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3-methylglutaconic aciduria, type VIII\", \"target\": \"27429|LOXL3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1496\", \"target\": \"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8802\", \"target\": \"Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84173\", \"target\": \"Deafness, autosomal recessive 88\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2677\", \"target\": \"Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2677\", \"target\": \"Vitamin k-dependent clotting factors, combined deficiency of, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6439\", \"target\": \"Surfactant metabolism dysfunction, pulmonary, 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8869\", \"target\": \"Salt and pepper developmental regression syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"25885\", \"target\": \"Acrofacial dysostosis, Cincinnati type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"65055\", \"target\": \"Spastic paraplegia 31, autosomal dominant\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"65055\", \"target\": \"Distal hereditary motor neuronopathy type 5B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"65055\", \"target\": \"Spastic paraplegia 31, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"925\", \"target\": \"Cd8 deficiency, familial\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Cd8 deficiency, familial\", \"target\": \"7535\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9451|LOC101928371\", \"target\": \"Wolcott-Rallison dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Wolcott-Rallison dysplasia\", \"target\": \"9451\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22934\", \"target\": \"Deficiency of ribose-5-phosphate isomerase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55654\", \"target\": \"Pheochromocytoma, Hereditary cancer-predisposing syndrome, Pheochromocytoma, susceptibility to\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55654\", \"target\": \"Hereditary Paraganglioma-Pheochromocytoma Syndromes, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55654\", \"target\": \"Pheochromocytoma, Pheochromocytoma, susceptibility to\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23020\", \"target\": \"Retinitis pigmentosa 33\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23020\", \"target\": \"Retinitis pigmentosa, Retinitis pigmentosa 33\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23397\", \"target\": \"MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"81562\", \"target\": \"Mental retardation, autosomal recessive 52\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26504\", \"target\": \"Cone-rod dystrophy amelogenesis imperfecta\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7535\", \"target\": \"Combined immunodeficiency, Autoimmune disease, multisystem, infantile-onset, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7535\", \"target\": \"Severe combined immunodeficiency, atypical\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7535\", \"target\": \"Severe combined immunodeficiency, atypical, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200403\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 22\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1261\", \"target\": \"Achromatopsia 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1261\", \"target\": \"Achromatopsia 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1261\", \"target\": \"Achromatopsia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1261\", \"target\": \"Abnormality of color vision, Macular degeneration, Photophobia, Achromatopsia, Achromatopsia 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1261\", \"target\": \"Monochromacy, Achromatopsia 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1261\", \"target\": \"Macular dystrophy, Achromatopsia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1261\", \"target\": \"Achromatopsia, Achromatopsia 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1261\", \"target\": \"Abnormality of the eye, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"493753\", \"target\": \"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80705\", \"target\": \"SPERMATOGENIC FAILURE 26\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51601|MITD1\", \"target\": \"Lipoyltransferase 1 deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51601|MITD1\", \"target\": \"Lipoyltransferase 1 deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4862|LOC101927142\", \"target\": \"Non-obstructive azoospermia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"60482\", \"target\": \"Myasthenic syndrome, congenital, 20, presynaptic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903\", \"target\": \"Encephalopathy, acute, infection-induced, 3, suceptibility to\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Autosomal dominant hypohidrotic ectodermal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal dominant hypohidrotic ectodermal dysplasia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Autosomal dominant hypohidrotic ectodermal dysplasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Autosomal recessive hypohidrotic ectodermal dysplasia syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Autosomal dominant hypohidrotic ectodermal dysplasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Autosomal dominant hypohidrotic ectodermal dysplasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Ectodermal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4B, MNGIE type, Ectodermal dysplasia 10a, hypohidrotic/hair/tooth type, autosomal dominant, Autosomal recessive hypohidrotic ectodermal dysplasia syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5903|EDAR\", \"target\": \"Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4B, MNGIE type\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4867\", \"target\": \"Nephronophthisis 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4867\", \"target\": \"Nephronophthisis, Nephronophthisis 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4867\", \"target\": \"Nephronophthisis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4867\", \"target\": \"Nephronophthisis, Nephronophthisis 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Nephronophthisis\", \"target\": \"9657\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Nephronophthisis\", \"target\": \"27031|NPHP3-ACAD11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nephronophthisis\", \"target\": \"27031|NPHP3-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"699\", \"target\": \"Colorectal cancer with chromosomal instability\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10461\", \"target\": \"Retinitis pigmentosa 38\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10461\", \"target\": \"Inborn genetic diseases, Retinitis pigmentosa 38\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"150468\", \"target\": \"Filippi syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26525\", \"target\": \"Pustular psoriasis, generalized\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3557\", \"target\": \"Osteomyelitis, sterile multifocal, with periostitis and pustulosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7849|PAX8-AS1\", \"target\": \"Thyroid dysgenesis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55240|STEAP3-AS1\", \"target\": \"Hypochromic microcytic anemia with iron overload 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2736\", \"target\": \"Holoprosencephaly 9\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2736\", \"target\": \"Culler-Jones syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2736\", \"target\": \"Holoprosencephaly 9, Culler-Jones syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23332|RNU4ATAC\", \"target\": \"Roifman syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23332|RNU4ATAC\", \"target\": \"Osteodysplastic primordial dwarfism, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23332|RNU4ATAC\", \"target\": \"Roifman syndrome, Osteodysplastic primordial dwarfism, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"274\", \"target\": \"Autosomal recessive centronuclear myopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Autosomal recessive centronuclear myopathy\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2071\", \"target\": \"Xeroderma pigmentosum, complementation group b\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2071\", \"target\": \"Trichothiodystrophy 2, photosensitive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5624\", \"target\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5624\", \"target\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5624\", \"target\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5624\", \"target\": \"Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant, Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55679\", \"target\": \"MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"112714\", \"target\": \"Seizures, Global developmental delay, Lissencephaly, Primary microcephaly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"84317\", \"target\": \"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo, Congenital disorders of glycosylation type II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55997\", \"target\": \"Heterotaxy, visceral, 2, autosomal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"113457|MZT2A\", \"target\": \"KERATOCONUS 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22930\", \"target\": \"Warburg micro syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22930\", \"target\": \"Warburg micro syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Warburg micro syndrome 1\", \"target\": \"22930|ZRANB3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3938\", \"target\": \"Congenital lactase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1615\", \"target\": \"Hypomyelination with brainstem and spinal cord involvement and leg spasticity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1615\", \"target\": \"Hypomyelination with brainstem and spinal cord involvement and leg spasticity, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7852\", \"target\": \"Warts, hypogammaglobulinemia, infections, and myelokathexis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7852\", \"target\": \"Warts, hypogammaglobulinemia, infections, and myelokathexis, Myelokathexis, isolated\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3176\", \"target\": \"Mental retardation, autosomal recessive 51\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8942\", \"target\": \"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2, Congenital NAD deficiency disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8942\", \"target\": \"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2, Congenital NAD deficiency disorder, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8942\", \"target\": \"Hydroxykynureninuria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9839\", \"target\": \"Mowat-Wilson syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9839\", \"target\": \"Smith-Magenis Syndrome-like\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9839\", \"target\": \"Mowat-Wilson syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9839\", \"target\": \"Mowat-Wilson syndrome, History of neurodevelopmental disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9839\", \"target\": \"Inborn genetic diseases, Mowat-Wilson syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Mowat-Wilson syndrome\", \"target\": \"9839|LOC111721705\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5000\", \"target\": \"Meier-Gorlin syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5000\", \"target\": \"Meier-Gorlin syndrome 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55777\", \"target\": \"Mental retardation, autosomal dominant 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55777\", \"target\": \"Mental retardation, autosomal dominant 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55777\", \"target\": \"Inborn genetic diseases, Autism spectrum disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3800\", \"target\": \"Cortical dysplasia, complex, with other brain malformations 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3800\", \"target\": \"Cortical dysplasia, complex, with other brain malformations 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27249\", \"target\": \"Homocystinuria, cblD type, variant 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27249\", \"target\": \"Methylmalonic acidemia with homocystinuria cblD\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27249\", \"target\": \"Methylmalonic acidemia with homocystinuria cblD, Methylmalonic aciduria, cblD type, variant 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4703|RIF1\", \"target\": \"Nemaline myopathy 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4703|RIF1\", \"target\": \"Nemaline myopathy 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4703|RIF1\", \"target\": \"Nemaline myopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4703|RIF1\", \"target\": \"Nemaline myopathy, Nemaline myopathy 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4703|RIF1\", \"target\": \"Muscular dystrophy, Progressive proximal muscle weakness, Limb pain, Nemaline myopathy 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nemaline myopathy 2\", \"target\": \"4703\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nemaline myopathy 2, not provided\", \"target\": \"4703\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Nemaline myopathy, Nemaline myopathy 2\", \"target\": \"4703\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4703\", \"target\": \"Non-immune hydrops fetalis, Nemaline myopathy 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4703\", \"target\": \"Inborn genetic diseases, Nemaline myopathy 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4703\", \"target\": \"Nemaline myopathy 2, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"785\", \"target\": \"Epilepsy, idiopathic generalized 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2820\", \"target\": \"Diabetes mellitus type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Diabetes mellitus type 2\", \"target\": \"4760\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Diabetes mellitus type 2\", \"target\": \"3667\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Diabetes mellitus type 2\", \"target\": \"6514\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"90\", \"target\": \"Progressive myositis ossificans\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"90\", \"target\": \"Brainstem glioma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"90\", \"target\": \"Brainstem glioma, Inborn genetic diseases, Progressive myositis ossificans\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"90\", \"target\": \"Brainstem glioma, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"90\", \"target\": \"Brainstem glioma, Progressive myositis ossificans, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"90\", \"target\": \"Progressive myositis ossificans, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3694\", \"target\": \"Amelogenesis imperfecta, type IH\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3694\", \"target\": \"Adolescent alopeciam dentogingival abnormalitites and intellectual disability\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10716\", \"target\": \"Autistic behavior, Moderate global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10716\", \"target\": \"Autistic behavior, Severe global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10716\", \"target\": \"Moderate global developmental delay\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10716\", \"target\": \"Autism 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64135\", \"target\": \"Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"64135\", \"target\": \"Singleton-Merten syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64135\", \"target\": \"Neonatal hypotonia, Hyperreflexia, Abnormal upper motor neuron morphology, Abnormality of the basal ganglia, Clonus, Developmental regression, Abnormality of the cerebral white matter, Aicardi-Goutieres syndrome 7, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"64135\", \"target\": \"Aicardi-Goutieres syndrome 7, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"64135\", \"target\": \"Aicardi-Goutieres syndrome 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6328\", \"target\": \"Inborn genetic diseases, Early infantile epileptic encephalopathy 62\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6328\", \"target\": \"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6328\", \"target\": \"Early infantile epileptic encephalopathy 62, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6328\", \"target\": \"Polymicrogyria, Developmental delay, Early infantile epileptic encephalopathy 62, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Early infantile epileptic encephalopathy 11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Early infantile epileptic encephalopathy 11, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Benign familial neonatal-infantile seizures\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Focal epilepsy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"SCN2A-related condition, Epileptic encephalopathy, Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6326\", \"target\": \"Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Seizures, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Epileptic encephalopathy, Early infantile epileptic encephalopathy 11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Seizures, Episodic ataxia, Vertigo, Early infantile epileptic encephalopathy 11, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Mental retardation, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6326\", \"target\": \"Epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6326\", \"target\": \"Benign familial neonatal-infantile seizures, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6326\", \"target\": \"Malignant migrating partial seizures of infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6326\", \"target\": \"Inborn genetic diseases, Benign familial neonatal-infantile seizures, Early infantile epileptic encephalopathy 11, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2591\", \"target\": \"Tumoral calcinosis, familial, hyperphosphatemic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2591\", \"target\": \"Tumoral calcinosis, familial, hyperphosphatemic, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809\", \"target\": \"Type IV short rib polydactyly syndrome, Asphyxiating thoracic dystrophy 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809\", \"target\": \"Nephronophthisis, Jeune thoracic dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79809\", \"target\": \"Nephronophthisis 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809\", \"target\": \"Short rib-polydactyly syndrome, Majewski type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809\", \"target\": \"Asphyxiating thoracic dystrophy 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809\", \"target\": \"Type IV short rib polydactyly syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809\", \"target\": \"Asphyxiating thoracic dystrophy 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Short rib-polydactyly syndrome, Majewski type\", \"target\": \"26146\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79809|TTC21B-AS1\", \"target\": \"Nephronophthisis, Jeune thoracic dystrophy, Nephronophthisis 12, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Early infantile epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Autosomal dominant epilepsy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 1, Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Seizures, Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 1, Generalized epilepsy with febrile seizures plus, type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Inborn genetic diseases, Epileptic encephalopathy Lennox-Gastaut type, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Delayed speech and language development, Seizures, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Focal epilepsy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Familial hemiplegic migraine type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Inborn genetic diseases, Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"History of neurodevelopmental disorder, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Primary generalized epilepsy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2, History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323|LOC102724058\", \"target\": \"Inborn genetic diseases, History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Early infantile epileptic encephalopathy\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Early infantile epileptic encephalopathy\", \"target\": \"9254\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Severe myoclonic epilepsy in infancy, not provided\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Autosomal dominant epilepsy\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy, not provided\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, not provided\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Generalized epilepsy with febrile seizures plus, type 2, not provided\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"History of neurodevelopmental disorder, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"target\": \"6323\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323\", \"target\": \"Seizures\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 1, Generalized epilepsy with febrile seizures plus, type 2, History of neurodevelopmental disorder, Early infantile epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy, Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 2, Familial hemiplegic migraine type 3, Severe myoclonic epilepsy in infancy, Early infantile epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323\", \"target\": \"Early infantile epileptic encephalopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 1, Severe myoclonic epilepsy in infancy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323\", \"target\": \"Seizures, Severe myoclonic epilepsy in infancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6323\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 1, Generalized epilepsy with febrile seizures plus, type 2, Early infantile epileptic encephalopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6323\", \"target\": \"Febrile seizures\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Paroxysmal extreme pain disorder, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Hereditary sensory and autonomic neuropathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Paroxysmal extreme pain disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Primary erythromelalgia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Paroxysmal extreme pain disorder, Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Indifference to pain, congenital, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Small fiber neuropathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335|SCN1A-AS1\", \"target\": \"Pain insensitivity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Generalized epilepsy with febrile seizures plus, type 7, Hereditary sensory and autonomic neuropathy type IIA\", \"target\": \"6335\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Primary erythromelalgia\", \"target\": \"6335\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Indifference to pain, congenital, autosomal recessive\", \"target\": \"6335\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Pain insensitivity\", \"target\": \"6335\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6335\", \"target\": \"Febrile seizures, familial, 3b\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Benign recurrent intrahepatic cholestasis 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Benign recurrent intrahepatic cholestasis 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Progressive familial intrahepatic cholestasis 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Pruritus, Intrahepatic cholestasis, Abnormal liver function tests during pregnancy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Benign recurrent intrahepatic cholestasis 2, Progressive familial intrahepatic cholestasis 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Progressive familial intrahepatic cholestasis 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8647\", \"target\": \"Familial Intrahepatic Cholestasis, Benign recurrent intrahepatic cholestasis 2, Progressive familial intrahepatic cholestasis 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4036\", \"target\": \"Pituitary prolactin cell adenoma, Severe Myopia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4036\", \"target\": \"Donnai Barrow syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4036\", \"target\": \"Donnai Barrow syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"129880\", \"target\": \"Bardet-Biedl syndrome 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"129880\", \"target\": \"Bardet-Biedl syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10324\", \"target\": \"Nemaline myopathy 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79675\", \"target\": \"Glaucoma 1, open angle, B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2571\", \"target\": \"Cerebral palsy, spastic quadriplegic, 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79828|DCAF17\", \"target\": \"Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities\", \"target\": \"80067\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80067\", \"target\": \"Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8604\", \"target\": \"Hypomyelination, global cerebral\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51776\", \"target\": \"MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51776|MAP3K20-AS1\", \"target\": \"Split-hand/foot malformation 1, Split-foot malformation with mesoaxial polydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83879\", \"target\": \"Immunodeficiency-centromeric instability-facial anomalies syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1134\", \"target\": \"Autism, Seizures, Lethal multiple pterygium syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1134\", \"target\": \"Myasthenic syndrome, slow-channel congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1134\", \"target\": \"Congenital myasthenic syndrome 1B, fast-channel\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1134\", \"target\": \"Inborn genetic diseases, Myasthenic syndrome, slow-channel congenital\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1134\", \"target\": \"Lethal multiple pterygium syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1134\", \"target\": \"Lethal multiple pterygium syndrome, Myasthenic syndrome, slow-channel congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lethal multiple pterygium syndrome\", \"target\": \"1144\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Lethal multiple pterygium syndrome\", \"target\": \"1146\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1123\", \"target\": \"Duane syndrome type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1123\", \"target\": \"Dandy-Walker syndrome, Hydroureter, Hydronephrosis, Microglossia, Cleft palate, Micrognathia, Sensorineural hearing loss, Nyctalopia, Abnormality of the diaphragm, Abnormality of the vertebral column, Arachnodactyly, Global developmental delay, Cerebellar vermis hypoplasia, Laryngomalacia, Abnormality of the cervical spine, Diaphragmatic eventration, Duane anomaly, Feeding difficulties, Small hand\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"80856\", \"target\": \"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3239\", \"target\": \"Synpolydactyly 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3239\", \"target\": \"Type D brachydactyly, Brachydactyly type E1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3239\", \"target\": \"Brachydactyly-syndactyly-oligodactyly syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3239\", \"target\": \"Syndactyly, type V\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3236\", \"target\": \"Vertical talus, congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4780\", \"target\": \"IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4780\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4780\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4780\", \"target\": \"Colorectal cancer, IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4780\", \"target\": \"Renal cell carcinoma, papillary, 1, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8540\", \"target\": \"Rhizomelic chondrodysplasia punctata type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50940\", \"target\": \"Pigmented nodular adrenocortical disease, primary, 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8575|PRKRA-AS1\", \"target\": \"Dystonia 16\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"494513\", \"target\": \"Deafness, autosomal recessive 59\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"494513\", \"target\": \"Deafness, autosomal recessive 59, Nonsyndromic hearing loss and deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Distal myopathy Markesbery-Griggs type\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Waddling gait, Muscular dystrophy, Limb-girdle muscular dystrophy, Proximal lower limb amyotrophy, Decreased patellar reflex, Limb-girdle muscular dystrophy, type 2J\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Dilated cardiomyopathy 1G, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Dilated cardiomyopathy 1G\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Hereditary myopathy with early respiratory failure\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Hereditary myopathy with early respiratory failure, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Hereditary myopathy with early respiratory failure, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Congenital titinopathy, Myopathy, early-onset, with fatal cardiomyopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Wolff-Parkinson-White pattern\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Dilated cardiomyopathy 1S, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Left ventricular noncompaction 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Familial dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Familial hypertrophic cardiomyopathy 9\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J, Distal myopathy Markesbery-Griggs type, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Distal myopathy Markesbery-Griggs type, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Dilated cardiomyopathy 1G, not specified, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Inborn genetic diseases, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Dilated cardiomyopathy 1S\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"not specified, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, Familial hypertrophic cardiomyopathy 9, Hereditary myopathy with early respiratory failure, Myopathy, early-onset, with fatal cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Dilated cardiomyopathy 1S, Limb-girdle muscular dystrophy, type 2J, Dilated cardiomyopathy 1G, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273|TTN-AS1\", \"target\": \"Primary dilated cardiomyopathy, Cardiomyopathy, Low-output congestive heart failure, Noncompaction cardiomyopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Distal myopathy Markesbery-Griggs type\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Limb-girdle muscular dystrophy, type 2J\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Dilated cardiomyopathy 1G\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy, Cardiovascular phenotype\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Hereditary myopathy with early respiratory failure\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Congenital titinopathy, Myopathy, early-onset, with fatal cardiomyopathy\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Familial hypertrophic cardiomyopathy 9\", \"target\": \"7273\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Dilated cardiomyopathy 1S\", \"target\": \"1674\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273\", \"target\": \"Myopathy, early-onset, with fatal cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7273\", \"target\": \"Noncompaction cardiomyopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7273\", \"target\": \"Primary dilated cardiomyopathy, Limb-girdle muscular dystrophy, type 2J\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"375298\", \"target\": \"Retinitis pigmentosa 26\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"375298\", \"target\": \"Retinitis pigmentosa, Cone/cone-rod dystrophy, Retinal dystrophy, Retinal pigment epithelial atrophy, Retinitis pigmentosa 26, Cone-rod dystrophy, Retinitis Pigmentosa, Recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"375298\", \"target\": \"Severe photosensitivity, Macular dystrophy, Adult-onset night blindness\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"375298\", \"target\": \"Cone/cone-rod dystrophy, Retinal pigment epithelial atrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4760\", \"target\": \"Maturity-onset diabetes of the young, type 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"401024\", \"target\": \"SPERMATOGENIC FAILURE 34\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"POLYMICROGYRIA WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Thoracic aortic aneurysm and aortic dissection\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 4, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 4, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Familial aortopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 4, Thoracic aortic aneurysm and aortic dissection, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"EHLERS-DANLOS SYNDROME, NONVASCULAR VARIANT\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Seizures, Connective tissue nevi, Ehlers-Danlos syndrome, type 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 4, Loeys-Dietz syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1281\", \"target\": \"Ehlers-Danlos syndrome, type 3, Ehlers-Danlos syndrome, type 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Thoracic aortic aneurysm and aortic dissection\", \"target\": \"1290\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Thoracic aortic aneurysm and aortic dissection\", \"target\": \"7048\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Thoracic aortic aneurysm and aortic dissection\", \"target\": \"4638\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1290\", \"target\": \"Ehlers-Danlos syndrome, classic type\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1290\", \"target\": \"Telecanthus, Hyperextensible skin, Joint hypermobility, Spinal deformities\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"30061\", \"target\": \"Hemochromatosis type 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"30061\", \"target\": \"Hemochromatosis type 4, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2660|C2orf88\", \"target\": \"Muscle hypertrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26275\", \"target\": \"Beta-hydroxyisobutyryl-CoA deacylase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26275\", \"target\": \"Beta-hydroxyisobutyryl-CoA deacylase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26275\", \"target\": \"Neurodegeneration due to 3-hydroxyisobutyryl coenzyme A hydrolase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26275\", \"target\": \"Inborn genetic diseases, Beta-hydroxyisobutyryl-CoA deacylase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2744\", \"target\": \"INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6772\", \"target\": \"Immunodeficiency 31a\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6772\", \"target\": \"Mycobacterial and viral infections, susceptibility to, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6772\", \"target\": \"Mycobacterial and viral infections, susceptibility to, autosomal recessive, Immunodeficiency 31C, Immunodeficiency 31a\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6772\", \"target\": \"Delayed speech and language development, Hypothyroidism, Primary hypothyroidism, Failure to thrive, Chronic diarrhea, Bronchiectasis, Short stature, Severe T-cell immunodeficiency, Combined immunodeficiency, Chronic oral candidiasis, Liver abscess, Cognitive impairment, Mycobacterial and viral infections, susceptibility to, autosomal recessive, Immunodeficiency 31C, Immunodeficiency 31a\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6772\", \"target\": \"Immunodeficiency 31C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6772\", \"target\": \"Blepharitis, Eczema, Recurrent skin infections, Recurrent infections, Recurrent Staphylococcus aureus infections, Chronic mucocutaneous candidiasis, Recurrent fungal infections, Recurrent candida infections, Recurrent bacterial skin infections, Chronic oral candidiasis, Onychomycosis, Immunodeficiency 31C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56171\", \"target\": \"Situs inversus, Ciliary dyskinesia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56171\", \"target\": \"Seizures, Hypoplasia of the corpus callosum, Dyspnea, Abnormality of the basal ganglia, Abnormal muscle tone\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57520\", \"target\": \"Neurodevelopmental disorder with hypotonia, seizures, and absent language\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57520\", \"target\": \"Neurodevelopmental disorder with hypotonia, seizures, and absent language, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80055\", \"target\": \"Mental retardation, autosomal recessive 42\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23451\", \"target\": \"Chronic lymphocytic leukemia, Renal cell carcinoma, papillary, 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23451\", \"target\": \"Acute myeloid leukemia, Myelodysplastic syndrome, Myelodysplastic syndrome progressed to acute myeloid leukemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23451\", \"target\": \"Hepatocellular carcinoma, Acute myeloid leukemia, Chronic lymphocytic leukemia, Neoplasm of the breast, Malignant melanoma of skin\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23451\", \"target\": \"Hepatocellular carcinoma, Chronic lymphocytic leukemia, Neoplasm of the breast, Malignant melanoma of skin\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23451\", \"target\": \"Chronic lymphocytic leukemia, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Adenoid cystic carcinoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3329\", \"target\": \"Spastic paraplegia 13\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3329\", \"target\": \"Leukodystrophy, hypomyelinating, 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"92935\", \"target\": \"Combined oxidative phosphorylation deficiency 25\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23314\", \"target\": \"Chromosome 2q32-q33 deletion syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23314\", \"target\": \"Microcephaly, Micrognathia, Global developmental delay, Abnormal facial shape, Downturned corners of mouth, Speech articulation difficulties, Hyperplasia of midface\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23314\", \"target\": \"Chromosome 2q32-q33 deletion syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23314\", \"target\": \"Cleft palate, isolated, Chromosome 2q32-q33 deletion syndrome, History of neurodevelopmental disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23314\", \"target\": \"Inborn genetic diseases, Chromosome 2q32-q33 deletion syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23314\", \"target\": \"SATB2-Related Disorder, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4709\", \"target\": \"Inborn genetic diseases, Mitochondrial complex I deficiency, MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4709\", \"target\": \"Inborn genetic diseases, MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"843\", \"target\": \"Neoplasm of stomach, Non-Hodgkin lymphoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"843\", \"target\": \"Autoimmune lymphoproliferative syndrome, type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"841\", \"target\": \"Caspase-8 deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"65062\", \"target\": \"Joubert syndrome 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"65062\", \"target\": \"Meckel-Gruber syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"65062\", \"target\": \"Joubert syndrome, Joubert syndrome 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"58538\", \"target\": \"High palate, Wide nasal bridge, Strabismus, Intellectual disability, Seizures, Global developmental delay, Generalized hypotonia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57679\", \"target\": \"Peripheral axonal neuropathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57679\", \"target\": \"Inborn genetic diseases, Amyotrophic lateral sclerosis type 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57679\", \"target\": \"Infantile-onset ascending hereditary spastic paralysis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57679\", \"target\": \"Juvenile primary lateral sclerosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57679\", \"target\": \"Infantile-onset ascending hereditary spastic paralysis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57679\", \"target\": \"Amyotrophic lateral sclerosis type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Primary pulmonary hypertension\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary venoocclusive disease 1, Primary pulmonary hypertension\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary venoocclusive disease 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary arterial hypertension associated with congenital heart disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary hypertension, primary, dexfenfluramine-associated\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Primary pulmonary hypertension, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Primary pulmonary hypertension, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary hypertension, primary, dexfenfluramine-associated, Primary pulmonary hypertension, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary veno-occlusive disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary arterial hypertension associated with congenital heart disease, Primary pulmonary hypertension\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"659\", \"target\": \"Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia, Primary pulmonary hypertension\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1493\", \"target\": \"Autoimmune lymphoproliferatiVe syndrome, type V\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29851\", \"target\": \"Common variable immunodeficiency 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4719\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4719\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4719\", \"target\": \"Juvenile myopathy, encephalopathy, lactic acidosis AND stroke\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1421|LOC100507443\", \"target\": \"Cataract 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1421|LOC100507443\", \"target\": \"Congenital cataract, Cataract 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1420|LOC100507443\", \"target\": \"Congenital cataract, Cataract, coppock-like\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1420|LOC100507443\", \"target\": \"Cataract, coppock-like\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1420|LOC100507443\", \"target\": \"Cataract, coppock-like, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1420|LOC100507443\", \"target\": \"Cataract 2, Coppock-like\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1419|LOC100507443\", \"target\": \"Cataract 39, multiple types\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3417\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Brainstem glioma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Malignant melanoma of skin, Adenoid cystic carcinoma, Glioblastoma, Myelodysplastic syndrome, Adenocarcinoma of prostate\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3417\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Astrocytoma, Brainstem glioma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Malignant melanoma of skin, Adenoid cystic carcinoma, Glioblastoma, Myelodysplastic syndrome, Oligodendroglioma, Adenocarcinoma of prostate, Glioblastoma multiforme, somatic\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3417\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Acute myeloid leukemia, Transitional cell carcinoma of the bladder, Multiple myeloma, Astrocytoma, Brainstem glioma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Malignant melanoma of skin, Adenoid cystic carcinoma, Glioblastoma, Myelodysplastic syndrome, Adenocarcinoma of prostate\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"200576\", \"target\": \"Fleck corneal dystrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5746\", \"target\": \"Syndromic intellectual disability\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"285175\", \"target\": \"Hypotonia, infantile, with psychomotor retardation and characteristic facies 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"285175\", \"target\": \"Encephalopathy, Hypotonia, infantile, with psychomotor retardation and characteristic facies 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"285175\", \"target\": \"UNC80-Related Disorder, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1373\", \"target\": \"Congenital hyperammonemia, type I\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1373\", \"target\": \"Congenital hyperammonemia, type I, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2066\", \"target\": \"Amyotrophic lateral sclerosis 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Familial cancer of breast\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"580\", \"target\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome, Triple-Negative Breast Cancer Finding, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Hereditary breast and ovarian cancer syndrome, Familial cancer of breast, Hereditary cancer-predisposing syndrome, Triple-Negative Breast Cancer Finding, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Familial cancer of breast, Hereditary cancer-predisposing syndrome, Breast cancer, susceptibility to, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"580\", \"target\": \"Familial cancer of breast, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Neoplasm of the breast\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"580\", \"target\": \"Hereditary breast and ovarian cancer syndrome, Familial cancer of breast, Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26154|SNHG31\", \"target\": \"Autosomal recessive congenital ichthyosis 4B, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26154|SNHG31\", \"target\": \"Autosomal recessive congenital ichthyosis 4B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Autosomal recessive congenital ichthyosis 4B\", \"target\": \"26154\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26154\", \"target\": \"Autosomal recessive congenital ichthyosis 4A\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26154\", \"target\": \"Autosomal recessive congenital ichthyosis 4A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26154\", \"target\": \"Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"471\", \"target\": \"AICAR transformylase/IMP cyclohydrolase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2335\", \"target\": \"Glomerulopathy with fibronectin deposits 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2335\", \"target\": \"Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia - Sutcliffe type\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2335\", \"target\": \"Spondylometaphyseal dysplasia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2335\", \"target\": \"Spondylometaphyseal dysplasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"50485\", \"target\": \"Schimke immunoosseous dysplasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"50485\", \"target\": \"Focal segmental glomerulosclerosis, Microcephaly, Small for gestational age, Disproportionate short-trunk short stature, Short stature, Decreased body weight, Atrioventricular canal defect, Congenital microcephaly, Steroid-resistant nephrotic syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50485\", \"target\": \"Focal segmental glomerulosclerosis, Microcephaly, Small for gestational age, Disproportionate short-trunk short stature, Short stature, Decreased body weight, Atrioventricular canal defect, Congenital microcephaly, Steroid-resistant nephrotic syndrome, Schimke immunoosseous dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25953\", \"target\": \"Paroxysmal nonkinesigenic dyskinesia 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25953\", \"target\": \"Paroxysmal dystonia, Paroxysmal dyskinesia, Episodic hemiplegia, Paroxysmal nonkinesigenic dyskinesia 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9125\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Adenocarcinoma of prostate, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9125\", \"target\": \"Malignant melanoma of skin\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"617\", \"target\": \"GRACILE syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"617\", \"target\": \"Bjornstad syndrome with mild mitochondrial complex III deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"617\", \"target\": \"Mitochondrial complex III deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"617\", \"target\": \"GRACILE syndrome, Mitochondrial complex III deficiency, BCS1L-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"617\", \"target\": \"GRACILE syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"617\", \"target\": \"Leigh syndrome due to mitochondrial complex III deficiency, GRACILE syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"617\", \"target\": \"Pili torti-deafness syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"617\", \"target\": \"Mitochondrial complex III deficiency, Bjornstad syndrome with mild mitochondrial complex III deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"617\", \"target\": \"GRACILE syndrome, Mitochondrial complex III deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1593\", \"target\": \"Cholestanol storage disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1593\", \"target\": \"Cholestanol storage disease, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1593\", \"target\": \"Regression of motor development with severe dystonia and corresponding basal ganglia lesions, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"53632\", \"target\": \"Glycogen content in skeletal muscle, increased\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80326\", \"target\": \"Odontoonychodermal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80326\", \"target\": \"Inborn genetic diseases, Odontoonychodermal dysplasia, Tooth agenesis, selective, 4, Schopf-Schulz-Passarge syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80326\", \"target\": \"Odontoonychodermal dysplasia, Tooth agenesis, selective, 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80326\", \"target\": \"Odontoonychodermal dysplasia, Tooth agenesis, selective, 4, Schopf-Schulz-Passarge syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"80326\", \"target\": \"Odontoonychodermal dysplasia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3549\", \"target\": \"Acrocapitofemoral dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3549\", \"target\": \"Type A1 brachydactyly\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3549\", \"target\": \"Hirschsprung disease 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79840\", \"target\": \"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79840\", \"target\": \"Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10058\", \"target\": \"Microphthalmia, isolated, with coloboma 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10058\", \"target\": \"Pseudohyperkalemia, familial, 2, due to red cell leak\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10058\", \"target\": \"Dyschromatosis universalis hereditaria 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7277\", \"target\": \"Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7277\", \"target\": \"Amyotrophic lateral sclerosis 22 with frontotemporal dementia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3300\", \"target\": \"Charcot-Marie-Tooth disease, Spinal muscular atrophy, distal, autosomal recessive, 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3300\", \"target\": \"Spinal muscular atrophy, distal, autosomal recessive, 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3300\", \"target\": \"Spinal muscular atrophy, distal, autosomal recessive, 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3300\", \"target\": \"Charcot-Marie-Tooth disease, axonal, type 2T\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Charcot-Marie-Tooth disease, axonal, type 2T\", \"target\": \"4311\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1674\", \"target\": \"Myofibrillar myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1674\", \"target\": \"Primary dilated cardiomyopathy, Myofibrillar myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1674\", \"target\": \"Myofibrillar myopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1674\", \"target\": \"Myofibrillar myopathy 1, Muscular dystrophy, limb-girdle, type 2R, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1674\", \"target\": \"Myofibrillar myopathy 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1674\", \"target\": \"Myofibrillar myopathy 1, Muscular dystrophy, limb-girdle, type 2R\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1674\", \"target\": \"Myofibrillar myopathy 1, Scapuloperoneal syndrome, neurogenic, Kaeser type, Muscular dystrophy, limb-girdle, type 2R, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1674\", \"target\": \"Primary dilated cardiomyopathy, Primary familial hypertrophic cardiomyopathy, Myofibrillar myopathy 1, Dilated cardiomyopathy 1I, Muscular dystrophy, limb-girdle, type 2R, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10290\", \"target\": \"Myopathy, centronuclear, 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29926\", \"target\": \"Alacrima, achalasia, and mental retardation syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23363\", \"target\": \"Three M syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5077\", \"target\": \"Waardenburg syndrome type 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5077\", \"target\": \"Waardenburg syndrome type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5077\", \"target\": \"Waardenburg syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5077\", \"target\": \"Klein-Waardenberg's syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5077\", \"target\": \"Klein-Waardenberg's syndrome, Waardenburg syndrome type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5077\", \"target\": \"Craniofacial deafness hand syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Waardenburg syndrome\", \"target\": \"4286\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10056\", \"target\": \"Liver cirrhosis, Cerebral calcification, Dilatation, Interstitial pneumonitis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10056\", \"target\": \"Liver cirrhosis, Cerebral calcification, Dilatation, Interstitial pneumonitis, Rajab syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10056\", \"target\": \"Rajab syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10056\", \"target\": \"Rajab syndrome, Neurodevelopmental disorder with brain, liver, and lung abnormalities\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10056\", \"target\": \"Rajab syndrome, Interstitial lung and liver disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"65080\", \"target\": \"Combined oxidative phosphorylation deficiency 16, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8452\", \"target\": \"Pseudohypoaldosteronism, type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8452\", \"target\": \"Pseudohypoaldosteronism, type 2, Pseudohypoaldosteronism type 2E\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1286\", \"target\": \"Alport syndrome, autosomal recessive\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1286\", \"target\": \"Alport syndrome 3, autosomal dominant\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1286\", \"target\": \"Alport syndrome, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1286\", \"target\": \"Benign familial hematuria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1286\", \"target\": \"Benign familial hematuria, Alport syndrome, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1286\", \"target\": \"Proteinuria, Hearing impairment, Myopia, Hematuria, Hypertension, Alport syndrome, autosomal recessive\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Alport syndrome, autosomal recessive\", \"target\": \"1285\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Alport syndrome, autosomal recessive\", \"target\": \"1285|LOC654841\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Alport syndrome 3, autosomal dominant\", \"target\": \"1285|LOC654841\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Alport syndrome, autosomal recessive, not provided\", \"target\": \"1285|LOC654841\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Benign familial hematuria\", \"target\": \"1285|LOC654841\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1285|LOC654841\", \"target\": \"Benign familial hematuria, Alport syndrome 3, autosomal dominant, Alport syndrome, autosomal recessive\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1285|LOC654841\", \"target\": \"Alport syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1285|LOC654841\", \"target\": \"Alport syndrome 3, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1285|LOC654841\", \"target\": \"Alport syndrome 3, autosomal dominant, Alport syndrome, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1285|LOC654841\", \"target\": \"Alport syndrome 3, autosomal dominant, Alport syndrome, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56947\", \"target\": \"Global developmental delay, Mitochondrial encephalomyopathy, Encephalopathy due to defective mitochondrial and peroxisomal fission 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"56947\", \"target\": \"Encephalopathy due to defective mitochondrial and peroxisomal fission 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80704\", \"target\": \"Biotin-thiamine-responsive basal ganglia disease, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80704\", \"target\": \"Thiamine Metabolism Dysfunction Syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"80704\", \"target\": \"Biotin-thiamine-responsive basal ganglia disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9320\", \"target\": \"MENTAL RETARDATION, AUTOSOMAL DOMINANT 49\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3431|SP140\", \"target\": \"Hepatic venoocclusive disease with immunodeficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80210\", \"target\": \"ARMC9-related Joubert syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80210\", \"target\": \"JOUBERT SYNDROME 30, ARMC9-related Joubert syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80210\", \"target\": \"JOUBERT SYNDROME 30\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5147\", \"target\": \"Joubert syndrome 22\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"129563\", \"target\": \"Renal hamartomas nephroblastomatosis and fetal gigantism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9427\", \"target\": \"Distal arthrogryposis type 5D\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9427\", \"target\": \"Distal arthrogryposis type 5D, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"646960\", \"target\": \"Microphthalmia, isolated 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1144\", \"target\": \"Myasthenic syndrome, congenital, 3b, fast-channel\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1144\", \"target\": \"Myasthenic syndrome, congenital, 3a, slow-channel\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1144\", \"target\": \"Myasthenic syndrome, congenital, 3c, associated with acetylcholine receptor deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1144\", \"target\": \"Ptosis, Muscle weakness, Dyspnea, Breathing dysregulation\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1146\", \"target\": \"Multiple pterygium syndrome Escobar type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1146\", \"target\": \"Multiple pterygium syndrome Escobar type, Lethal multiple pterygium syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1146\", \"target\": \"Peripheral neuropathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26058|KCNJ13\", \"target\": \"Leber congenital amaurosis 16\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26058|KCNJ13\", \"target\": \"Snowflake vitreoretinal degeneration\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26058|KCNJ13\", \"target\": \"Leber congenital amaurosis, Leber congenital amaurosis 16\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26058|KCNJ13\", \"target\": \"Leber congenital amaurosis 16, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26058\", \"target\": \"Parkinson disease 11\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6295\", \"target\": \"Oguchi's disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6295\", \"target\": \"Retinitis pigmentosa 47, Oguchi's disease\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Crigler-Najjar syndrome, type II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Crigler Najjar syndrome, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Crigler-Najjar syndrome, Crigler-Najjar syndrome, type II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Inborn genetic diseases, Crigler-Najjar syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Crigler Najjar syndrome, type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Crigler-Najjar syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Gilbert's syndrome, Crigler Najjar syndrome, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Crigler-Najjar syndrome, type II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Hyperbilirubinemia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Gilbert's syndrome, Crigler-Najjar syndrome, type II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7361|UGT1A10\", \"target\": \"Hyperbilirubinemia, Lucey-Driscoll syndrome, Crigler-Najjar syndrome, type II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1293\", \"target\": \"Dystonia 27, Bethlem myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1293\", \"target\": \"Dystonia 27, Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1293\", \"target\": \"Bethlem myopathy 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1293\", \"target\": \"Bethlem myopathy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1293\", \"target\": \"Inborn genetic diseases, Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1293\", \"target\": \"Ullrich congenital muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1293\", \"target\": \"Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1293\", \"target\": \"Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1293\", \"target\": \"Ullrich congenital muscular dystrophy 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1293\", \"target\": \"Dystonia 27, Bethlem myopathy 1, Ullrich congenital muscular dystrophy 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79083\", \"target\": \"Griscelli syndrome type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8864\", \"target\": \"Familial advanced sleep phase syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26146\", \"target\": \"Senior-Loken syndrome 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"117581\", \"target\": \"Congenital ectodermal dysplasia of face\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"117581\", \"target\": \"Inborn genetic diseases, Ablepharon macrostomia syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"117581\", \"target\": \"Barber-Say syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4705\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIA, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Mental retardation, autosomal dominant 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia 30, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Mental retardation, autosomal dominant 9, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"547\", \"target\": \"PEHO syndrome, Mental retardation, autosomal dominant 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia 30, autosomal recessive, PEHO syndrome, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia, Hyperreflexia, Clonus, Lower limb hyperreflexia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"547\", \"target\": \"Hereditary spastic paraplegia, Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"547\", \"target\": \"Spastic paraplegia, Spastic paraplegia 30, autosomal recessive, Hereditary sensory and autonomic neuropathy type IIC, Mental retardation, autosomal dominant 9, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"189\", \"target\": \"Primary hyperoxaluria, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"189\", \"target\": \"Nephrocalcinosis, Nephrolithiasis, Primary hyperoxaluria, type I\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"189\", \"target\": \"Primary hyperoxaluria, type I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"189\", \"target\": \"Primary hyperoxaluria, Primary hyperoxaluria, type I, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"189\", \"target\": \"Nephrocalcinosis, Nephrolithiasis, Primary hyperoxaluria, Primary hyperoxaluria, type I\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"728294\", \"target\": \"D-2-hydroxyglutaric aciduria 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"728294\", \"target\": \"D-2-hydroxyglutaric aciduria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27255\", \"target\": \"Autistic behavior\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"51095\", \"target\": \"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51095\", \"target\": \"Retinitis pigmentosa and erythrocytic microcytosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51095\", \"target\": \"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51095|CRBN\", \"target\": \"Mental retardation, autosomal recessive 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51095|CRBN\", \"target\": \"Mental retardation, autosomal recessive 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"285362\", \"target\": \"Multiple sulfatase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"285362\", \"target\": \"Multiple sulfatase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3708\", \"target\": \"Inborn genetic diseases, Spinocerebellar ataxia 29, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3708\", \"target\": \"Spinocerebellar ataxia 29\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3708\", \"target\": \"Gillespie syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3708\", \"target\": \"Spinocerebellar ataxia 15\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3708\", \"target\": \"Inborn genetic diseases, Spinocerebellar ataxia 29\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3708\", \"target\": \"Inborn genetic diseases, Gillespie syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3708\", \"target\": \"ITPR1-associated cerebellar ataxia spectrum disorder\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2917\", \"target\": \"Seizures, Muscular hypotonia, Global developmental delay, Hypoplasia of the corpus callosum, Brain atrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2917\", \"target\": \"Intellectual disability, Seizures, Muscular hypotonia, Global developmental delay, CNS hypomyelination, Brain atrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"859|SSUH2\", \"target\": \"Long QT syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"859|SSUH2\", \"target\": \"Long QT syndrome 9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"859|SSUH2\", \"target\": \"Elevated serum creatine phosphokinase, Long QT syndrome, Rippling muscle disease 2, Limb-girdle muscular dystrophy, type 1C, Distal myopathy, Tateyama type, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"859|SSUH2\", \"target\": \"Rippling muscle disease 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"859|SSUH2\", \"target\": \"Elevated serum creatine phosphokinase, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"859|SSUH2\", \"target\": \"Distal myopathy, Tateyama type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Long QT syndrome 9, not provided\", \"target\": \"859\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Rippling muscle disease 2, not provided\", \"target\": \"859\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"859\", \"target\": \"Elevated serum creatine phosphokinase, Limb-girdle muscular dystrophy, type 1C, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"859\", \"target\": \"Rippling muscle disease 2, Distal myopathy, Tateyama type, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"859\", \"target\": \"Long QT syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"859\", \"target\": \"Limb-girdle muscular dystrophy, type 1C, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55209\", \"target\": \"Mental retardation, autosomal dominant 23\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55209\", \"target\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 23\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7862\", \"target\": \"Intellectual developmental disorder with dysmorphic facies and ptosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7862\", \"target\": \"Intellectual developmental disorder with dysmorphic facies and ptosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4968\", \"target\": \"Clear cell carcinoma of kidney\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"63924\", \"target\": \"Familial partial lipodystrophy 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84522\", \"target\": \"Severe congenital neutropenia, Severe congenital neutropenia 6, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84522\", \"target\": \"Severe congenital neutropenia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84818\", \"target\": \"Candidiasis, familial, 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2177|LOC107303338\", \"target\": \"Fanconi anemia, complementation group D2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2177|LOC107303338\", \"target\": \"Fanconi anemia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Fanconi anemia, complementation group D2\", \"target\": \"2177|FANCD2OS\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Pheochromocytoma, Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Pancreatic cysts, Cerebellar hemangioblastoma, Retinal capillary hemangioma, Spinal hemangioblastoma, Von Hippel-Lindau syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Neoplasm\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Cerebellar hemangioblastoma, Von Hippel-Lindau syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Renal cell carcinoma, papillary, 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7428\", \"target\": \"Pheochromocytoma, Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428\", \"target\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, not provided\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, not provided\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Neoplasm\", \"target\": \"1499\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2, not provided\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Renal cell carcinoma, papillary, 1\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\", \"target\": \"7428|LOC107303340\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Erythrocytosis, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Cerebellar hemangioblastoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Renal cell carcinoma, papillary, 1, Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Renal cell carcinoma with paraneoplastic erythrocytosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Pheochromocytoma, Renal cell carcinoma, papillary, 1, Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome, Erythrocytosis, familial, 2, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7428|LOC107303340\", \"target\": \"Renal cell carcinoma, papillary, 1, Von Hippel-Lindau syndrome, Erythrocytosis, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51738|GHRLOS\", \"target\": \"Metabolic syndrome, susceptibility to, Obesity, age at onset of\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6529|SLC6A1-AS1\", \"target\": \"Myoclonic-atonic epilepsy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6529|SLC6A1-AS1\", \"target\": \"Myoclonic-atonic epilepsy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Myoclonic-atonic epilepsy\", \"target\": \"6529\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Myoclonic-atonic epilepsy, not provided\", \"target\": \"6529\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6529\", \"target\": \"Inborn genetic diseases, Myoclonic-atonic epilepsy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5468\", \"target\": \"Morbid obesity\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5468\", \"target\": \"Familial partial lipodystrophy 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5468\", \"target\": \"Carcinoma of colon\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80746\", \"target\": \"Pontocerebellar hypoplasia type 2B\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"Cardiomyopathy, dilated, 1NN\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Noonan syndrome with multiple lentigines, LEOPARD syndrome 2, Noonan syndrome 5, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Noonan syndrome with multiple lentigines, Rasopathy, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome with multiple lentigines\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Noonan syndrome 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Noonan syndrome 5, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Inborn genetic diseases, Primary familial hypertrophic cardiomyopathy, Noonan syndrome 5, Rasopathy, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Primary familial hypertrophic cardiomyopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"Noonan syndrome, Rasopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Noonan syndrome, Inborn genetic diseases, Noonan syndrome with multiple lentigines, Adenocarcinoma of stomach, LEOPARD syndrome 2, Noonan syndrome 5, Cardiomyopathy, dilated, 1NN, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5894\", \"target\": \"Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"Cutaneous melanoma, Noonan syndrome, Primary familial hypertrophic cardiomyopathy, Rasopathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5894\", \"target\": \"LEOPARD syndrome 2, Noonan syndrome 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7476\", \"target\": \"Ulna and fibula absence of with severe limb deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7476\", \"target\": \"Ulna and fibula absence of with severe limb deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7476\", \"target\": \"Fuhrmann syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79188\", \"target\": \"Emery-Dreifuss muscular dystrophy 7, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79188\", \"target\": \"Cardiomyopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79188\", \"target\": \"Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, type 5, Arrhythmogenic right ventricular dysplasia/cardiomyopathy, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7508\", \"target\": \"Xeroderma pigmentosum, group C\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7508\", \"target\": \"Xeroderma pigmentosum, Xeroderma pigmentosum, group C\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7508\", \"target\": \"Xeroderma pigmentosum, type 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7508\", \"target\": \"Xeroderma pigmentosum, group C, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7508\", \"target\": \"Xeroderma pigmentosum\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51244\", \"target\": \"Hypotonia, infantile, with psychomotor retardation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8292\", \"target\": \"Endplate acetylcholinesterase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8292\", \"target\": \"Endplate acetylcholinesterase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"686\", \"target\": \"Biotinidase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"686\", \"target\": \"Biotinidase deficiency, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"686\", \"target\": \"Biotinidase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"686\", \"target\": \"Inborn genetic diseases, Biotinidase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"686\", \"target\": \"Biotinidase deficiency, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"151648|SGO1-AS1\", \"target\": \"Chronic atrial and intestinal dysrhythmia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, generalized, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, generalized\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, generalized, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, generalized, autosomal dominant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, generalized, autosomal dominant, Thyroid Hormone Resistance\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, selective pituitary, Thyroid hormone resistance, generalized, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7068\", \"target\": \"Thyroid hormone resistance, selective pituitary\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5915\", \"target\": \"Microphthalmia, syndromic 12\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5915\", \"target\": \"Inborn genetic diseases, Microphthalmia, syndromic 12, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7155\", \"target\": \"Autism spectrum disorder\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55768\", \"target\": \"Congenital disorder of deglycosylation, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55768\", \"target\": \"Congenital disorder of deglycosylation\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55768\", \"target\": \"Inborn genetic diseases, Congenital disorder of deglycosylation, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 2, Loeys-Dietz syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 1, Thoracic aortic aneurysm and aortic dissection, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 2, Thoracic aortic aneurysm and aortic dissection, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 2, Thoracic aortic aneurysm and aortic dissection, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 2, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome 2, Loeys-Dietz syndrome, Thoracic aortic aneurysm and aortic dissection, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Loeys-Dietz syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7048\", \"target\": \"Hereditary nonpolyposis colorectal cancer type 6, Loeys-Dietz syndrome 2, Loeys-Dietz syndrome, Thoracic aortic aneurysm and aortic dissection, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"201595\", \"target\": \"Congenital disorder of glycosylation type 1x\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"GM1-gangliosidosis, type I, with cardiac involvement\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, Gangliosidosis GM1 type 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Mucopolysaccharidosis, MPS-IV-B\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"Gangliosidosis GM1 type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, GM1-gangliosidosis, type I, with cardiac involvement\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Infantile GM1 gangliosidosis\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Inborn genetic diseases, GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, GLB1-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"GM1 gangliosidosis, Mucopolysaccharidosis, MPS-IV-B, GM1 gangliosidosis type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Infantile GM1 gangliosidosis, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Inborn genetic diseases, GM1 gangliosidosis type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Inborn genetic diseases, Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2720\", \"target\": \"Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"Mucopolysaccharidosis, MPS-IV-B, Infantile GM1 gangliosidosis, GM1 gangliosidosis type 2, Gangliosidosis GM1 type 3, GM1-gangliosidosis, type I, with cardiac involvement, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2720\", \"target\": \"GM1 gangliosidosis type 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10491\", \"target\": \"Osteogenesis imperfecta type 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10491\", \"target\": \"Osteogenesis imperfecta type 7, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not specified\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Turcot syndrome, Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome I, not specified\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Lynch syndrome I, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome I, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Lynch syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Lynch syndrome II\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Colon cancer\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Carcinoma of colon, Lynch syndrome, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Colon cancer, Hereditary nonpolyposis colon cancer, Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Colon cancer, Lynch syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome I, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome II, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Colon cancer, Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Lynch syndrome, Lynch syndrome II\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary cancer-predisposing syndrome, Turcot syndrome, Muir-Torr\\u00e9 syndrome, Lynch syndrome II, Lynch syndrome I\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Lynch syndrome I, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4292\", \"target\": \"Hereditary nonpolyposis colon cancer, Hereditary cancer-predisposing syndrome, Lynch syndrome, Lynch syndrome II, not specified, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5333\", \"target\": \"Leukonychia totalis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4615\", \"target\": \"Myd88 deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"93\", \"target\": \"Heterotaxy, visceral, 4, autosomal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Arrhythmogenic right ventricular dysplasia/cardiomyopathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Atrial fibrillation, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Brugada syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Sinus node disease, Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3, Long QT syndrome 1, Brugada syndrome 1, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Long QT syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Heart block, nonprogressive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Ventricular fibrillation, Brugada syndrome, Paroxysmal familial ventricular fibrillation 1, Brugada syndrome 1, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Long QT syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Long QT syndrome 3, Long qt syndrome 3/6, digenic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Sick sinus syndrome 1, autosomal recessive, Long QT syndrome 3, Arrhythmogenic right ventricular dysplasia/cardiomyopathy, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Primary dilated cardiomyopathy, Dilated cardiomyopathy 1E\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Atrioventricular block, Brugada syndrome, Progressive familial heart block type 1A, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Cardiac conduction defect, nonspecific, Brugada syndrome, Sick sinus syndrome 1, autosomal recessive, Brugada syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"SCN5A-related disorder, Congenital long QT syndrome, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Long QT syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Progressive familial heart block type 1A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Long QT syndrome 3, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome (shorter-than-normal QT interval), not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Sick sinus syndrome, Sick sinus syndrome 1, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Dilated cardiomyopathy 1E, Long QT syndrome 3, Atrial fibrillation, familial, 10, Atrial standstill 1, digenic, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Inborn genetic diseases, Brugada syndrome, Cardiovascular phenotype\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Long QT syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Primary dilated cardiomyopathy, Brugada syndrome, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Atrial fibrillation, Atrial fibrillation, familial, 10, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Long QT syndrome, Brugada syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Arrhythmia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Cardiac conduction defect, nonspecific, Cardiac conduction defect, nonprogressive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Atrial fibrillation, Atrial fibrillation, familial, 10\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Syncope\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Sick sinus syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Long QT syndrome, Congenital long QT syndrome, Brugada syndrome, Long QT syndrome 3, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Brugada syndrome, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Brugada syndrome 1, Brugada syndrome (shorter-than-normal QT interval), not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6331\", \"target\": \"Primary dilated cardiomyopathy, Congenital long QT syndrome, Brugada syndrome, Dilated cardiomyopathy 1E, Long QT syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Congenital long QT syndrome, Atrial standstill 1, digenic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Dilated cardiomyopathy 1E, Long QT syndrome 3, Atrial fibrillation, familial, 10, Brugada syndrome 1, SCN5A-Related Disorders\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331\", \"target\": \"Brugada syndrome, Brugada syndrome 1, Cardiovascular phenotype, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Brugada syndrome\", \"target\": \"6331|LOC110121269\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Brugada syndrome, not provided\", \"target\": \"6331|LOC110121269\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6331|LOC110121269\", \"target\": \"Congenital long QT syndrome, Long QT syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6336\", \"target\": \"Episodic pain syndrome, familial, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11280\", \"target\": \"Neuropathy, hereditary sensory and autonomic, type VII\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11280\", \"target\": \"Episodic pain syndrome, familial, 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11280\", \"target\": \"Neuropathy, hereditary sensory and autonomic, type VII, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"165904\", \"target\": \"Classical primary microcephaly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"54977\", \"target\": \"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54977\", \"target\": \"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3921\", \"target\": \"Asplenia, isolated congenital\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Esophageal Squamous Cell Carcinoma, Uterine cervical neoplasms, Endometrial neoplasm, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Cutaneous melanoma, Malignant melanoma of skin, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Hepatoblastoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Craniopharyngioma, Pilomatrixoma, Malignant melanoma of skin, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Cutaneous melanoma, Pilomatrixoma, Malignant melanoma of skin, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Malignant melanoma of skin, Uterine cervical neoplasms, Endometrial neoplasm, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Pilomatrixoma, Neoplasm of the large intestine, Malignant melanoma of skin, Endometrial neoplasm, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Carcinoma of colon\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the parathyroid gland, Neoplasm of the large intestine, Malignant melanoma of skin, Ovarian Neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"ADRENAL CORTICAL NEOPLASM, Hepatocellular carcinoma, Medulloblastoma, Pancreatic adenocarcinoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Pilomatrixoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Craniopharyngioma, Pilomatrixoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Adrenocortical carcinoma, Craniopharyngioma, Lung adenocarcinoma, Pilomatrixoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Adrenocortical carcinoma, Lung adenocarcinoma, Pilomatrixoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Ovarian Neoplasms, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Adrenocortical carcinoma, Lung adenocarcinoma, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Neoplasm of stomach, Carcinoma of esophagus, Lung adenocarcinoma, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Neoplasm of the parathyroid gland, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Neoplasm of stomach, Carcinoma of esophagus, Cutaneous melanoma, Lung adenocarcinoma, Uterine cervical neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Neoplasm of ovary, Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Lung adenocarcinoma, Pilomatrixoma, Uterine cervical neoplasms, Ovarian Neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder, Carcinoma of esophagus, Cutaneous melanoma, Lung adenocarcinoma, Pilomatrixoma, Uterine cervical neoplasms, Ovarian Neoplasms, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Pancreatic adenocarcinoma, Adrenocortical carcinoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Pancreatic adenocarcinoma, Adrenocortical carcinoma, Lung adenocarcinoma, Pilomatrixoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Disease, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Neoplasm of brain, Disease\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Disease, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Adrenocortical carcinoma, Cutaneous melanoma, Lung adenocarcinoma, Neoplasm of the large intestine, Malignant melanoma of skin, Disease, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Wilms Tumor\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Mental retardation, autosomal dominant 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1499\", \"target\": \"Inborn genetic diseases, Mental retardation, autosomal dominant 19, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1499\", \"target\": \"Mental retardation, autosomal dominant 19\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Microcephaly, Global developmental delay, Absent speech, Imperforate anus, Teratoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1499\", \"target\": \"Exudative vitreoretinopathy 1, EXUDATIVE VITREORETINOPATHY 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22906\", \"target\": \"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"131377\", \"target\": \"Nemaline myopathy 8, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"131377\", \"target\": \"Nemaline myopathy 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84892\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84892\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8, MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84892\", \"target\": \"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84892\", \"target\": \"Neonatal death, Severe hydrocephalus, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"55129\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 10\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55129\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 10, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51099|ANO10\", \"target\": \"Triglyceride storage disease with ichthyosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Triglyceride storage disease with ichthyosis\", \"target\": \"51099\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23395\", \"target\": \"Perrault syndrome 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23395|LARS2-AS1\", \"target\": \"Hydrops, lactic acidosis, and sideroblastic anemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23395|LARS2-AS1\", \"target\": \"Perrault syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"23395|LARS2-AS1\", \"target\": \"Perrault syndrome, Perrault syndrome 4, Hydrops, lactic acidosis, and sideroblastic anemia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"54585\", \"target\": \"Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 17\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79443\", \"target\": \"Cataract, autosomal recessive congenital 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1234|LOC102724297\", \"target\": \"Human immunodeficiency virus type 1, increased perinatal transmission of\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6997|LRRC2\", \"target\": \"Forebrain defects\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"259236\", \"target\": \"Deafness, autosomal recessive 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4634\", \"target\": \"Hypertrophic cardiomyopathy, Familial hypertrophic cardiomyopathy 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4634\", \"target\": \"Primary familial hypertrophic cardiomyopathy, Familial hypertrophic cardiomyopathy 8, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5745\", \"target\": \"Chondrodysplasia Blomstrand type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5745\", \"target\": \"Failure of tooth eruption, primary\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5745\", \"target\": \"Metaphyseal chondrodysplasia, Jansen type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5745\", \"target\": \"Eiken skeletal dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23218\", \"target\": \"Gray platelet syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29072\", \"target\": \"Luscan-lumish syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25930\", \"target\": \"Seizures, Global developmental delay, Brain atrophy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"22907\", \"target\": \"Microcephaly, Strabismus, Oculomotor apraxia, Seizures, Unsteady gait, Short stature, NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22907\", \"target\": \"Microcephaly, Hearing impairment, Strabismus, Delayed speech and language development, Global developmental delay, Sleep disturbance, Muscular hypotonia of the trunk, NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22907\", \"target\": \"NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"22907\", \"target\": \"Microcephaly, Hirsutism, Intellectual disability, Global developmental delay, Generalized hypotonia, Failure to thrive, EEG abnormality, Short stature, NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"22907\", \"target\": \"NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11277|ATRIP-TREX1\", \"target\": \"Aicardi Goutieres syndrome 1, Aicardi Goutieres syndrome 1, autosomal dominant, Chilblain lupus 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11277|ATRIP-TREX1\", \"target\": \"Aicardi Goutieres syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11277|ATRIP-TREX1\", \"target\": \"Aicardi Goutieres syndrome 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11277|ATRIP-TREX1\", \"target\": \"Aicardi Goutieres syndrome 1, Aicardi Goutieres syndrome 1, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11277|ATRIP-TREX1\", \"target\": \"Aicardi Goutieres syndrome 1, Vasculopathy, retinal, with cerebral leukodystrophy, Chilblain lupus erythematosus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1294\", \"target\": \"Epidermolysis bullosa dystrophica inversa, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Recessive dystrophic epidermolysis bullosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Toe syndactyly, Short stature, Finger syndactyly, Palmoplantar blistering\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1294\", \"target\": \"Pretibial epidermolysis bullosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Epidermolysis bullosa dystrophica, AD, Epidermolysis bullosa dystrophica, AR\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1294\", \"target\": \"Recessive dystrophic epidermolysis bullosa, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Generalized dominant dystrophic epidermolysis bullosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa, Nail disorder, nonsyndromic congenital, 8, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Nail disorder, nonsyndromic congenital, 8, Transient bullous dermolysis of the newborn, Epidermolysis bullosa pruriginosa, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Epidermolysis bullosa pruriginosa, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Abnormality of the dentition, Microcephaly, Abnormality of dental enamel, Hyperpigmentation of the skin, Failure to thrive, Alopecia of scalp, Distal muscle weakness, EMG abnormality, Short stature, Decreased body weight, Scarring alopecia of scalp, Abnormal blistering of the skin, Nail dystrophy, Scarring, Epidermolysis bullosa dystrophica inversa, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Generalized dominant dystrophic epidermolysis bullosa, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1294\", \"target\": \"Dystrophic epidermolysis bullosa\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Inborn genetic diseases, Dominant dystrophic epidermolysis bullosa with absence of skin, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Recessive dystrophic epidermolysis bullosa, Dominant dystrophic epidermolysis bullosa with absence of skin, Nail disorder, nonsyndromic congenital, 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Epidermolysis bullosa, pretibial, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Epidermolysis bullosa pruriginosa, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Recessive dystrophic epidermolysis bullosa, Nail disorder, nonsyndromic congenital, 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Transient bullous dermolysis of the newborn\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Epidermolysis bullosa dystrophica, autosomal recessive, localisata variant, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Abnormality of the skin, Toe syndactyly, Anonychia, Short stature, Finger syndactyly, Palmoplantar blistering, Abnormal blistering of the skin, Nail dystrophy, Skin erosion, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Dystrophic epidermolysis bullosa, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1294\", \"target\": \"Abnormality of the thyroid gland, Bullous ichthyosiform erythroderma, Ichthyosis, Epidermal nevus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1294\", \"target\": \"Abnormality of the dentition, Microcephaly, Abnormality of dental enamel, Hyperpigmentation of the skin, Failure to thrive, Alopecia of scalp, Distal muscle weakness, EMG abnormality, Short stature, Decreased body weight, Scarring alopecia of scalp, Abnormal blistering of the skin, Nail dystrophy, Scarring, Recessive dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica inversa, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1294\", \"target\": \"Abnormality of the skin, Anonychia, Nail dystrophy, Skin erosion, Recessive dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica inversa, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"788\", \"target\": \"Carnitine acylcarnitine translocase deficiency, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"788\", \"target\": \"Carnitine acylcarnitine translocase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25915\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54870\", \"target\": \"VERVERI-BRADY SYNDROME\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5859\", \"target\": \"Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5859\", \"target\": \"Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5859\", \"target\": \"Microcephaly, Strabismus, Impaired use of nonverbal behaviors, Seizures, Short foot, Hypoplasia of the corpus callosum, Heterotopia, Profound global developmental delay, Cortical visual impairment, Insomnia, Small hand\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"3913\", \"target\": \"Nephrotic syndrome, type 5, with or without ocular abnormalities\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3913\", \"target\": \"Pierson syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3913\", \"target\": \"Pierson syndrome, Nephrotic syndrome, type 5, with or without ocular abnormalities\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200942\", \"target\": \"Hodgkin lymphoma\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"387\", \"target\": \"Non-Hodgkin lymphoma, Squamous cell carcinoma of the head and neck, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"387\", \"target\": \"Lung adenocarcinoma, Neoplasm of the breast, Squamous cell carcinoma of the head and neck, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"387\", \"target\": \"Carcinoma of esophagus, Non-Hodgkin lymphoma, Neoplasm of the breast, Neoplasm of the large intestine, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"275\", \"target\": \"Non-ketotic hyperglycinemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Non-ketotic hyperglycinemia\", \"target\": \"275|NICN1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1605\", \"target\": \"Limb-girdle muscular dystrophy-dystroglycanopathy, type C9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1605\", \"target\": \"Limb-girdle muscular dystrophy-dystroglycanopathy, type C9, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1605\", \"target\": \"Limb-girdle muscular dystrophy-dystroglycanopathy, type C9, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1605\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy, Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"29925\", \"target\": \"Inborn genetic diseases, Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14, Muscular dystrophy-dystroglycanopathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"29925\", \"target\": \"Elevated serum creatine phosphokinase\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29925\", \"target\": \"Muscular dystrophy, Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14, Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10293\", \"target\": \"Seckel syndrome 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2779\", \"target\": \"Congenital stationary night blindness, autosomal dominant 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2779\", \"target\": \"Night blindness, congenital stationary, type 1g\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2771\", \"target\": \"Pituitary dependent hypercortisolism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2771\", \"target\": \"Granulosa cell tumor of the ovary, Thecoma, somatic, Adrenocortical tumor, somatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2771\", \"target\": \"Ventricular tachycardia, somatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3373\", \"target\": \"Deficiency of hyaluronoglucosaminidase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51364\", \"target\": \"Ciliary dyskinesia, primary, 22\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51364\", \"target\": \"Ciliary dyskinesia, Ciliary dyskinesia, primary, 22, Kartagener syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10641\", \"target\": \"Epilepsy, familial focal, with variable foci 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7867\", \"target\": \"Macular dystrophy, patterned, 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1795\", \"target\": \"Inborn genetic diseases, NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1795\", \"target\": \"Muscular hypotonia, Global developmental delay\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"95|ABHD14A-ACY1\", \"target\": \"Aminoacylase 1 deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25886\", \"target\": \"Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25886\", \"target\": \"Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, Primordial dwarfism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"132158\", \"target\": \"Deficiency of glycerate kinase\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"25981\", \"target\": \"Ciliary dyskinesia, primary, 37, Kartagener syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25981\", \"target\": \"SPERMATOGENIC FAILURE 18\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25981\", \"target\": \"SPERMATOGENIC FAILURE 18, Ciliary dyskinesia, primary, 37\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8314\", \"target\": \"Tumor susceptibility linked to germline BAP1 mutations\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8314\", \"target\": \"Tumor susceptibility linked to germline BAP1 mutations, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8314\", \"target\": \"Hereditary cancer-predisposing syndrome, Tumor susceptibility linked to germline BAP1 mutations, BAP1 Cancer Syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8314\", \"target\": \"Hereditary cancer-predisposing syndrome, Tumor susceptibility linked to germline BAP1 mutations\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7134\", \"target\": \"Dilated cardiomyopathy 1Z, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7134\", \"target\": \"Familial hypertrophic cardiomyopathy 13\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"91869\", \"target\": \"Congenital disorder of glycosylation type 1N\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5580\", \"target\": \"Autoimmune lymphoproliferative syndrome, type III\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7086\", \"target\": \"Short stature, developmental delay, and congenital heart defects\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"776\", \"target\": \"Sinoatrial node dysfunction and deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"776\", \"target\": \"Primary aldosteronism, seizures, and neurologic abnormalities, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7474\", \"target\": \"Robinow syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54756\", \"target\": \"Hypogonadotropic hypogonadism 18 with anosmia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"54756\", \"target\": \"Delayed puberty\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8820\", \"target\": \"Septo-optic dysplasia sequence\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8820\", \"target\": \"Growth hormone deficiency with pituitary anomalies\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8820\", \"target\": \"Pituitary hormone deficiency, combined 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8820\", \"target\": \"Septo-optic dysplasia sequence, Pituitary hormone deficiency, combined 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8820\", \"target\": \"Septo-optic dysplasia sequence, Pituitary hormone deficiency, combined 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"8820\", \"target\": \"Septo-optic dysplasia sequence, Growth hormone deficiency with pituitary anomalies\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26060\", \"target\": \"Maturity-onset diabetes of the young, type 14\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Atelosteogenesis type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Larsen syndrome, Larsen syndrome, dominant type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"FLNB-Related Disorders\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Boomerang dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Atelosteogenesis type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Atelosteogenesis type 1, Atelosteogenesis type 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Larsen syndrome, dominant type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Spondylocarpotarsal synostosis syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2317\", \"target\": \"Atelosteogenesis type 3, not specified\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"Spondylocarpotarsal synostosis syndrome\", \"target\": \"2317|FLNB-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5162\", \"target\": \"Pyruvate dehydrogenase E1-beta deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8309\", \"target\": \"Bile acid synthesis defect, congenital, 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"166336|PRICKLE2-AS1\", \"target\": \"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, Epilepsy, progressive myoclonic 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"166336\", \"target\": \"Epilepsy, progressive myoclonic 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"115286\", \"target\": \"Combined oxidative phosphorylation deficiency 28\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"285203\", \"target\": \"Adams-Oliver syndrome 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"285203\", \"target\": \"Adams-Oliver syndrome, Adams-Oliver syndrome 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"56203\", \"target\": \"Nemaline myopathy 10\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4286\", \"target\": \"Waardenburg syndrome type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4286\", \"target\": \"Waardenburg syndrome type 2\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4286\", \"target\": \"Tietz syndrome, Waardenburg syndrome type 2A\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4286\", \"target\": \"Waardenburg syndrome type 2A, Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4286\", \"target\": \"Tietz syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4286\", \"target\": \"Hearing impairment, Prelingual sensorineural hearing impairment, Heterochromia iridis, Poliosis, Waardenburg syndrome type 2A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4286\", \"target\": \"Congenital sensorineural hearing impairment, Waardenburg syndrome type 2A, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27086\", \"target\": \"Mental retardation with language impairment and with or without autistic features\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27086\", \"target\": \"Mental retardation with language impairment and with or without autistic features, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27086\", \"target\": \"Inborn genetic diseases, Mental retardation with language impairment and with or without autistic features, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27086\", \"target\": \"Strabismus, Delayed speech and language development, Glabellar hemangioma, Intellectual disability, Anterior creases of earlobe\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27086\", \"target\": \"Autistic disorder of childhood onset\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27086\", \"target\": \"Autistic disorder of childhood onset, Intellectual disability\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"60675\", \"target\": \"Hypogonadotropic hypogonadism 4 with or without anosmia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6092\", \"target\": \"Vesicoureteral reflux 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"GBE1-Related Disorders\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, childhood neuromuscular\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, congenital neuromuscular\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, fatal perinatal neuromuscular\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, combined hepatic and myopathic, Adult polyglucosan body neuropathy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, Glycogen storage disease IV, childhood neuromuscular, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, Adult polyglucosan body neuropathy, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2632\", \"target\": \"Inborn genetic diseases, Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, Glycogen storage disease IV, nonprogressive hepatic, Adult polyglucosan body neuropathy, GBE1-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Polyglucosan body disease, adult, Glycogen storage disease IV, congenital neuromuscular\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease IV, congenital neuromuscular\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Polyglucosan body disease, adult, Glycogen storage disease IV, classic hepatic, GBE1-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, nonprogressive hepatic, Adult polyglucosan body neuropathy\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2632\", \"target\": \"Glycogen storage disease, type IV, Glycogen storage disease IV, classic hepatic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25978\", \"target\": \"Frontotemporal Dementia, Chromosome 3-Linked, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25978\", \"target\": \"Frontotemporal Dementia, Chromosome 3-Linked\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"25978\", \"target\": \"Frontotemporal Dementia, Chromosome 3-Linked, Amyotrophic lateral sclerosis 17, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5449\", \"target\": \"Pituitary hormone deficiency, combined 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5449\", \"target\": \"Pituitary hormone deficiency, combined 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5627\", \"target\": \"Protein S deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5627\", \"target\": \"Thrombophilia due to protein S deficiency, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200894\", \"target\": \"Joubert syndrome 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"200894\", \"target\": \"Joubert Syndrome and Related Disorders\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"84100\", \"target\": \"Bardet-Biedl syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84100\", \"target\": \"Bardet-Biedl syndrome 3, Retinitis pigmentosa 55\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"84100\", \"target\": \"Retinitis pigmentosa 55\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84100\", \"target\": \"Bardet-Biedl syndrome 1, modifier of, Bardet-Biedl syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1371\", \"target\": \"Hereditary coproporphyria, Coproporphyria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1371\", \"target\": \"Harderoporphyria, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1371\", \"target\": \"Coproporphyria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1371\", \"target\": \"Harderoporphyria\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1371\", \"target\": \"Coproporphyria, digenic\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55773\", \"target\": \"PONTOCEREBELLAR HYPOPLASIA, TYPE 11\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55773\", \"target\": \"Pontoneocerebellar hypoplasia, PONTOCEREBELLAR HYPOPLASIA, TYPE 11\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10342\", \"target\": \"Spastic paraplegia 57, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10342\", \"target\": \"Neuropathy, hereditary motor and sensory, Okinawa type\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"10342\", \"target\": \"Neuropathy, hereditary motor and sensory, Okinawa type, Spastic paraplegia 57, autosomal recessive, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50939\", \"target\": \"Macular dystrophy, vitelliform, 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50939\", \"target\": \"Retinitis pigmentosa 56\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50939\", \"target\": \"Abnormality of the eye, Retinal dystrophy\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"50939\", \"target\": \"Macular dystrophy, vitelliform, 5, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"54931\", \"target\": \"Mitochondrial diseases, Combined oxidative phosphorylation deficiency 30\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55081\", \"target\": \"OROFACIODIGITAL SYNDROME XVIII\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10225\", \"target\": \"C syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55779\", \"target\": \"SPERMATOGENIC FAILURE 20\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"523\", \"target\": \"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"523\", \"target\": \"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26137\", \"target\": \"Autistic behavior, Abnormal facial shape, Clinodactyly of the 5th finger, Moderate global developmental delay, Clinodactyly of the 4th toe\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"26137\", \"target\": \"Primrose syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"26137\", \"target\": \"Inborn genetic diseases, Primrose syndrome\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57514\", \"target\": \"Adams-Oliver syndrome 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56983\", \"target\": \"Dowling-degos disease 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56983\", \"target\": \"Muscular dystrophy, limb-girdle, type 2z\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"51300\", \"target\": \"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"3081\", \"target\": \"Alkaptonuria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"9657\", \"target\": \"Senior-Loken syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9657\", \"target\": \"Nephronophthisis, Retinal dystrophy, Senior-Loken syndrome 5, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9657\", \"target\": \"Nephronophthisis, Senior-Loken syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9657\", \"target\": \"Nephronophthisis, Leber congenital amaurosis, Senior-Loken syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9657\", \"target\": \"Leber congenital amaurosis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"286676\", \"target\": \"Deafness, autosomal recessive 42\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalciuric hypercalcemia, familial, type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, with bartter syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalciuric hypercalcemia, familial, type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Familial hypocalciuric hypercalcemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"846\", \"target\": \"Neonatal severe hyperparathyroidism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, Hypocalcemia, autosomal dominant 1, with bartter syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Familial hypocalciuric hypercalcemia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1, Neonatal severe hyperparathyroidism, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalcemia, autosomal dominant 1, Hypocalciuric hypercalcemia, familial, type 1, Neonatal severe hyperparathyroidism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypoparathyroidism familial isolated\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypocalciuric hypercalcemia, familial, type 1, Neonatal severe hyperparathyroidism\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"846\", \"target\": \"Hypertrophic cardiomyopathy, Parathyroid adenoma, Hypercalcemia, Hypocalciuria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"1475\", \"target\": \"Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"111\", \"target\": \"Dyskinesia, familial, with facial myokymia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"111\", \"target\": \"Dyskinesia, familial, with facial myokymia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4638|MYLK-AS1\", \"target\": \"Aortic aneurysm, familial thoracic 7, Thoracic aortic aneurysm and aortic dissection\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"4638\", \"target\": \"Aortic aneurysm, familial thoracic 7\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7372\", \"target\": \"Orotic aciduria\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7707\", \"target\": \"Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"131669\", \"target\": \"Urocanate hydratase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4171\", \"target\": \"Deafness, autosomal dominant 70\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29927\", \"target\": \"Hyperuricemic nephropathy, familial juvenile, 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"29927\", \"target\": \"Decreased antibody level in blood\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2624\", \"target\": \"Acute myeloid leukemia, Leukemia, acute myeloid, susceptibility to, Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2624\", \"target\": \"Lymphedema, primary, with myelodysplasia, Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2624\", \"target\": \"Lymphedema, primary, with myelodysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2624\", \"target\": \"Leukemia, acute myeloid, susceptibility to\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2624\", \"target\": \"Acute myeloid leukemia, Myelodysplastic syndrome, Leukemia, acute myeloid, susceptibility to, Lymphedema, primary, with myelodysplasia, Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2624\", \"target\": \"Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7879\", \"target\": \"Charcot-Marie-Tooth disease, axonal, type 2b, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"28976\", \"target\": \"Acyl-CoA dehydrogenase family, member 9, deficiency of\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"28976\", \"target\": \"Mitochondrial complex I deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"28976\", \"target\": \"Acyl-CoA dehydrogenase family, member 9, deficiency of, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Acyl-CoA dehydrogenase family, member 9, deficiency of\", \"target\": \"28976|KIAA1257\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Acyl-CoA dehydrogenase family, member 9, deficiency of, not provided\", \"target\": \"28976|KIAA1257\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2815\", \"target\": \"Bernard-Soulier syndrome type C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2815\", \"target\": \"Bernard-Soulier syndrome type C, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2815\", \"target\": \"Bernard Soulier syndrome, Bernard-Soulier syndrome type C\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55764\", \"target\": \"Cranioectodermal dysplasia 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"55764\", \"target\": \"Cranioectodermal dysplasia, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa, Retinitis pigmentosa 4\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa 4\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Congenital stationary night blindness, autosomal dominant 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa, Retinitis punctata albescens, Retinitis pigmentosa 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa 4, autosomal recessive\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa, Retinitis pigmentosa 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Exudative retinopathy, Rod-cone dystrophy, Cataract, Progressive visual loss, Retinal detachment, Blindness, Nystagmus, Retinal exudate, Abnormality of retinal pigmentation, Unilateral strabismus, Optic disc drusen\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Autosomal dominant retinitis pigmentosa, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6010\", \"target\": \"Retinitis pigmentosa, Blurred vision, Nyctalopia, Peripheral visual field loss, Retinitis pigmentosa 4, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27032\", \"target\": \"Familial benign pemphigus\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11222\", \"target\": \"Combined oxidative phosphorylation deficiency 9\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79876|NPHP3-ACAD11\", \"target\": \"Epileptic encephalopathy, early infantile, 44\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79876|NPHP3-ACAD11\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 24, Epileptic encephalopathy, early infantile, 44\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"79876|NPHP3-ACAD11\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 24\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79876|NPHP3-ACAD11\", \"target\": \"Spinocerebellar ataxia, autosomal recessive 24, Epileptic encephalopathy, early infantile, 44, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27031|NPHP3-ACAD11\", \"target\": \"Adolescent nephronophthisis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27031|NPHP3-ACAD11\", \"target\": \"Adolescent nephronophthisis, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27031|NPHP3-ACAD11\", \"target\": \"Adolescent nephronophthisis, Renal-hepatic-pancreatic dysplasia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"27031|NPHP3-ACAD11\", \"target\": \"Renal-hepatic-pancreatic dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27031|NPHP3-ACAD11\", \"target\": \"Nephronophthisis, Adolescent nephronophthisis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"27031|NPHP3-ACAD11\", \"target\": \"Adolescent nephronophthisis, Meckel syndrome type 7, Renal-hepatic-pancreatic dysplasia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"8419|BFSP2-AS1\", \"target\": \"Cataract 12, multiple types, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7018\", \"target\": \"Atransferrinemia\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7018\", \"target\": \"Transferrin variant d1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7018\", \"target\": \"Transferrin variant bv\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7018\", \"target\": \"Transferrin variant b2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6578\", \"target\": \"Primary hypertrophic osteoarthropathy, autosomal recessive 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"80254\", \"target\": \"Seckel syndrome 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2047|CEP63\", \"target\": \"Myopathy, myofibrillar, 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5096\", \"target\": \"Propionyl-CoA carboxylase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5096\", \"target\": \"Propionyl-CoA carboxylase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5096\", \"target\": \"Propionyl-CoA carboxylase deficiency, not specified, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10274\", \"target\": \"STAG1-related disorder\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10274\", \"target\": \"STAG1-related disorder, MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10274\", \"target\": \"STAG1-Related Disorders, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10274\", \"target\": \"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"10274\", \"target\": \"STAG1-related disorder, Inborn genetic diseases, MENTAL RETARDATION, AUTOSOMAL DOMINANT 47\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"199221\", \"target\": \"POLYCYSTIC KIDNEY DISEASE 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1, Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Premature ovarian failure 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus, Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus, Premature ovarian failure 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"668\", \"target\": \"Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56945\", \"target\": \"Combined oxidative phosphorylation deficiency 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"56945\", \"target\": \"46,XX gonadal dysgenesis, OVARIAN DYSGENESIS 7\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9276\", \"target\": \"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"545\", \"target\": \"Seckel syndrome 1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"545\", \"target\": \"Cutaneous telangiectasia and cancer syndrome, familial\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5352\", \"target\": \"Cleft of soft palate, Talipes equinovarus, Femoral bowing, Radial bowing, Ulnar bowing, Short femur, Aplasia/hypoplasia of the femur, Bowing of the long bones, Camptodactyly, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5352\", \"target\": \"Bruck syndrome 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5352\", \"target\": \"Cleft of soft palate, Talipes equinovarus, Femoral bowing, Radial bowing, Ulnar bowing, Short femur, Aplasia/hypoplasia of the femur, Bowing of the long bones, Camptodactyly\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7545\", \"target\": \"Craniosynostosis 6\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7545\", \"target\": \"Craniosynostosis 6, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2992\", \"target\": \"Polyglucosan body myopathy 2, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2992\", \"target\": \"Glycogen storage disease XV, Polyglucosan body myopathy 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2992\", \"target\": \"Glycogen storage disease XV\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2992\", \"target\": \"Glycogen storage disease XV, Polyglucosan body myopathy 2, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2992\", \"target\": \"Polyglucosan body myopathy 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84343\", \"target\": \"Hermansky-Pudlak syndrome 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"84343\", \"target\": \"Hermansky-Pudlak syndrome 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Hermansky-Pudlak syndrome 3\", \"target\": \"1356|HPS3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1356\", \"target\": \"Deficiency of ferroxidase, Hemosiderosis, systemic, due to aceruloplasminemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1356\", \"target\": \"Deficiency of ferroxidase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1356\", \"target\": \"Deficiency of ferroxidase, Hypoceruloplasminemia, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1356\", \"target\": \"Ceruloplasmin belfast, Deficiency of ferroxidase\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"1356\", \"target\": \"Deficiency of ferroxidase, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7401\", \"target\": \"Usher syndrome, type 3A\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"7401\", \"target\": \"Usher syndrome, type 3A, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7401\", \"target\": \"Retinitis pigmentosa 61\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7401\", \"target\": \"Retinitis pigmentosa, Usher syndrome, type 3A\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Usher syndrome, type 3A\", \"target\": \"7401|CLRN1-AS1\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"64805|MED12L\", \"target\": \"Platelet-type bleeding disorder 8\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4311\", \"target\": \"Spinocerebellar ataxia 43\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4311\", \"target\": \"Charcot-Marie-Tooth disease, axonal, type 2T, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"4311\", \"target\": \"Idiopathic membranous glomerulonephritis\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9197\", \"target\": \"Spastic paraplegia 42, autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"9197\", \"target\": \"Congenital cataracts, hearing loss, and neurodegeneration, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"85476\", \"target\": \"Combined oxidative phosphorylation deficiency 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"85476\", \"target\": \"Combined oxidative phosphorylation deficiency 1, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"57560|TRIM59-IFT80\", \"target\": \"Asphyxiating thoracic dystrophy 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6476\", \"target\": \"Sucrase-isomaltase deficiency\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6476\", \"target\": \"Inborn genetic diseases, Sucrase-isomaltase deficiency\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"6476\", \"target\": \"Sucrase-isomaltase deficiency, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"590\", \"target\": \"Deficiency of butyrylcholine esterase\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"590\", \"target\": \"Bche, j variant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"590\", \"target\": \"Butyrylcholinesterase deficiency, fluoride 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"590\", \"target\": \"Bche, h variant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"590\", \"target\": \"Deficiency of butyrylcholine esterase, Postanesthetic apnea\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"11235\", \"target\": \"Cerebral cavernous malformations 3, not provided\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"11235\", \"target\": \"Cavernous hemangioma, Seizures, Hemiparesis, Cerebral arteriovenous malformation, Cerebral cavernous malformations 3, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"11235\", \"target\": \"Cerebral cavernous malformations 3\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5274\", \"target\": \"Encephalopathy, familial, with neuroserpin inclusion bodies\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2122\", \"target\": \"Radioulnar synostosis with amegakaryocytic thrombocytopenia 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7012\", \"target\": \"Dyskeratosis congenita autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7012\", \"target\": \"Aplastic anemia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7012\", \"target\": \"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2, Dyskeratosis congenita autosomal dominant\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7012\", \"target\": \"Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7012\", \"target\": \"Idiopathic fibrosing alveolitis, chronic form, Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"7012\", \"target\": \"Aplastic anemia, Pulmonary fibrosis and/or bone marrow failure, telomere-related, 2\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Dyskeratosis congenita autosomal dominant\", \"target\": \"7012|LOC110806306\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"110806306\", \"target\": \"Paroxysmal nocturnal hemoglobinuria 1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"57709\", \"target\": \"Retinitis pigmentosa 68\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"Retinitis pigmentosa 68\", \"target\": \"57709|SLC7A14-AS1\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"6514\", \"target\": \"Fanconi-Bickel syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"23043\", \"target\": \"Mental retardation, autosomal recessive 54\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5337\", \"target\": \"Cardiac valvular defect, developmental\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"2693\", \"target\": \"Inborn genetic diseases, Short stature, idiopathic, autosomal\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"2693\", \"target\": \"Short stature, idiopathic, autosomal\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"83893\", \"target\": \"Globozoospermia\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79718\", \"target\": \"Pierpont syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"79718\", \"target\": \"Fitzsimmons-Guilbert syndrome\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5290\", \"target\": \"Squamous cell lung carcinoma, Neoplasm of the large intestine, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Squamous cell lung carcinoma, Neoplasm of the large intestine, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Malignant Colorectal Neoplasm\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Medulloblastoma, Renal cell carcinoma, papillary, 1, Lung adenocarcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5290\", \"target\": \"Transitional cell carcinoma of the bladder, Brainstem glioma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Glioblastoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Uterine Carcinosarcoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"PIK3CA related overgrowth spectrum\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Transitional cell carcinoma of the bladder, Squamous cell lung carcinoma, Neoplasm of the large intestine, Uterine cervical neoplasms, Malignant neoplasm of body of uterus, Uterine Carcinosarcoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Neuroblastoma, Multiple myeloma, Lung adenocarcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Megalencephaly cutis marmorata telangiectatica congenita\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5290\", \"target\": \"Pancreatic adenocarcinoma, Squamous cell lung carcinoma, Neoplasm of brain, Neoplasm of the breast, Neoplasm of the thyroid gland, Squamous cell carcinoma of the head and neck, Uterine cervical neoplasms, Glioblastoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Cowden syndrome 5\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Cowden syndrome 5\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5290\", \"target\": \"Non-Hodgkin lymphoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Cowden syndrome, Malignant neoplasm of body of uterus, not provided\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Non-Hodgkin lymphoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Malignant melanoma of skin, Uterine cervical neoplasms, Glioblastoma, Malignant neoplasm of body of uterus\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Lung adenocarcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Squamous cell carcinoma of the head and neck, Adenoid cystic carcinoma, Glioblastoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Uterine Carcinosarcoma\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Neoplasm of the breast, Neoplasm of the large intestine\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Megalencephaly cutis marmorata telangiectatica congenita, PIK3CA related overgrowth spectrum\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5290\", \"target\": \"CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH, SOMATIC, Neoplasm of ovary, Squamous cell lung carcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Adenoid cystic carcinoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach, Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, PIK3CA related overgrowth spectrum\", \"Clinical Significance Grouped\": \"Pathogenic\"}, {\"source\": \"5290\", \"target\": \"Squamous cell lung carcinoma, Neoplasm of the breast, Neoplasm of the large intestine, Adenoid cystic carcinoma, Adenocarcinoma of prostate, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}, {\"source\": \"5290\", \"target\": \"Hepatocellular carcinoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma, Squamous cell lung carcinoma, Neoplasm of brain, Neoplasm of the breast, Squamous cell carcinoma of the head and neck, Glioblastoma, Malignant neoplasm of body of uterus, Adenocarcinoma of stomach\", \"Clinical Significance Grouped\": \"Likely_pathogenic\"}]}}, {\"mode\": \"vega-lite\"});\n",
       "</script>"
      ],
      "text/plain": [
       "alt.LayerChart(...)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Filter top 20 mutation values\n",
    "top_mutations = data['Mutation Value'].value_counts().head(20).index\n",
    "top_df = data[data['Mutation Value'].isin(top_mutations)]\n",
    "\n",
    "# Create network graph\n",
    "G = nx.from_pandas_edgelist(top_df, 'Gene Name', 'Disease Implicated', ['Clinical Significance Grouped'])\n",
    "\n",
    "# Convert the graph to a format Altair can use\n",
    "nodes, edges = [], []\n",
    "for node in G.nodes():\n",
    "    nodes.append({'id': node})\n",
    "for edge in G.edges(data=True):\n",
    "    edges.append({'source': edge[0], 'target': edge[1], 'Clinical Significance Grouped': edge[2]['Clinical Significance Grouped']})\n",
    "\n",
    "nodes_df = pd.DataFrame(nodes)\n",
    "edges_df = pd.DataFrame(edges)\n",
    "\n",
    "# Create Altair chart for nodes\n",
    "nodes_chart = alt.Chart(nodes_df).mark_circle(size=400).encode(\n",
    "    x=alt.X('id:N', axis=None),\n",
    "    y=alt.Y('id:N', axis=None),\n",
    "    tooltip=['id']\n",
    ").properties(\n",
    "    width=800,\n",
    "    height=800\n",
    ")\n",
    "\n",
    "# Create Altair chart for edges\n",
    "edges_chart = alt.Chart(edges_df).mark_line().encode(\n",
    "    x='source:N',\n",
    "    y='target:N',\n",
    "    color='Clinical Significance Grouped:N'\n",
    ")\n",
    "\n",
    "# Combine nodes and edges\n",
    "final_chart = nodes_chart + edges_chart\n",
    "final_chart.configure_mark(\n",
    "    opacity=0.8,\n",
    "    color='lightblue'\n",
    ").interactive()\n",
    "\n",
    "final_chart.display()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
